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1.1 Steroidal Compounds: An Overview 
 
Steroids are a class of natural or synthetic organic compounds, characterised by a molecular 
structure of 17 carbon atoms constituting 4 cycloalkane ring systems fused together in a 
certain fashion (Figure 1.1).
1-9
 Steroids have important biological, chemical and medicinal 
roles, ranging from pain relief to promoting growth of muscles and bones. However in 
humans, most steroids function as hormones. That such diverse physiological functions and 
effects should be exhibited by steroids, all of which are synthesized by essentially the same 
central biosynthetic pathway, is a remarkable example of biological economy.
10
 
The most abundant steroids are the sterols, a subclass of steroid compounds which contain 
alcohol functionality. Typically, cholesterol is the most familiar sterol in public awareness, 
due to the now widespread knowledge that excess cholesterol is a risk factor for 
cardiovascular disease. For this reason much attention has been focussed on cholesterol 
lowering substances, both in the academic community and in the media.
11,12
 However, sterols 
have a wide range of functions in animals
13
 such as acting as a structural component of 
membranes, as sex hormones
14
 and in pheromone signalling.
15
  
Phytosterols are the sterols which are synthesised only in plant materials, and which 
mammals must obtain via dietary sources.
16
  They are commonly referred to as plant sterols, 
and they are known for their cholesterol-lowering properties when they are consumed via 
phytosterol enriched food substances.
17,18
 The ability of phytosterols to lower cholesterol 
levels in humans is well documented,
19
 however there is no evidence to show that they 













Lanosterol 1 is a naturally occuring steroid found in sheep wool.
22
 Its structure comprises the 
core four rings of the steroidal nucleus and an unsaturated alkyl side chain at C-17, as shown, 
with numbering Scheme, in Figure 1.2. Functionality of note in the structure of lanosterol 1 
are the alkenes and the alcohol. Two alkene bonds are present in the compound, one highly 
sterically hindered double bond at C-8,9, and one in the side chain at C-24,25, which is less 
sterically hindered. The “sterol” component of the lanosterol 1 nomenclature arises from the 
alcohol moiety present in the structure at C-3.   
 
Figure 1.2 Lanosterol 1 numbering scheme 
 
The six membered rings in lanosterol 1 exist in chair conformations, with their attached 
methyl groups orientated in axial and equatorial positions accordingly, as shown in Figure 
1.3.
23
 The orientation of these methyl groups is crucial in terms of the chemical reactivity of 
lanosterol, and in particular the stereochemical outcomes of reactions at the C-8,9 alkene, 








Lanosterol, being the precursor of cholesterol, is also the precursor for the steroid hormones 
oestrogens androgens and progesterones.
24,25
 Steroid hormones (or sterones) are crucial 
substances for the correct function of the body. They mediate a wide variety of vital 
physiological functions ranging from anti-inflammatory agents to regulating events during 
pregnancy.  
As well as being naturally present in the body, lanosterol is applied topically due to its 
presence in a variety of cosmetic formulations. Various hair conditioners, skin moisturisers 





Cholesterol 2 is a sterol produced naturally in the human body and also consumed via dietary 
fats.
29-32
 The structure of cholesterol 2 is similar to that of lanosterol. The four ring steroidal 
skeleton of cholesterol 2 differs from that of lanosterol in the position of the alkene bond at 
C-5,6 and also the absence of the C-28, C-29 and C-30 methyl groups, as highlighted in 
Figure 1.4. The side chain of cholesterol 2 contains the same number of carbon atoms with 






Figure 1.4 Cholesterol 2 structure and points of differentiation from lanosterol 
 
The six membered steroidal rings of cholesterol 2 adopt the same chair conformation as 
lanosterol. However, when the structure of cholesterol is viewed in perspective, it is clear that 
Chapter 1: Introduction 
8 
 
the sites of reactivity are far less sterically hindered in cholesterol, due to the absence of three 








Stigmasterol 3 is a naturally occuring phytosterol which is found in the plant fats or oils of 
soybean, calabar bean and rape seed.
1,2,34-37
 It is also found in medicinal herbs including 
American Ginseng, along with various vegetables, nuts and seeds. As phytosterols are 
essential components of plant cells, they are naturally present in the human diet.
38
  
As discussed earlier in the overview section, phytosterols have been widely publicised due to 
their cholesterol lowering abilities. Although cholesterol is not a phytosterol, it is closely 
structurally related to common dietary phytosterols such as campesterol 4, sitosterol 5, and 
stigmasterol 3 (Figure 1.6). It is generally believed that the cholesterol-lowering properties of 
phytosterols are therefore centred on metabolic events shared by the two steroids. For 
example, one way phytosterols lower serum LDL cholesterol is by disrupting intestinal 
cholesterol solubilization into micelles.
39
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1.5 Biosynthesis of Lanosterol  
Lanosterol is biosynthesised via the C30 compound squalene 6, also a natural substance, found 
in abundance in shark liver oil.
40,41
 Squalene 6 contains two C15 farnesyl 7 moieties, joined 
together in a tail-to-tail fashion, as opposed to the head-to-tail fashion observed for smaller 
terpenoids. The mechanism by which these two C15 units condense proceeds via the 








Squalene 6 is selectively epoxidised to form 2,3-oxidosqualene 9 which then cyclises in an 
apparently concerted fashion to yield lanosterol 1 (Figure 1.8).
42
 The catalysts involved in this 




1.6 Biosynthesis of Cholesterol  
Lanosterol 1 is the precursor for cholesterol 2 biosynthesis, an intricate nineteen step process 
which utilises nine different enzymes, (Scheme 1.1).
10
 All animal cells manufacture 
cholesterol, with relative production rates varying depending on cell type and organ function. 
The rate limiting step in the overall biosynthesis of cholesterol is catalysed by 3-hydroxy-3-
methylglutaryl coenzyme A reductase (HMG-CoA reductase) which catalyses production of 
mevalonate from HMG-CoA. Therefore, this enzyme is a prime target for inhibition, if 










The biosynthesis of cholesterol from lanosterol is similar to other metabolic pathways, in that 
the enzymes involved catalyse a series of reduction and oxidation reactions, along with 
carbon-carbon bond cleavage, epimerisation, isomeration and dehydrogenation processes. 
Removal of three methyl groups from lanosterol requires carbon-carbon bond cleavage, a 
process which is accomplished by oxidation of the methyl groups and their subsequent 
elimination as formic acid or carbon dioxide. 




1.7 Biosynthesis of Stigmasterol 
The isoprene units needed for the biosynthesis of stigmasterol 3 are supplied exclusively from 
the mevalonate pathway. The biosynthesis follows a similar pattern to that of lanosterol, with 







1.8 Isolation of Lanostane Compounds from Natural Sources 
While there has been a long standing high level of interest in the biological effects of 
cholesterol and the phytosterols, interest in lanosterol and its oxidation products has been a 
much more recent development. The isolation of lanostane type compounds from various 




An example of a natural source of lanostane compounds which has attracted much 
pharmaceutical attention, is the medicinal mushroom Antrodia camphorata, a Ganoderma-
like parasitic fungus which belongs to the Polyporaceae Basidiomycotine family. It is a rare 
species which grows only on the endemic perennial Bull Camphor tree at an altitude of 450 – 
2000 m in the Taiwanese mountains.
49
 The medicinal value of this mushroom has long been 
known, as it has been used in traditional Chinese remedies for abdominal pain, diarrhoea, 
hypertension and skin itching. Recently, Antrodia camphorata has attracted the attention of 
the pharmaceutical industry due to its potential anti-tumour activity. It has also displayed 
other biological activities of pharmaceutical interest, including antihepatotoxic,
50
 









 activities. More recently A. 
camphorata has been reported to display antiproliferation, cytotoxic, or DNA topoisomerase-







Figure 1.10 Ganoderma type fungus 
 
The chemical constituents of the Antrodia camphorata include diterpenoids, triterpenoids, 
sesquiterpene lactone and benzenoids. The major phytochemical constituents of medicinal 
mushrooms are polysaccharides and triterpenes. Eight triterpene compounds (10 – 17) have 
been isolated from Antrodia camphorata, comprising five lanostane (11 – 13, 15, 17) and 
three ergostane type compounds (10, 14, 16). The structures of these eight isolates are shown 
below in Figure 1.11. 







Several studies have been undertaken on these compounds in order to establish their anti-
tumour properties against various cancer cell types.
49,56,57
 The most potent isolates were found 
to be 10, 14, 16 as can be seen from Table 1.1 below. These compounds displayed a strong 
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Table 1.1 IC50 values (M) of compounds 10 - 17 
Cell type Cell Line IC50 values (M) of compounds 10 - 17 
  10 11 12 13 14 15 16 17 
Colon HT-29 22.3 387 59.8 233 30 inact 28.0 293 
 HCT116 32.1 336 79.9 274 38.3 inact 42.6 289 
 SW480 27.3 inact 86.5 276 30.7 inact 44.0 254 
          
Liver Huh7 30.4 inact 134 inact 42.8 inact 45.1 428 
 HepG2 23.4 inact inact inact 38.6 inact 48.7 171 
 Hep3B 68.3 inact 326 inact 48.4 inact 50.7 476 
          
Breast MDAMB231 25.1 370 55.9 133 25.6 399 27.8 89.2 
 MCF-7 57.8 inact inact 376 36.1 inact 53 357 
          
Lung A549 25.1 129 inact 312 41.9 194 34.4 inact 
 CL1-0 31.5 140 inact 476 75 241 64.3 inact 
Inact = IC50 value > 500 M 
Zhankuic acid 14 was found to be the most inhibitory of the eight isolates on average over the 
10 cancer cell lines screened. It has several defining chemical features including ketone 
moieties at positions 7 and 11 on the steroid ring, monomethylation at position 4, and alkene 
and carboxylic acid functionality at positions 24 and 25 respectively. The cytotoxicity of 14 













IC50 values of 14 against  
10 cancer cell lines 




The wood-decay fungus Wolfiporia extensa is also used in traditional Chinese remedies. In 
combination with other herbs, it shows diuretic, sedative and analgesic effects.
58
 Lanostane 
type triterpene acids isolated from the dried sclerotia of W. extensa have displayed anti-
tumour, anti-inflammatory and anti-oxidant activities.
59-65
 She et al. have recently isolated 
three new lanostane steroids (18 – 20) which contain the interesting conjugated diene motif 
across the B and C rings.
66
 The structures of the new isolates are shown in Figure 1.13 below, 





The anticancer activities of four new lanostane acids, isolated from the edible mushroom 
Astraeus odoratus, have been described by Arpha et al.
67
 The mushroom is widely known for 
its popularity in Thai food dishes and is one of the most expensive edible mushrooms 
available.
68
 Astraodoric acids A-D (21 – 24) isolated from the mushroom, shown below in 
Figure 1.14, display high levels of oxidation in the lanostane side chain. They were evaluated 
against three cancer cell lines, namely human carcinoma in the mouth, human lung cancer 
and human breast cancer. 







Table 1.2 Cytotoxicity of Astraodoric acids 








Astraodoric Acid A 34.69 18.57 Inactive
d
 
Astraodoric Acid B 19.99 48.37 Inactive
d
 







Astraodoric Acid D 31.55 34.15 40.15 
 
a
 Human mouth carcinoma, 
b
 human lung cancer, 
c
 human breast cancer, 
d
 Inactive at > 50 g/mL 
 




Cytotoxic activity against KB and NCI-H187 cell lines was displayed by Astraodoric acids A 
21 and B 22, while Astraodoric acid C 23 was inactive against all three cancer cell lines at 
concentrations above 50 g/mL. Astraodoric acid D 24 exhibited slight cytotoxicity against 
all three cell lines. The best biological result in this study was the IC50 value of 18.57 g/mL 
seen for Astraodoric acid A in the NCI-H187 cell line. It is worth noting that the active 
compound contains a ketone moiety at C-3, which became important in this research.  
 
New lanostane steroids (25 – 28) have also recently been isolated from the Korean wild 
mushroom Naematoloma fascuculare.
69
 The bitter poisonous mushroom N. fasciculare grows 
on the stumps of old trees.
70
 The mushroom is well known for its diverse phytochemical 
constituents including ergosterols, triterpenoids and sesquiterpenoids,
71-77
 and particularly for 
the presence of lanostane triterpenoids as the toxic components.
72-76
 Kim et al. isolated four 
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The isolates were evaluated for their cytotoxicity against four human cancer cell lines, 
namely A549 (non-small-cell lung adenocarcinoma), SK-OV3 (ovary malignant ascites), SK-
MEL-2 (skin melanoma) and HTC-15 (colon adenocarcinoma), and the results are presented 
below in Table 1.3. 
 
Table 1.3 
 IC50 (M) 
A549 SK-OV-3 SK-MEL-2 HCT-15 
Fasciculol J 25 >30 >30 >30 >30 
Fasciculol K 26 >30 >30 >30 >30 
Fasciculol L 27 6.59 7.08 8.26 8.53 
Fasciculol M 28 3.99 7.36 4.77 8.50 
 
 
Kim et al. state that Fasciculols J and K (25 and 26) showed no cytotoxic activity against the 
four human cancer cell lines, however Fasciculols L and M (27 and 28) showed moderate 
cytotoxicity.
71
 The positive control used in this study was the compound doxorubicin which 
has IC50 values of 0.02, 0.01, 0.01 and 0.13 M against A549, SK-OV3, SK-MEL-2 and 
HTC-15 respectively. A notable structural feature of the active lanostanes is the diol moiety at 
C-24,25 in the side chain. This functionality will be incorporated into the side chain through 
the course of this research. The main difference between the inactive compounds Fasciculols 
J 25 and K 26, and the active Fasciculols L 27 and M 28, is the long acid side chain at C-3. 
The active compounds have less sterically bulky alcohols at this position, which may improve 
biological activity due to hydrogen bond forming potential.  
 
In addition to lanostane derivatives being present in fungi, they have also been isolated from 
plant sources. Four interesting lanostane type compounds were isolated by Lu et al. from the 
plant Euphorbia humifusa, which is found in eastern Asia and central Europe.
78
 Euphorbia 









Figure 1.16 Euphorbia humifusa 
 
The four lanostanes isolated (29 – 32 Figure 1.17) are relevant to this research because they 
possess oxygen functionalities at key sites in the lanostane structure, namely C-7 and C-11. 
Ketones in these positions give rise to the conjugated diketone moiety also seen in isolates 
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Though these compounds were not biologically evaluated in the study by Lu, their isolation 
shows the relevance of lanosterol oxidation products in natural sources. 
 
Another natural source of lanostanes is the white rot fungus Inonotus obliquus, which is 
widely distributed across Europe and North America, and also found in Africa and Asia 
(Figure 1.8).
80
 The relatively diverse locations of I. obliquus, as compared to A. camphroata 
which is only found in the mountains of Taiwan, give rise to a high level of interest in its 





Figure 1.18 Worldwide locations of the white rot fungus Inonotus obliquus 
 
Nakamura et al. report the isolation of six new lanostane type triterpenoids (33 – 38) from the 
methanolic extract of the sclerotia of I. obliquus (Figure 1.9 below). This methanolic extract 
was shown to have an inhibitory effect on HT1080 cells.
80
 The triols (33 and 34) highlighted 
in Figure 1.19 contain interesting structural features in terms of work within our research, as 
discussed in Chapter 2. 
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1.9 Chemical Reactivity of Lanosterol 
The synthetic chemistry of lanosterol revolves around the functionality intrinsic in the 
compound. The C-8,9 alkene is ideal for exploitation via allylic oxidations or epoxidations. 
Allylic oxidation of the tetrasubstituted alkene affords ketones at positions 7 and 11 in the 
steroidal ring system, comparable to isolates 10, 14 and 16 from A. camphorata (Figure 1.11). 
The side chain C-24,25 alkene provides a platform for a variety of oxidations, including the 
possibility to oxidatively cleave the side chain and thus explore synthetic chemistry beyond 
the lanostane nucleus. Additionally, the C-3 alcohol is an excellent target for oxidations, 
which can be carried out under much milder conditions than the harsh allylic oxidations. 





Figure 1.20 Sites of Chemical Reactivity in Lanosterol 1 
 
1.10 Synthetic Lanosterol Derivatives and their Biological Activities 
Early work in the area of synthesising lanostane derivatives was carried out by McGhie and 
Barton.
88-92
 Initial reactions in 1957 involved transformations on the A ring of the steroid via 
brominations and reductions (Scheme 1.2).
88
  






This work was elaborated on by McGhie and Barton in 1963 by further derivatising the A 





More recently, Parvez et al. describe the manipulation of the lanostane B and C rings in 
experiments directed at transforming the lanostane skeleton into that of curcurbitane, which 
possesses a methyl group at C-10 and the alkene bond is repositioned to C-5,6.
93
  
Towards this end, two epoxides were prepared by the m-CPBA oxidation of 3-acetoxy-
lanosta-9(11)-en-7-one 45,
94,95
 one epoxide being formed on the  face 46a, the other on the 
 face 46b. Upon treatment of these epoxides with boron trifluoride, the  epoxide yielded 
the lanostane derivative 3-acetoxy-18(13→12)-abeo-lanosta-8,13(17)-dien-7-one 47, while 
the  epoxide yielded the curcurbitane derivative 3,11-diacetoxy-10-curcubit-1(10)-en-7-
one 48 (Scheme 1.4). 





Note: mass yields for unpurified materials only are described by Paryzek.
93
                                             
The products shown are described as the “major” products of these pathways. 
 




The variation of these final structures, formed by  and  forms of the same compound 46, 
shows how diverse products can be synthesised from the lanostane nucleus.  
Paryzek et al.
93
 describe the ring opening of the  and  lanostane epoxides 46 and the 
subsequent cascade which yields a cucurbitacin skeleton. Following ring opening of the 
epoxide, carbocationic intermediates are formed, which invoke a series of 1,2 methyl and 
hydride shifts. It has been established that the carbon oxygen epoxide bond at C-9 must break 
prior to methyl migration, and that two factors contribute to the direction of the migration of 
the methyl group from its position at C-10 to C-9. Firstly, the steric interaction between the 
migrating methyl group and the bulky Lewis acid/acetic anhydride complex facilitates the 
10 → 9 methyl shift. An additional directive effect is exerted by the 1,3-diaxial repulsion 
between the C-4 methyl group and the C-10 methyl group. Both of these factors combine to 
transform the lanostane skeleton into the cucurbitane skeleton, as can be seen in Figure 1.21. 
 
Figure 1.21 




This rearrangement is stereoselective to an extent, in that the  epoxide undergoes ring 
opening and rearrangement to form the cucurbitane skeleton as the major product, while the  
epoxide ring opens under the same conditions but the subsequent cascade has been shown to 
yield the lanostane derivative 47 as the major product. 
This result shows the diversity of products available from the ring opening of epoxides in the 
steroidal rings.  
Briggs showed that ring opening of the C-8,9 epoxide 49 using boron trifluoride leads to a 
different chemical outcome.
96
 As can be seen from Scheme 1.5,  in this instance, the diene at 
C-7,8 and C-9,11 is formed 50. This diene can be subsequently oxidised to form 3-acetoxy-
lanosta-9(11)-en-7-one 45. 
 
Note: Briggs does not report yields for these transformations 
Scheme 1.5 
 





It is clear from these examples of modification of the steroidal rings that the C-8,9 alkene has 
enormous potential for the synthesis of a diverse range of functional groups. While this 
alkene opens up a variety of chemistry for the steroidal rings, the alcohol at C-3 in the 
lanostane structure can also be exploited for functional group transformations and nearby 
carbon derivatisations.  
Given the biological activity of the lanostane type isolates from natural sources, along with 
the accessibility of a wide range of derivatives, it is unsurprising that much research attention 
has been focussed on synthetic lanosterol derivatives and their biological activities.  
Wada et al. have synthesised derivatives shown below from 3-oxolanost-9(11)-en-24S,25-diol 








Compounds 52 - 55 were synthesised via a similar synthetic sequence. Firstly, the protection 
of the C-24,25 diol 51 by forming the acetonide 60 was achieved with dimethoxypropane. 
Phenylselenyl chloride followed by hydrogen peroxide facilitated the formation of a double 
bond at C-1 61, while C-2 was then derivatised, via intermediate 62, using hydrochloric acid, 
hydrobromic acid and sodium methoxide to yield 53, 54 and 55 (Scheme 1.7).  




a = dimethoxypropane, TsOH, DCM, (90%); b = PhSeCl, EtOAc, then H2O2, THF, (78%); c = 1N HCl, DCM, 
MeOH, (89%); d = H2O2, NaOH, THF, (65%); e = HCl, AcOH, CHCl3, (60%); f = HBr, AcOH, CHCl3, (63%); 
g = NaOMe, MeOH, (54%). 
Scheme 1.7 
 
Compounds 56 – 59 were synthesised via another synthetic route, but a similar initial 









The biological activity of these synthetic derivatives was evaluated against DNA 
topoisomerase II, one of the target enzymes for chemotherapeutic drug development. The 
cytotoxic activity of the compounds against A549 cells was also examined. The results are 








1 52 149.97 ± 2.33 26.90 ± 4.58 
2 53 106.80 ± 5.98 38.15 ± 5.18 
3 54 18.27 ± 2.20 14.27 ± 4.81 
4 55 22.77 ± 6.06 29.57 ± 1.60 
5 56 1.86 ± 2.57 13.05±  2.59 
6 57 83.23 ± 5.65 25.49 ± 3.54 
7 58 23.80 ± 3.35 7.33 ± 1.31 
8 59 66.51 ± 5.51 3.96 ± 0.31 
9 Etoposide 50.40 ± 3.29 3.39 ± 0.61 
* IC50 values against topoisomerase II activity and ED50 values against A549 cells 
All the compounds inhibited Topoisomerase II activity with IC50 values ranging from 1.86 to 
149.97 M. Compound 56 showed the highest inhibitory effect, having an IC50 value of 1.86 
M. Perhaps the ability of the aldehyde to exhibit an electrostatic effect with the enzyme gave 
rise to this high inhibitory effect.  
In terms of cytotoxic activity, acid 58 and ester 59 exhibited potent activity with ED50 values 
of ~ 7 and ~ 4 M respectively, in contrast to their Topoisomerase II activity. Particularly 
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excellent results were displayed by the methyl ester derivative 59 in terms of a comparison 
with etoposide, as can be seen from Table 1.4. 
These results show that the introduction of functional groups at C-2 of the triterpenoid 
skeleton have increased the Topoisomerase II inhibitory effect and the cytotoxic activity.  
Honda et al. also report C-2 derivatised lanostane products, and discuss an interesting 





Formylation of the starting material lanost-8-en-3-one 63 gave the intermediate enol 64, 
which was carried forward to yield the isoxazole 65. Cleavage of the isoxazole with sodium 
methoxide gave the nitrile 66 which was subsequently treated with 2,3-dichloro-5,6-dicyano-
1,4-benzoquinone (DDQ) to yield the desired cyanoenone 67. Studies on the biological 
properties of this compound are in progress.   
From these examples, it is evident that the steroid rings of lanosterol can be modified to 
include a wide range of functionalities by exploiting the C-8,9 alkene and the C-3 alcohol in 
the structure. There is also scope for further derivitisation of lanosterol in the side chain, due 
to the presence of the C-24,25 alkene.  




Sato et al. describe the synthesis of lanosterol analogues with modified side chains starting 
from lanosterol acetate 68. Functional groups including epoxides 69, ketones 70 and 72, 
aldehydes 71 and 73, and acids 74 can be synthesised from the C-24,25 alkene, Scheme 1.9.
99
   
 
a = m-CPBA, CHCl3; b = BF3.OEt2, benzene; c = SeO2, EtOH; d = KMnO4, acetone.                                       
Sato et al. did not report yields for purified products. 
Scheme 1.9 
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The C-24,25 alkene is the starting point for this chemistry and is the basis for the 
modification of the side chain to include epoxides, aldehydes, ketones and carboxylic acids.  
The C-24,25 epoxide shown in Scheme 1.10  is a particularly useful intermediate, and can be 
derivatised beyond ketone and aldehyde functional groups, as shown by Davis et al.,
100
 who 
report the formation of azohydrins (76 and 77) in the lanostane side chain. The 
diethylaluminium azide mediated opening of the 1:1 diastereomeric mixture of C-24,25 
epoxides, protected at C-3 by tert-butyldimethylsilyl ethers, gives rise to a 3:1 mixture of 
tertiary and secondary azohydrins, both of which were 1:1 C-24 diastereomers, as shown in 
Scheme 1.10.  
 
Scheme 1.10 




The reaction of Et2AlN3 with the trisubstituted epoxide affords the tertiary azido alcohol 76 as 
the major product, consistent with an SN1-like mechanism. The major product arises from the 
ring opening of the epoxide and coordination of the oxygen to the aluminium, followed by 




The C-3 protection of lanosterol is necessary in this case to avoid the possible formation of 
side products arising from hydrazoic acid generated by OH-Et2Al exchange (Scheme 1.2).  
 
Scheme 1.12 
The C-24,25 alkene can also be derivatised without the use of the epoxide intermediate, and 
an example of a useful moiety as a precursor to various functionalities is a 1,2 diol.  
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It is known that 1,2 diols may be converted to -hydroxy ketones, and such transformations 
have been carried out by Corey and Kim.
101
 The side chain glycol, easily accessible from 
lanosterol, may thus be converted to the corresponding -hydroxy ketone 79. The synthetic 
versatility of these moieties has been highlighted by Plietker,
102
 who demonstrated the various 
functional groups which can be derived from -hydroxy ketones (Scheme 1.13).   
 
Scheme 1.13 




In conclusion, the main sites of reactivity of lanosterol are the alcohol at C-3, the  carbon at 
C-2 and the alkenes at C-8,9 and C-24,25. By manipulation of these reactive sites, many 
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1.11 Synthetic Stigmasterol Derivatives and their Biological Activities 
 
In the drive to reduce cholesterol absorption, an increase in dietary phytosterols has become 
prevalent in recent years, with esters of phytosterols being incorporated into an ever 
increasing number of food products, such as margarine and oils.
103-108
 In recent years, much 
work has been conducted on the negative health effects of cholesterol oxidation products 
(COP’s), which include atherosclerosis, cytotoxicity and mutagenicity.
109-111
 
The structural connection between cholesterol and the plant sterols infers that these 
compounds can undergo oxidation by similar means to those documented for cholesterol.
16,112
 
Given the unsaturated nature of the phytosterols, there is a possibility of oxidation of the 
compound occuring upon exposure to air, a process which may be enhanced by heating, 
chemicals or enzymes.  
Therefore, due to the increase in dietary uptake of phytosterols, coupled with the knowledge 
that these compounds may undergo oxidation in vivo and the adverse effects of their 
cholesterol oxide analogues, the biological evaluation of the oxides of phytosterols is now an 















First and foremost, early work in this area was carried out in 1957 by Chamberlin et al. who 
performed a variety of synthetic transformations at multiple reactive sites in stigmasterol.
113
 
This work involved halogenations at the C-5,6 alkene bond to yield 81, and cleavage of the 




The formation of the C-22 aldehyde, as shown in Scheme 1.14 above was an attractive 
method for the derivitisation of the side chain of stigmasterol, and was also exploited by 
Terasawa et al. in 1983 en route to the stereocontrolled synthesis of gorgosterol 85 in 9 steps 
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A literature search of synthetic stigmasterol derivatives shows that much of the work on this 
topic in the 1960’s – 1990’s is under patent, which adds further relevance to this area. 
In 2010, the synthesis of eight oxides of stigmasterol (88 – 95) was described by Foley et 
al.
115
 Scheme 1.16 below describes the synthesis of six of these eight isolates, through a 
variety of protections, oxidations, epoxidations, ring openings and deprotections.   
 
 
a = 0.95 eq m-CPBA, DCM (77%); b = Ac2O, pyridine (89%); c = KMnO4-CuSO4.5H2O, t-BuOH, H2O (49%); 
d = Na2CO3, MeOH (92%); e = 3.7 eq m-CPBA, DCM (54%); f = H2SO4, THF-H2O (32%) g = CrO3, 
dimethylpyrazole, DCM −20 to 5 °C (66%); h = K2CO3, MeOH (59%); i = CeCl3.7H2O, NaBH4, MeOH (54%). 
Scheme 1.16 
 
The final two of the eight stigmasterol oxides described by Foley et al.
115
 are synthesised 
according to Scheme 1.17, shown below. In this case, the protection of the C-5,6 alkene is 
required in order to facilitate chemistry of the side chain alkene at C-22,23. The protection 
reaction described by Foley will be utilised in this project and will be seen in Chapter 2.  






a = p-TsCl, DMAP, pyridine (94%); b = MeOH (anhydrous), pyridine, (60%), 
*
 the side product of the 
solvolysis reaction is removed from the scheme for clarity; c = OsO4, NMO, t-BuOH, THF, H2O (47%); d = 
H2SO4, THF, H2O (87%); e = OsO4, NMO, DHQD PHN (dihydroquinidine 9’-phenanthryl ether), t-BuOH, 
THF, H2O (30%); f = H2SO4, THF, H2O (67%); g = m-CPBA, DCM (45%) 
#
 formed as a 5:1 mixture of the  
and  epoxides. This scheme is adapted from Foley et al.,115 side products and unsuccessful reactions are 
removed for clarity. 
Scheme 1.17 
 
All eight compounds were strategically synthesised for comparison with the most toxic -
sitosterol oxidation products described by McCarthy et al,
116
 which will be discussed in the 
following section. This study was moved forward by exploiting the additional sites for 
oxidation, due to the presence of the second alkene bond on the side chain of stigmasterol. 
Through a variety of selective epoxidations and oxidations, a number of epoxide, alcohol and 
ketone derivatives of stigmasterol were synthesised.  
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One of the challenges associated with the analysis of phytosterol oxidation products is that 
much of the studies available in the literature have been carried out on phytosterol 
blends,
117,118
 primarily because the phytosterols are readily available as mixtures with other 
plant sterols, namely -sitosterol and campesterol. The advantage of this study is that the 
series of stigmasterol oxides were synthesised in a pure state, and that their biological 
characteristics can be evaluated accurately.  
The percentage of viable cells following a 24 hour incubation period with each of the eight 
oxidised derivatives of stigmasterol was determined in the U937 cell line using the 
Fluorescein Diacetate/Ethidium Bromide (FDA/EtBr) staining assay. This assay will also be 
used to determine the biological activity of compounds synthesised in our research, as will be 
discussed in Chapter 2. The results following exposure to 30 M, 60 M or 120 M of each 
compound are presented below (Table 1.5). 
 
Table 1.5 Percentage viable U937 cells following a 24 h exposure to stigmasterol oxides 
Entry Compound 30 M 60 M 120 M 
1 88 96.8 ± 1.7 96.0 ± 1.5 94.0 ± 0.6 
2 89 98.0 ± 1.5 96.3 ± 1.4 96.3 ± 0.9 
3 90 51.4 ± 8.3 39.6 ± 4.6 7.6 ± 2.2 
4 91 95.4 ± 1.5 23.3 ± 3.4 3.6 ± 0.7 
5 92 95.7 ± 2.0 96.7 ± 0.7 93.7 ± 1.8 
6 93 85.8 ± 4.0 56.3 ± 6.5 22.8 ± 0.6 
7 94 97.7 ± 0.6 95.0 ± 1.5 92.3 ± 3.5 
8 95 75.0 ± 2.8 63.3 ± 13.0 52.3 ± 4.1 
 











The diepoxide 90 (Table 1.5, Entry 3) showed the lowest percentage viability of the U937 
cells across the 30 M and 60 M range of concentrations, and therefore is the most cytotoxic 
of the compounds screened. Interestingly, at a concentration of 120 M, the epoxydiol 91 is 
slightly more active than the diepoxide 90, having a percentage viability of 3.6% compared to 
7.6%. Another interesting trend seen across the compounds screened is that both the  and  
epoxides 88 and 89, the 7-keto derivative 92 and the 3,5,6 triol 94 show very poor biological 
activity across all concentration values, each having percentage viabilities in the high 90’s. 
 
The cytotoxicity of each of these compounds was also examined in terms of apoptosis, using 
the MTT assay. Unlike the FDA/EtBr staining method, which quantifies the number of live 
cells in a population, this assay reflects cell proliferation and metabolic activity, which may 
be increased or decreased under certain conditions, such as the addition of chemical 
compounds. Each of the oxides of stigmasterol was tested for its ability to induce apoptosis 
by a morphological examination of the cell nuclei following staining with Hoechst 33342. In 
apoptotic nuclei, the DNA is cleaved into regular sized fragments that appear sufficiently 










88 89 90 91 92 93 94 95 
Percentage viability of U937 cells following  
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Table 1.6 Percentage apoptotic nuclei following 24 h incubation with stigmasterol oxides 
Entry Compound 30 M 60 M 120 M 
1 88 2.6 ± 0.2 4.1 ± 1.4 4.4 ± 0.9 
2 89 2.9 ± 1.1 3.6 ± 1.1 4.8 ± 0.1 
3 90 43.9 ± 2.5 36.8 ± 4.3 21.6 ± 2.4 
4 91 6.4±  0.9 29.3 ± 3.0 25.3 ± 5.0 
5 92 5.1 ± 0.6 3.5 ± 0.2 3.9 ± 0.4 
6 93 9.6 ± 1.1 20.3 ± 2.2 19.8 ± 3.8 
7 94 2.6 ± 0.3 2.7 ± 1.2 3.0 ± 0.9 
8 95 1.7 ± 0.9 2.7 ± 0.6 3.0 ± 0.5 
 
 
A comparable trend was observed for this assay, in that the relative toxicities of each of the 
compounds were similar. The diepoxide 90 shows a significant increase in the percentage of 
apoptotic cells at all concentrations tested, relative to the untreated control cells. It is 
interesting to note that increasing concentrations of stigmasterol oxide did not correlate with 
an increase in apoptosis in all samples. An example of this is in the case where cells were 
exposed to the diepoxide 90. In this case the level of apoptosis was highest at the lowest 




In an interesting contrast to the findings by Ryan et al., namely the apoptosis induced by both 
the 7-keto derivatives of cholesterol and sitosterol,
122
 there was no evidence of apoptosis for 










1.12 Synthetic -Sitosterol Derivatives and their Biological Activities 
 
As mentioned in the previous section, the synthesis of stigmasterol oxides was preceeded by a 
study on -sitosterol 5 and its oxidation products, both their synthesis and biological 
activity.
116
 This study is closely comparable to that of the stigmasterol oxides, in its 
objectives, chemical transformations and biological evaluation. -Sitosterol is the most 
prevalent phytosterol synthesised in plants, and given its structural similarity to cholesterol, 
can undergo oxidation by the same means as cholesterol. Therefore, for the reasons outlined 
at the beginning of the previous section, a study of the biological activity of -sitosterol 
oxides is an important research concern. 
McCarthy et al. present an attractive route for the synthesis of -sitosterol from stigmasterol 3 
(Scheme 1.18).
116
 The product is formed in 98.9% purity and with moderate to high yields 
across the four synthetic steps.  
 
a = p-TsCl, DMAP, pyridine (90%); b = MeOH (anhydrous), pyridine (74%) 
*
 the side product of the solvolysis 




Upon synthesis of -sitosterol in a pure state, several -sitosterol oxidation products (96 – 
100) were chosen as synthetic targets for biological evaluation. The synthesis of the oxides of 
-sitosterol was carried out by manipulation of the C-5,6 alkene bond, incorporating allylic 
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oxidations and epoxidation chemistry, and using an acetate protecting group for the C-3 
alcohol where necessary (Scheme 1.19).  
 
 
a = Ac2O, pyridine (88%); b = CuSO4/KMnO4, t-BuOH, H2O (54%), followed by K2CO3, MeOH (71%); c = 
CrO3, dimethylpryazole, DCM, −20 to 5 °C (79%), followed by K2CO3, MeOH (91%); d = CeCl3.7H2O, NaBH4 
(87%); e = m-CPBA, DCM, 0 °C (70%); f = HCOOH, 80 °C, 10 min, followed by H2O2, followed by MeOH, 
NaOH (49% for three steps). 
Scheme 1.19 
 
These five compounds (96 – 100) were evaluated for their cytotoxicity in U937 and CaCo-2 
cells. The percentage of viable cells following a 24 hour incubation period with the five 
oxidised derivatives of -sitosterol was determined using the Fluorescein Diacetate/Ethidium 
Bromide (FDA/EtBr) staining assay. Although these compounds showed poor activity in the 
U937 cell line,
122
 an improvement in cytotoxicity was seen in the CaCo-2 cell line (Table 1.7 
and Figure 1.24). 
 




Table 1.7 Percentage viable CaCo-2 cells following a 24 h exposure to-sitosterol oxides 
Entry Compound 30 M 60 M 120 M 
1 96 102.6 ± 1.2  101.1 ± 2.2 101.1 ± 4.4 
2 97 111.7 ± 3.5 110.2 ± 4.7 109.0 ± 0.6 
3 98 91.6 ± 11.7 61.9 ± 9.1 40.8 ± 4.0 
4 99 93.0 ± 4.7 64.4 ± 7.0 23.3 ± 4.2 




While both  and  epoxides, 96 and 97, were found to be inactive in the CaCo-2 cell line as 
well as the U937 cell line, there was an improvement in cytotoxicity of the other three 
compounds (98 – 100) at a concentration of 120 M. The standout result from this biological 
screen was the cytotoxicity of the 7-keto derivative of -sitosterol 99, giving a percentage 
viability of CaCo-2 cells of 23.3% at 120 M. By analysis of the results from the stigmasterol 
and -sitosterol studies, a conclusion can be drawn that there is greater potential for cytotoxic 
activity in the stigmasterol oxides. This result is appreciable given the possibility of further 
functionalisation of the stigmsterol moiety by exploiting the additional alkene present in the 
side chain of the structure. Therefore, novel derivatives of stigmasterol would warrant 
attention in further studies, in the expectation that these compounds would prove significantly 
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1.13 Aminosteroids and Amidosteroids 
Steroidal compounds containing various nitrogen functionalities, including primary, 




Preliminary work in this field was carried out by James et al.
127
 and Dodgson et al.
128
 who 
prepared amino derivatives of cholesterol. These derivatives were examined as antibacterial 
agents or amoebicides and found to be not particularly effective. Herzog et al. developed this 
area by synthesising a range of amides and amines of a cholestane nature.
123
 The 
methodology employed to synthesise the derivatives, shown in Scheme 1.20, involved 
conversion of 
5
-3-acetoxybisnorcholenic acid 101 to the corresponding acid chloride 102, 










Figure 1.25. R groups for amide and amine derivatives shown in Scheme 1.20 
None of the amide derivatives shown in Figure 1.25 possessed significant activity, however 
the amines were effective in inhibiting the fungus Candida albicans. The piperidino and 
pyrrolidino derivatives were the most effective of these amines, exhibiting activity at 
concentrations as low as 0.1 – 1.0 mg/mL.  
 
Antifungal activity is also displayed in the amine derivatives of the lanostane nucleus (103 – 
107), as reported by Chung et al.
124
 The derivatives are characterised by various amine 
moieties as substituents at C-24, and were synthesised by initially treating lanosterol (or 
lanosterol acetate) with m-CPBA followed by BF3-OEt2 affording 24-keto lanosterol 108 in 
43% overall yield (Scheme 1.24).
129
 This was followed by subsequent reductive amination 
with the appropriate amine, zinc chloride and sodium cyanoborohydride to synthesise 104 – 
107 in moderate yields.
130
  




a = m-CPBA, DCM, r.t, 3 h, then BF3.OEt2, DCM, r.t, 10 min (43%); b = amine, NaBH3CN, ZnCl2, MeOH, r.t, 





The antifungal properties of these amines were evaluated against several fungal strains as 
shown below in Table 1.8. 
Table 1.8 in vitro Antifungal Activities (g/mL) 
Entry Fungal Strain 103a 104a 104b 105a 105b 106a 107a 
1 C. albicans 100 100 100 25 100 50 100 
2 C. krusei 100 100 100 50 100 100 100 
3 C. parapsilosis 100 100 100 100 100 100 100 
4 C. pseudotropicalis 100 100 100 100 100 100 100 
5 Cr. neoformans 0.10 0.78 100 25 50 12.5 3.13 
6 S. carlsbergensis 25 6.25 100 25 50 50 50 
7 S. cerevisiae 25 6.25 100 12.5 100 50 50 
8 T. candida 100 100 100 100 100 100 100 
9 C. glabrata 50 25 100 25 100 100 100 
 




Clear trends in this series of results are noteworthy. Firstly, the C-3 alcohol derivatives show 
higher antifungal activities than their corresponding C-3 acetate analogues. Secondly, the 
methyl amino derivative (104a) generally displayed improved activity against several fungal 
strains than its other amine counterparts (Table 1.8, Entries 5, 6, 7, 9).  
Beuchet et al. progressed the work of Chung by investigating the impact of a C-25 
aminosterol on antifungal activity.
125
 Synthesis of C-25 amino lanostane and cholestane 
compounds (108 and 109) proceeded via the hydroxylation of the C-25 position, followed by 
bromination, azidotisation and reduction to yield the desired aminosterols in good yield.
131
 
Notes: NL = Nucleus, SC = Side chain, reduction of the azide species yielded compounds shown below (Figure 
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Both of these amines were found to inhibit Candida albicans, with the cholestane derivative 
showing excellent growth inhibition at 4 M. These results are in perfect concordance with 





1.14 Amines in Pharmaceutical Compounds 
 
The role of amines in pharmaceuticals is immense, and typical functions of amine based 
drugs are stimulants, vasoconstrictors, decongestants, analgesics, antihistamines and 
antidepressants.  
Perhaps the most recognized pharmaceutical amine is morphine 110, a potent alkaloid 
analgesic drug used to relieve severe pain. In clinical medicine, morphine is regarded as the 
benchmark of opioid analgesics for the relief of chronic pain.
132
 As with other opioids, 
morphine acts directly on the central nervous system to reduce pain. Its duration of analgesia 
is approximately four hours when administered via the intravenous or intramuscular route and 
approximately six hours when administered orally. Although morphine is a natural substance, 
isolable from the poppy plant, the synthesis of morphine has been reported in the literature 
dating back to 1952.
133-142
 While morphine exhibits potent analgesic properties, excess intake 
of the drug can lead to asphyxiation and death. Therefore, milder drugs or “morphine 
substitutes” are often employed for pain relief. 
Codeine 111, or 3-methyl morphine, is also used as an analgesic to treat mild to moderate 
pain. It is marketed either as a single ingredient drug, or as a combination preparation with 
paracetamol, ibuprofen or aspirin. By comparison with morphine, the adverse effects of 
codeine are far less serious, with the most common side effect being drowsiness. However, 
tolerance to the side effects of codeine develops with prolonged use, and addiction to the 
substance becomes an issue.
143
 In the Republic of Ireland, codeine remains semi non-
prescriptive up to a limit of 12.8 milligrams per tablet. However, regulations introduced in 
August 2010 requires that these products are “not accessible to the public for self selection”, 
meaning the patient must discuss their pain relief requirements with a pharmacist prior to 
obtaining products containing codeine. [Source: “Codeine regulations cause a few 
Headaches” The Irish Times 24/08/2010] 






A selection of other pharmaceuticals containing amine functionality is detailed in Table 1.9. 
Possibly the most well known of these drugs is the antihistamine cinnarizine, marketed as 
Stugeron
®
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Loxapine 112 is a first-generation antipsychotic that has been reformulated into an inhaled 
powder, which allows for direct administration to the lungs. Inhaled Loxapine at a 10 mg 
dose was approved by the US Food and Drug Administration in December 2012 for the 
treatment of agitation associated with schizophrenia and bipolar disorder in adults.
145
 The 



























In summary, steroidal compounds are known to be hugely important, both in terms of 
regulating biological events in the human body, and as pharmaceuticals. Their multiple 
alkene functionalities make them suitable for modification by conventional means, and allow 
a range of functional groups to be synthesised at strategic positions.  
Lanosterol and stigmasterol were the precursors chosen for this work due to their structural 
features and the fact that they are readily available. Literature precedent for the synthesis of 
lanosterol oxidation products is widely available, as seen in the anti-tumour properties of 
Antrodia camphorata isolates.
49
 Functional group transformations which are similar to those 
described in Figure 1.22 will be carried out in this research. Namely the formation of acetate 
and ketone groups at C-3 by manipulation of the alcohol moiety at this position, allylic 
oxidations and epoxidations at the C-8,9 alkene to synthesise epoxides and ketones, and side 
chain derivitisation by means of epoxidations, oxidative cleavage and reductive amination. 
The antifungal activity of many amine derivatives of the cholestane and lanostane nucleus 
provides incentive for the elaboration of this work with the view to evaluating these types of 
compounds for anti-cancer activity.
123-125
 Compounds synthesised will be biologically 
evaluated for cytotoxicity against CaCo-2 and U937 cell lines using the MTT assay, and the 
results will be presented in terms of percentage viability of cells and IC50 results. In addition, 
the apoptosis potential of the compounds is presented in terms of a fold increase relative to 
the ethanol carrier control. 
The research described herein undertakes the synthesis of novel lanosterol oxidation products 
as well as side chain amine derivatives of lanosterol and stigmaserol. Literature precedent for 
manipulation at key sites in the steroids has been described in Chapter 1, and the results of the 
research carried out in this project will be discussed in Chapter 2. The biological evaluation 
of these compounds forms part of the process of the strategic design of successful derivatives, 
and these evaluations will be performed at intermediate stages throughout the research in 
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2.1 Project Background 
The concept for this project came from the reported anticancer activity of isolates from the 
medicinal mushroom Antrodia camphorata. From this rare mushroom, five lanostane and 
three ergostane type tritperpenoids were isolated.
1
 Certain isolates were shown to be cytotoxic 
against colon cancer and breast cancer cell lines, as discussed in the introductory chapter. A 
common thread of defining structural features is seen throughout these compounds. 
Specifically, the conjugated diketone at C-7 and C-11, the conjugated diene at C-7,8 – 9,11, 




Chapter 2: Results and Discussion 
66 
 
Therefore, we wished to exploit the structural similarities between these isolates and the 
commercially available lanosterol precursor, which contains the core A, B, C, D ring system 
in addition to the C-8,9 alkene, which would open up a range of core functionalisations and 
derivitisations, and the C-24,25 alkene which is susceptible to oxidations, epoxidations etc.  
Recent work within our research group focussed on the synthesis of lanostane type natural 
products similar to the isolates from Antrodia camphorata.
2,3
 This previous work had 
concentrated on mimicking the structural motifs seen in these isolates, such as the conjugated 
diketone, the conjugated diene and the alcohol at C-3, as highlighted in Figure 2.1. In 
particular, the research investigated the derivitisation of lanostane steroids by modifying the 
ring structures to include these structural features. Through a variety of chemical 
transformations, such as allylic oxidations and epoxidations, a number of key targets were 
synthesised (Figure 2.2).  
The work proved very successful, with five modified lanostane compounds being accepted 
for biological screening, (Figure 2.2). This evaluation was carried out by Professor John 
Luong of the Biotechnology Research institute, Quebec, Canada. The compounds were tested 
against Spodoptera frugiperda Sf9 insect cells using a technique called electric cell-substrate 
impedance sensing (ECIS).
2,4
 In brief, the technique performs real time cell monitoring 
through impedance measurement of a small electrode to AC current flow. When the cells are 
inoculated onto this small gold electrode, they behave like dielectric particles due to the 
insulating properties of their membranes. Thus, impedance increases with increasing cell 
coverage of the electrode. As cell morphology is extremely sensitive to chemical stimulus, the 
change in impedance of the electrode, upon addition of chemical compounds, can provide 
information on the compounds inhibitory and cytotoxicity effects.  
 







Compounds 1, 2 and 3, which have an ester group at C-3 and an aliphatic side chain in 
common, displayed no inhibitory activity against the Sf9 cells. Though the mode of action of 
steroids as transcription factors is well known,
5
 the specific mode of action of these lanosterol 
oxidation products as anticancer agents is not yet established; however it is possible that an 
alcohol group would lead to greater inhibition than an ester group due to its increased 
solubility, polarity and hydrogen bonding capabilities. The epoxide 1 is inactive up to a 
concentration of 150 M, while both diene 2 and ketone 3 are inactive up to 300 M and 100 
M respectively in this screening. However, these preliminary tests serve as an indication of 
possible activity only, and further screening of these compounds is necessary across a broad 
range of cell lines. By contrast, triketone 4 and triol 5 display more promising results against 
the Sf9 cells using the ECIS technique. After 20 hours the triketone displays an ECIS50 (half 
inhibitory concentration using the ECIS method) of 150 M. Characteristic features of this 
compound are the conjugated diketone moiety and the ketone at C-3, which may have 
increased its inhibitory properties. Triol 5 shows a lower inhibitory activity, with an ECIS50 
value of 250 M after 20 hours. This compound was the only one to be tested in this screen 
with a functionalised side chain, and this too may have increased its inhibitory properties 
through increased solubility and polarity.  
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From the graph (Figure 2.3), it can be seen that the triol maintains a relatively constant 
ECIS50 value over the monitored time period. By contrast, the inhibitory properties of the 




Initial stages of a collaboration between Professor John Luong and our research group 
culminated in a publication in 2010,
2
 and we were keen to carry on this work, whilst moving 
the project in a new direction.  
While these advances had been made in the derivitisation of the core four ring structure 
(Figure 2.2), the side chain, which has great potential for derivitisation, remained mostly 





























2.2 Project Outline 
Lanostane type natural products have been shown to display a wide range of biological 




 activity. The aim of the project was to 
synthesise structural analogues of these lanostane type natural products and evaluate their 
biological activity. These biological results would be used to strategically design the synthesis 
plans for future target molecules throughout the research. The project is subdivided into three 
main sections. 
1. Lanosterol Oxidation Products (LOPs).  
Initially our work focused on isolates from the medicinal mushroom Antrodia camphorata.
3
 
Structural analogues of these isolates were synthetically accessible from our chosen precursor 
lanosterol 6. A number of protection, oxidation, epoxidation and deprotection reactions 
constitute this section. Though lanosterol 6 is an excellent starting material for the synthesis 
of these analogues, the necessity to remove the dihydrolanosterol 7 analogue, which is present 
in commercial lanosterol, remained a key challenge during this body of work. 
2. Amine Derivatives of Lanosterol. 
Our attention turned towards the incorporation of tertiary nitrogen functionalities in the side 
chain of lanosterol 6, by utilising the activity of the C-24,25 alkene. As well as having 
literature precedent for the synthesis of novel analogues of this type,
6
 collaborative work was 
carried out within the research group to mimic the chemistry and biological activity of the 
aglycone solanidine 8. Reductive amination reactions emerged as the means of choice for the 
synthesis of these derivatives via a route devised in the LOPs section. 
3. Cholestane Derivates of Biologically Active Amines. 
The final section of the project focused on establishing a food related aspect to our research, 
as part of an ongoing collaboration with the food research group of Professor Nora O’Brien in 
UCC. We were attracted to working with stigmasterol 9 because it is a phytosterol present in 
the human diet,
7
 with a chemical structure suitable for modification by our established 
synthetic routes. The amine side chains showing the most promising biological activity from 
the previous lanostane section would be incorporated in the cholestane series derived from 
stigmasterol 9.  





Figure 2.4 Lanosterol 6, Solanidine 8 and Stigmasterol 9 
 
2.3 Lanosterol Oxidation Products (LOPs) 
2.3.1 Purification of commercial lanosterol 
In order to synthesise a new range of lanosterol oxidation products incorporating the 
structural features of compounds isolated from A. camphorata, lanosterol 6 was the most 
appropriate starting material. Lanosterol is also the direct precursor in the biosynthesis of 
lanostane type triterpenoids and is relatively inexpensive and readily available from a number 
of chemical suppliers. However, the purity of this lanosterol 6 is inadequate, as it contains 
approximately 50% dihydrolanosterol 7, and other steroids, such as agnosterol, as trace 
impurities. Therefore, the separation of dihydrolanosterol from the commercial mixture to 
yield two viable starting materials was necessary. This separation was carried out as 
described by Kavtaradze et al.
8
 
The initial step of the separation route involved the protection of the C-3 secondary alcohol of 
the 1:1 mixture of lanosterol 6 and dihydrolanosterol 7 through the introduction of an acetyl 
protecting group (Scheme 2.1).
8
 The acetate ester was used for the protection of this alcohol 
as its stability properties suited the conditions of our separation route. This protecting group is 
easily introduced to mask the alcohol, and could be removed at a later stage. Standard 
reagents acetic anhydride, dimethylaminopyridine and pyridine were employed for the 
acetylation reaction. The resulting off white residue was easily recrystallised from acetone to 
afford lanosterol acetate 10 and dihydrolanosterol acetate 11 (1:1) in 32% yield. The effect of 
the acetyl functionality is clearly observed in the 
1
H NMR spectrum of the product.
9
 3-CH 
shifts from 3.23 ppm in the mixture of alcohols 6 and 7, to 4.50 ppm in the mixture of 




acetates 10 and 11. Furthermore, the 3H singlet at 2.05 ppm in the 
1
H NMR spectrum of 10 
and 11 is consistent with the presence of the new methyl group of the acetate ester. The 
13
C 
NMR spectrum of the recrystallised product showed a shift in the 3-CH signal from 78.7 ppm 
to 80.9 ppm, along with the emergence of a new signal at 171.0 ppm, owing to the carbonyl 




Attempts to separate 10 and 11 by column chromatography at this stage were unsuccessful. 
Moreover, the attempted separation of trace steroid impurities from the bulk majority of 10 




 showed the separation of very 
closely related alkenes, such as cis and trans alkenes, using silica impregnated with silver 
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nitrate. This process involved treatment of the silica with 10% silver nitrate solution in 
methanol, before allowing the silica to dry overnight at > 150 °C in the dark. While 11 does 
not contain an alkene in its side chain, we were keen to attempt the chromatography described 
by Li and Williams as both 10 and 11 both contain an alkene at C-8,9. However, separation of 
10 and 11 by chromatography using silica impregnated with silver nitrate also failed, 
although the literature indicated promising precedent for this separation.
10,11
 This shows that 
the dihydrolanosterol acetate 11, in addition to trace impurities are too close in polarity to the 
desired lanosterol acetate 10 component of the mixture, and that side chain functionalisation 
is necessary in order to achieve a sufficient difference in polarity between the two compounds 
to allow for separation to take place by column chromatography.  
The next step in the separation process is the hydroxy-bromination of the C-24,25 alkene of 
lanosterol acetate 10. The mixture of acetates 10 and 11 was reacted with N-
bromosuccinimide in aqueous acetone and hypophosphorous acid as a catalyst (Scheme 2.2). 
This reaction leaves the dihydrolanosterol acetate 11 component of the mixture unreacted, 
while the C-24,25 alkene of lanosterol acetate 10 reacts to form the halo-hydroxy 
intermediate 12. The reaction proceeds regiospecifically, and affords only the 24-bromo, 25-
hydroxyl moiety. This regiospecifity is attributable to the choice of solvent.
12
 Mixtures of 
isomers are normally obtained; for instance, the same reaction in dichloromethane lacks this 
regiospecificity, and also yields the 24-OH, 25-Br compound. Upon addition of the N-
bromosuccinimide, a colour change was observed from a clear to a bright yellow solution. 
The reaction was complete after 5 min, indicated by TLC analysis. As the bromo-hydroxy 
intermediate 12 decomposes readily,
12
 the mixture of 11 and 12 was carried forward to the 
next reaction without further purification or analysis.  








The final step of the separation sequence involved refluxing the halo-hydroxy intermediate in 
2-propanol and aqueous hypophosphorous acid for 4 h to form the target diol mixture 13a and 
13b. Addition of sodium hydrogen carbonate generates the sodium hypophosphite salt in situ. 
2-Propanol was the solvent of choice as competing nucleophilic reactions are avoided on the 
grounds of steric hinderance.
13
 The use of a different solvent, such as methanol or ethanol, 
may lead to the generation of undesired methyl or ethyl ethers in side reactions at the C-24 
position. An acidic off white solid was obtained and this solid was washed with deionised 
water until it reached pH 7.  
 





When the side chain functionalisation of lanosterol acetate 10 was complete, there was now a 
sufficient difference in polarity between the diols 13a and 13b and the dihydrolanosterol 
acetate 11 to enable separation by column chromatography. Dichloromethane was used as the 
first eluant yielding 11 as a white solid in 41% yield as the first fraction from the column. 
When the eluant was changed to ethyl acetate, the diol mixture 13a and 13b was recovered as 
an off white solid in 72% yield as the second major fraction from the column. Some minor 
trace products with polarity ranging between 11 and 13a and 13b were distinguishable on the 
TLC plate of the crude material. These minor products were not further purified or 
characterised.  




Diol 13 (Figure 2.5) was recognised by the doublet at 3.29 ppm corresponding to the CH of 
the 24R isomer and the singlet at 3.34 ppm corresponding to the CH of the 24S isomer in the 
1
H NMR spectrum of the product.
9
 In the 
13
C NMR spectrum the tertiary alcohol at C-25 
appeared at 73.2 ppm, while a difference in the secondary alcohols at C-24 of 13a and 13b 
was evident by signals at 78.7 ppm and 79.6 ppm respectively. IR analysis showed a broad 
peak at 3431 cm
−1
, consistent with the presence of the alcohol moieties in the mixture. The 
sharp signal at 1732 cm
−1






Following separation, both compounds served as viable starting materials for different aspects 
of the research. Diol 13 would serve as an invaluable starting material in the synthesis of 
target molecules with derivatised side chains. These were our main targets initially, as a 
number of the potent isolates from Antrodia camphorata have several oxygen containing 
functionalities in the side chains, including carboxylic acids and esters.
3
 In contrast, the 
dihydrolanosterol acetate 11 is unfunctionalised in the side chain. However, its usefulness 
cannot be devalued, as it would serve as a starting material in test reactions for synthetic 
modifications of the lanostane nucleus. This chemistry is equally as important in the research, 
as seven of the eight isolates from Antrodia camphorata possess either conjugated diketones 
at C-7,11, or conjugated dienes across the B and C ring motifs.
3
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Therefore, a process had been set in place, whereby test oxidations and reductions would be 
carried out on 11, while diol 13 would be preserved for side chain chemistry where the 
lanostane nucleus modification routes had been established.  
 
2.3.2 Target transformations 
Following the synthesis of these two starting materials, we pinpointed the most interesting 
and useful synthetic transformations to target. The selected transformations (Figure 2.6), 
which would lead to an array of novel compounds, were devised in conjunction with the 














2.3.3 Allylic oxidations of C-8,9 alkene, and deprotections of C-3 alcohols 
At this early stage in the project our aim was to expand on the previous research carried out 
and move this research in new directions, focussing on the lead compound 4. Triketone 4, the 
most biologically active compound synthesised in previous work within the research group, 
was used as the template for prospective target molecules. We wished to focus on the 
synthesis of novel compounds which would retain the C-7,11 conjugated diketone moiety, 
while progressing our work to incorporate side chain functionality. And so, an initial target 






Previous research within our group successfully carried out the allylic oxidation of the C-7 
and C-11 positions in the lanostane systems.
2
 The oxidising agent chromium trioxide had 
been used for this transformation. We opted to continue with the CrO3 method as it had 
shown the most success in the group to date. However, alternative methods of allylic 
oxidation would be explored at a later stage in this project. With our diol starting material, it 
was envisaged that the C-24 OH group would also be oxidised to the C-24 ketone during the 
course of this reaction, which would be very advantageous. Therefore, our first objective was 
the synthesis of our novel target molecule via the allylic oxidation of diol mixture 13a and 
13b using chromium trioxide. Diol mixture 13a and 13b was reacted with 4 molar equivalents 
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of chromium trioxide in refluxing acetic acid. Upon reaction initiation, the instantaneous 
colour change of the chromium trioxide from dark orange to dark green confirmed oxidation 
was taking place. As the substrate is being oxidised, the oxidising agent is itself being 




. The colour change of the chromium is consistent with 
its reduction, as chromium is known to be orange in its +6 oxidation state, and green in its +3 
oxidation state. The oxidation reaction led to the formation of one major product 14, plus a 








The products were separable by column chromatography using hexane : ethyl acetate (80:20). 
The desired product 14 was isolated as a yellow solid in 31% yield as the second fraction 
from the column. As expected, the C-8,9 alkene underwent allylic oxidation to form the C-
7,11 conjugated diketone. However, the new feature of interest in this product, the keto-
alcohol in the side chain, is of greater significance. It marks the commencement of a new 
stage in the project, following on from the previous work. The secondary alcohol at C-24 in 
the diol starting material had been oxidised to a ketone, while the tertiary alcohol, which is 
not susceptible to oxidation, remained intact.  
The product 14 showed characteristic new peaks in the 2.10 – 3.00 ppm region of the 
1
H 
NMR spectrum. The 1H signals at 2.60 and 2.78 ppm are characteristic of the 12-CHs in the 
 and  positions respectively. The downfield shift of these signals is good evidence for the 
formation of the ketone moiety at C-11. The doublet of triplets at 2.89 ppm was assigned to 
1-CH, owing to the fact that C-11 is in close proximity to 1-CH due to the conformational 
arrangement of the B and C steroidal rings (Figure 2.8). The 
13
C NMR spectrum showed new 
signals in the carbonyl region at 201.9 and 202.2 ppm corresponding to ketones at C-11 and 
C-7 respectively. As the carbonyl group of the acetate ester is at the standard chemical shift 
value of 170.9 ppm, the new signal at ~180 ppm is being tentatively assigned as the ketone at 
C-24. Although this is a very low chemical shift value for a ketone, it is assigned as C-24 
C=O given that it is the only signal remaining in the carbonyl region (Figure 2.9). Moreover, 
the signals corresponding to 24-C-OH in the starting diol 13 at 3.29 and 3.34 ppm in the 
1
H 









Figure 2.9 C values for the noteworthy features of the novel compound 14. 
 
The side product 15 was isolated as part of a complex mixture as the first fraction from the 
column, and was an unexpected product of the reaction. It is being assigned as one compound 
in a mixture with trace amounts of a number of unidentifiable products. 
1
H NMR 
spectroscopic evidence for this shift appears as a 1H singlet at 2.89 ppm which corresponds to 
8-CH. Therefore the C-8,9 double bond has moved out of conjugation into the C-9,11 
position. The 1H multiplet between 5.40 and 5.41 ppm represents the vinylic proton 11-CH, 
further verifying the existence of the C-9,11 double bond (Figure 2.10).  
 
 
Figure 2.10 Side product 15 




Interestingly, in this product, the alkene bond shifts out of conjugation with the carbonyl 
group from C8-9 to C9-11. Usually conjugation is a favourable entity on electronic grounds, 
allowing free resonance over multiple bonds and increasing stability. However, in this case, 
one must consider the puckered nature of the C-C bonds in the chair conformation of 
cyclohexene. A plausible explanation for this uncharacteristic behaviour is that the 
conjugation may put too much strain on ring B, and thus the alkene bond moves out of 






The new compounds synthesised, 14 and 15, were intended to be evaluated for anti-cancer 
activity. Our main target, and major product of the reaction 14, was sufficiently pure and 
stable to be evaluated for biological activity, the results from which will be presented in due 
course. However, given the impurity of side product 15, it was not a viable candidate for this 
screening.  
A significant number of the potent isolates from Antrodia camphorata contain a hydroxyl 
group at C-3. Therefore, after formation of the acetyl protected lanosterol derivative 14, the 
next logical step was to proceed with deprotection of the alcohol at C-3 by removal of the 
acetate ester. This deprotection was investigated under various conditions using 14 as a 





Chapter 2: Results and Discussion 
82 
 
Table 2.1 Various conditions employed for the hydrolysis of 14 
 
 
Reagent Equivalents Solvent Temperature Time Reaction Outcome 
K2CO3 (aq) 1.1 MeOH r.t. 24 h S.M. 
K2CO3 (aq) 2 MeOH r.t. 24 h S.M. 
CH3COCl 5 DCM/MeOH r.t. 72 h S.M. 
KOH 10% EtOH 60 °C 2 h 70% 
  
 
The first set of conditions investigated were the use of 1.1 equivalents of aqueous potassium 
carbonate in methanol at room temperature for 24 hours.
14
 Spectroscopic analysis after this 
time showed that the identifiable peaks in the 
1
H NMR spectrum corresponded to the starting 
material 14. This material was retrieved in 100% recovery and the material was re-exposed to 
the base in the next test reaction. The concentration of potassium carbonate was increased to 
two equivalents and the reaction was repeated under the same conditions of temperature and 
time. 
1
H NMR spectroscopic analysis revealed the same outcome that 14 was the main 
compound recovered, along with trace quantities of unidentifiable materials. This material 
was retrieved in 90% recovery. Previous work in the research group had employed acetyl 
chloride as a deacetylating agent.
15
 This procedure, using acetyl chloride in 1:1 anhydrous 
dichloromethane: methanol, was undertaken on the material from the failed potassium 
carbonate reactions. 
1
H NMR analysis revealed a broad multiplet in the 3.20 – 3.50 ppm 




region. This is the region where the signal of the 3-CH proton would be expected to appear. 
However, the desired splitting pattern of a doublet of doublets was not observed in this 
region. The successful deprotection was achieved with 10% potassium hydroxide in ethanol. 
The desired product 16 was formed in 70% yield and the characteristic disappearance of the 
1H doublet of doublets at 4.50 ppm and appearance of the signal at 3.20 ppm in the 
1
H NMR 
spectrum was evidence of successful deprotection.  
This deprotection was also carried out on 15, which contained trace amounts of other 
unidentifiable products, with 10% potassium hydroxide in ethanol in an attempt to synthesise 
17 (Scheme 2.5). 
1
H NMR analysis of the crude material revealed a complex mixture of 
products. A shift in the 3-CH peak from 4.52 ppm to 3.30 ppm indicated successful alcohol 
deprotection. However other materials in the 
1
H NMR spectrum of the crude material were 
unidentifiable due to the impure nature of the starting material. Purification of the product 
was not deemed viable due to limited quantities of material, and the relatively small amount 
of the desired product within the material, as seen by 
1
H NMR analysis. The synthesis of 17 




After this initial allylic oxidation and deprotection had been investigated, our next target was 
to use dihydrolanosterol acetate 11 in a similar fashion. This would expand on our set of 
compounds with the conjugated diketone motif, and give a level of structural consistency in 
the first grouping of lanostane derivatives to be sent for biological evaluation. 
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Dihydrolanosterol acetate 11 also underwent allylic oxidation with 4 molar equivalents of 
chromium trioxide, to yield diketone 18 as a yellow solid. Deprotection of 18, using the 






Characteristic signals in the 
1
H NMR spectrum of the allylic oxidation product 18 at 2.61 
ppm and 2.75 ppm represent 12-CH and 12-CH respectively. The 1-CH behaved in a 
similar fashion to the previous diketones synthesised, shifting downfield to 2.89 ppm due to 
its proximity to 11-C=O. The downfield shift of these signals indicates the proximity of the 
protons to the ketone functionalites at C-7 and C-11. The 
13
C NMR spectrum is as expected, 




with the characteristic C-7 and C-11 ketone signals appearing at 202.5 ppm and 202.0 ppm 
respectively (Figure 2.12). Other standard signals also appear in the 
13
C NMR spectrum. The 
carbonyl group of the acetate ester appears at 170.8 ppm, and the C-8 and C-9 alkene signals 
remain at 150.7 ppm and 151.7 ppm respectively. This result is due to the high ratio of 




Figure 2.12 C and H values for the noteworthy features of 18 
The resulting diketone 18 was used for the next step which was deprotection of the C-3 
alcohol group by removal of the acetate ester. This deprotection was accomplished 
successfully using the earlier optimised conditions of 10% KOH in EtOH yielding 19 (90%) 
following repeated chromatography. Again the characteristic disappearance of the 1H doublet 
of doublets at 4.53 ppm and appearance of the new signal at 3.28 ppm in the 
1
H NMR 
spectrum was evidence of successful deprotection (Figure 2.13). 





While the allylic oxidation using chromium trioxide is clearly an efficient method of 
synthesising ketones in these positions, it is not without its drawbacks. The Cr
VI
 reagent is 
highly toxic and carcinogenic, making it hazardous to researchers and the environment. Its 
disposal is not trivial, requiring separate containment and incineration of wastes. Therefore 
we had great interest in finding alternative methods for this oxidation. The dihydrolanosterol 
acetate 11 would be used as a substrate for these test conditions. This is an example of 
utilising 11 in order to test and optimise skeletal oxidations. Many literature reports detail 
unconventional allylic oxidation systems when the alkene bond is at the C-5,6 position.
16,17
 
The introduction of a ketone moiety at C-7 appears to be considerably more difficult when the 
alkene is at the C-8,9 position. This may be due to the synergistic effects of increased steric 
hindrance exerted by additional methyl groups (ie. C-18, C-19 and C-30) around the site of 
reactivity, and also the steric unavailability of the tetrasubstituted C-8,9 double bond. Though 
previous work in our group attempted to oxidise the C-7 and C-11 positions using cumene 
hydroperoxide, t-butylhydroperoxide catalysed by both RuCl3 and TBAB, and Rh2(cap)4 and 
K2CO3, these attempts had been unsuccessful and chromium reagents were instead employed. 
The ruthenium trichloride – 
t
butyl hydroperoxide allylic oxidation of lanosterol derivatives is 
reported in the literature.
18
 A noteworthy property of ruthenium complexes is the existence of 
several oxidation states, most of which are kinetically inert. These oxidation states range from 
0 to +8 and −2; the +2, +3 and +4 oxidation states being the most common. In the case of 
ruthenium chloride, ruthenium exists in its +3 oxidation state, one of its most stable states. 
t
Butyl hydroperoxide is a commonly used oxidising agent, most notably used in the Sharpless 
epoxidation. It is supplied as a 69 – 70% aqueous solution due to its instability at higher 
concentrations. This is the concentration of the oxidant used in the aforementioned literature 
example of the reaction. 




In this literature example, where the substrate was identical to our starting material 11, the 
authors report an 89% yield of product 18. However in our hands, using an inseparable 
mixture of 10 and 11 (Scheme 2.7), observation of the 
1
H NMR spectrum of the crude 
material showed no evidence of formation of the desired product. It has been reported in the 
literature that ruthenium trichloride is very hygroscopic and absorbs some atmospheric 
moisture in the form of water of crystallisation, thus rendering its catalytic efficiency 
diminished.
18
 The reaction was repeated, doubling the concentration of the catalyst from 1 
mol% to 2 mol%. However, no evidence of product formation was seen on this occasion. As 
the reaction was unsuccessful in our hands after repeated attempts, it was not further pursued 
using this reagent. Future work will involve investigations into methods of allylic oxidation 




Though the allylic oxidation of the C-8,9 alkene is difficult using milder reagents such as 
t
butyl hydroperoxide and ruthenium trichloride, the alkene in the side chain at C-24,25 is 
theoretically more susceptible to an allylic oxidation under mild conditions, given its exposed 
position. Therefore, we were also interested in allylic oxidation reactions which could be 
carried out on the lanosterol side chain.  
Thus, an attempted allylic oxidation of the C-24,25 alkene was carried out on the inseparable 
mixture of lanosterol 6 and dihydrolanosterol 7 using selenium dioxide, in an attempt to 
exploit the alkene functionality present in the lanosterol side chain, and synthesise 20 
(Scheme 2.8).  







This reaction was also unsuccessful in our hands, although Zhao reports the allylic oxidation 
of an isopropylidene group using selenium dioxide.
19
 A majority of starting material was 
recovered, with evidence of a trace amount (~6%) of product formation owing to the 
appearance of a broad singlet at 9.34 ppm in the 
1
H NMR spectrum. Due to the limited 
amount of desired product within the crude material, purification was not attempted. This 
transformation could be revisited in future work, however, to date, chromium trioxide 
remains the best reagent for allylic oxidations in our work. 
 
 





Figure 2.14 Mechanism of allylic oxidation using selenium dioxide 
 
2.3.4 Revised route to new starting material; 3-acetoxy-5-lanost-8-ene-24-al 21 
Though synthesis of the starting material diol 13 proved useful, both in order to separate the 
dihydrolanosterol component of the mixture, and as a precursor for side chain 
transformations, a C-24 aldehyde intermediate seemed to be a useful starting material for our 
work, due to the wide range of derivitisation prospects associated with an aldehyde group 
(Figure 2.15). Such derivitisations include Wittig reactions, Grignard reactions and reductive 
aminations, which will be discussed in due course.  
Figure 2.15 
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A synthetic route to this aldehyde, which proceeded through the selective epoxidation of C-
24,25, was chosen. This route to the aldehyde starting material 21 had major advantages over 
the route to diol starting material 13. Firstly the route involved two steps rather than three: the 
aldehyde was synthesised by formation of the side chain epoxide 22 (Scheme 2.9) followed 
by oxidative cleavage to yield 21 (Scheme 2.10), whereas the route to diol 13 involved the 
protection of the C-3 alcohol, followed by halohydrin formation, followed by diol formation. 
Secondly, there were less side products formed which in turn led to less tedious purification. 








The selective epoxidation of the lanosterol acetate component of the mixture of  10 and 11  
proceeded in good yield (75%) under mild conditions and short reaction time. The C-24,25 
alkene is epoxidised in preference to the C-8,9 alkene due to it being less sterically hindered. 
The epoxide 22 is formed as a 1:1 mixture of R and S isomers, and these isomers were 





The epoxide 22 is distinguished by the characteristic signals in the 
1
H NMR spectrum. The 
triplet at 5.10 ppm corresponding to 24-CH of the starting alkene 10  had disappeared, and a 
new triplet at 2.69 ppm corresponding to 24-CH in the product 22 was observed. The absence 
of the C-24,25 alkene signals at 125.3 ppm and 130.9 ppm in the 
13
C NMR spectrum of the 
starting material 10 and the presence of new epoxide signals at ~58 ppm and ~64 ppm in the 
product 22 is further evidence for this transformation. Peaks in the 
1
H NMR spectrum are 
indistinguishable for the R and S isomers. However, clear differences can be deciphered in the 
13
C NMR spectrum. Key distinctions between the R and S isomers are seen at C-12, C-16, C-













Carbon C for 24-R isomer C for 24-S isomer 
12 30.90 30.95 
16 28.22 28.17 
17 50.27 50.38 
20 36.21 36.34 
22 32.60 32.80 
23 25.61 25.91 
24 64.94 64.79 
25 58.41 58.14 
27 18.73 18.66 
 
It was not necessary to attempt to separate these isomers, as our synthetic route involved the 
oxidative cleavage of the epoxide in the next step. This was achieved using periodic acid in 
diethyl ether under mild conditions with a very short reaction time of 10 minutes.
21
 It is worth 
noting the ease with which this cleavage took place, due to the steric availability of the 
epoxide at the end of the steroidal chain. The yield reported in Scheme 2.10 below is the yield 
of analytically pure product, with a further ~ 80% of the sample having a purity ≥ 95%. The 
formation of side product 30 will be discussed in due course.  
 
Scheme 2.10 
Mechanistically this reaction proceeds via initial acid ring opening of the epoxide (Figure 
2.17). The periodic acid H5IO6, which can be thought of as HIO4 with two H2O molecules 
attached, forms a five membered cyclic periodate intermediate with the diol. The concerted 




collapse of this five membered intermediate leads to the formation of two carbonyl moieties; 
in our case, an aldehyde and a ketone. By fortunate coincidence, the ketone side product of 
this reaction is, in fact, acetone. Therefore, removal of the side product by column 
chromatography was not necessary, as it was lost in the concentration of the crude product 
under reduced pressure.  
 
Figure 2.17 
The formation of the aldehyde 21 was evident from a new triplet at 9.77 ppm in the 
1
H NMR 
spectrum corresponding to 24-CH, and a new multiplet between 2.31 ppm and 2.52 ppm 
corresponding to 23-CH2. The absence of the 24-CH epoxide signal at 2.69 ppm in the 
starting epoxide 22 was also observed upon analysis of the 
1
H NMR spectrum. By 
comparison of the 
13
C NMR spectra, the transformation is also evident. A new signal at 203.3 
ppm in the 
13
C NMR spectrum of the product is clear evidence for the formation of the 
desired aldehyde 21 (Figure 2.18). 
 
Figure 2.18 
As already mentioned, the successful synthetic route to this aldehyde 21 would open up an 
exciting area of the project in the future.    
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2.3.5 Biological Testing 1: Lanosterol Oxidation Products 
 
At this stage in the project we began our first biological evaluation of the products 
synthesised. The biological testing results would serve as a tool in strategically planning the 
next stage of synthetic chemistry. Compounds which showed good biological activity would 
be used as templates, and their functional groups would be incorporated as much as possible 
in the next batch of compounds. This first batch of lanosterol oxidation products was screened 
against two different cancer cell lines. The CaCo-2 cells are human colon cancer cells and the 
U937 cells are human lymphoma cells.
22
 The results are presented in terms of percentage 
viability of the cells after treatment with the test compounds in question. A low percentage 
viability relative to the concentration of compound used, indicates a positive result. For 
example, 5 – 10% viability of the cells using a concentration of 5 – 10 g/mL of test 
compound would be considered a good result. The evaluation of our first set of compounds is 












 % Viability of CaCo-2 cells % Viability of U937 cells 
 50 g/ml 200 g/ml 50 g/ml 200 g/ml 
13  107.63 ± 1.63  78.87 ± 0.32 
14  74.77 ± 3.47  80.45 ± 1.00 
18  86.58 ± 2.81  79.96 ± 3.20 
19  88.15 ± 1.92  94.54 ± 3.31 
16  96.07 ± 3.89  95.01 ± 2.35 
22 95.63 ± 1.03  10.43 ± 2.40  
 
 
Figure 2.20: Percentage viability of CaCo-2 and U937 cells following treatment with 200 
g/mL of compounds 13, 14, 18, 19 and 16. 
It is evident that the epoxide 22 displayed the highest cytotoxicity, at a concentration of 50 
g/mL giving ~ 10% viability. This result means that ~ 90% of U937 cells were killed when 
treated with 50 g/mL of epoxide 22.  
We were disappointed with the poor results from 14, 18, 19 and 16, in these cell lines. As 
discussed earlier, the conjugated diketone was one of our biggest target structural features 
owing to its presence in many A. camphorata isolates. While these compounds did not show 
biological activity in the two cell lines tested, they will be screened against a larger number of 

















% Viability of cells at  
Compound Concentration of 200 g/mL  
CaCo-2 cells 
U937 cells 
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Despite our disappointment with the poor activity of the diketones, we gained the valuable 
knowledge that the epoxide was the most active compound in this initial screen. Our aim was 
to take the most positive result from this screen and utilise the new biological knowledge as 
efficiently as possible. Our initial target was to incorporate epoxide functionality in further 
derivatives.  
 
2.3.6 Synthesis of side chain epoxide derivatives 3-hydroxy-24R,S,25-epoxy-5α-lanost-8-
ene 23 and 3-keto-24R,S,25-epoxy-5α-lanost-8-ene 24 
The next objective was to alter the functionality at carbon 3, while maintaining the epoxide 
incorporated into the side chain of the lanostane compound. Our next targets emerged as the 
alcohol 23 and ketone 24 at carbon 3 (Figure 2.21). Considering the structures of the 
biologically active isolates from Antrodia camphorata in conjunction with our first set of 
biological results, it appeared from our tests to date that the conjugated diketone was not as 






Firstly, the target epoxide with C-3 alcohol 23 was found to be relatively straightforward to 
synthesise. Given that the commercial lanosterol already has the alcohol in place at C-3, our 
synthetic strategy involved the selective epoxidation of the C-24,25 alkene and separation of 
the dihydrolanosterol species 7 (Scheme 2.11). The 16% yield of epoxides is the analytically 




pure sample, the remainder of material is of a purity ≥ 95%, which is sufficiently pure for 
further synthetic work. 
 
Scheme 2.11 
The epoxide is again distinguished by the characteristic peaks in the 
1
H NMR spectrum. The 
triplet at 5.10 ppm corresponding to 24-CH of the starting alkene 6 had disappeared, and a 
new triplet at 2.69 ppm corresponding to 24-CH in the product 23 was observed. The absence 
of the C-24,25 alkene signals at 125.2 ppm and 130.9 ppm in the 
13
C NMR spectrum of the 
starting material 6 and the presence of new epoxide signals at ~58 ppm and ~64 ppm in the 
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product is supporting evidence for this transformation. This compound was synthesised in 
57% yield and was available for the next round of biological screening. 
It was logical at this stage to mimic the chemistry of the related C-3 acetate compound 22, by 
performing an oxidative cleavage on epoxide 23, to yield aldehyde 25 (Scheme 2.12). 
 
Scheme 2.12 
The formation of the aldehyde 25 was evident from a new triplet at 9.77 ppm in the 
1
H NMR 
spectrum corresponding to 24-CH, and a new multiplet between 2.25 ppm and 2.55 ppm 
corresponding to 23-CH2. The absence of the 24-CH epoxide signal at 2.69 ppm in the 
starting epoxide 23 was also observed upon analysis of the 
1
H NMR spectrum. By 
comparison of the 
13
C NMR spectra, the change is also evident. A new signal at 203.3 ppm in 
the 
13
C NMR spectrum of the product is clear evidence for the formation of the desired 
aldehyde 25. This reaction proceeded in 73% yield and gave the alcohol analogue of the C-24 
aldehyde.  
Secondly, epoxide 24, with ketone functionality at C-3, was more challenging to synthesise. It 
involved the selective epoxidation of the C-24,25 alkene, as well as the selective oxidation of 
the sterically hindered C-3 alcohol, without allylic oxidation or opening of the epoxide ring. 
Therefore, a synthetic strategy was devised by a trial and error approach to this sequence of 
synthetic steps.  
Our initial aim was to synthesise the epoxide prior to the secondary alcohol oxidation. A 
literature search
23
 then revealed a procedure for the selective oxidation of the secondary 
alcohol in steroids using a mild procedure involving iodine and potassium carbonate.  
 






This reaction was carried out over a 36 hour reflux period. After this time 
1
H NMR analysis 
showed the reaction had only gone ~ 10% to completion. Our judgement of this reaction was 
that the epoxide was in some way interfering with the alcohol oxidation, given that the 
literature example
23
 was an unfunctionalised steroid. It is known that epoxides can be 
converted into halohydrins by means of elemental halogen (Scheme 2.14).
24
 This is a sluggish 
reaction, often requiring a catalyst. However, under our reaction conditions of refluxing over 
a 36 hour period, it is possible that this transformation had taken place.  
 
Scheme 2.14 
We decided to proceed with a different synthetic strategy. This involved oxidising the 
commercial lanosterol 6 and dihydrolanosterol 7 mixture prior to epoxidation. Literature 
precedent indicated two equivalents of iodine and potassium carbonate were sufficient for the 
oxidation of the secondary alcohol. In our first attempt of this reaction, two equivalents of 
both reagents were employed over a 36 h time period, resulting in 35% yield of product. The 
reaction time was then increased to 48 h, which increased the yield to 57%. However, our 
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optimisation work involved shortening the reaction time from 48 to 36 hours using four 




Entry I2 equivalents K2CO3 equivalents Time  Yield 
1 2 2 36 h  35% 
2 2 2 48 h 57% 
3 4 4 36 h  50% 
 
 
Although this diminished the reaction yield by 7%, the shortening of the reaction time from 
48 hours to 36 hours enabled the reflux to be carried out through one night instead of two. 
This was considered significantly advantageous, from both a laboratory safety and time 
management point of view.  




The oxidation is indicated by the loss of the 3-CH signal at 3.24 ppm in the 
1
H NMR 
spectrum of the starting alcohol mixture 6 and 7.  
While several attempts to separate the two ketones 26 and 27 proved unsuccessful, the 
mixture could be separated when the side chain of 26 had been epoxidised at the C-24,25 
alkene (Scheme 2.15).  
 
Scheme 2.15 
This was the final successful route which led to the synthesis of the keto epoxide 24 in 44% 
yield after purification. The 
1
H NMR spectrum of the product showed the triplet at 2.69 ppm 
corresponding to the epoxide 24-CH as its only distinguishable peak. The signal at 217.9 ppm 
in the 
13
C NMR spectrum was evidence that the ketone functional group at C-3 was still 
intact. The 
13
C NMR spectrum gave further support to the structure of the product with the 
epoxide carbons appearing at ~58 ppm and ~64 ppm.  
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This was a big milestone in the project as it involved the combination of our most 
biologically significant results to date. The epoxide in the side chain was retained in this new 
product and the ketone functionality had been introduced.  




C NMR analysis, 
the main characteristic signal being a peak at 218.0 ppm which corresponds to the ketone at 
C-3. This product was carried on to a further step and reacted with m-CPBA to epoxidise the 
C-8,9 double bond, in order to synthesise 28 (Scheme 2.16). However, purification was found 
to be very difficult, requiring repeated column chromatography. The 
1
H NMR analysis 
described was carried out on a sample containing minor residual amounts of m-CPBA. 





When the keto epoxide 24 was synthesised and available for biological testing, the next step 
was to synthesise the aldehyde at the C-24 position 29 from this substrate. This would lead to 
the completion of the library of C-24 aldehydes with acetate 21, alcohol 25 and ketone 29 
groups at C-3 respectively.  
The established oxidative cleavage method was used for the synthesis of aldehyde 29 
(Scheme 2.17).  
 








Again, the oxidative cleavage reaction took place over a short time period of 15 min. The 
desired aldehyde was formed in 16% yield after repeated chromatography. The formation of 
the aldehyde 29 was evident from a new triplet at 9.78 ppm in the 
1
H NMR spectrum 
corresponding to 24-CH,  In this case, the 23-CH2 multiplet in the 2.20 ppm – 2.60 ppm 
region was obscured by the overlapping 2-CH2 multiplet, which appears with greater 
downfield shift due to its proximity to the ketone at C-3. The disappearance of the 24-CH 
epoxide signal at 2.69 ppm in the starting material 24 was also observed upon analysis of the 
1
H NMR spectrum. By comparison of the 
13
C NMR spectra, the change is also apparent. A 
new signal at 203.3 ppm in the 
13
C NMR spectrum of the product is clear evidence for the 
formation of the desired aldehyde 29. 
While the purified yield of the C-3 alcohol analogue 25 of these C-24 aldehydes is quite good 
(73%), the isolated yields of the acetate 21 and ketone 29 analogues were rather 
disappointing, at 12% and 16% respectively. Encouragingly, this is not due to failed 
conversion of epoxide to aldehyde, as ≥95% conversion is observed by analysis of the 
1
H 
NMR spectra, but instead is a purification issue. As the Rf values of the side products are very 
close to that of the desired product on a TLC plate, the isolated yield of analytically pure 
sample of aldehyde is, in this case, 12 – 16%. The other ~80% of sample has a purity of ≥ 
95%, which was used in the synthetic work described in this thesis.  
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The formation of side products in this oxidative cleavage reaction could be playing a role in 
diminishing the yield. By analysis of the 
1
H NMR spectrum of the crude material, only the 
desired aldehyde is observed. However, trace amounts of side products are seen as faint spots 
on a TLC plate. One such side product is ketone 30 (Figure 2.22), which was formed in 1% 




This is a side product from the oxidative cleavage reaction of 22. The 
1
H NMR spectrum of 
this isolated side product showed the characteristic multiplet between 2.26 ppm and 2.69 ppm 
which occurs when 23-CH2 is adjacent to a carbonyl functionality. However there was no 
trace of an aldehyde signal at ~9.7 ppm in the 
1
H NMR spectrum. This led us to believe a 
ketone rather than an aldehyde was present at C-24, and 
13
C NMR analysis confirmed this. 
The signal at 215.4 ppm in the 
13
C NMR spectrum showed a ketone functionality was present. 
The side chain structure was then confirmed by revisiting the 
1
H NMR spectrum and noting 
the recurrence of the 26-CH3 or 27-CH3 as a distinct doublet at 1.09 ppm, indicating that the 
C-24,25 bond had not been cleaved in this case, and leading us to the tentative assignment
25
 
of the structure of this side product as 30 (Figure 2.22).  
Mechanistically, we propose that this product is formed in a similar fashion to the aldehyde. 
The acid ring opening of the epoxide, followed by insertion of the iodine complex to form the 
five membered ring system remains the same. However, the concerted collapse proceeds via a 
different pathway leading to the formation of the ketone and not cleavage of the C-C bond to 
form the aldehyde (Figure 2.23). 
 









2.3.7 Synthesis of 3-acetoxy-lanost-8,9-epoxide 1, and 3-acetoxy-5-lanost-7,9(11)-
diene 2 
As discussed in the “Target Transformations” Section 2.32, the conjugated diene of the 
central ring structure was a desirable moiety to synthesise, as it is present in four isolates from 
A. camphorata. Compound 2 (Figure 2.24) had been previously synthesised in the group and 
contained the diene motif across the B and C rings. Unfortunately, this compound had shown 
poor activity against the Sf9 insect cells. Therefore, our aim was to synthesise this compound 
again, in order to test it against the CaCo-2 cells and the U937 cells, with a view to expanding 
a series of conjugated dienes if 2 showed good activity. 






Epoxidation at C-8,9 is the first step in the strategic transformation of dihydrolanosterol 
acetate 11, via epoxide 1, to diene 2 (Scheme 2.18 and Scheme 2.19).  
Dihydrolanosterol acetate 11 was reacted with m-CPBA and epoxidation occurred at the only 
available position, the alkene at C-8,9. Purification by repeated column chromatography 
yielded the pure product 1 as a white solid (38%). The 
1
H NMR spectrum of 1 was 
indistinguishable from starting material 11 due to quaternary carbons at the site of reactivity 
in both the starting material and product. The 
13
C NMR spectrum gave good evidence for the 
transformation, showing an upfield shift of the C-8 and C-9 signals from 134.2 ppm and 
134.5 ppm to 68.0 ppm and 70.5 ppm respectively.  
 
Scheme 2.18 
This reaction took 72 hours to go to completion and required 4.2 equivalents of m-CPBA. 
This result is not unexpected, as the C-18, C-19 and C-30 methyl groups are causing steric 
hindrance near the site of reactivity. It is the orientation of these methyl groups which 
determines the stereoselectivity of the reaction. The methyl groups at C-18 and C-19 are both 




lying on the  face, thus inhibiting free approach of the peroxy acid reagent. Though 30-CH3 
and 5-CH are both lying on the  face, the steric availability of this side of the steroid is far 
greater as a CH group exerts less steric hindrance than a CH3 group. Therefore,  face attack 





The ring opening of the C-8,9 epoxide 1 is the next step in the synthesis of the conjugated 
diene. p-Toluenesulfonic acid was used to ring open the epoxide, which was followed by 












Formation of the desired product is evident from analysis of the 
1
H NMR spectrum. The 
acetyl group at C-3 is still present due to the 1H doublet of doublets at 4.52 ppm. New signals 
at 5.34 ppm and 5.46 ppm correspond to the vinylic protons 11-CH and 7-CH respectively. 
The 
13
C NMR spectrum showed C-11 and C-7 shifting downfield from 21.5 ppm and 23.3 
ppm to 116.6 ppm and 119.8 ppm. These characteristic signals of vinylic protons are good 
evidence for the formation of the conjugated diene moiety.  
The reaction proceeded with ~ 60% conversion to the desired product.  This is evident from 
the characteristic shift of the 3-CH signal in the 
1
H NMR spectra. This signal is shifted 
slightly downfield from 4.46 ppm in the starting material, to 4.52 ppm in the product. 
Purification required repeated chromatography, yielding the product 2 in 22% yield. This 
reaction would need to be optimised in future work, to increase the percentage conversion of 
starting material to product. Optimisation work could include use of additional equivalents of 
p-toluenesulfonic acid, or longer reaction times. 
This compound was characterised and prepared for a future screening. It also had the 
potential to be further derivatised, as the conjugated diene introduces new reactive sites on 
both rings. However, the initial objective would be to test the parent compound before any 
derivitisation would take place. Unfortunately, when the compound was sent for testing, it 
was found to show unusual poor solubility in the appropriate solvents, for example, ethanol, 









2.3.8 Grignard reactions on aldehyde 21 
As previously discussed, the C-24 aldehyde moiety in the lanostane structure was highly 
synthetically useful in terms of Grignard reactions, Wittig reactions, and reductive aminations 
(Figure 2.15). Takatsuto et al. report a Grignard reaction on a protected cholestane steroid to 




Isomers were formed in the following yields:                                                                                              
(22S,24S) isomer, 19%; (22S,24R) isomer, 46%; inseparable mixture of (22R,24R) and (22R,24S) isomers, 7%. 
Scheme 2.21 
The Grignard reaction could also be applied to our C-24 aldehydes in the lanostane 
derivatives. As our side chain functionalisation had thus far incorporated oxygen groups at 
carbons 24 and 25, a carboxylic acid or ester at C-26 was our next objective, as certain 
isolates from A. camphorata bear an ester moiety at this position in the side chain (Figure 
2.26). Selective activation of one of the 26-CH3 or 27-CH3 groups to selectively form one 
ester seemed, at first, to be an unrealistic goal. However, aldehyde 21 opened up this area of 
chemistry for us. By use of a Grignard reaction
29
 we could choose a suitable precursor with 
an appropriate side chain to attach at this position.  
 
Figure 2.26 
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The first Grignard reaction that was attempted was a test reaction, in order to establish the 
optimum conditions under which this transformation could be achieved. Aldehyde 21 was 
reacted with 1-bromo-2-methyl propane to form 3-acetoxy-5-lanost-8-ene-24-ol 31. All 
glassware to be used for the Grignard reaction was dried overnight at 150 °C prior to use, as 
traces of water could impede the reaction by reacting with the Grignard reagent to form 
alkanes, an example of which is shown in Scheme 2.22. 
 
Scheme 2.22 
The standard method of using iodine to initiate the reaction was used. The iodine helps to 
remove an outer layer of oxide from the magnesium, thus exposing fresh magnesium surface 
and improving the rate of formation of the Grignard reagent, and consequently improving the 
rate of reaction. The Grignard reagent was seen to form spontaneously when the bromide was 





The desired product 31 was formed as a dark orange oil in 66% yield (Scheme 2.23). 
Confirmation of its formation is seen in the 
1
H NMR spectrum. A new signal is observed as a 
multiplet between 3.52 ppm and 3.72 ppm. This multiplet is assigned as the hydrogen of the 
new alcohol group at C-24. The doublet of doublets at 4.50 ppm is consistent with the 
presence of the acetyl group at C-3. The 
13
C NMR spectrum shows new signals at 71.4 ppm 




and 71.7 ppm respectively, which correspond to 24-CH R or S isomers. 3-CH appears at 80.2 
ppm, showing the presence of the acetyl group.  
Given the success of this trial reaction, we focussed on our main target, which was to 
introduce an ester containing group into the side chain, similar to those seen in the most 
active compounds from A. camphorata. A Grignard reaction was performed using a different 
bromide to achieve this transformation. Aldehyde 21 was reacted with methyl 3-bromo-2-





Unfortunately this reaction was unsuccessful following several attempts. In this case, there 
were no signs of initiation of the reaction to form the Grignard reagent as reflux did not occur 
spontaneously, as was seen in the previous reaction to synthesise 31. A heat gun was 
employed to allow reflux to occur, and the solution was maintained at reflux using an oil 
bath. However, despite our best efforts, it was not apparent that the Grignard reagent had 
formed by observation of the orange colour of the reaction solution. As this was the first 
attempt at this reaction, we were unsure of the exact colour change, but after an appreciable 
amount of time to allow Grignard reagent formation the reaction was proceeded with, to 
establish if any products could be isolated from the reaction.  
Of course, the 
1
H NMR spectrum revealed a mixture of starting aldehyde 21 and methyl 3-
bromo-2-methylpropanoate with no evidence of product formation. The starting aldehyde is 
still present due to the characteristic triplet at 9.77 ppm in the 
1
H NMR spectrum. An 
unidentified alkene signal at 5.12 ppm is also observed in the spectrum. An excess of bromide 
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starting material in relation to the steroid component is observed. Characteristic signals for 
methyl 3-bromo-2-methylpropanoate in the 
1
H NMR spectrum are a 3H doublet at 1.23 ppm, 
a 1H quartet at 2.91 ppm, a 2H doublet of doublet doublets at 3.53 ppm, and a 3H singlet at 
3.73 ppm. 
Unfortunately, after several attempts, this reaction remained unsuccessful. It is interesting that 
the trial reaction with 1-bromo-2-methyl propane yielded the desired product (Scheme 2.23), 
while methyl 3-bromo-2-methylpropanoate did not show any signs of forming the Grignard 
reagent. This may be due to increased steric bulk of the latter reagent, or an electronic effect 
imposed by the ester group. Nonetheless, this reaction will need to be repeated in future work, 




















2.3.9 Wittig reaction on 3-acetoxy-5-lanost-8-ene-7,11,24-one-25-ol 14 
As can be seen above, the Grignard route for introduction of an alternative side chain was 
unsuccessful for the ester derivative. Therefore, our attention turned to the incorporation of a 
side chain by means of a Wittig reaction. As seven of the eight isolates from A. camphorata 
bear an alkene moiety at C-24 (Figure 2.27), it was a target for us to try to incorporate this 
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Successful Wittig reactions have been carried out by O’Connell et al.
7
 on a protected 





Upon consideration of this reaction, we determined that a C-24 aldehyde would be a less 
advantageous precursor, due to the fact that the terminal isopropyl group could not be 
achieved, and a more useful starting material would contain a ketone in place at C-24, 









We had previously synthesised a compound containing a ketone at C-24, 14. Therefore, we 
turned our focus to a Wittig reaction to possibly introduce an alkene at this position. It was 
envisaged that the steric availability of this ketone at C-24 would allow it to react in 
preference to the other two ketones at C-7 and C-11.  
Triketone 14 was used as substrate in a Wittig reaction (Scheme 2.26). The reaction was 
carried out using sodium hydride, dimethyl sulfoxide and methyltriphenylphosphonium 
bromide.
30,31
 Analysis of the 
1
H NMR spectrum of the crude product showed no evidence of 
the formation of the desired product 33, and also no evidence of starting material 14. The 
crude product of the reaction was determined to be a complex mixture of unidentifiable 
products. It is possible that the site of reactivity at the C-24 ketone is too sterically hindered 
for the bulky triphenyl phosphonium reagent to approach. A longer reaction time, or 
increased equivalents of the Wittig reagent may lead to a successful outcome in future work, 
however, in our case the reaction was not pursued further due to insufficient starting material, 





2.3.10 A ring contraction of dihydrolanosterol 7 
Following on from our side chain functionalisation and modification of the B and C rings, our 
interest turned to variations on the A ring of the lanostane structure. Although modifications 
had already been made at C-3, including the introduction of ester and ketone functionalities, 
we saw the opportunity to contract the A ring to a 5 membered ring,
32,33
 with scope for further 
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derivitisation. This body of work would add diversity to our collection of lanosterol oxidation 
products and possibly provide interesting compounds for biological evaluation.   
Paryzek et al. studied the solvent effect in reactions of tetrasubstituted triterpenoidal alkenes 
with ozone, and reported an A ring contraction procedure using phosphorous pentachloride.
32
 
The A ring contracted product was subsequently treated with ozone as shown in Scheme 2.27. 
 
 
Paryzek does not report exact conditions for the A ring contraction in his publication.                                         




The ketone product of this ozonolysis reaction 34 was an initial target for our series of A ring 
contracted compounds, with a view to further functionalising the C-8,9 alkene and 
synthesising  37 (Scheme 2.27) which is an extremely useful analogue for our research, as 
will be discussed in due course. The initial step in the synthesis of ketone 34 was the A ring 
contraction. 




Thus, an 83:17 mixture of dihydrolanosterol 7 and lanosterol 6 was reacted with phosphorous 
pentachloride in a retropinacolic rearrangement  reaction (Scheme 2.28) to yield 3-
isopropyliden-14-methyl-A-nor-5-cholest-8-ene 35 and 3-isopropyliden-14-methyl-A-




Purification by column chromatography afforded 35 in 39% yield as the first fraction from 
the column. This interesting reaction proceeds via the mechanism proposed below in Scheme 
2.29, beginning with chlorine displacement of the alcohol group, followed by rearrangement 
of the A ring.  










C NMR spectra. There were few 
characteristic signals for the product in the 
1
H NMR spectrum, as there are no heteroatoms 
present in its structure. However, the absence of the doublet of doublets at 3.23 ppm 
corresponding to 3-CH of the starting material is good evidence for the formation of the 
product. The 
13
C NMR spectrum is much more informative. A second alkene in the structure 
is evident with new signals at 121.6 ppm and 135.2 ppm, corresponding to the new C-4 and 
C-3 respectively. The C-8,9 alkene is also retained, with signals at 133.6 ppm and 134.2 ppm. 
The second fraction from the column was 3-isopropyliden-14-methyl-A-nor-5-cholest-
8,24-diene 36, formed in 9% yield. The additional signals at 125.3 ppm and 130.9 ppm in the 
13
C NMR spectrum, correspond to C-24 and C-25 respectively. 
When the A ring contraction was complete, the possibility for exploitation of the diene of 35 
led to the emergence of a target molecule containing ketone and epoxide functionalities  
(Figure 2.29). This target molecule could be synthesised through an ozonolysis reaction to 
form 34 followed by epoxidation of the C-8,9 alkene to yield 37. 






The first step in the synthesis of 37 involved the cleavage of the A ring alkene bond via 
ozonolysis.
32
 Oxygen was passed through the reaction set up before ozone as a precautionary 
measure to identify any leaks in tubing. Once the set up was satisfactory the ozone generator 
was switched on and ozone was allowed to pass through the reaction vessel. 10% potassium 
iodide solutions in water were used to destroy excess ozone emerging from the reaction set 
up. Upon reaction completion, triphenylphosphine was added to the reaction mixture, in order 
to remove any residual ozonide. The crude ozonolysis product was purified by column 




C NMR spectra of the purified material revealed 
an unexpected result. The major product of the reaction was not 34 as anticipated, but rather 
37, which was isolated as a clear oil in 22% yield containing trace amounts of 
triphenylphosphine oxide (Scheme 2.30).  







The formation of the epoxide in this reaction was a very positive result, as our desired product 




H NMR spectrum revealed a 1H doublet of doublets at 2.68 ppm which corresponds to 
5-CH. This downfield shift is good evidence for the presence of the ketone at C-3. The 
13
C 
NMR spectrum, however, was more elucidatory. It was quite evident, upon first inspection, 
that the C-8,9 functionality had been lost, due to complete disappearance of the alkene carbon 
signals at 133.6 ppm and 134.2 ppm in the spectrum. The appearance of two new quaternary 
carbon signals at 68.6 ppm and 69.3 ppm gave rise to the proposal that the epoxide had been 
formed across this alkene bond, and high resolution mass spectrometry confirmed this theory. 
The signal at 217.4 ppm corresponds to the ketone in the contracted A ring.  




Though non polar solvents such as hexane have been shown to yield the enone as the major 
product of the reaction,
32
 in our attempt, this was not the case. The formation of 37 at this 
stage opened up a range of possibilities for further derivitisation and biological testing. One 
such possibility is the double expoxidation of the C-7,8 and C-9,11 diene as shown in Scheme 




However, the procedure for ozonolysis requires excess triphenylphosphine to be added to the 
reaction mixture upon completion as it removes residual ozonide and is itself converted to 
triphenylphosphine oxide. This triphenylphosphine oxide is quite difficult to remove 
completely by chromatography, and unfortunately, in our case, limited quantities of the 
product did not allow the repeated chromatography necessary for purification. Therefore it 
was not possible to have the biological activity of 37 evaluated, due to insufficient purity 
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2.3.11 Biological Testing 2: Lanosterol Oxidation Products 
Eight more lanosterol oxidation products were evaluated in our second screen, as can be seen 
in Table 2.5. These results are presented in terms of IC50 value and apoptosis fold increases, 
in addition to the percentage viability of U937 cells. The IC50 measures half the maximum 
inhibitory concentration of a substance. The apoptosis result indicates the fold increase of 
visible apoptotic bodies when a particular compound is introduced to the cells in relation to 
the ethanol control. Any result greater than or equal to a four fold increase is considered quite 
significant. Therefore, a number of these results have been highlighted for their importance.  
First of all, the keto-epoxide 24, which had been specifically identified as a synthetic target, 
showed notable biological activity. This compound displayed a 16.4 fold increase at a 
concentration of 56 M, whereas its C-3 alcohol analogue 23 showed no apoptosis. 
Therefore, as we expected, the epoxide is an important feature in the side chain of the 
molecule, and a ketone at C-3 emphasises its biological activity.  
By comparison, 27 and 29, which both also contain the ketone functionality at C-3, did not 
show such significant activity. A 1.2 fold increase in apoptotic bodies was seen at a 
concentration of 50 M for 27, and a 1.8 fold increase was observed at 50 M of 29. Another 
compound of note within this set is 30. The ketone exhibits a 9 fold increase in apoptotic 
bodies at a concentration of 103 M. This is also quite a significant result, though not as 
outstanding as the 16.4 fold increase at 56 M displayed by 24.  
It is also worth noting the compounds which did not show particularly good biological 
activity. 7 and 11 displayed poor IC50 values, and little or no apoptotic activity. This result is 


















% Viability of U937 cells 
200 g/mL 100 g/mL 50 g/mL 
7 33.86 ± 3.33   
11 51.77 ± 3.89   
23  31.79 ± 1.70  
24   7.97 ±0.38 
25  13.98 ±1.32  




% Viability of U937 cells 
100 M 
27 31.23 ± 5.40 
29 20.92 ± 5.02 
 
 
Figure 2.30: Percentage viability of U937 cells following treatment with varying 




















Percentage Viability of U937 cells at Compound 










 IC50 values in U937 cells 
g/mL M 
7 165.5 386 
11 208 442 
23 45.6 103 
24 25.2 57 
25 16.5 41 
30 31.6 65 
27 30 75 
29 25 62 
 
 
Figure 2.31: IC50 values of compounds 7, 11, 23, 24, 25, 30, 27 and 29 (M) 
The effect of this set of compounds on the percentage viability of U937 cells was also 
examined. Again, dihydro derivatives 7 and 11 showed poor biological activity giving ~ 33% 
and ~ 51% viability at a concentration of 200 g/mL. Both compounds have an aliphatic side 





















IC50 values M 
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compounds were the poorest in terms of IC50 values also, giving results of 165.5 g/mL and 
208 g/mL respectively.  
Epoxides 23 and 24 showed improving activity giving values of ~ 31% and ~ 8% at 
concentrations of 100 g/mL and 50 g/mL respectively. This result shows that keto epoxide 
24 is significantly more active than its analogous C-3 alcohol 23. We were delighted with this 
result, as we had specifically targeted the C-3 alcohol and ketone derivatives of the side chain 
epoxide based on the knowledge from our initial biological screen. By comparing 7 to its C-
24,25 epoxide analogue 23, the effect of the epoxide can be seen clearly in the IC50 value, 
which is decreased from 386 M to 103 M. 
Aldehyde 25 also displayed good activity, with ~ 14% viability at 100 g/mL in the U937 
cells, and an IC50 value of 41 M, the best in this series. However, these results are not 
mirrored in terms of apoptosis, as almost 500 M of the compound is required to exhibit a 10 
fold increase in apoptotic bodies. Aldehyde 25 and its C-3 ketone analogue 29 show similar 
biological activity in terms of IC50 values, at 41 M and 62 M respectively. 
Ketone 30 is quite potent also, giving  ~ 7% viability at 50 g/mL, consistent with its activity 
in terms of apoptosis, showing a 9 fold increase in apoptotic bodies with 103 M of the 
compound. Its IC50 value is moderate at 65 M. It is worth highlighting the significance of 
the C-24 ketone in the side chain of 30 as a direct comparison to 11, as it has a large effect on 
biological activity of the compounds in U937 cells, with ketone 30 having a ~ 7% viability at 
50 g/mL, while its side chain dihydro analogue 11 shows a viability of ~52% at 200 g/mL, 
a four fold increase in concentration.  
Compounds 27 and 29 were evaluated at a later date, and in the intermediate time period, we 
took the decision to report the percentage viability results in terms of M, to be in line with 
current literature reporting. Compound 29 was seen to be a more active compound than 27, as 
they display ~ 21% and ~ 31% viability respectively. This result is as expected, owing to the 
extra functionality in compound 29. Moderate IC50 values of 30 g/mL and 25 g/mL are 








2.3.12 Double epoxidation of lanosterol 6 
An interesting opportunity arose for the one pot synthesis of the novel diepoxide 38 (mixture 
of R and S isomers) with potentially good biological activity. 5,6,22,23-Diepoxystigmastane 
39, formed by the double epoxidation of stigmasterol, had been evaluated against U937 cells 
in previous work by our collaborators,
34
 and had displayed promising results (Table 2.7). 
Table 2.7 Percentage viable U937 cells following  
24 h exposure to 39 at various concentrations 
 
Compound 30 M 60 M 120 M 
39 51.4 ± 8.3 39.6 ± 4.6 7.6 ± 2.2 
Note: 39 is a mixture of four isomers,  and  epoxides at the C-5,6 position,                                                      
and R,R and S,S epoxides at the C-22,23 position. 
 
This compound contains an epoxide in its ring structure at C-5,6 and also in the side chain at 
C-22,23. Therefore, we saw the potential to make use of the dual alkene functionality of 
lanosterol, and epoxidise both double bonds available in the ring structure and the side chain.  
A mixture of lanosterol 6 and dihydrolanosterol 7 was treated with 3 equivalents of m-CPBA 
to synthesise the novel compound 38 (Scheme 2.32). Separation of the dihydro derivative 40 
by column chromatography afforded 38 in 60% yield after repeated chromatography. The 
side chain epoxide was formed as a mixture of R and S isomers at the C-24 position, which is 
consistent with our previous epoxidation work. All literature precedent indicates internal C-
8,9 epoxide formation exclusively on the  face.
9,20
  





The side chain epoxide is characterised by the 1H triplet at 2.68 ppm in the 
1
H NMR 
spectrum. As the transformation from the C-8,9 alkene to the epoxide involves quaternary 
carbons only, the 
13
C NMR spectrum is needed as evidence that the C-8,9 epoxide had 
formed. The new C-8 and C-9 signals are seen at 68.1 ppm and 70.7 ppm respectively in the 
13
C NMR spectrum.  
This novel compound was fully characterised and prepared for biological testing. It was 
hoped that this compound would be biologically active against the U937 cells, given the 
success of our epoxides in previous screens.  
 




2.3.13 Summary of Lanosterol Oxidation Products 
In this area of the project, the research had been developed from previous work to include 
side chain functionalisation in lanostane derivatives and several interesting and biologically 
active compounds have been synthesised.  
Several structural features of Antrodia camphorata, such as the C-7,11 conjugated diketone, 
the C-7,8 and C-9,11 diene and the side chain functionality, have been successfully 
incorporated into the lanostane steroid, achieving a target established at the outset of the 
project.  
Fourteen of these lanosterol oxidation products underwent biological evaluation, and the 
results obtained were used to strategically pinpoint future transformations in order to increase 
biological activity.  
Thus far, our most active compounds in terms of apoptosis, IC50 value and percentage 
viability were 24 and 30, which shows that incorporation of ketone and epoxide groups 
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2.4 Amine Derivatives of Lanosterol 
2.4.1 Solanidine 
Solanidine is the aglycone unit of the glycoalkaloid -solanine, which has been shown to be 
biologically active in humans, inhibiting acetylcholinesterase.
35
 Our interest in this compound 
stemmed from a collaboration within our research group, concerning the use of potato peel as 
a source of phytopharmaceuticals. Due to difficulties with the isolation of solanidine from the 
potato peel, and thus the availability of solanidine as a viable precursor, progress with 
synthetic modification was severely limited, compounded by the fact that commercial 
solanidine is very expensive. 
 
 
Figure 2.32  Solanine 
Therefore, at this stage in the project our attention turned towards the incorporation of tertiary 
nitrogen functionality in the side chain of the lanosterol derivatives to mimic the structure and 
chemistry of solanidine, and to evaluate and compare the biological activity with that of 
solanidine. Thus, the C-24 aldehyde in compounds 21, 25 and 29 became crucial in our 
project because of its potential to undergo reductive aminations.  





Figure 2.33 Aldehydes 21, 25 and 29 
Through a number of test reactions, we successfully established a very efficient one pot 
reductive amination procedure for the synthesis of amines from the aldehyde derivatives of 
lanosterol.  
While amine derivatives of the cholestane nucleus have been synthesised,
36,37
 there has been 
limited work carried out on amination of lanostane derivatives. Chung et al. have described 
the synthesis and antifungal activity of a variety of amine derivatives of lanosterol at the C-24 
position (Scheme 2.33).
6
 The antifungal activities of these amines against Cryptococcus 
neoformans, a fungal strain considered to be important in connection with AIDS, was seen to 
improve along the order of ethyl, cyclohexyl, benzyl, methyl and primary amino derivatives. 
However, a drawback to this work was that amination at this position required multistep 
synthesis. 
Scheme 2.33 
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Our reductive amination procedure would lead to the synthesis of a variety of novel amines in 
a one pot reaction from the C-24 aldehyde compound. This reaction also has several 
advantages over the route described above (Scheme 2.33), namely the elimination of 
activating groups and of the toxic sodium azide reagent, and scope for a wider variety of 
amines to be synthesised. Furthermore, our amines would be screened for anticancer activity, 
which, to the best of our knowledge, has not been reported in the literature for such lanostane 
derivatives. 
 
2.4.2 Reductive aminations of 3-acetoxy-5α-lanost-8-ene-24-al 21 and 3-hydroxy-5α-
lanost-8-ene-24-al 25 
Reductive amination is a well known reaction in organic synthesis, whereby aldehydes or 
ketones react with ammonia, primary or secondary amines in the presence of a reducing agent 
to yield primary, secondary or tertiary amines respectively. These reactions are considered to 
be the most efficient carbon – nitrogen bond forming reactions, and an important method for 
the synthesis of a large scope of amines.
38,39
  
An ordered sequence of steps defines the reductive amination pathway. Firstly, a species 
known as a carbinol amine is formed, which dehydrates to form an imine. The reaction 
conditions employed are generally weakly acidic, which allows the imine to be protonated to 
form an iminium ion. The iminium ion then undergoes reduction to form the alkylated amine 
product (Figure 2.34).
40
 It is critical to the success of the reaction that a very selective 
reducing agent is chosen. This is to avoid the unwanted reduction of aldehydes or ketones, 
and the selective reduction of the iminium ion.  






Reductive aminations can be described as direct or indirect reactions. The direct pathway 
refers to when the carbonyl compound and the amine are mixed together with the correct 
reducing agent, without prior formation of the iminium ion. The indirect (or stepwise) 
pathway pertains to the pre-formation of the imine or iminium ion followed by reduction in a 
separate step. 
Chung et al. report a reductive amination on a C-24 ketone involving the use of sodium 
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The success of sodium cyanoborohydride as a reducing agent is attributable to its stability in 
strongly acidic solutions (up to pH 3), selectivity at different pH values, and solubility in 
hydroxylic solvents.  
Our method development was carried out with aldehyde 21 and piperidine (Table 2.8). The 
reducing agent was used in conjunction with zinc chloride, and stirred in methanol at room 
temperature for 16 hours,
6
  giving a crude yield of 84%. Attempted column chromatography, 
using 90:10 hexane: ethyl acetate, to remove minor impurities from the crude material 
resulted in loss of the product. While successful product formation was observed in the 
1
H 
NMR spectrum of the crude material, this method had its drawbacks. It is known that the 
reaction may require up to a fivefold excess of the amine, which, while not observed in this 
case, may have led to complications in future syntheses.
40
 Nonetheless, this method was not 
ideal, because of potential hazardous by-products and the potential for sluggish reactions with 
weakly basic amines. Though the 84% yield was satisfactory, the reaction time of 16 hours 




Amine Reducing Agent Solvent Temperature Time Crude Yield 
Piperidine NaBH3CN 
ZnCl2 
MeOH r.t 16 h 84% 
Piperidine NaBH(OAc)3 1,2-DCE r.t 1.5 h 91% 
 
A literature search then revealed an alternative method for the reductive amination.
40
 The 
method involved addition of the significantly milder reducing agent sodium 




triacetoxyborohydride to a stirring solution of aldehyde and amine in 1,2-dichloroethane. The 
reducing agent exhibits remarkable selectivity, as no reduction of the aldehyde to form the 
alcohol at C-24 is observed. The steric and electron-withdrawing effects of the three acetoxy 
groups stabilise the boron-hydrogen bond resulting in the mild reducing properties of the 
substance. The reaction was also carried out at room temperature, but with the significantly 
shorter reaction time of 1.5 hours and a higher yield of 91%. It is evident that this method is 
superior to that previously reported, and it was employed in future reactions.  
We then set about the synthesis of a library of novel lanosterol derivatives which incorporate 
amines in the side chain. Amines chosen for the first set of reductive aminations were 











Compound Yield Compound Yield 
1   41 94% 42 85% 
2   43 65% 44 75% 
3   45 54% 46 87% 
4   47 94% 48 70% 
5 
  
49 71% 50 96% 
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2.4.2.1 Reductive aminations of aldehydes 21 and 25 with piperidine 
Aldehyde 21 underwent reductive amination with piperidine to give 41 in 91% yield (Table 
2.9, Entry 1a). The disappearance of the 24-CH aldehyde signal at 9.77 ppm in the 
1
H NMR 
spectrum showed the aldehyde had reacted fully. A new multiplet appeared at 2.25 – 2.30 
ppm, which was assigned as 24-CH2 (adjacent to N). Another new signal at 2.41 ppm, 
appearing as a 4H broad singlet was assigned to the two CH2 groups adjacent to the nitrogen 
of the piperidine ring. The 
13
C NMR spectrum of the product showed further evidence for 
successful reductive amination, with three new signals being observed. Signals at 24.4 ppm, 
25.8 ppm and 54.5 ppm correspond to piperidine CH2, piperidine CH2 × 2, piperidine N-CH2 
× 2 respectively. A shift in the C-24 signal from 203.3 ppm in 21 to 59.9 ppm in 41 is the 
characteristic difference between the starting material and product, therefore the most 
significant new signal in the 
13
C NMR spectrum is that at 59.9 ppm. The signals being 
assigned as two carbons were twice the relative intensity of the other signals in the spectrum 
(Figure 2.35).  
 
 
Figure 2.35: Noteworthy 
13
C NMR data for 41 
 
Alcohol derivative 25 underwent reductive amination to form 42 in 85% yield (Table 2.29, 
Entry 1b). Identical reaction conditions of temperature and time were employed, and no 
difficulties were observed when the substrate was changed from a C-3 acetate to the more 
acidic C-3 alcohol. A similar pattern of signals to that described above for the acetate was 




C NMR spectra.  
 




As both of these novel compounds 41 and 42 were synthesised in high purity, they were fully 
characterised and prepared for biological evaluation. 
2.4.2.2 Reductive aminations of aldehydes 21and 25 with diethylamine 
Diethylamine was the next amine to be used in reductive amination reactions. This amine 
would also yield a tertiary nitrogen at the site of reductive amination. However, there is a 
difference in the conformational mobility of the diethylamine moiety, when compared to the 
piperidine moiety. Free rotation of the two ethyl chains may give a difference in reactivity of 
the amine towards reductive amination, and also biological activity of the derivatives 
synthesised, due to increased steric hinderance. This may lead to an interesting comparison  







Thus, aldehyde 21 was reacted with diethylamine to afford 43 in 65% yield (Table 2.9, Entry 
2a). As anticipated, this yield is ~ 30% less for the diethylamine derivative than for the 
piperidine derivative. This decrease in yield is possibly due to the free rotation of the ethyl 
groups hindering reductive amination by restricting the accessibility of the nitrogen lone pair 
to the carbonyl group. Though a decrease in yield from 94% to 65% is observed, 43 was 
formed in reasonable yield and high purity, with a sufficient quantity available for biological 
testing after full characterisation of this novel compound. Evidence for the successful 




C NMR spectra. The 
1
H NMR 
spectrum shows complete loss of the 24-CH aldehyde proton of the starting material, given 
that there is no signal at 9.77 ppm. Two overlapping 3H triplets at 1.06 ppm, appearing as a 
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6H triplet, are assigned to the diethylamine CH3 × 2. The 24-CH2 multiplet appears in the 
usual region of 2.32 – 2.51 ppm, while the 4H multiplet at 2.52 – 2.67 ppm represents the 
diethylamine CH2 × 2. The 
13
C NMR spectrum of the product is also quite indicative of 
successful reductive amination. The strong signals at 11.2 ppm and 46.6 ppm represent 
diethylamine CH3 × 2 and N-CH2 × 2. 24-CH2 remains in the same region as the piperidine 
derivatives, in this case having a signal at 53.2 ppm (Figure 2.37).  
 
Figure 2.37: Noteworthy 
13
C NMR signal for 43 
 
The aldehyde bearing an alcohol at C-3 25 also underwent reductive amination with 
diethylamine. In this case product 44 was formed in 75% yield (Table 2.9, Entry 2b). It is 
interesting to note that, in this case, there was a 10% decrease in the yield of 44, as compared 
with its analogous piperidine derivative 42. This is an improvement on the ~30% decrease in 
yield seen between acetate derivatives 41 and 43 (Table 2.9, Entries 1a, 1b, 2a, 2b). The main 
conclusion drawn from this section of Table 2.9 is that piperidine is the more reactive amine 
in reductive amination reactions, which we believe is due to the nitrogen lone pair being 
sterically unhindered. Spectroscopic evidence for the formation of the desired product 44 
correlates with the previous spectra for the product of the reductive amination on the acetate 
derivative 43. Again, these two novel compounds were fully characterised and prepared for 
biological screening. 
Having had much success with these piperidine and diethylamine reductive aminations, we 
were interested in incorporating cyclic amines containing heteroatoms. Our first choice of 
amine was the readily available morpholine, which is a natural analogue of piperidine. The 
effect of the contrasting electronic properties of the oxygen in morpholine relative to the CH2 
group in piperidine would be interesting to compare in these new derivatives. It is feasible 
that the hydrogen bond accepting properties of oxygen could lead to a difference in reactivity 
of morpholine in the reductive amination reactions. 




2.4.2.3 Reductive aminations of aldehydes 21 and 25 with morpholine 
Aldehyde 21 reacted with morpholine to form 45 in 54% yield (Table 2.9, Entry 3a). This 
yield was considerably more modest than the previous reactions. However, there was no trace 
of starting material in the 
1
H NMR spectrum of 45, and it transpired that this moderate yield 
was a once off occurrence, though it is unclear why the yield in this instance was so low.   
The influence of the heteroatom on the 
1
H NMR spectrum was significant. A 4H triplet at 
3.72 ppm represents the overlapping morpholine O-CH2 × 2. This signal was much further 
downfield than any non-heteroatom bearing amine which was attached before. The broad 
singlet at 2.44 ppm, representing the morpholine N-CH2 × 2, is comparable to the N-CH2 × 2 
at 2.41 ppm in the piperidine analogue. This shows that the oxygen in morpholine only has an 
effect on the adjacent CH2 groups. The 
13
C NMR spectrum is as expected, with the N-CH2 × 
2 and 24-CH2 signals appearing at 53.8 ppm and 59.7 ppm respectively. The key shift in the 
C-24 signal from 203.3 ppm in the starting aldehyde to ~ 60 ppm in the reductive amination 
product is observed again in this case. In correlation with the 
1
H NMR spectrum, the 
morpholine O-CH2 × 2 is considerably further downfield, appearing at 67.0 ppm in the 
13
C 
NMR spectrum.  
Alcohol 25 was also reacted with morpholine in a reductive amination reaction to give 46 in 
87% yield (Table 2.9, Entry 3b). Again, no starting aldehyde was observed in the 
1
H NMR 
spectrum of 46 and almost identical signals are seen in the spectra of the acetate and alcohol 
analogues of the morpholine derivatives, 45 and 46 (Figure 2.38). The main difference 
between these sets of spectra is the 3-CH signal, which is at its usual positions, ie. 4.50 ppm 
in the acetate derivative and 3.23 ppm in the alcohol derivative.  
 
 








C NMR spectra for both morpholine derivatives 
45 and 46 
A striking comparison between the piperidine derivatives, 41 and 42, and morpholine 
derivatives, 45 and 46, (Table 2.9, Entries 1a, 1b, 3a and 3b) is that a similarly good yield is 
seen for the C-3 alcohols (85% and 87% respectively). By contrast, the C-3 acetates show a 
40% difference in yield, decreasing from 94% in the piperidine derivative to 54% in the 
morpholine derivative. However, all other acetate derivatives (Table 2.9, Entries 1a, 2a, 4a, 
and 5a) display good to excellent yields. Therefore it can be postulated, with reasonable 
certainty, that the acetate group is not impairing the reaction outcome, but rather this low 
yield of 54% for compound 45 is a once off occurrence.  
 
2.4.2.4 Reductive aminations of aldehydes 21 and 25 with aniline 
Our attention turned towards the incorporation of an aromatic group to vary the side chain 
derivatives (Table 2.9, Entries 4a and 4b). We chose aniline as the aromatic amine because it 
is a cheap and readily available starting material. It was envisaged that the nitrogen lone pair 
may have reduced nucleophillicity as it is in conjugation with the aromatic ring. However, in 
our work, this was not the case and successful reductive amination yielded both alcohol and 
aldehyde derivatives.  
Aldehyde 21 underwent reductive amination with aniline to give product 47 in 94% yield. 
This yield is an excellent result, both in terms of reactivity and yield, since we envisaged 
possible reduced nucleophilicity of the lone pair in the amine. The 
1
H NMR spectrum of this 
product is quite different to those previously described. Firstly, the aromatic peaks are evident 
in the 6.50 – 7.20 ppm region of the spectrum. All five hydrogens of the aromatic ring are 




accounted for in this region. The 24-CH2 signal is shifted slightly downfield, at 3.01 – 3.13 
ppm. This methylene group is now adjacent to a free NH, which gives rise to this downfield 
shift. The 
13
C NMR spectrum shows 24-CH2 has shifted upfield to 44.6 ppm from 203.3 ppm 
in the starting aldehyde. This upfield shift is expected, however it is significantly further 
upfield than was observed for other amine products, which showed the 24-CH2 signal at ~ 60 
ppm (Figure 2.39). This observation can be rationalised by the fact that 24-CH2 is adjacent to 
a secondary amine rather than a tertiary amine in this case. The carbons on the aromatic ring 
are seen in the expected region, at 112.7 ppm, 117.1 ppm, 129.2 ppm and 148.6 ppm. 
The 
1
H NMR spectrum of the alcohol derivative 48, synthesised from aldehyde 25, shows a 
majority of similarities to the acetate derivative 47. The main difference between this 
spectrum and that of 47 is the 3-CH appearing as a doublet of doublets at 3.23 ppm. A similar 
case is seen in the 
13
C NMR spectrum, where a majority of common signals are seen in both 








C NMR spectra for both aniline derivatives 47 
and 48 
 
A comparison can be drawn between the piperidine and aniline derivatives (Table 2.9, Entries 
1a, 1b, 4a and 4b) in terms of reaction yield. In these cases, the acetate derivatives of both 
amines gave an excellent yield of 94%, while the alcohol derivatives 1b and 4b showed lower 
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2.4.2.5 Reductive aminations of aldehydes 21and 25 with thiomorpholine 
 
As will be discussed in the biological results of these novel amines, the morpholine 
derivatives 45 and 46 showed quite poor toxicity in our biological screen. Therefore, we were 
enthusiastic to explore the biological effects of other heteroatoms in this position, namely 
sulfur and nitrogen. Thiomorpholine was chosen as the amine for the synthesis of further 
derivatives. 
Aldehyde 21 was reacted with thiomorpholine using our standard reductive amination 
procedure. The desired product 49 was formed in 71% yield (Table 2.9, Entry 5a) as an 
orange solid. We were enthusiastic to see this return to good yield from the 54% displayed by 
morpholine analogue 45 (Table 2.9, Entry 3a), reaffirming that the heteroatom does not play a 
role in reaction yield diminishment. 
The four CH2 groups of the thiomorpholine ring could be seen as a multiplet between 2.60 – 
2.80 ppm in the 
1
H NMR spectrum. This observation is in contrast to the splitting of the four 
CH2 groups in the morpholine ring into two distinct sets of signals, ie. the broad singlet at 
2.44 ppm correlating to N-CH2 × 2, and the triplet at 3.72 ppm corresponding to O-CH2 × 2. 
 
Figure 2.40: Comparison of splitting patterns of morpholine and thiomorpholine derivatives 
in 
1




C NMR spectrum showed clearer splitting of these four CH2 signals. The S-CH2 × 2 
could be seen as a strong peak at 28.0 ppm, whereas the N-CH2 × 2 peak was observed at 
55.1 ppm. An interesting comparison of note is that these CH2 groups adjacent to the sulfur 
are much further upfield than the analogous morpholine CH2 groups, which appear at 67.0 
ppm in the 
13
C NMR spectrum. As expected, the 24-CH2 signal appears at 59.9 ppm, in 
accordance with all other tertiary amines synthesised to date.  




The alcohol 25 also underwent reductive amination to form thiomorpholine derivative 50,  as 
an orange solid in 96% yield, the spectra of which are very comparable to those of 49. This is 
the best yield we have obtained for a reductive amination to date, remembering that all of 
these compounds are synthesised without a need for purification. 
 




C NMR spectra for thiomorpholine derivatives 
49 and 50 
Both novel compounds 49 and 50 were fully characterised and prepared for biological testing. 
 
2.4.2.6 Attempted reductive aminations with dicyclohexylamine, isopropylamine, 
oxazolidinone and pyrrole 
Our next objective was to expand our library using larger amines, while still keeping the 
tertiary nitrogen in the side chain. However, attempted syntheses of dicyclohexylamine and 













Starting material was not fully converted to product. 
 
In the case of 51, after using the standard 1:1 ratio of aldehyde to amine, 
1
H NMR analysis 
revealed the crude product contained 25% aldehyde starting material. When the reaction was 
repeated using 1.5 equivalents of dicyclohexylamine and an increased reaction time of 3 
hours, 14% of the starting aldehyde still remained. This aldehyde was indicated by the signal 
at 9.77 ppm in the 
1
H NMR spectrum, which integrated for 0.14 relative to 1 for the 3-CH 
signal. This attempt to consume all of the aldehyde was not successful, and created an excess 
amount of dicyclohexylamine in the product, seen as strong signals at 25.3 ppm, 26.2 ppm, 
34.3 ppm, and 53.0 ppm in the 
13
C NMR spectrum. Our assessment of this reaction was that 
the nitrogen lone pair of the dicyclohexylamine was too sterically hindered to approach the 
carbonyl carbon. Given our previous difficulty with column chromatography, when 
attempting to remove impurities from 41 after the test reductive amination using sodium 
cyanoborohydride resulted in the loss of all product (Section 2.4.2, page 134), purification 
was not attempted on this material.    
With this new knowledge of the reactivity of sterically bulky amines, we attempted another 
reaction. This time, the less bulky diisopropylamine was chosen. However, after standard 
reaction conditions, the 
1
H NMR spectrum of the crude product showed 55% starting 
aldehyde with no evidence of product formation.  
 
Having synthesised several six membered cyclic amine derivatives of lanosterol, we began an 
initial investigation into reductive amination with a five membered cyclic amine, namely 
oxazolidinone, to expand on our library of novel compounds.  
Aldehyde 25 was reacted with oxazolidinone in an attempt to synthesise 53 (Scheme 2.35). 
Upon reaction completion and work up, 
1
H NMR analysis showed a majority (75%) of 










 = isopropyl 52 Trace 




starting aldehyde present. Trace oxazolidinone signals were also observed, including the NH 




This reaction was repeated using the crude material from the first attempt, with the reaction 
time increased to 24 h. In this case, the product consisted of 55% starting aldehyde with no 
increase in oxazolidone signals or any evidence of product formation.  
It was unfortunate that this novel lanostane structure with an interesting amine side chain 
could not be synthesised. Should future work be undertaken in this area, amines with no 
potential for delocalisation would be favourable.  
Given the impurity of 51 and 52, and the unsuccessful formation of 53, these compounds 
were not available for biological evaluation. However, we proceeded with biological 
screening on the pure amines (Table 2.11). These samples were tested against U937 cells in 
terms of apoptosis, IC50 value and percentage viability of the cells after treatment with the test 
compounds.  
 
2.4.3 Biological testing 3 
The results of this screening were quite promising, and showed a remarkable increase in 
toxicity at lower concentrations towards the lanosterol oxidation products. The results are 
presented below. 
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Table 2.11 Biological screening of amine derivatives.* 
 






% Viability of U937 cells 
10 g/mL 50 g/mL 200 g/mL 
41 41.39 ± 3.47 27.98 ± 2.71 - 
42 3.92 ± 0.23 - - 
43 34.86 ± 8.01 - - 
44 3.73 ± 0.32 - - 
45 83.96 ± 3.09 71.45 ± 3.55 26.91 ± 0.47 
46 92.70 ± 2.94 71.05 ± 3.64 5.24 ± 0.49 
47 99.87 ± 2.90 96.38 ± 1.73 50.74 ± 6.47 
48 97.65 ± 2.94 71.74 ± 2.99 6.12 ± 0.33 
 
*Thiomorpholine derivatives were not available for this round of biological screening 
 
Figure 2.42: Percentage viability of U937 cells following treatment with 10 g/mL of 
























Percentage Viability of U937 cells at Compound 
Concentration of 10 g/mL 






IC50 values in U937 cells 
g/mL M 
41 7.6 14.9 
42 0.9 1.9 
43 8.2 16.4 
44 1.6 3.5 
45 76.1 148 
46 60.2 128 
47 190.5 367 
48 62.8 132 
 
 
Figure 2.43: IC50 values of compounds 41 - 48 (M)  
The standout results from this biological screen are from compounds 42 and 44, giving a 
percentage viability of U937 cells of ~ 3.9% and ~ 3.7% respectively. This is a marked 
increase in activity from our previous screen of the lanosterol oxidation products. The 
concentration of compound is reduced to 10 g/mL in this case, as compared to ~ 10% 
viability at 50 g/mL for epoxide 22, our best result in the last screen. The IC50 values for 
these compounds mirror the results expressed in terms of percentage viability of the U937 
















IC50 values in U937 cells M 




g/mL (3.5 M) respectively, which compares well with etoposide which is a marketed 
topoisomerase II inhibitor and has an IC50 value of 1.5 M. Thus, we were very happy with 
these results, as they are our best to date. 
Many deductions can be drawn from this new biological information and the knowledge 
gained would be put to use in future aspects of the project by incorporation of specific 
functionalities.   
Firstly, it is worth noting that the two most active compounds, 42 and 44, both have alcohols 
in the C-3 position. Their analogous acetate derivatives, 41 and 43, gave an approximately 10 
fold poorer result at the same concentration, having viabilities of ~ 41% and ~ 35% 
respectively and IC50’s of 7.6 g/mL and 8.2 g/mL respectively. The increased biological 
effect of these alcohols may be due to improved solubility or less steric hinderance imposed 
by their analogous acetate groups. However, it is very interesting to note, that in terms of 
apoptosis, a reverse biological effect is observed. At relatively similar concentrations of 20 
and 22 M, 43 exhibited a 6.9 fold increase in apoptotic bodies, whereas 44 showed a 3 fold 
increase. In this instance, the acetate diethylamine derivative has an improved biological 
effect as compared to the alcohol diethylamine derivative. 
Secondly, a comparison between the piperidine and morpholine derivatives, 42 and 46, is also 
striking. On replacement of the CH2 group by an oxygen atom, the biological activity is 
completely diminished, going from ~ 4% to ~ 93% viability. These percentage viability 
results in the U937 cells are reflected in the IC50 values, going from 0.9 g/mL for 42 to 60. 2 
g/mL for 46.  
It is also worth noting the poor results displayed by the aniline derivatives 47 and 48. These 
compounds had almost no effect on the U937 cells, 47 being particularly poor, with ~ 100% 
viable U937 cells remaining after treatment with the compound, and an IC50 value of 190.5 
g/mL. Given this knowledge, aniline would not be used for future reductive aminations in 
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2.4.4 Reductive Aminations 
2.4.4.1 Reductive aminations of aldehydes 21and 25 with piperazine 
Given the success of the particular amines discussed above, from both a synthetic chemistry 
and biological activity point of view, we were eager to expand our tertiary nitrogen library of 
compounds, and introduce the potential for substituted piperazines with longer side chains. 
Firstly, we began this area of chemistry with the parent piperazine to ascertain how this amine 
would behave in our optimised methodology established to date.  
Piperazine and aldehyde 21 were reacted together in a reductive amination using sodium 
triacetoxyborohydride (Scheme 2.37). However, inspection of the 
1
H NMR spectrum of the 
crude material showed a result we had not initially anticipated. We had expected to see a 
broad singlet at ~ 2.9 ppm in the 
1
H NMR spectrum corresponding to the two CH2 groups 
adjacent to the free NH in the desired product 55 as reported in the literature, however this 
signal was not observed.
41
  Therefore, it was necessary to explore the possibilities for 
alternative products formed. We rationalised that, as piperazine contains two nitrogens, both 
had acted as nucleophiles in the reaction to form a dimer via a double reductive amination.  




C NMR spectroscopic analysis would 
prove difficult, as all steroidal signals were overlapping and indistinguishable. However, 
given that the dimer contains one piperazine ring and two steroidal moieties, it was observed 
that the integration of the steroidal signals was doubled as compared with the piperazine 
signals. This NMR evidence is indicative of the presence of a dimer, and high resolution mass 
spectrometry confirmed our structural assignment. The exact mass calculated for the dimer 
was 939.7918, and a mass of 939.7879 was found by HRMS, while the mass of the desired 
product 55, was not present. With this evidence, we were content to assign the structure of the 
product as dimer 56. 
This compound was formed as a white solid in 52% yield. Although the yield is moderate, the 
compound is formed as a pure dimer, with no evidence of the formation of 55. Though it was 
not the intended product of the reaction, it contributed to our novel library of amines and was 
an interesting synthetic result. The biological activity of this compound would also be 
evaluated at a later date.  







The reductive amination using piperazine was also carried out on aldehyde 25 (Scheme 2.38). 
As for the acetate, we expected to form a dimer in this case also. However, in this instance, 
another unexpected result emerged. We were surprised to see a broad singlet at 2.94 ppm in 
the 
1
H NMR spectrum of the product 57, which corresponds to the two CH2 groups adjacent 
to the free NH. This signifies that a dimer had not been formed in this case, but rather, only 
one of the two nitrogens available had acted as a nucleophile in the reductive amination. The 
product was submitted for HRMS analysis, which found an exact mass of 471.4309, 
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correlating closely to the calculated mass of 471.4314 for 57. The HRMS evidence gives 




The formation of the dimer using the acetyl derivative of the aldehyde 21, and the 
“monomer” using the alcohol derivative 25, is a surprising result. This may have been due to 
increased or decreased solubility of either substrate in the chosen solvent. Electronic effects 
are unlikely to be the determining factor in this case, as the acetate and alcohol groups are too 
far removed from the aldehyde moiety to have any influence. 
2.4.4.2 Reductive aminations of aldehydes 21, 25 and 29 with 1-(2-
hydroxyethyl)piperazine 
As previously discussed, the lanostanes containing the C-3 hydroxyl group was seen to be 
more biologically active than the C-3 acetate group in our screening to date. Therefore, our 
interest turned to strategically targeting the synthesis of a molecule with hydroxyl groups at 
both extremities of the steroid (Figure 2.44). 1-(2-Hydroxyethyl)piperazine was chosen, as it 
is has an OH group at the end of the two carbon chain which could have significant effects on 
hydrogen bonding and solubility. This amine is also a good choice of starting material 
because there is no possibility of formation of a dimer in this case, as there is only one free 
NH in this piperazine derivative.  







The reductive amination of each of the three aldehydes 21, 25 and 29 with 1-(2-
hydroxyethyl)piperazine was carried out under our standard conditions using sodium 
triacetoxyborohydride as can be seen in Table 2.13. From this point, our series of amines 














Entry R Starting Aldehyde Yield Product 
1  OAc 21 94% 58 
2  OH 25 88% 59 
3 =O 29 72% 60 
 
Firstly, aldehyde 21 was reacted with 1-(2-hydroxyethyl)piperazine to yield 3-acetoxy-5-
4,4,14-trimethyl-24-piperazino-N-2-hydroxyethyl-chol-8-ene 58 as a light orange solid in 
94% yield. This excellent yield showed very promising prospects for the use of this amine 
across the series of C-3 acetate, alcohol and ketone. No difficulties were encountered in terms 
of reaction workup or solubility when the amine side chain was introduced. However, a minor 
issue arose in the handling of this amine. As will be discussed in the experimental section, 
hydroxyethyl piperazine is a very viscous oil, which impairs the ability to measure its mass or 
volume by conventional methods. Therefore, specific measures were taken to ensure accurate 
volume determination, as described in due course. Once this issue had been circumvented, no 
further complications occurred. 
Evidence for the formation of the desired product was seen in the 
1
H NMR spectrum. Firstly, 
the absence of the triplet at 9.77 ppm shows that the aldehyde had been entirely consumed 
and the reaction had gone to completion. Secondly, a new multiplet between 2.24 and 2.37 
ppm accounts for the new 24-CH2 signal. A further multiplet between 2.38 and 2.64 ppm, 
accounting for 10 hydrogens, corresponds to overlapping signals from piperazine N-CH2 × 4 




and N-CH2 of the hydroxyethyl moiety (Figure 2.45). A new broad singlet at 3.28 ppm 
correlates with the presence of the OH group in the new side chain, while the 2H triplet at 





H NMR signals of 58 
 
Aldehyde 25 also underwent reductive amination with 1-(2-hydroxyethyl)piperazine, to yield 
59 as an off white solid in 88% yield.  
A similar pattern was seen in the 
1
H NMR spectrum of this product. The CH2 group adjacent 
to the OH in the side chain was seen as a 2H multiplet between 3.52 and 3.66 ppm. In this 
case, the signal did not appear as a triplet, as was the case for 58, but rather a multiplet in the 
same region. The hydroxyl hydrogen, which was clearly visible at 3.28 ppm in the 
1
H NMR 
spectrum of 58, was not evident in the spectrum of 59. However, this hydrogen may have 
been obscured by the nearby doublet of doublets at 3.23 ppm, corresponding to the 3-CH 
geminal to the C-3 hydroxy group (Figure 2.46).  






At this stage in the project we began to incorporate a C-3 ketone into our series of amine 
derivatives, with the use of aldehyde 29 in our reductive amination reactions. The aldehyde in 
this starting material remained at C-24, however C-3 now had a ketone moiety, as opposed to 
an acetate or alcohol, as in previous cases. There was only a small possibility of reductive 
amination taking place at the ketone position, given that aldehydes are far more reactive than 
ketones.  
 
Figure 2.47: Sites of possible reductive amination in starting material 29 
 
Compound 29 underwent reductive amination with 1-(2-hydroxyethyl)piperazine, to yield 60 
as an orange solidifying oil in 72% yield. Though this yield was lower than the previously 
reported 94% and 88% for acetate and alcohol derivatives respectively, the product was 
formed in good purity with sufficient quantities available for biological evaluation. The 
reductive amination reaction proceeded as normal, using our standard conditions of room 




temperature and 1.5 hour reaction time, with complete conversion of starting material to 
product.  
Evidence for the formation of this compound is seen in a 12H multiplet between 2.25 and 
2.95 ppm in the 
1
H NMR spectrum. This multiplet contains piperazine N-CH2 × 4 and N-CH2 
of the hydroxyethyl moiety, as well as a 2H triplet at 2.33 ppm, corresponding to 24-CH2. As 
C-3 now bears a ketone moiety, there is no longer a distinct 3-CH signal, as was present in 
the acetate and alcohol derivatives. Therefore, to establish the presence of the ketone, it is 
necessary to turn to the 
13
C NMR spectrum. A quaternary C signal at 218.0 ppm in the 
13
C 






A series of novel 1-(2-hydroxyethyl)piperazine derivatives, 58, 59 and 60, had now been 
synthesised and characterised (Figure 2.49). These compounds were synthesised in a 
sufficiently pure form to be evaluated for biological activity. An interesting comparison 
between the cytotoxicities of the compounds containing various functionalities at C-3, 
namely, the acetate, alcohol and ketone, could be established.  







2.4.4.3 Reductive Aminations of aldehydes 21, 25 and 29 with 1-(2-
aminoethyl)piperazine 
Given the success of the reductive amination reactions using 1-(2-hydroxyethyl)piperazine 
across a series of aldehydes, the next amine chosen for reductive amination reaction was 1-(2-
aminoethyl)piperazine (Figure 2.50). This work was carried out in order to synthesise an 
analogous series to the hydroxyethyl series described above, particularly focusing on a 
comparison of these compounds in terms of the chemistry and biological activity of the free 




However, prior to carrying out the reaction using 1-(2-aminoethyl)piperazine, we discovered 
literature evidence that the reaction at the primary amine site is the major pathway in the 
reductive amination.
40
 Having already purchased this starting material, we proceeded with the 
reaction, expecting to obtain target molecule 61. Though the synthesis of this molecule was 
not our original intention, it was considered to be a useful target in terms of hydrogen 
bonding and biological activity prospects. 






Figure 2.51: Target molecule 61 
 
Aldehyde 21, bearing the C-3 acetate group, was the starting material in the reductive 
aminations with 1-(2-aminoethyl)piperazine. The reaction proceeded using the conditions as 
described previously, with stirring at room temperature over a 1.5 hour period. However, 
upon reaction completion and work up, 
1
H NMR analysis revealed a complicated mixture of 
products, and the reductive amination reaction using this amine transpired to be more 
complicated than first envisaged. 
We believe that in addition to obtaining the product from the reductive amination via the 
primary amine pathway, this product subsequently underwent further reductive amination to 
yield unsymmetrical dimer 62. In addition, reductive amination via the secondary amine 
pathway was also observed, yielding 63 in trace quantities.  
Therefore, we tentatively propose the following three compounds to be present in the crude 





C NMR spectra of all three compounds, rendering an attempt at assigning their relative 
ratios difficult and inaccurate. Therefore, we are reporting a very tentative assignment of 
structures in this section for all reductive aminations concerning 1-(2-aminoethyl)piperazine. 





Key signals of the aminoethyl side chain can be seen below (Figure 2.52). The peak at ~ 45 
ppm corresponds to the CH2 groups adjacent to the free NH of the aminoethyl ring in 
regioisomer 61 and is a distinguishing signal for this compound. The peak at ~ 38 ppm is 
characteristic of regioisomer 63, and corresponds to the CH2 group adjacent to the free NH2 
of the aminoethyl side chain. Peaks at ~53 ppm and ~59 ppm are common to both 
regioisomers, as shown. 






Figure 2.52:  
13
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Evidence for the formation of the dimer lies in the high resolution mass spectrum, where a 
peak at 982.3848 is seen, corresponding to the exact mass of unsymmetrical dimer 62. The 
mass of regioisomers 61 and 63 is also seen at 556.4841 which corresponds to both 
regiosiomers. 
By interpretation of the 
1
H NMR spectrum, the most upfield multiplet, between 2.16 and 2.26 
ppm, is assigned as 24-CH2, in accordance with its position in the other amines synthesised to 
date. However, the signal for this CH2 group, adjacent to a tertiary amine on one side and 
another CH2 group on the other side, could feasibly correspond to either of the other two N-
CH2 groups shown in Figure 2.53. The signal at 2.90 ppm is due to the two CH2 groups 
adjacent to the free NH in the piperazine ring for regioisomer 61, however the lack of 


















A quantity of the crude material was separated from the bulk and allocated for testing. The 
remainder was used to attempt purification, however all attempts to separate these 
regioisomers by recrystallisation and column chromatography were unsuccessful, leading to 
the eventual loss of the product.  
The reductive amination using 1-(2-aminoethyl)piperazine was repeated with starting 
aldehyde 25. In this case a similar result emerged, and a mixture of regioisomers 64 and 65, 
and dimer 66, was formed, as an off white solid (Scheme 2.40). 










The formation of dimer 66 is confirmed by high resolution mass spectrometry, as the mass 
found of 898.8117 corresponds to the exact mass of the unsymmetrical dimer. The formation 
of regioisomers 64 and 65 is seen by a peak at 514.4719 in the high resolution mass spectrum. 
As discussed in detail above, the signals shown in Figure 2.54 are indicative of the formation 






C NMR spectrum of 65 and 64 run in the DEPT 135 mode 
 Note: Structure of dimer 66 is removed from Figure 2.54 for clarity. Signals follow the same pattern as dimer 
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A similar pattern occurs in the 
1
H NMR spectrum (Figure 2.55), where the signal at ~ 2.90 
ppm is the only distinctive signal in the mixture of compounds, being assigned to the two CH2 





















Separation of this mixture of regioisomers was not attempted in this case, given the loss of all 
product in the attempted purification of the C-3 acetate analogues 61, 62 and 63 by 
recrystallisation and column chromatography. 
In correlation with our 1-(2-hydroxyethyl)piperazine series, we extended the reductive 
aminations in this series to include the C-3 ketone derivative, yielding regioisomers 67 and 68 
(Scheme 2.41). This work was carried out at approximately the same time period as previous 
reductive aminations involving 1-(2-aminoethyl)piperazine, where the regioisomer formation 
and dimerisation issue had not yet come to light. 
 
Scheme 2.41 
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No evidence for the presence of the dimer is seen in the high resolution mass spectrum in this 
case, however its formation and subsequent fragmentation upon electrospray ionisation 
cannot be ruled out. Turning to the 
1
H NMR spectrum (Figure 2.56), the broad singlet at 2.95 
ppm which correlates with the CH2 groups adjacent to the free NH group on the piperazine 
ring, is of a higher intensity relative to the other two signals at 2.82 ppm and 2.32 ppm. This 
leads us to believe that 67 is formed in a much higher proportion in this instance. The ratio of 
regioisomers remains indecipherable as we cannot rule out the formation of the dimer in this 
















In summary, and with the benefit of hindsight, we are aware that 1-(2-aminoethyl) piperazine 
was a problematic choice of amine starting material, as it led to the formation of regioisomers 
and dimerisation. Upon reflection of this body of work, we conclude that the inseparability of 
these complex mixtures of products renders futile reductive amination with starting materials 
containing diamine functionalities due to the primary and secondary amine sites. It may be 
possible in future work to rationalise this regiospecificity through modifications of reaction 
conditions. In our case, the products were retained for biological evaluation. 
 
2.4.5 N-oxide Study 
Having successfully synthesised amine derivatives of lanosterol that showed promising 
biological activity, we were enthusiastic to ascertain their chemical reactivity towards 
oxidation. The opportunity to synthesise novel compounds by oxidising our amine derivatives 
was an exciting prospect, as it would combine the most important aspects of our research to 
date. Previous work in our group, carried out by Dr. Sinead Milner, had been focused on the 
oxidation of solanidine in the presence of tertiary nitrogens, the results from which would be 
of great benefit to us in this study. Dr. Milner found that the major reaction pathway under 
these conditions was the oxidation of the tertiary nitrogen in preference to the alkene, 
although, upon purification of the crude material, a fraction was isolated which contained 
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Given the results of our biological screen on the amine derivatives, we wanted to incorporate 
the diethylamine and piperidine functionalities in as much as possible in further derivatives 
synthesised, as these had given the most promising results. An initial aim was to synthesise 
the C-8,9 epoxide of these derivatives given that an epoxide was the most active functionality 
from the first screen. However, we were unsure about the order of oxidation of this 
compound, given that the alkene is significantly more sterically hindered than that in 
solanidine, and the amine is more exposed.  
The first test reaction carried out was the oxidation of diethylamine derivative 43 with 1.4 
equivalents of m-CPBA (Scheme 2.43). Upon reaction completion and work up, the crude 
material was observed to be a dark orange solidifying oil. Recrystallisation from ethyl acetate 
yielded the product 69 as a light orange solid in 34% yield. 
1
H NMR spectroscopic analysis 
showed a downfield shift in 24-CH2 and both diethylamine CH2 groups, indicating the 
oxidation of the adjacent nitrogen to an N-oxide. 24-CH2 shifted downfield from 2.32 – 2.51 
ppm to 3.20 – 3.40 ppm. A similar pattern was seen for the diethylamine CH2 groups, shifting 
from 2.52 – 2.67 ppm to 3.42 – 3.57 ppm. From these shifts in methylene groups adjacent to 
the nitrogen, it can be reasonably concluded that the N-oxide 69 had formed. However, the 
13
C NMR spectrum would be the most elucidatory when determining that the alkene at C-8,9 
remained unreacted. Peaks at 134.3 and 134.4 ppm showed that epoxidation had not taken 









The piperidine derivative 41 was also oxidised with m-CPBA, however, in this instance, two 
equivalents of oxidant were used, in order to allow both oxidisable sites to react and form 70 
(Scheme 2.44). Difficulty was encountered in the work up of this reaction, as several 
emulsions formed in the sodium bicarbonate washing process. When the crude material was 
retrieved from the emulsion and concentrated under reduced pressure it was found to also be 
an orange oil. Unfortunately, multiple crystallisations from hexane and ethyl acetate did not 
remove the trace amounts of m-CPBA in this case. Therefore, an accurate yield could not be 
calculated, as it would not be a true reflection of the reaction yield. The 
1
H NMR spectrum 
showed similar downfield shifts of the methylene groups adjacent to the nitrogen, confirming 
that the N-oxide had formed. Unfortunately, 
13
C NMR analysis was not possible due to 
substantial loss of product following multiple recrystallisations, therefore high resolution 
mass spectrometry was used to confirm the presence of the epoxide at the C-8,9 position. The 
calculated mass of 544.4366 for 70 correlated very closely with the found mass of 544.4367. 





These two test reactions had given us a valuable insight into this chemistry. As shown above, 
the tertiary nitrogen site is the first to be oxidised with the lesser equivalency of m-CPBA. It 
required two equivalents of the oxidant to react with both the tertiary nitrogen and the alkene, 
and these compounds were found to be very difficult to purify due to the excess m-CPBA. 
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Two further test reactions were carried out on piperazine and morpholine derivatives to 
conclude this chemistry. 
Firstly, piperazine dimer derivative 56 was reacted with two equivalents of m-CPBA (Scheme 
2.45) to yield 71. This reaction was carried out to verify that the epoxide had formed at the C-
8,9 position by 
13
C NMR analysis, as insufficient quantities of 70 had prevented us obtaining 
this information. Again, purification was difficult, and recrystallisation of the product was 
unsuccessful. However, as our interest lay in the proof of the formation of the epoxide, we 
were keen anlayse to the 
13
C NMR spectrum, and the observation of two epoxide peaks at 
67.8 and 70.4 ppm was a positive result. The presence of one alkene signal at 134.3 ppm 






The final test reaction carried out in this section was to explore the possibility of the 
formation of these compounds via an alternative route. Thus far, the reductive aminations had 
preceeded epoxidation and N-oxidation. It was therefore investigated if the C-8,9 epoxide 
could be formed first, with subsequent reductive amination taking place at the C-24 aldehyde. 
Aldehyde 25 was reacted under the standard conditions of m-CPBA in dichloromethane in 
order to epoxidise the internal C-8,9 alkene bond (Scheme 2.46). The reaction was stirred 




over a 48 hour period. After this time the work up was found to be difficult, and several 
emulsions were formed. Extensive brine washes eventually broke up the emulsion and the 
desired product 72 was isolated in crude form. However, the product contained residual m-
CPBA which could not be removed after multiple sodium bicarbonate washes and several 
recrystallisation attempts. Characteristic signals for the desired product in the 
1
H NMR 
spectrum are the 2H multiplet between 2.35 ppm and 2.55 ppm assigned to 23-CH2, the 1H 
doublet of doublets at 3.21 ppm assigned to 3-CH and the triplet at 9.77 ppm which is the 
aldehyde proton. This aldehyde triplet integrates for ~0.3 when compared to the 1H integral 
of the doublet of doublets at 3.21 ppm, indicating that the desired aldehyde accounts for 
~30% of the product mixture. Characteristic epoxide signals at 68.1 ppm and 70.7 ppm verify 




When this epoxy-aldehyde 72 was synthesised, albeit in crude form, the reductive amination 
using morpholine was attempted (Scheme 2.47). The reaction time was increased to 24 h, to 
account for the lower quantity of aldehyde present in the starting material. Upon reaction 
work up, the 
1
H NMR spectrum of the crude material showed impurities, including m-CPBA, 
dihydrolanosterol and numerous unidentifiable products, were present in addition to the 
desired product 73. Purification was not attempted, as limited quantities of material remained, 
and it was our priority to gather as much raw analysis as possible with this material. 
Encouragingly, the 
1
H NMR spectrum showed that the reaction had gone to completion, as no 
aldehyde remained in the product. The characteristic methylene groups adjacent to the oxygen 
in morpholine were present, as seen by 4H broad singlet at 3.82 ppm. Further evidence for the 
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formation of the product was found in the 
13
C NMR spectrum, where the morpholine N-CH2 
and O-CH2 groups were seen in the expected regions at 52.6 ppm and 65.6 ppm. The 
quaternary carbon signals at 68.1 ppm and 70.9 ppm were evidence for the epoxide at this 
position remaining present after the reductive amination reaction. There was no evidence to 
suggest that the amine nucleophile had opened the hindered C-8,9 epoxide. Rather, the 




This reaction has shown that the prior epoxidation of the C-8,9 alkene, followed by reductive 
amination could become a viable pathway in the synthesis of novel amines with higher 
oxygenation. Unfortunately this morpholine derivative 73 was insufficiently pure for 
biological evaluation or further derivitisation, for example the synthesis of its corresponding 
N-oxide.  
This series of reactions had been of limited success in terms of producing products with the 
high level of purity required for biological testing. However, the range of reactions carried 
out give us an insight into this chemistry for future work, and two main conclusions have 
been drawn from this N-oxide study.  
Firstly, the nitrogen of the tertiary amine is the first point of oxidation when a compound 
containing alkene and amine sites is treated with m-CBPA. Additionally, preliminary work 
has shown that it is possible to perform the reductive amination reaction without unwanted 
reactions at the C-8,9 epoxide. Optimisation of this work would open up a wide range of 
synthetic scope for novel amine derivatives. 








*  Results are presented for a mixture of  61, 62 and 63, and a mixture of 64, 65 and 66. 
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 % Viability of U937 cells 
200 g/mL 100 g/mL 50 g/mL 10 g/mL 5 g/mL 
56    94.41 ± 1.29 96.96 ± 2.85 
58    14.10 ± 0.85 53.42 ± 3.46 
59    5.89 ± 0.48 5.83 ± 0.37 
61, 62, 63   6.51 ± 0.49 46.91± 4.20 78.76 ± 4.37 
64, 65, 66   7.35 ± 0.71 91.43 ± 4.10 93.48 ± 2.86 
69   5.78 ± 0.70 56.99 ± 4.37 75.12 ± 3.98 
71 48.89 ± 5.63 51.90 ± 0.43 52.10 ± 0.71 86.26 ± 1.60  
 
  
Figure 2.57: Percentage viability of U937 cells at compound concentration of 10 g/mL for 






















Percentage Viability of U937 cells at 
Compound Concentration of 10 g/mL 
64 & 66 
61 & 62 




 IC50 values 
g/mL M 
56 - - 
58 5.2 9.3 
59 1.4 2.7 
61, 62, 63 9.2 16.6 
64, 65, 66 24.5 47.7 
69 10.9 21.1 




Figure 2.58: IC50 values of compounds 56, 58, 59, 61-63, 64-66, 69 and 71 (M). 
The standout biological result from this screen is undoubtedly the activity of 59. At a 
concentration of just 5 g/mL, the percentage viability of U937 cells is ~5%. This is an 
improvement on all other compounds in our previous screens. The IC50 result for this 
compound is also excellent, 59 having an IC50 value of 2.7 M. When this IC50 value is 
compared to Etoposide, a topoisomerase II inhibitor on the market, which has an IC50 value of 





















IC50 values in U937 cells M 
64 & 66 
61 & 62 
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We were particularly delighted with the biological results of this compound because it had 
been strategically designed from knowledge gained in the previous screens. As discussed 
earlier, we had selected an amine with a free alcohol group due to the fact that the alcohol 
functionality had given promising results in compounds 42 and 44. This excellent result, 
based on the strategic manipulation of our compounds, is a great triumph of our chemical and 
biological collaboration, and indeed the project as a whole.  
The second most active compound of our biological screen was the analogous acetate 
derivative 58, having a percentage viability of ~ 14% at 10 g/mL and an IC50 value of 5.2 
g/mL. This is an interesting result to compare with previous screens. For instance, other C-3 
acetate derivatives proved much less biologically active than their analogous C-3 alcohols. 
However, in this case, although 58 contains the C-3 acetate group, the alcohol in the side 
chain is improving its biological activity.  
Compounds which showed extremely poor biological activity were the dimers 56 and 71, 
showing negligible IC50 values, and poor percentage viability results. This is to be expected 
due to the large steric bulk of the dimer and consequent poor solubility and hydrogen bond 
donating properties.  
Compounds 61 -  66 were tested as mixtures of the major and minor regioisomers, and the 
dimer in both cases, as detailed in the footnote to Table 2.14. While these compounds show 
poorer biological activity than their comparable hydroxyethyl analogues, it is interesting to 
compare them in terms of acetate and alcohol derivatives. A striking result is that, in this case, 
the acetate derivative shows better activity than the corresponding alcohol in terms of IC50 
values, displaying IC50’s of 9.2 g/mL and 24.5 g/mL respectively. This result is in contrast 
to our other compounds tested, where the C-3 alcohol was the most active of comparable 
analogues. Although this is an unexpected result, these compounds were not tested in pure 
form. Therefore, further studies must be carried out into the selective formation of the desired 









2.4.7 Sugar chemistry 
2.4.7.1 Glycosylation of 3-hydroxy-5-4,4,14-trimethyl-24-piperadino-chol-8-ene 42 
The glycosylation of steroids has been reported in a review by Pellissier in 2004.
42
 Prior to 
this report, more general O-glycosylation methods, which were applied to the synthesis of 
natural products, have been documented in several publications.
43-46
   
It is well known that an important class of drugs are glycosides, and the presence of the sugar 
moiety greatly enhances the biological properties of these compounds. The sugars play a key 
role in the interaction of drugs with their receptors, as well as significantly affecting the 
pharmacokinetics of the drug in question.
47
 Moreover, glucoronides are often the final form 




Steroidal glycosides constitute a diverse class of compounds which have been isolated from a 
wide variety of plant and animal species.
48,49
 They display a wide range of pharmacological 




 and anti-inflammatory activity.
42
 While extensive 
research has been conducted into the synthesis of oligosaccharides and steroids, the challenge 
in the synthesis of steroidal glycosides lies in the construction of the glycosidic linkage at the 
anomeric carbon.  
Despite a wealth of knowledge of carbohydrate chemistry,
53-56
 the stereoselective formation 
of O-glycosidic bonds between carbohydrates and steroids is relatively cumbersome. This is 
due to the low reactivity of the secondary alcohol in the steroid moiety, and the necessity to 
activate the glycosyl donors.
42
 The scheme for a general glycosylation reaction is shown 
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Our interest in glycosylation of steroids stems from the literature precedent that enhancement 
of the biological properties in naturally occuring structures and their mimetics.
47
 As we had 
accomplished our main objectives in this section, i.e. the synthesis of amine derivatives of 
lanosterol, their biological evaluation, and the determination of their chemical reactivity, we 
were keen to investigate the glycoslylation of our steroid derivatives. 
Lee et al. describe the O-glycosylation of phenol and phenol derivatives using penta-O-
acetyl--D-glucopyranose in the presence of BF3.Et2O and an organic base resulting in both 






Entry BF3.Et2O (eq) Base (eq) Reaction time (h) Yield (%) Ratio (/) 
1 2.5 None 5.5 72 18/82 
2 2.5 Et3N 3 89 7/93 
3 2.5 Et3N 3 92 2/98 
4 2.5 TMG
a
 5 89 4/96 
5 2.5 2.6-lutidine (0.5) 5.5 91 3/97 
6 2.5 DTBMP
b
 (0.5) 7 88 3/97 
7 2.5 Et3N 5 87 3/97 
8 1.5 Et3N 11 72 1/99 
9 1.5 Et3N 5.5 87 2/98 
10 4 Et3N 2 80 2/98 
11 10 Et3N 0.5 92 9/91 
 
a: 1,1,3,3-tetramethylguanidine. b: 2,6-di-tert-butyl-4-methylpyridine 
 




As can be seen from Table 2.16, Entry 3, glycosylation of phenol in the presence of 2.5 
equivalents of BF3.Et2O and 0.5 equivalent of triethylamine to penta-O-acetyl--D-
glucopyranose gave the highest yield and excellent -stereoselectivity. Thus we employed 
these initial conditions in our attempted glycosylation of a steroid. 
Penta-O-acetyl--D-glucopyranose was kindly supplied to our research group by Lorna 
Lennon, under the supervision of Dr. Humphrey Moynihan, Chemistry Department, UCC. 







Compound 42 was the natural choice for method development in this instance, as it had 
shown the most superior biological activity of our compounds screened in this series in terms 
of IC50 value. Additionally, the side chain tertiary amine functionality would be comparable 
to solanidine and the C-3 alcohol group would be susceptible to glycosylation. Thus, we 
attempted O-glycosylation of 42 with penta-O-acetyl--D-glucopyranose using standard 
Lewis acid coupling conditions outlined by Lee et al. in an attempt to synthesise 74.
57
 Boron 
trifluoride diethyletherate and triethylamine were employed in the glycosylation reaction 
(Scheme 2.50)  





Upon reaction completion and work up, inspection of the 
1
H NMR spectrum revealed no 
traces of desired product had been formed. This is evident by the 1H doublet at 5.72 ppm, 
corresponding to 1-CH of starting material penta-O-acetyl--D-glucopyranose, appearing at 
an identical chemical shift in the 
1
H NMR spectrum. Furthermore, the 3-CH doublet of 
doublets appearing at 3.23 ppm in the 
1
H NMR spectrum of starting amine 42 would also 
have been expected to shift, which was not observed. The 
13
C NMR spectrum also shows 
evidence that the reaction was unsuccessful, most strikingly in the fact that five carbonyl 
peaks remain in the product, corresponding to the five acetate groups. One of these acetate 
groups would have been expected to disappear had the reaction been successful.  
 
Despite our disappointment with this initial attempt at glycosylation, we were keen to persist 
with this chemistry. The previously mentioned review
42
 detailed a procedure for the 




formation of steroidal glycosides using silver oxide in the Koenigs-Knorr reaction. This 









Again, the required sugar 1-bromo-1-deoxy-2,3,4,6-tetra-O-acetyl--D-glucose was kindly 
supplied to our research group by Lorna Lennon, under the supervision of Dr. Humphrey 








Thus, we reacted 1-bromo-1-deoxy-2,3,4,6-tetra-O-acetyl--D-glucose with 42 using silver 
oxide (Scheme 2.53). 






Unfortunately, upon reaction completion and work up, 
1
H NMR analysis revealed that the 
crude reaction material consisted of a mixture of starting sugar and steroid, with no evidence 
of formation of the desired compound 74. The lack of any visible shift of either the 1-CH 
signal of 1-bromo-1-deoxy-2,3,4,6-tetra-O-acetyl--D-glucose at 6.62 ppm or the 3-CH signal 
of 42 at 3.24 ppm is evidence that the coupling had been unsuccessful.  
We did not pursue this area of the project further, however, the glycosylation methodology 
will be investigated in future work, as the synthesis and biological evaluation of these 
compounds is a potentially important aspect of the research going forward. 
 
 




2.5 Stigmasterol Chemistry 
2.5.1 Stigmasterol 
Stigmasterol 9 belongs to a class of steroidal compounds known as phytosterols, an umbrella 
term for plant stanols and sterols. The importance of phytosterols lies in their ability to lower 
cholesterol, and thus phytosterol enriched foods and dietary supplements have been popular 
in recent decades. As discussed in the project outline, stigmasterol is naturally present in the 
human diet, consisting of ~ 3% of phytosterol intake,
62
 and we were attracted to working with 
this compound as we were keen to establish a food related aspect to our research given that 
our biological collaborators have a strong interest in food chemistry and have several 
publications in this area. As lanosterol is found naturally in wool wax, and lanostane 
derivatives used in cosmetics, we were unable to establish a food angle to this research. 
Additionally, stigmasterol had a chemical structure suitable for modification by our 
established synthetic routes, namely cleavage of the side chain alkene to form an aldehyde 
and subsequent reductive amination, which could lead to an analogous series of tertiary 
amines similar to those derived thus far for lanosterol. 
 
Figure 2.59 Stigmasterol 9 
 
Recent literature reports have detailed the cytotoxic effects of oxygenated derivatives of 
stigmasterol in U937 cells.
34,63
  These derivatives were synthesised by exploiting the alkene 
functionalities of stigmasterol to form epoxides, diols, and allylic oxidation products. The 
most biologically active of these derivatives in the U937 cells was, the previously discussed, 
diepoxystigmastane 39, which gave a ~ 51% viability of cells at a concentration of 30 M.  




Figure 2.60 Diepoxystigmastane 39 
 
2.5.2 Target Molecules 
Our intention was to focus on the synthesis of novel amine analogues of stigmasterol (Figure 
2.61), as much data on the oxidation products of stigmasterol exists in the literature.
34,63
 This 
new library of compounds would be useful to compare to the lanostane series, both in terms 




As with the lanostane series, the gateway to these amine derivatives is the side chain aldehyde 
75 (Figure 2.62). 
 
Figure 2.62   




Thus, we report our strategies for the synthesis of aldehyde 75, by both our optimised 
synthetic route, established for the lanostane series (Route 1), and the route documented in 
the literature
7,64-66
 which proceeds via ozonolysis (Route 2). Both of these routes use 
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2.5.3 Epoxidations of stigmasterol 9 
We were very keen to attempt our established oxidative cleavage methodology on the 
stigmasterol precursor, as we had optimised the reaction conditions and purification 
procedures to a high degree of efficiency in the lanostane derivative. We were also 
enthusiastic to avoid recourse to formation of the aldehyde by ozonolysis for several reasons. 
Firstly, the need to protect the C-5,6 alkene requires the two additional steps of protection and 
deprotection, as the ozonolysis reaction is not selective for the side chain alkene in 
stigmasterol. These two additional steps give rise to the possible loss of material in both the 
reactions and the purifications. Also, by avoiding the use of ozone, we could potentially 
eliminate the tedious and time consuming removal of triphenylphosphine oxide, used to 
decompose residual ozonide, from our product.  
 
For the reasons outlined above, our preferred route to aldehyde 75 was Route 1. Thus we set 
about the test conditions outlined in Route 1, to establish if the chemistry optimised for 
lanosterol could be applied to the stigmasterol side chain. The aim was to selectively 
epoxidise the side chain alkene and subsequently cleave the epoxide to form 75. Should this 
experiment be unsuccessful, we were content in the knowledge that Route 2 was available to 
us as an alternative method of synthesising the desired target molecule successfully.  
 
Thus, our first reaction involved the selective epoxidation of the C-22,23 alkene by 
methodology effective for the lanostane derivatives. Stigmasterol 9 was reacted with m-
CPBA and sodium bicarbonate over a three hour period in an attempt to synthesise 76 
(Scheme 2.55).  






Unfortunately, instead of forming the desired product 76, the conditions employed selectively 
epoxidised the C-5,6 alkene to form 77.  
Although we were hopeful that the conditions which selectively epoxidised the side chain 
alkene in lanosterol would reproduce a similar result in stigmasterol, this is not an unexpected 
result, as the C-5,6 alkene is less sterically hindered compared to that at C-22,23. It was 
surprising that no trace of the C-22,23 epoxide was seen in the NMR spectra of the product, 
and that all of the oxidant was consumed in the epoxidation of C-5,6.  
The signals in the 
1
H NMR spectrum which we had expected to see, should epoxidation have 
taken place at the C-22,23 position, were a 3H multiplet between 2.45 and 2.55 ppm 
corresponding to 22-CH R and S and one of 23-CH, and a 1H multiplet between 2.72 and 
2.77 ppm corresponding to one of 23-CH.  
Instead, very distinctive signals for compounds 77a and 77b in the mixture of products can be 
seen upon inspection of the 
1
H NMR spectrum. The signal corresponding to 6-CH shows the 
greatest difference between the alpha and the beta isomers, and a clear difference in the 
chemical shifts of 3-CH for the isomers is also evident, as can be seen in Figure 2.63. The 
absence of the alkene hydrogen appearing as a multiplet between 5.30 – 5.37 ppm in the 
1
H 
NMR spectrum also indicates epoxidation at the C-5,6 position. 







Having obtained the epoxides at the C-5,6 position, we persisted with our strategy of 
synthesising the aldehyde via oxidative cleavage of the side chain epoxide. We were 
optimistic that the side chain epoxide, once formed, would be selectively cleaved to yield the 
C-22 aldehyde, leaving the C-5,6 epoxide unreacted. Knowing that the first site of 
epoxidation is the C-5,6 alkene, and with this synthetic sequence in mind, stigmasterol was 
reacted with excess m-CPBA for 48 hours leading to the formation of the desired diepoxides 
as four isomers 39a, 39b, 39c and 39d in a 3.7:3.7:1:1 ratio (Scheme 2.56). Attempts at 
removal of residual m-CPBA by washing with sodium bicarbonate were unsuccessful. 
Removal of this material by column chromatography was not attempted on the grounds of 
potential loss of product, due to the small scale of the reaction and the limited quantity of 
material to work with. Therefore, we considered the subsequent test oxidative cleavage 
reaction of greater significance in our optimisation route.   






The C-22,23 epoxide showed overlapping signals appearing as a 3H multiplet at 2.45 – 2.55 
ppm for both R and S isomers at 22-CH, and one of 23-CH, and a 1H multiplet at 2.72 – 2.77 
ppm corresponded to the other 23-CH (Figure 2.64). The distinguishable signals for these 4 
diastereomers are at the 6-CH position. When the C-5,6 epoxide is in the alpha position, the 
6-CH proton appears as a doublet at 2.92 ppm, whereas when the C-5,6 epoxide is in the beta 
position, the 6-CH proton appears as a doublet at 3.08 ppm. It is the integration of these two 
signals which establishes the 3.7:3.7:1:1 ratio of the diastereoisomers.  





The positions and relative intensities of the pertinent peaks are seen in the 
1
H NMR spectrum 
below,
65
 where the 3.7:3.7:1:1 ratio of the a:b:c:d isomers of 39 can be seen clearly (Figure 
2.65). 







H NMR spectrum showing relevant peaks of 39 
 
2.5.4 Oxidative Cleavage of Stigmsterol Epoxides 
As discussed above, this material was carried forward in an oxidative cleavage reaction using 
periodic acid, with the intention of selectively cleaving the side chain epoxide to yield 78 
(Scheme 2.57). However, upon inspection of the 
1
H NMR spectrum of the crude material, it 
was seen that the side chain epoxide had not been cleaved, as the C-22,23 epoxide peaks at 
2.45 – 2.55 ppm and 2.72 – 2.77 ppm were still present. It was also noted from the 
1
H NMR 
spectrum of the crude material that the C-5,6 epoxide signals at 2.92 ppm and 3.08 ppm had 
disappeared, and there were new aldehyde signals in the ~ 9 ppm region. To establish the 
outcome of this reaction, the crude material was purified by column chromatography, leading 






















As can be seen from Scheme 2.57, the desired product had not been formed, and 
unfortunately, oxidative cleavage had taken place at the C-5,6 epoxide, yielding 79 and 80, 
both of which are mixtures of R and S isomers.  Purification by column chromatography 
yielded two products, the structures of which are tentatively assigned as shown in Scheme 
2.57.  
In the case of 79, an aldehyde signal was seen in the 
13
C NMR spectrum at 204.5 ppm, and a 





C NMR spectrum of 80 leads us to tentatively assign its structure as shown, 
due to the ketone peak seen at 217.3 ppm and the aldehyde signal at 202.7 ppm. 
Given that the core steroidal structure in these products had been lost due to the opening of 
the B ring, these products would be of no further use to us. Our biggest disappointment, 
however, was the fact that our synthetic strategy outlined in Route 1 (Scheme 2.54) would not 
be applicable to the synthesis of the key C-22 aldehyde in stigmasterol. Unfortunately, the C-




22,23 position of stigmasterol had proven much more sterically hindered than the analogous 
alkene in the side chain of lanosterol at C-24,25, both in terms of epoxidation and oxidative 
cleavage. The ethyl group at C-24 clearly has a greater effect on steric hindrance at this site 
than we had originally anticipated (Figure 2.66 ). Therefore, it was necessary to approach this 
chemistry from a different angle, and our revised strategy would involve proceeding to 
synthesise the C-22 aldehyde by Route 2 (Scheme 2.54).  
 
Figure 2.66: Comparison of the side chains of lanosterol and sigmasterol 
 
 
2.5.5 Protection of C-5,6 alkene of stigmasterol 9 as methoxy ether  
The first step in Route 2 involves the protection of the C-5,6 alkene, and the protecting group 
of choice was the i-stigmasterol methyl ether, due to its ease of formation, via a two step 
synthetic route involving tosylation and solvolysis, its stability throughout a variety of 
conditions, and its ease of removal using acidic reagents.
63
  
This methodology has been used extensively in cases where chemistry on the C-22,23 side 
chain alkene of stigmasterol requires protection of the less sterically hindered, and therefore 
more reactive, C-5,6 alkene.
7,63
  
Foley et al. detail the protection of the C-5,6 alkene of stigmasterol by formation of i-
stigmasterol methyl ether. Subsequent reaction of the protected steroid with osmium tetroxide 
under different conditions yields the 22S,23S and 22R,23R diols. These two compounds are 
then deprotected under acidic conditions to reform the C-5,6 alkene, which can be reacted 
further as shown in Scheme 2.58.
63
 




(i) p-TsCl, DMAP, pyridine (94%); (ii) MeOH (anhydrous), pyridine (60%); (iii) OsO4, NMO, t-BuOH, THF, 
H2O (47%); (iv) OsO4, NMO, dihydroquinidine 9’-phenanthryl ether, t-BuOH, THF, H2O (30%); (v) H2SO4, 
THF, H2O (87%); (vi) H2SO4, THF, H2O (67%); (vii) m-CPBA, DCM (45%). 
Scheme 2.58 




O’Connell et al. used the same protection strategy for the synthesis of the C-22 aldehyde and 





(i) p-TsCl, DMAP, pyridine; (ii) MeOH (anhydrous), pyridine; (iii) O3; (iv) n-BuLi, THF, 0 C (31%); (v) Pd/C, 
H2, EtOH, 50 psi (88%); (vi) H2SO4, THF, H2O (57%); (vii) m-CPBA, DCM (45%). 
Note: Steps (i), (ii) and (iii) are sparsely detailed by O’Connell et al. and are referenced elsewhere.
14,34,63-67
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The chemistry outlined by O’Connell et al. is similar to our proposed modification, in that the 
side chain would be cleaved to yield the C-22 aldehyde, and a new fragment added at this 
position. Thus we began route 2 optimistic that it would yield our desired aldehyde, given the 
array of literature precedent for the synthesis of this compound.
7,14,34,63-67
 
The tosylation of stigmasterol was achieved under standard conditions using p-
toluenesulfonylchloride in pyridine, with 4-DMAP as a catalyst. The crude material was 







H NMR spectrum of the product shows a characteristic shift in the 3-CH signal from 
3.46 – 3.57 ppm in stigmasterol to 4.24 – 4.38 ppm in the tosylate derivative as clear evidence 
for successful tosylation.  
The tosylate 81 was carried forward to the next step of the protection which was the 
solvolysis reaction, a type of nucleophilic substitution or elimination where the nucleophile is 
a solvent molecule. This was carried out using pyridine and anhydrous methanol at reflux 
over a 6 hour period, leading to the formation of two products (Scheme 2.61). The desired 
product 82 and side product 83 were found to be formed as a 4.15:1 mixture of structural 
isomers, by analysis of the 
1
H NMR spectrum of the mixture. 






Distinctive signals for these isomers in the 
1
H NMR spectrum of the mixture are the methyl 
groups of the ether functionality, appearing at 3.32 ppm in 82 and 3.35 ppm in 83 (Figure 
2.67). The 6-CH signal is also very distinguishing, appearing as a triplet at 2.76 ppm in 82 
and an alkene signal at 5.35 ppm in 83.  
 
Figure 2.67: Interesting 
1
H NMR differences between structural isomers 82 and 83 
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Careful and repeated chromatography of these isomers yielded 82 in 59% yield and 83 in 
20% yield. The formation of these isomers is by the mechanistic pathways proposed below, 
with the pathway leading to isomer 82 clearly being the more favourable of the two. This is 
due to the site of nucleophilic attack, ie C-6, being significantly less sterically hindered in this 
case, leading to the ~ 4:1 ratio seen in the 
1





When this protected stigmasterol derivative 82 had been synthesised, we postulated that it 
may be possible to revert to our epoxidation and oxidative cleavage methodology for the 
synthesis of the C-22 aldehyde in stigmasterol. This methodology had failed in route 1 due to 
the fact that the C-5,6 alkene was unprotected and available for reaction. Now that we had 
successfully masked the C-5,6 alkene, it was worthwhile to attempt this chemistry, given the 
only site of reactivity would be the side chain alkene. Thus a third route, Route 3, was 
proposed at this point (Figure 2.69). This Route 3 is an improvement on Route 2 due to the 
fact that the repeated column chromatography necessary to remove triphenylphosphine oxide 
after the ozonolysis step would be eliminated. 







The first reaction was the epoxidation of 82, carried out in the usual fashion with m-CPBA to 
yield 84 in 66% yield after chromatography (Scheme 2.62). 






The key signals for the C-22,23 epoxide in the 
1
H NMR spectrum were similar to those seen 
in the previous compound with this group at this position. The R and S hydrogens at C-22, as 
well as 23-CH of one diastereomer appear in the multiplet at 2.43 – 2.54 ppm, while the 23-
CH of the other diastereomer appears separately at 2.70 – 2.80 ppm.  
 
2.5.6 Oxidative Cleavage of C-22,23 epoxide of stigmasterol 84 
At this point, as we had now successfully synthesised the C-5,6 protected, C-22,23 epoxide, 
the aim was to cleave the side chain and form the aldehyde at C-22. The reaction was carried 
out under our conditions which were successful for the lanostane derivative, using periodic 
acid in diethyl ether. As we had difficulty accessing this site in previous reactions discussed 
above, in this instance, the reaction progress was monitored by TLC analysis until all starting 
material was consumed. Thus, the reaction time was increased from 10 minutes to 3 hours, in 
an effort to ensure complete conversion. 
1
H NMR analysis of the crude material revealed that 
the desired aldehyde 85 had not been formed, and instead, the periodic acid had deprotected 
the C-5,6 alkene, yielding 76 (Scheme 2.63). 







While 76 was not the intended product of the reaction, its formation would be advantageous, 
if oxidative cleavage could be facilitated, as the deprotection of the C-5,6 alkene would have 
been undertaken in due course anyway. Therefore, this was considered an opportunity to 
optimise suitable conditions for the formation of the C-22 aldehyde and deprotection the C-
5,6 alkene in one pot. The conditions attempted for the oxidative cleavage of the C-22,23 
epoxide and synthesis of 75 are detailed in Table 2.17. 
Table 2.17 
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Entry Reagent Equivalents Temp Time Solvent Reaction Outcome 
1 H5IO6 6 reflux 6 h Et2O No evidence of product 
2 NaIO4 2 r.t 6 h 2:1 THF:H2O No evidence of product 
3 NaIO4 4 r.t 6 h 4:1 AcCN:H2O No evidence of product 
 
As can be seen in Table 2.17, there was no evidence of product formation after multiple 
attempts at oxidative cleavage. 
It was our belief that the chemistry, which was so successful for the lanostane side chain, 
could be applied in some way to the relatively similar side chain of stigmasterol. However, it 
has transpired that the presence of an ethyl group at C-24 in stigmasterol has an adverse effect 
in terms of steric hinderance and completely blocks the oxidative cleavage at the site of 
interest, regardless of the protection of other vulnerable functionalities.  
Due to the fact that Routes 1 and 3 had failed, we reverted to Route 2 for the synthesis of the 




2.5.7 Ozonolysis of protected stigmasterol 82 
Ozone gas is the reagent for this process, and is prepared by passing a stream of oxygen 
through a high voltage electrical discharge. At low temperatures, ozone adds rapidly to an 
alkene to form a highly reactive species known as an ozonide. The ozonide then breaks down 
to form two carbonyl moieties where the carbon carbon double bond had been.  
This procedure was undertaken on our protected C-5,6 alkene 82, as the ozonolysis reaction 
has no selectivity for specific double bonds. Prior solvent studies were carried out to ensure 
the substrate would remain in the chosen solvent at −78 °C. Dichloromethane emerged as the 
most suitable solvent for reaction at this temperature, as none of the substrate was observed to 
precipitate at −78 °C. This low temperature is necessary to prevent detonation of the reactive 
ozonide. 
The reaction proceeded well, yielding the desired compound 85 as a white solid in 54% yield 
following multiple purifications via column chromatography (Scheme 2.64).  







Repeated column chromatography was necessary to remove excess triphenylphosphine oxide 
present in the crude product. In fact, the triphenylphosphine oxide was present at such a level 
that the steroidal signals were completely diminished in the 
1
H NMR spectrum of the crude 
product. This presence of triphenylphosphine oxide is due to the addition of a vast excess of 
triphenylphosphine to the reaction mixture upon completion of the ozonolysis, in order to 
remove residual ozonide.  
 
A pure sample of 85 was ultimately obtained in 54% yield. Though this yield may seem 
moderate, it is in fact quite satisfactory for a reaction of this type, given the repeated and 





spectroscopy, showing very distinctive signals at 9.58 ppm in the 
1
H NMR spectrum and 
205.3 ppm in the 
13
C NMR spectrum. It was also important to note that the protecting group 
had been retained, given the presence of the singlet at 3.33 ppm in the 
1
H NMR spectrum and 
the signal at 56.6 ppm in the 
13
C NMR spectrum (Figure 2.70). 






We were delighted with the successful synthesis of the C-22 aldehyde, following much work 
in this area. Moreover, the compound was synthesised in such a high level of purity that we 
were content to proceed with reductive aminations on this aldehyde.  
 
2.5.8 Amine Derivatives of Stigmasterol 
Thus our target molecules emerged as the stigmasterol nucleus with amine side chains (Figure 
2.71), which would provide a valuable comparison with the side chain amines on the 
lanostane nucleus, both in terms of the chemical reactivity towards reductive amination, and 









There have been reports of the synthesis of amine derivatives of the stigmasterol nucleus in 
the literature by Herzog et al. in 1955 and Lorente et al. in 2005.
36,37
 These compounds were 
formed by multi step syntheses in both cases and biologically evaluated for antifungal activity 
and enzyme inhibition. 
Herzog et al.
36
 report the synthesis of amine derivatives starting from stigmasterol. The 







 describe an alternative route for formation of amines in the side chain of the 
stigmasterol nucleus, starting from the commercially available sterol 3-acetoxy-5-cholenic 
acid. This acid was reduced to the alcohol using borane-dimethyl sulfide, which was selective 
for the carboxylic acid functionality and did not affect the acetate group or the double bond in 
the sterol.
68,69
 The alcohol was then tosylated,
70
 and displacement of the tosyl group by four 
different methods led to the synthesis of a library of amines, as shown in Scheme 2.66. The 








Reagents and conditions: (Method a) amine (10 – 20 eq.), diisopropylethylamine (3 eq.), DMF, 60 °C, 48h; 




 (cat.), DMF, 100 °C, 4 h; (Method c) Diamine (4 eq.), 
EtOH (40 mL), reflux; (Method d) Diamine (4 eq.), EtOH (30 mL), DMF (20 mL) reflux. 
Scheme 2.66 
These compounds were evaluated against the recombinant L. major 24-SMT. The enzyme 
was over expressed in E. coli, and the enzyme assays were conducted using E. coli cell-free 
extracts containing soluble protein as the enzyme source. The results of the study conducted 
by Lorente et al.
37
 are displayed in Table 2.18. 
 








 IC50 (M) L. major 24-SMT 
1 Ac NHbutyl > 100 
2 Ac Piperidyl > 100 
3 Ac NHCH2Ph > 100 
4 Ac NH(CH2)4NH2 16 
5 Ac NH(CH2)6NH2  
6 Ac NH(CH2)8NH2 35 
7 Ac NH(CH2)10NH2  
8 Ac Trans-1,4-C6H10NH2 > 100 
9 H NHbutyl 0.97 
10 H Piperidyl 6.4 
11 H NH(CH2)8NH2 2 
12 H NH(CH2)10NH2  
13 H Trans-1,4-C6H10NH2 45 
 
It has been proposed by Nes
72
 that inhibitors of 24-SMT must have a free 3-OH for binding 
to the active site. However, the compounds protected with an acetate at the 3 position were 
also assayed for activity, as Lorente envisaged the acetate group being cleaved in vitro or in 
vivo.
37
 Upon biological evaluation of these amines for enzyme inhibition, it was found that 
the proposal by Nes was proven accurate, as the OH protected analogues showed little or no 
activity. However, compounds with free alcohol functionality at C-3 exhibited good 
inhibition of the enzyme, as can be seen in Table 2.18. 
With the knowledge of the work done in this area we set about the synthesis of such 
derivatives, with the intention of having these compounds biologically evaluated for anti 
cancer activity, which to our knowledge, has not been previously reported.  
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2.5.9 Reductive aminations of 20(S)-methyl-6(R)-methoxy-3,5-cyclo-pregnane-21-al 85 
Our target molecules emerged as the morpholine, piperidine, thiomorpholine, 1-(2-
hydroxyethyl) piperazine and diethylamine derivatives. These specific amines were chosen 
for reductive amination based on the success of their analogous lanostane derivatives, from a 
chemical or biological point of view. The morpholine and thiomorpholine derivatives were 
unproblematic in terms of chemical reactivity in our lanostane series, and gave moderate to 
good yields. Whereas the piperidine, 1-(2-hydroxyethyl) piperazine, and diethylamine 
derivatives were successful in terms of both a chemical and biological point of view, giving 
good yields and excellent biological activity. Thus, we synthesised a range of novel amine 
derivatives of our protected stigmasterol (Table 2.19). 
Table 2.19 
 























* Upon inspection of the 
1
H NMR spectrum there was no evidence of any consumption of starting material or 
conversion to product 




It can be immediately seen from Table 2.19 that the yields of these compounds were 
significantly lower than their corresponding lanostane derivatives. This is explicable by the 
lower percentage conversions of these reactions as discussed below.  
 
2.5.9.1 Reductive amination of 85 with morpholine 
The first novel derivative, 86, was synthesised by reductive amination of aldehyde 85 with 
morpholine (Table 2.19, entry 1).
 1
H NMR analysis of the crude material showed the reaction 
had gone 60% to completion, with ~ 40% of aldehyde 85 remaining, therefore, it was 
necessary to purify the product. Initially, we were reluctant to resort to column 
chromatography, as our previous steroidal amines had been incompatible with this 
purification technique. In the case where separation of the minor regioisomer of the 1-(2-
aminoethyl) derivative in the lanostane series was necessary, column chromatography using 
hexane and ethyl acetate led to the complete loss of product. However, given the quantity of 
aldehyde starting material present in the crude product from this reaction, it was necessary to 
revise our purification strategy. Several test TLC eluents were employed to establish the Rf 
values of the product in different solvents, and we concluded that an 85:15 mixture of ethyl 
acetate and ether was the optimum solvent system for column chromatography of this 
product. Therefore a very fast column was undertaken, with the desired product eluting in 
very early fractions. It is possible that the shorter alkyl side chain in the stigmasterol analogue 
of the amine renders the compound slightly less polar and allows successful column 
chromatography when a highly non-polar solvent system is used. Thus, the morpholine 
derivative 86 was recovered in 43% yield following column chromatography.  
 
We were satisfied with the successful purification of this derivative to remove the starting 
aldehyde material from the crude product, and were optimistic that the same purification 
strategy could be applied going forward, should starting material remain after future reactions 
of this type. It is likely that this incomplete conversion of aldehyde to amine is attributable to 
the site of reactivity now being in much closer proximity to the steroidal rings and C-21, 
causing increased steric hindrance to an approaching nucleophile (Figure 2.72).  







H NMR spectrum of the purified product, 86, shows the expected characteristic 
disappearance of the 22-CH aldehyde signal at ~9.5 ppm. This new signal, corresponding to 
22-CH2, shows an intricate splitting pattern. One hydrogen of the methylene group appears as 
a doublet of triplets at 2.02 ppm, while the other hydrogen is contained within a multiplet 
between 2.14 and 2.32 ppm. It will transpire, upon further discussion, that this is a common 
occurrence across the series of stigmastane amine derivatives. In fact, the methylene 
hydrogens, contained within the multiplet in this case, become distinctive in the 
thiomorpholine derivative when nearby protons display a different chemical shift.  
Returning to analysis of the 
1
H NMR spectrum of 86, another key characteristic of successful 
reductive amination is that the stereogenic 20-CH, originally adjacent to a carbonyl, is now 
shifted upfield from a multiplet between 2.32 – 2.45 ppm to within the large 40H multiplet 
accounting for the majority of the steroidal signals. The very distinctive 4H multiplet between 
3.60 and 3.75 ppm corresponding to the two morpholine O-CH2 groups is visible in this 
spectrum also, in a comparable region to previous morpholine derivatives (Figure 2.73).  
The absence of the carbonyl peak at 205.3 ppm in the 
13
C NMR spectrum substantiates 
successful reductive amination, however the new C-22 signal is indecipherable between 54.3 
and 65.2 ppm. This CH2 group adjacent to the new nitrogen moiety previously appeared at ~ 
60 ppm in our lanosterol derivatives, however, in the stigmastane derivatives it is directly 
adjacent to a stereogenic centre, which has an unknown effect on the chemical shift value. A 
distinctive peak in the 
13
C NMR spectrum is that at 67.2 ppm, corresponding to the 
morpholine O-CH2 groups.  








This compound is awaiting evaluation for cytotoxicity and has been fully characterised and 
stored in preservation for possible future acceptance for biological screening. 
 
2.5.9.2 Reductive amination of 85 with piperidine 
Piperidine derivative 87 (Table 2.19, entry 2) was formed in 50% conversion, however 
isolated in particularly low yield of 13%. Upon reaction completion, inspection of the 
1
H 
NMR spectrum of the crude material showed only 50% conversion of aldehyde to amine was 
achieved. There had been no change in the reaction conditions for the synthesis of this 
derivative, as we had established a successful purification technique for these compounds. 
When column chromatography was performed, using 85:15 ethyl acetate:ether only the 
analytically pure fractions were combined and characterised, leading to the poor yield of 
13%. By comparison with morpholine derivative, (Table 2.19, entry 1) the piperidine 
derivative (Table 2.19, entry 2), it is evident that the reductive amination involving piperidine 
was less successful than that of morpholine, both in terms of percentage conversion and yield. 
This is a surprising result, as no issues arose with piperidine in the lanostane series of amines. 
The 
1
H NMR spectrum of 87 was much the same as that of 86 in terms of characteristic shifts 
of key signals. The interesting appearance of the 22-CH2 hydrogens separately, as a doublet 
of triplets at 2.01 ppm and within a multiplet between 2.09 and 2.28 ppm, is evident again in 
this derivative (Figure 2.74). In the 
13
C NMR spectrum, it is not clear where the 22-CH2 
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signal appears, as there is no distinctive methylene signal in the 60 ppm region. As with the 
morpholine derivative, the C-22 signal is indecipherable between two possibilities. HRMS 
shows the presence of the desired product, as an exact mass of 414.3729 was found, 





2.5.9.3 Reductive amination of 85 with thiomorpholine 
Thiomorpholine derivative 88 (Table 2.19, entry 3) was synthesised in 80% conversion and 
29% yield following reductive amination. This is an encouragingly high percentage 
conversion to the desired product, however, the repeated column chromatography required to 
obtain an analytically pure sample significantly lowered the percentage yield.   
As discussed earlier, the 
1
H NMR spectrum of 88 clearly shows the two hydrogens of 22-CH2 
as separate peaks occuring as a doublet of triplets at 2.01 ppm, and a doublet of doublets at 
2.31 ppm (Figure 2.75). The more downfield of these signals, at 2.31 ppm, previously 
obscured by the overlapping N-CH2 signal in other derivatives, is now clearly visible. This is 
explained by the N-CH2 signal shifting further downfield, due to the presence of the nearby 
sulfur heteroatom, and now being contained within the 2.40 – 2.72 ppm multiplet.  







Indeed, it was the assignment of 88 which gave us the insight into the unusual splitting 
pattern the methylene group at C-22, adjacent to a stereogenic centre. It is the 
diastereotopicity of these protons which leads to their different chemical shifts and unusual 
multiplicities.  
This novel compound was fully characterised and preserved for possible future biological 
testing.  
 
2.5.9.4 Reductive amination of 85 with 1-(2-hydroxyethyl)piperazine 
Given the excellent biological activity of the 1-(2-hydroxyethyl)piperazine derivative in our 
lanostane series, we were enthusiastic about  the stigmastane analogue. Compound 89 (Table 
2.19, entry 4) was synthesised in 31% yield. Interestingly, 
1
H NMR analysis of the crude 
material showed complete conversion of aldehyde starting material to product 89, as there 
was no signal observed in the 9.5 ppm region. Column chromatography was not required in 
this case, as integration of the characteristic peaks in the 
1
H NMR spectrum showed the 
product was analytically pure. The poor yield of this material is disappointing, however, the 
reaction was only carried out on one occasion. This reaction will need to be repeated in future 
work to establish the reproducible yield. 
This is a surprising result, as previous derivatives showed incomplete conversion of starting 
material to product in varying degrees. It would be expected that incomplete conversion 
would occur in this case also, possibly to an even higher extent as a more sterically bulky 
amine is being used, however this was not the observed case. 
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The poor yield for the 1-(2-hydroxyethyl)amine derivative of stigmasterol cannot be 
attributed to a poor nucleophilic effect of the amine, as previous reductive aminations using 
this amine showed very good yield in the lanostane derivatives. Yields of 94%, 88% and 72% 
were achieved for the acetate, alcohol and ketone derivatives of the lanostane nucleus upon 
reductive amination with this amine.  
The 
1
H NMR spectrum of the product did not show the key 22-CH2 signals as distinctly as the 
thiomorpholine derivative. In fact, the signals corresponding to these two hydrogens were 
contained within separate multiplets at 0.77 – 2.08 ppm and 2.10 – 2.40 ppm. The CH2 group 
adjacent to the alcohol in the hydroxyethyl side chain can be clearly seen as a distinctive 
triplet at 3.61 ppm, while three of the N-CH2 groups are contained within a multiplet at 2.45 – 
2.70 ppm. 
Again, this novel compound was fully characterised and preserved for future biological 
evaluation.  
 
2.5.9.5 Reductive amination of 85 with diethylamine 
The remaining target molecule to be synthesised in this series was the diethylamine derivative 
90 (Table 2.19, entry 5). Identical conditions of temperature and time were employed for the 
synthesis of this derivative, however, upon reaction completion and work up, analysis of the 
1
H NMR spectrum of the crude material showed only starting aldehyde 85 was present, with 
no indication of formation of the desired product.  
This complete non-conversion of starting material to product was a somewhat unexpected 
result. As discussed previously, the conformationally unrestricted nature of the diethyl groups 
was envisaged to have an impact on reductive amination, as the rotation of these groups could 
potentially block the nitrogen lone pair from acting in a nucleophilic reaction. However, in 
our previously synthesised lanostane analogues, this issue was not problematic.  
The reaction was repeated using the crude material from the first attempt and increasing the 
reaction time to 24 hours. Again there was no evidence of the formation of the desired 
product and the reaction was not pursued further. 
It is postulated that the free rotation of the ethyl groups, coupled with the proximity of the 
aldehyde to the steroidal ring and the C-21 methyl group, creates an insurmountable barrier to 




reaction on steric grounds (Figure 2.76). While this effect was not seen in the lanostane 
derivatives, it becomes relevant in this case due to the proximity of the C-21 methyl group to 
the site of reactivity, blocking the attack of the already hindered nitrogen lone pair.  
 
Figure 2.76 
In summary, with the exception of the diethylamine derivative, these reductive aminations 
proceeded with moderate to excellent percentage conversions (50% - ≥ 95%). It is 
unfortunate that purification of these compounds required repeated column chromatography, 
resulting in lower yields than their corresponding lanostane derivatives. However, the 
synthesis of these compounds provides a starting point for further research in this area, which 
would hopefully lead to better yields and an increase in the library of these amines with a 
cholestane nucleus. 
 
2.5.10 Deprotection of C-5,6 alkene  
In a previous reaction in Route 3, Scheme 2.67 , we had inadvertently deprotected the C-5,6 
alkene of 84, in a reaction that was intended to cleave the C-22,23 epoxide, using periodic 
acid. 





We therefore employed these conditions to deprotect aldehyde 85, which was formed by 
ozonolysis. Although the deprotection conditions used by Foley et al., namely sulfuric acid in 
water and THF,
63
 were not employed in this case, our acidic deprotection yielded 75 as an off 
white solid in 79% yield (Scheme 2.68). The periodic acid was considered a better reagent 
than sulfuric acid for this deprotection as it led to an improvement on the 67% yield reported 








Clear evidence for deprotection of the C-5,6 alkene was seen by the re-appearance of key 
signals in the 
1
H NMR spectrum of the product (Figure 2.77). The alkene hydrogen 6-CH 
appeared at 5.35 ppm, while 3-CH appeared as a multiplet between 3.46 and 3.59 ppm, both 
in their original regions as seen in the stigmasterol starting material. The absence of the 3H 
singlet at 3.33 ppm further demonstrated that the methyl ether was no longer present at C-6. 
The 
13
C NMR spectrum of the product is indicative of successful deprotection also, showing 




2.5.11 Reductive aminations of 3-hydroxy-20(S)-methyl-pregnan-5-ene-21-al 75 
Our final objective was to increase our amine derivatives of stigmasterol using 1-(2-
hydroxyethyl) piperazine, 4-piperidine methanol and 4-piperidine ethanol, all of which would 
lead to novel products, Table 2.20.  
Table 2.20 
 




















a: compounds were not purified due to insufficient quantities of material following the reaction. 
 
As can be seen from Table 2.20, the only successful reaction in this series was entry 1, the 
synthesis of 91. Interestingly, as was the case with the protected analogue 89, the 1-(2-
hydroxyethyl) piperazine derivative did not require purification upon reaction completion. 
The product 91 is isolated in 24% yield, a comparable result to the protected analogue 89, 
which was isolated in 31% yield.  
In the 
1
H NMR spectrum of this product, a large multiplet between 0.60 and 2.40 ppm 
obscures many of the characteristic signals corresponding to key changes at the site of 
reactivity. However, three of the piperazine N-CH2 signals are seen as a clear multiplet 
between 2.45 and 2.73 ppm.  
Entries 2 and 3 of Table 2.20 show the attempted syntheses of piperidine methanol and 
piperidine ethanol derivatives 92 and 93 respectively. Unfortunately, both of these products 
were not successfully isolated. The formation of new multiplets which could be attributed to 
92 and 93 are seen in the 
1
H NMR spectra for these compounds, however we have no further 
evidence for the formation of these products. 
In the case of 92, initial diminishment of the aldehyde signal looked promising by 
1
H NMR 
analysis, and the reaction was repeated on the crude material from the first attempt. However, 




after repeated attempted reductive aminations, it became clear that complete conversion of the 
aldehyde would not take place. Impurity peaks were also increasing from the multiple 
reactions. Purification of the material was not attempted due to the limited amount of product, 
and the quantity of impurity now present. The reaction was not pursued further at this stage.  
It is worth noting that 4-piperidine methanol was the only solid amine we encountered in this 
project. We believe that the solid nature of the amine may have contributed to the poor 
reaction outcome in this case, possibly due to decreased solubility in 1,2-dichloroethane.  
In the case of 93, though TLC analysis appeared to show complete consumption of the 
starting material, upon reaction completion and work up, 
1
H NMR analysis revealed that there 
was in fact ~ 70% starting aldehyde remaining. Due to the fact that 0.011 g of crude material 
was recovered from a starting mass of 0.020 g, and with our knowledge that these reactions 
yielded in the region of ~30%, the reaction was not repeated.  
Due to the difficulty encountered with reductive aminations of 75 with piperidine methanol 
and piperidine ethanol, further optimisation must be carried out in this area to establish the 
conditions under which these reactions would be successful.   
 
2.5.12 Deprotection of 20(S)-Methyl-6(R)-methoxy-3,5-cyclo-21-morpholio-pregnane 86 
As only one fully deprotected stigmastane amine derivative 91 was synthesised in this work, 
our enthusiasm remained to increase our number of compounds of this nature. Towards the 
end of this project we resorted to the possibility that deprotection of an amine derivative may 
be a viable possibility, as our prior methodology was to deprotect the starting aldehyde and 
subsequently perform the reductive amination. 
Periodic acid was employed to deprotect the morpholine derivative 86 in an attempt to 
synthesise 94 (Scheme 2.69). However, upon reaction completion, the 
1
H NMR spectrum 
showed a complex mixture of unidentifiable materials with no evidence of formation of the 
desired product. 





This result was not an unexpected outcome, as throughout the project the amine moiety has 
proven to be susceptible to degradation upon further reaction, and indeed under 
chromatographic conditions. This initial work carried out in this section on stigmasterol 
derivatives represents the starting point of a vast area of novel chemistry which could be 
explored in future work. As research into the derivatives of this steroid had not been 
previously carried out in the group, this initial work provides an excellent platform for further 
study of these derivatives.  
2.6 Conclusions 
The combination of the synthesis of novel compounds and the excellent biological activity of 
a selection of these derivatives leads to the conclusion that this overall project was a great 
success. The aims of the project were achieved, and previous work was expanded on, 
particularly utilising non side chain functionalised dihydrolanosterol derivatives and 
introducing key functionality in terms of oxidation and the useful side chain aldehyde. The 
main summary points of each section of this project are discussed below, by way of 
conclusion. 
1. Lanosterol Oxidation Products: 
The highlight of this section was the initially promising biological results of the side chain 
epoxide moieties 22, 23 and 24, with the C-3 ketone derivative 24 having an IC50 value of 57 
M in U937 cells and a 16.4 fold increase in apoptotic bodies at 56M. These results 
provided an insight into the structure activity relationships of lanosterol oxidation products, 
and were used to strategically synthesise target molecules, which showed improved biological 
activity. Of great significance also was the synthesis of the C-24 aldehyde in the side chain of 
lanosterol with acetate 21, alcohol 25 and ketone 29 moieties at C-3. This new series of 




compounds opened up an exciting area of amine chemistry which would ultimately lead to 




2. Amine derivatives of Lanosterol: 
In this section, a synthetic strategy was developed involving reductive amination at the side 
chain aldehydes. This strategy yielded a panel of novel amine derivatives of lanosterol, 
incorporating a variety of alkyl amines such as piperidine and diethylamine (compounds 42 
and 44 respectively), and heteroatom containing amines including morpholine and 
thiomorpholine (compounds 46 and 50 respectively). We are very satisfied with this area of 
the project from a synthetic chemistry point of view, as the successful synthesis and full 
characterisation of novel derivatives is always challenging. Biological screening of these 
compounds revealed excellent IC50 results for piperidine and 1-(2-hydroxyethyl)piperazine 
derivatives (compounds 42 and 59, having IC50 values of 1.9 M and 2.7 M in U937 cells 
respectively), comparable to the marketed Etoposide. This biological success was the 
pinnacle of our project and we were delighted to have achieved such an excellent result. 
Reductive amination forms the centrepiece of this project, with a large number of novel 
secondary and tertiary amines derived from both lanosterol and stigmasterol. 
 




3. Cholestane Derivatives of Biologically Active Amines: 
The side chain chemistry undertaken on stigmasterol has shown that, despite our best efforts 
to form the C-22 aldehyde by oxidative cleavage of the C-22,23 epoxide, recourse to 
ozonolysis was necessary to achieve this transformation. Optimisation of column 
chromatography work on the C-3 protected C-22 aldehyde 85 led to the isolation of this 
compound in a sufficiently pure state to carry out reductive amination reactions. Thus four 
novel amine derivatives were synthesised and fully characterised. One successful synthesis of 
a C-3 alcohol derivative of stigmasterol with amine side chain  91 gives scope for further 
work in this area, and we are keen to have this derivative biologically tested. We believe that 
the initial work carried out on the cholestane derivatives will prove invaluable in future 
research. Optimisation of key reactions along the synthetic route to amine derivatives will 
allow for the efficient synthesis of further novel compounds at a later date. Immediate targets 
in this area would be reaction yield improvement and biological evaluation of the products. 
 
2.7 Future Work 
Many areas of this research could potentially be expanded and further investigated. Following 
on from the synthetic strategies which have been put in place during the course of this work, 
one could envisage a number of potential target molecules for future synthesis. In the 
lanosterol oxidation products section, a C-7,8 and C-9,11 diepoxide would be an interesting 
addition to the novel compounds synthesised in this area. Finally, with much of the necessary 
methodology work put in place during this project, the stigmasterol chemistry area now 
shows very promising potential. 
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3.1 General Procedures 
 
Solvents were distilled prior to use as follows: dichloromethane was distilled from 
phosphorous pentoxide, ethyl acetate was distilled from potassium carbonate, hexane was 
stored and distilled prior to use. Organic phases were dried using anhydrous magnesium 
sulfate. All commercial reagents were used without further purification. 
Proton (300 MHz and 400 MHz) NMR and carbon (75.5 MHz) NMR spectra were recorded 
on Bruker Avance 300 NMR and 400 NMR spectrometers. All spectra were recorded at 20 
°C in deuterated chloroform (CDCl3) unless otherwise stated, using tetramethylsilane (TMS) 
as internal standard. Chemical shifts, H and C, are expressed as parts per million (ppm).  
Splitting patterns in 
1
H NMR spectra are designated as s (singlet), d (doublet), t (triplet) and 
m (multiplet). Coupling constants (J) are quoted in Hz. 
13
C NMR spectra were assigned with the aid of DEPT experiments run in the DEPT-90, 
DEPT-135 and DEPT-Q modes. 
Infrared spectra were measured as potassium bromide discs for solids, or thin films on sodium 
chloride plates for oils, on a Perkin-Elmer Paragon 1000 FT-IR spectrometer in the range 
4000 to 450 cm
−1
. 
Thin layer chromatography (TLC) was carried out on pre-coated silica gel plates (Merck 
Silica Gel 60, F254). Wet flash chromatography was performed using Merck silica gel 60 and 
the fractions are reported in the order with which they eluted unless otherwise stated.  
Visualisation of compounds on TLC plates was achieved by ultra-violet light (254 nm) 
detection or vanillin staining.  
Melting points were carried out on a uni-melt Thomas Hoover Capillary melting point 
apparatus and are uncorrected.  
Elemental analyses were performed by the Microanalysis Laboratory, National University of 
Ireland, Cork, using Perkin-Elmer 240 and Exeter Analytical CE440 elemental analysers.  
Low resolution mass spectra were recorded on a Waters Quattro Micro triple quadrupole 
spectrometer on electrospray ionisation (ESI) mode using 50% water/acetonitrile containing 
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0.1% formic acid as eluent. Samples were submitted for analysis dissolved in 1 mL of 
acetonitrile, unless otherwise stated. 
High resolution mass spectra were recorded on a Waters LCT Premier Time of Flight 
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3.2 Lanosterol Oxidation Products 
3-Acetoxy-5-lanosta-8,24-diene 10 and 3-acetoxy-5-lanost-8-ene
1
 11.  
Acetic anhydride (0.344 g, 3.37 mM) 
was added to a stirring solution of a 
50:50 mixture of lanosterol 6 and 
dihydrolanosterol 7 (1.000 g, 2.34 
mmol) dimethylaminopyridine (0.020 
g, 0.07 mM) and pyridine (1.52 mL, 
18.79 mM) in dichloromethane (10 
mL). The solution was stirred under a 
blanket of nitrogen at room temperature for 24 h. The solution was washed sequentially with 
5% hydrochloric acid (3 × 10 mL), 10% sodium hydrogen carbonate (3 × 10 mL), brine (1 × 
10 mL) and water (1 × 10 mL) respectively. The organic layer was dried over MgSO4 and 
concentrated in vacuo to give a pale yellow residue. The residue was recrystallised from 
acetone to yield an inseparable mixture of 3-acetoxy-5-lanosta-8,24-diene 10 and 3-
acetoxy-5-lanost-8-ene 11 (50:50 ratio) as a white solid (0.353 g, 32%): mp 110 – 118 °C 
(literature,
1
 125 – 129 °C); max (KBr)/cm
-1
: 2953, 1736. Exact mass calculated for C32H53O2 
[M + H]
+
 469.4046, found 469.4046; Exact mass calculated for C32H55O2 [M + H]
+
 471.4202, 





δH (300 MHz, CDCl3) 0.69 – 1.76 [51H, m, containing: 0.69 (3H, s, 18-CH3), 0.85 – 0.92 
(12H, m,  4 × CH3: 30-CH3, 29-CH3, 28-CH3, 21-CH3), 1.00 (3H, s, 19-CH3), 1.12 – 1.21 
(1H, m, 5-CH), 1.25-1.37 (1H, m, 20-CH), 1.60 (3H, s, 27-CH3), 1.68 (3H, s, 26-CH3), 2.05 
(3H, s, Ac-CH3)] 4.50 (1H, dd, J 11.2, 4.7, 3-CH), 5.10 (1H, t, J 7.0, 24-CH); δC (75 MHz, 
CDCl3)15.8 (18-CH3), 16.5 (29-CH3), 17.7 (27-CH3), 18.1 (6-CH2), 18.6 (21-CH3), 19.2 (19-
CH3), 21.0 (11-CH2), 21.4 (OAc, CH3), 24.2 (2-CH2), 24.3 (30-CH3), 24.9 (23-CH2), 25.8 
(26-CH3), 26.4 (7-CH2), 27.9 (28-CH3), 28.2 (16-CH2), 30.8 (15-CH2), 31.0 (12-CH2), 35.3 
(1-CH2), 36.4 (20-CH), 36.5 (22-CH2), 36.9 (10-quaternary C), 37.8 (4-quaternary C), 44.5 
(13-quaternary C), 49.8 (14-quaternary C), 50.4 (5-CH or 17-CH),  50.5 (5-CH or 17-CH), 
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80.9 (3-CH), 125.3 (24-CH), 130.9 (25-quaternary C), 134.2 (9-quaternary C), 134.5 (8-




δH (300 MHz, CDCl3) 0.69 – 1.76 [54H, m, containing: 0.69 (3H, s, 18-CH3), 0.85 – 0.92 
(12H, m,  4 × CH3: 30-CH3, 29-CH3, 28-CH3, 21-CH3), 1.00 (3H, s, 19-CH3), 1.12 – 1.21 
(1H, m, 5-CH), 1.25 – 1.37 (1H, m, 20-CH), 1.60 (3H, s, 27-CH3), 1.68 (3H, s, 26-CH3), 2.05 
(3H, s, Ac-CH3)] 4.50 (1H, dd, J 11.2, 4.7, 3-CH), 
13
C NMR spectrum contains a majority of 
overlapping signals with key differences at C-24, C-25, C-26 and C-27. δC (75 MHz, CDCl3) 
15.7 (18-CH3), 16.5 (29-CH3), 18.1 (6-CH2), 18.7 (21-CH3), 19.2 (19-CH3), 21.0 (11-CH2), 
21.4 (OAc, CH3), 22.6 (26-CH3), 22.9 (27-CH3), 24.1 (23-CH2), 24.2 (2-CH2), 24.3 (30-CH3), 
26.4 (7-CH2), 27.9 (28-CH3), 28.0 (25-CH), 28.2 (16-CH2), 30.4 (15-CH2), 31.0 (12-CH2), 
35.3 (1-CH2), 36.3 (20-CH), 36.5 (22-CH2), 36.9 (10-quaternary C), 37.8 (4-quaternary C), 
39.5 (24-CH2), 44.5 (13-quaternary C), 49.8 (14-quaternary C), 50.4 (5-CH or 17-CH), 50.5 
(5-CH or 17-CH), 80.9 (3-CH), 134.2 (9-quaternary C), 134.5 (8-quaternary C), 171.0 




 12 and 3-acetoxy-5-
lanost-8-ene 11 
N-bromosuccinimide (1.350 g, 7.59 
mM) was added to a stirring solution 
of the inseparable 50:50 mixture of 
lanosterol acetate 10 and 
dihydrolanosterol acetate 11 (4.449 
g, 9.49 mM) in acetone (450 mL), 
deionised water (7 mL) and 
hypophosphorous acid (1.19 mL, 
21.80 mM). The solution was stirred at room temperature for 5 min, whereupon NaHCO3 
(1.350 g, 16.13 mM) was added. The solution was concentrated in vacuo to yield a mixture of 
24(R,S)-3-acetoxy-24-bromo-25-hydroxy-5-lanost-8-ene 12 and 3-acetoxy-5-lanost-8-
ene 11 (7.960 g) which was carried forward without purification.  
 





 13a and 13b 
A mixture of 24(R,S)-3-acetoxy-24-bromo-25-
hydroxy-5-lanost-8-ene 12 and 3-acetoxy-5-
lanost-8-ene 11 (6.56 g, 11.6 mM) was dissolved in 
2-propanol (196 mL), deionised water (65 mL), and 
hypophosphorous acid (4.09 mL, 74.8 mM). 
NaHCO3 (6.045 g, 71.88 mM) was added and the 
mixture was refluxed at 160 °C for 4 h. After this 
time period, water (200 mL) was added to the reaction mixture.  The resulting solid was 
filtered through a sintered Büchner funnel. The solid was washed with water and tested with 
pH paper, while in a wet state, until pH 7 was obtained. The crude product was purified by 
column chromatography using dichloromethane. The first fraction from the column was 3-
acetoxy-5-lanost-8-ene 11, isolated as a white solid (2.06 g, 41%). The second fraction from 
the column was a 1:1 diastereomeric mixture of 24(R,S)-3-acetoxy-24,25-dihydroxy-5-
lanost-8-ene 13a and 13b isolated as a white solid (2.59 g, 72%); mp 121 – 125 °C 
(literature,
1
 172 – 175 °C); max (KBr)/cm
-1






H (300 MHz, CDCl3) 0.69 (3H, s, 18-CH3), 0.84 – 0.94 (12H, m, 28-CH3, 29-CH3, 30-CH3, 
21-CH3), 1.00 (3H, s, 19-CH3), 1.09 – 1.16 (1H, m, 5-CH), 1.21 (3H, s, 27-CH3), 1.25 – 1.75 
(5H, m, 26-CH3, 20-CH, 17-CH), 2.05 (3H, s, OAc, CH3), 3.29 (1H, d, J 9.5, 24(R)-CH), 4.50 
(1H, dd, J 11.2, 4.7, 3-CH). δC (75 MHz, CDCl3) 15.8 (18-CH3), 16.5 (29-CH3), 18.0 (6-CH2) 
18.5 (21-CH3), 21.0 (11-CH2), 21.3 (OAc, CH3), 23.2 (26-CH3), 26.4 (7-CH2), 27.9 (2 of  or 
23 of ), 28.2 (28-CH3), 30.8 (15-CH2), 31.0 (12-CH2), 33.6 (22-CH2), 35.2 (1-CH2), 36.9 
(10-quaternary C), 36.7 (20-CH), 37.8 (4-quaternary C), 44.5 (13-quaternary C), 49.8 
(14quaternary C), 50.5 (5-CH), 53.4 (quaternary C), 63.4 (CH), 73.2 (25-quaternary C), 78.7 
(24(R)-CH), 81.0 (3-CH), 134.2 (9-quaternary C). 134.4 (8-quaternary C), 171.1 (quaternary 










H (300 MHz, CDCl3) 0.69 (3H, s, 18-CH3), 0.84 – 0.94 (12H, m, 28-CH3, 29-CH3, 30-CH3, 
21-CH3), 1.00 (3H, s, 19-CH3), 1.09 – 1.16 (1H, m, 5-CH), 1.21 (3H, s, 27-CH3), 1.25 – 1.75 
(5H, m, 26-CH3, 20-CH, 17-CH), 2.05 (3H, s, OAc, CH3), 3.34 (1H, s, 24(S)-CH), 4.50 (1H, 
dd, J 11.2, 4.7, 3-CH); δC (75 MHz, CDCl3) 15.8 (18-CH3), 16.5 (29-CH3), 18.0 (6-CH2), 
18.8 (21-CH3), 21.0 (11-CH2), 21.3 (OAc, CH3), 23.2 (26-CH3), 26.4 (7-CH2), 27. 9 (2-CH2 
of  or 23-CH2 of ), 28.2 (28-CH3), 30.8 (15-CH2), 31.0 (12-CH2), 33.2 (22-CH2), 35.2 (1-
CH2), 36.9 (10-quaternary C), 36.7 (20-CH), 37.8 (4-quaternary C), 44.5 (13-quaternary C), 
49.8 (14-quaternary C), 50.5 (5-CH), 53.4 (quaternary C), 63.4 (CH), 73.2 (25-quaternary C), 
79.6 (24(S)-CH), 81.0 (3-CH), 134.2 (9-quaternary C). 134.4 (8-quaternary C), 171.1 




A solution of chromium trioxide (0.955 g, 9.55 
mM) in acetic acid (30mL, 90% v/v) heated to 80 
°C was added to a stirring solution of 1:1 24(R,S) 
3-acetoxy-24,25-dihydroxy-5-lanost-8-ene 13a 
and 13b  (1.200 g, 2.38 mM) in glacial acetic acid 
(48 mL) also heated to 80 °C
3
. The solution was 
stirred for 50 min at 80 °C, removed from the oil 
bath and allowed to cool to room temperature. The reaction was then cooled on an ice bath 
for 1 h, poured into water (100 mL) and extracted with chloroform (3 × 50 mL). The 
combined organic extracts were washed with water (4 × 25 mL) dried over MgSO4 and 
concentrated under reduced pressure to give the crude product consisting of 3-acetoxy-5-
lanost-8-ene-7,11,24-one-25-ol 14 and 3-acetoxy-5-lanost-9(11)-en-7,24-one-25-ol 15 as a 
yellow solidifying oil. Purification by column chromatography (hexane:ethyl acetate 80:20) 
led to the isolation of the desired product, as the second fraction from the column, 3-
acetoxy-5-lanost-8-ene-7,11,24-one-25-ol 14 as a yellow solid (0.392 g, 31%); mp 186 – 
190 °C; Found C, 73.18;H, 9.41. C32H48O6 requires C, 72.69; H 9.15%; max (KBr)/cm
-1
: 
3367, 1734, 1676; H (300 MHz, CDCl3) 0.80 (3H, s, 18-CH3), 0.90 (3H, s, 26-CH3), 0.91 – 
1.90 [20H, m, containing 0.96 (3H, s, 19-CH3), 0.90 – 1.27 (9H, m, 21-CH3, 30-CH3, 28-CH3 
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or 29-CH3), 1.17 (3H, s, 28-CH3 or 29-CH3), 1.33 (3H, s, 27-CH3)], 2.00 – 2.50 [5H, m, 
containing 2.06 (3H, s, OAc CH3)], 2.60 (1H, d, J 15.8 12-CH), 2.78 (1H, d, J 16.1, 12-
CH), 2.89 (1H, dt, J 13.6, 3.5, 1-CH), 4.55 (1H, dd, J 5.4, 11.0, 3-CH); δC (75 MHz, CDCl3) 
16.5 (29-CH3), 16.8 (18-CH3), 17.6 (27-CH3), 18.1 (21-CH3), 21.3 (OAc, CH3 or 30-CH3), 
23.9 (2-CH2), 25.9 (28-CH3), 27.2 (16-CH2), 27.8 (19-CH3), 30.7 (22-CH2), 31.1 (23-CH2), 
32.1 (15-CH2), 33.7 (1-CH2), 35.7 (20-CH), 36.2 (6-CH2), 37.7 (10-quaternary C), 39.6 (4-
quaternary C), 47.5 (13-quaternary C), 48.9 (5-CH), 49.0 (14-quaternary C), 50.1 (17-CH), 
51.5 (12-CH2), 79.3 (3-CH), 150.5 (8-quaternary C), 151.7 (9-quaternary C), 170.9 
(quaternary C, OAc C=O), 179.6 (quaternary C, C=O), 201.9 (C=O, 11-quaternary C), 202.2 




 (14%), 473 (100); Exact mass calculated for 
C32H49O6 [M + H]
+ 




The first fraction from the column described above 
was isolated as a yellow oil containing a mixture of 
numerous products (0.088 g), one of which being 
tentatively assigned as 3-acetoxy-5-lanost-9(11)-
en-7,24-one-25-ol 15. 
Characteristic signals, within the mixture of 
numerous products, for this tentative assignment are described below: 
H (300 MHz, CDCl3) 0.68 (3H, s, 18-CH3), 0.76 (3H, s, 30-CH3), 0.83 (3H, s, 28-CH3), 0.85-
0.92 (9H, m, 21-CH3, 26-CH3, 27-CH3), 0.93 (3H, s, 29-CH3), 1.12 (3H, s, 19-CH3), 1.27-
1.98 (3H, m, 5-CH, 17-CH, 20-CH), 2.07 (3H, s, OAc, CH3), 2.89 (1H, s, H-8), 4.52 (1H, 
dd, J 10.8, 4.3, H-3), 5.40-5.41 (1H, m, H-11); max (film)/cm
-1
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Attempted Synthesis of 3-Acetoxy-5-lanost-8-ene-7,11-one-24-ene-25-ol 33 
Sodium hydride (0.006 g, 0.18 mM) was placed in a 
dry 100 mL three neck round bottom flask. 
Dimethylsulfoxide (0.7 mL) was added immediately 
and the solution was heated to 75 °C for 1 h. The 
methylsulfinyl carbanion solution was cooled to 18 
°C and methyltriphenylphosphonium bromide 
(0.068 g, 0.19mM) in dimethylsulfoxide (0.2 mL) 
was added dropwise. After addition was complete the solution was allowed to warm to room 
temperature over a 30 min period. Ketone 14 (0.080 g, 0.15 mM) in dimethylsulfoxide (10 
mL) was added dropwise to the Wittig reagent and the reaction was allowed to stir at room 
temperature for 6 h.
4
 After this time, cold water (50 mL) was added to the reaction solution. 
The product was extracted with hexane (4 × 40 mL). The hexane remained clear and the 
orange aqueous layer was not observed to change. The combined hexane extracts were 
washed with water (2 × 40 mL) and dried over magnesium sulfate. The solvent was removed 
under reduced pressure and 
1
H NMR analysis was obtained. The 
1
H NMR spectrum showed 
no evidence of formation of the desired product 33, and also no evidence of any steroidal 
material in this sample. The aqueous layer was extracted with dichloromethane (3 × 40 mL) 
and the orange colour of the aqueous layer was observed to transfer to the organic layer. The 
combined dichloromethane extracts were washed with water (2 × 20 mL), dried over 
magnesium sulfate and concentrated under reduced pressure to yield an orange oil. Analysis 
of the 
1
H NMR spectrum of the crude product showed no evidence of the formation of the 
desired product, and also no evidence of any steroidal material in this sample. The reaction 




10% KOH in EtOH (10 mL) was added to 3β-acetoxy-
5α-lanost-8-ene-7,11,24-one-25-ol 14 (0.075 g, 0.14 
mM) and the solution was heated to 60 °C for 2 h. The 
resulting mixture was poured onto ice water and 
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allowed to stand for 6 h. 10% HCl (2 mL) was added and the precipitate was isolated by 
suction filtration
1
 which yielded the desired product 16 as a yellow solid (0.048 g, 70%); mp 
181 – 183 °C max (KBr)/cm
-1
: 3400, 2918, 1670; H (300 MHz, CDCl3) 0.80 (3H, s, 18-CH3), 
0.89 (3H, s, 26-CH3), 0.90 – 1.27 (9H, m, 21-CH3, 30-CH3, 28-CH3 or 29-CH3), 1.02 (3H, s, 
19-CH3), 1.18 (3H, s, 28-CH3 or 29-CH3), 1.30 (3H, s, 27-CH3), 1.31 – 2.52 (20H, m), 2.60 
(1H, d, J 15.8 12-CH), 2.78 (1H, d, J 16.1, 12-CH), 2.89 (1H, dt, J 13.6, 3.5, 1-CH), 3.23 
(1H, dd, J 11.0, 5.4, 3-CH); δC (75 MHz, CDCl3) 15.5 (CH3), 16.8 (29-CH3), 17.5 (18-CH3), 
18.1 (27-CH3), 25.8 (26-CH3), 27.2 (CH2), 27.5 (16-CH2), 27.8 (28-CH3), 29.7 (15-CH2), 
30.7 (22-CH2), 32.1 (23-CH2), 34.0 (1-CH2), 35.7 (20-CH), 36.4 (2-CH2), 38.8 (10-
quaternary C), 39.7 (4-quaternary C), 47.3 (13-quaternary C), 48.7 (5-CH), 48. 9 (14-
quaternary C), 50.1 (17-CH), 51.5 (12-CH2), 77.6 (3-CH), 150.5 (8-quaternary C), 151.8 (9-
quaternary C) 177.8 (quaternary C, C=O), 202.2 (11-quaternary C, C=O), 202.3 (7-quaternary 
C, C=O); exact mass calculated for C30H46O5 [M - H]
+ 





Potassium carbonate (0.025 g, 0.19 mM) was dissolved in water (10 mL) and added to a 
suspension of 3β-acetoxy-5α-lanost-8-ene-7,11,24-one-25-ol 14 (0.090 g, 0.17 mM) in 
methanol stirring at room temperature for 5 min. The reaction mixture was stirred at room 
temperature for 24 h. The mixture was partitioned between water and ethyl acetate, washed 
with water (2 × 50 mL) and brine (2 × 50mL), dried over MgSO4 and concentrated under 
reduced pressure to yield starting material 14 and unidentified materials by 
1
H NMR analysis 
(0.090 g).  
 
Method C:  
Procedure as outlined in Method B, using the substrate isolated from method B and twice the 
equivalents of potassium carbonate (0.047 g, 0.34 mM). Again, starting material 3β-acetoxy-
5α-lanost-8-ene-7,11,24-one-25-ol 14 was isolated (0.81g, 90% recovery). Trace amounts of 
unidentified materials were also present by 
1
H NMR analysis. 
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Method D:  
Acetyl chloride (0.05 mL, 0.77 mM) was added dropwise to a solution of the material isolated 
from method C (0.081 g, 0.15 mM)* dissolved in a 50:50 mixture of anhydrous 
dichloromethane and anhydrous methanol at 0 °C. The solution was then stirred for 72 h at 
room temperature after which time the reaction mixture was neutralised with triethylamine 
(0.11 mL 0.77 mM) and poured into water (100 mL). The solution was extracted with 
dichloromethane (3 × 30 mL), washed with water (4 × 25 mL), washed with brine (2 × 
25mL), dried over MgSO4 and concentrated under reduced pressure to yield 3β-acetoxy-5α-
lanost-8-ene-7,11,24-one-25-ol 14 : 5α-lanost-8-ene-7,11,24-one-25,3-ol  16 (1 : 1) (0.080 g). 
*Starting material was contaminated from previous attempts of the reaction. 
 
5-Lanost-9(11)-ene-7,24-dione-3,25-diol  17 
10% KOH in ethanol (4.5 ml) was added to 3-
acetoxy-5-lanost-9(11)-en-7,24-one-25-ol 15 (0.146 
g) and the solution was heated to 60 °C for 2 h. The 
resulting mixture was poured onto ice water left to 
stand for 6 h. The mixture was acidified to pH 2 with 
dropwise addition of 10% HCl.
1
 Suction filtration 
yielded 5-lanost-9(11)-ene-7,24-dione-3,25-diol 
17, among other materials, as a white solid (0.02 g, 15%). Mp 198 – 200 °C; max (film)/cm
-1
: 
3410, 1707, 1673. 
1
H NMR analysis of the crude material revealed a complex mixture of products. A shift in the 
3-CH peak from 4.52 ppm to 3.30 ppm indicated successful alcohol deprotection. However 
other materials in the 
1
H NMR spectrum of the crude material were unidentifiable due to 











A solution of chromium trioxide (0.709 g, 7.10 mM, 4 
eq) in acetic acid (30 mL, 90% v/v) heated to 80 °C 
was added to a stirring solution of 3-acetoxy-5-
lanost-8-ene 11 (0.835 g, 1.77 mM) in glacial acetic 
acid (40 mL) also heated to 80 °C. The solution was 
stirred for 1 h at 80 °C,
3
 removed from the oil bath 
and allowed to cool to room temperature. The reaction 
was then cooled on an ice bath for 1 h and poured on to water (100 mL). The solution was 
extracted with chloroform (3 × 30 mL) and the combined organic extracts were washed with 
water (2 × 30 mL), dried over MgSO4 and concentrated under reduced pressure to give the 
crude product as a green/yellow solidifying oil (0.740 g). 
1
H NMR analysis of the crude 
material showed the reaction had gone to completion, with minor impurity peaks being 
observed at 4.02 ppm and 4.20 ppm. Purification by repeated column chromatography using 
70:30 hexane : ethyl acetate removed the impurity peak at 4.05 ppm and led to the isolation of 
the desired product 3β-acetoxy-5α-lanost-8-ene-7,11-dione 18 as a yellow solid (0.265 g 
30%), mp 152 – 154 °C (literature,
6
 159 – 161 °C); max (KBr)/cm
-1
: 1737, 1716, 1676. H 
(300 MHz, CDCl3) 0.79 (3H, s, 18-CH3), 0.85 – 0.90 (12H, m, containing 4 × CH3, 19-CH3, 
21-CH3, 26-CH3, 27-CH3), 0.95 (3H, s, 29-CH3 or 28-CH3), 1.17 (3H, s, 29-CH3 or 28-CH3), 
1.32 (3H, s, 30-CH3) 1.49 – 1.80 (7H, m, 20-CH, 16-CH2, 15-CH2, 17-CH, 25-CH), 1.92 – 
2.05 (1H, m), 2.06 (3H, s, OAc, CH3), 2.10 – 2.20 (1H, m), 2.40 – 2.55 (2H, m), 2.62 (1H, d, 
J 15.9, 12-CH), 2.77 (1H, d, J 15.9, 12-CH), 2.90 (1H, dt, J 13.7, 3.6, 1-CH), 4.53 (1H, 
dd, J 11.0, 5.5, 3-CH); δC (75 MHz, CDCl3) 16.5 (29-CH3), 16.8 (CH3), 17.5 (18-CH3), 18.6 
(CH3), 21.3 (30-CH3), 22.5 (26-CH3), 22.8 (27-CH3), 23.9 and 24.0 (23-CH2 or 2-CH2), 25.9 
(28-CH3), 27.3 (16-CH2), 27.81 (OAc, CH3 or 19-CH3), 27.98 (25-CH), 32.2 (15-CH2), 33.8 
(1-CH2), 36.2 (20), 36.20 (6-CH2), 36.3 (22-CH2), 37.7 (4), 39.4 (24-CH2), 39.6 (10-
quaternary C), 47.5 (13-quaternary C), 49.0 (14-quaternary C), 49.1 (17-CH), 50.1 (5-CH), 
51.6 (12-CH2), 79.3 (3-CH), 150.7 (8-quaternary C), 151.7 (9-quaternary C), 170.8 (OAc), 
202.0 (11-quaternary C, C=O), 202.5 (7-quaternary C, C=O); m/z 499 [M + H]
+
 (28%), 267 
(100); exact mass calculated for C32H51O4 [M + H]
+












Butyl hydroperoxide (0.95 mL, 9.90 mM) was added dropwise to a stirring solution of 
an inseparable mixture of lanosterol acetate 10 and dihydrolanosterol acetate 11 (1:1) (0.150 
g, 0.32 mM) and ruthenium trichloride (0.0009 g, 0.004 mM) in hexane (20 mL). The 
reaction solution was stirred at room temperature for 6 h. Saturated aqueous sodium 
bicarbonate (20 mL) was added to the reaction solution. The solution was then washed with 
sodium thiosulfate (2 × 20 mL) and brine (20 mL). The organic layer was dried over 
magnesium sulfate and concentrated under reduced pressure to yield the crude product (0.136 
g). Analysis of the 
1
H NMR spectrum of the crude material showed only starting materials 
present, with no evidence of formation of the desired product. Likewise, no product formation 
was observed upon analysis of the carbonyl region of the 
13
C NMR spectrum.  
 
 
5α-lanost-8-ene-7,11 dione 3-ol 19 
10% KOH in ethanol (6 mL) was added to 3β-acetoxy-
5α-lanost-8-ene-7,11 dione 18 (0.265 g, 0.53 mM) and 
the solution was heated to 60 °C for 2 h. The resulting 
mixture was poured onto ice water allowed to stand for 6 
h.
1
 Suction filtration yielded the crude product as an off 
white solid (0.237 g). Analysis of the 
1
H NMR spectrum 
of the crude material showed the reaction had gone 92% 
to completion, with the remainder accounting for residual starting material and an 
unidentified by product displaying a triplet at 3.60 ppm. Purification required repeated 
column chromatography using 70:30 hexane:ethyl acetate, and yielded the desired product 
5-lanost-8-ene-7,11 dione 3-ol 19 as a yellow solidifying oil (0.219 g, 90%); max (KBr)/cm
-
1
: 3247, 1670; H (300 MHz, CDCl3) 0.80 (3H, s, 18-CH3), 0.86 – 0.89 (12H, m, containing 4 
× CH3,19-CH3, 21-CH3, 26-CH3, 27-CH3), 1.02 (3H, s), 1.08-1.21 (6H, m, 29-CH3, 28-CH3), 
1.30 (3H, s, 30-CH3), 2.61 (1H, d, J 16.0, 12-CH), 2.75 (1H, d, J 16.1, 12-CH), 2.89 (1H, 
dt, J 13.7, 3.6, 1-CH), 3.28 (1H, dd, J 11.1, 5.1, 3-CH); δC (75 MHz, CDCl3) 15.5 (29-CH3), 
16.8 (18-CH3), 17.5 (30-CH3), 18.6 (21-CH3), 22.5 (26-CH3), 22.8 (27-CH3), 24.0 (23-CH2), 
25.9 (28-CH3), 27.4 (16-CH2), 27.6 (2-CH2), 27.9 (19-CH3), 28.0 (25-CH), 32.2 (15-CH2), 
34.1 (1-CH2), 36.2 (20-CH), 36.2 (6-CH2), 36.4 (22-CH2), 38.9 (4-quaternary C), 39.4 (24-
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CH2), 39.8 (10-quaternary C), 47.4 (13-quaternary C), 49.0 (14-quaternary C), 49.1 (5-CH), 
50.2 (17-CH), 51.7 (12-CH), 77.7 (3-CH), 150.7 (8-quaternary C), 151.8 (9-quaternary C), 
202.3 (11-quaternary C, C=O), 202.6 (7-quaternary C, C=O); m/z 457 [M + H]
+
 (22%), 279 
(100); exact mass calculated for C30H48O3 [M + H]
+







Butyl hydroperoxide (0.70 mL, 7.26 mM) was added dropwise to a stirring solution of 
an inseparable mixture of lanosterol 6 and dihydrolanosterol 7 (1:1) (0.100 g, 0.23 mM) and 
ruthenium trichloride (0.0007 g, 0.003 mM) in hexane (20 mL). The reaction solution was 
stirred at room temperature for 6 h. Saturated aqueous sodium bicarbonate (20 mL) was 
added to the reaction solution. The solution was then washed with sodium thiosulfate (2 × 20 
mL) and brine (20 mL). The organic layer was dried over magnesium sulfate and 
concentrated under reduced pressure to yield the crude product (0.086 g). Analysis of the 
1
H 
NMR spectrum of the crude material showed only starting materials present, with no 
evidence of formation of the desired product. Likewise, no product formation was observed 
upon analysis of the carbonyl region of the 
13
C NMR spectrum.  
 
Attempted Allylic Oxidation using Selenium Dioxide Lanost-8-ene-27-al 20 
An inseparable mixture of lanosterol 6 and 
dihydrolanosterol 7 (0.200 g, 0.47 mM) (1:1) was 
dissolved in 95% ethanol (25 mL) and selenium 
dioxide (0.052 g, 0.47 mM) was added. The resulting 
solution was heated at reflux for 2 h.
7
 The reaction 
mixture was diluted with ethyl acetate (20 mL) and 
filtered through a bed of Celite 
®
. The organic solution 
was washed with brine (2 × 20 mL), dried over magnesium sulfate and concentrated under 
reduced pressure to yield the crude product as a yellow oil. Analysis of the 
1
H NMR spectrum 
of the crude material showed a majority of starting material, with evidence of the formation 
of ~6% of the desired product 20, due to a broad singlet at 9.34 ppm.  
 





 22a and 22b 
A 50:50 mixture of 3-acetoxy-5-lanosta-8,24-diene 
10 and 3-acetoxy-5-lanost-8-ene 11 (4.160 g, 8.88 
mM) was dissolved in dichloromethane (125 mL). m-
CPBA (1.04 g, 6.04 mM), and sodium hydrogen 
carbonate (0.79 g, 9.41 mM) powders were mixed 
together. Half of this mixture was added at room 
temperature over 30 min, followed by the second half 
at 0 °C over 30 min. The reaction mixture was stirred at 0 °C for 1 hour. The reaction mixture 
was filtered and washed with 10% sodium hydrogen carbonate (4 × 50 mL) and brine (1 × 50 
mL). The organic layer was dried over magnesium sulfate and concentrated under reduced 
pressure to yield the crude product as a 1:1 mixture of 3-acetoxy-5α-24-R,S,25-epoxy-
lanost-8-ene 22a and 22b and 3-acetoxy-5-lanost-8-ene 11 (3.562 g). Purification by 
column chromatography using gradient elution with hexane:ethyl acetate led to the isolation 
of the desired product 22a and 22b as an off white solid as the second fraction from the 
column (1.600  g, 75%); mp 184 – 187 °C (literature,
9
 171 – 172 °C); max (KBr)/cm
-1
 2953, 
1735, 1716; m/z (ESI
+
) 485 [M + H]
+
; exact mass calculated for C32H52O3 [M + H]
+
 
485.3995, found 485.3988. H (300 MHz, CDCl3) 0.69 (3H, s, 18-CH3), 0.88 (6H, s, 28-CH3 
and 29-CH3), 0.91 – 0.95 (5H, m), 1.00 (3H, s, 19-CH3), 1.11 – 1.15 (1H, m, 5-CH), 1.17 – 
1.21 (2H, m), 1.27 (3H, s, 27-CH3), 1.31 (3H, s, 26-CH3), 1.48 – 2.10 (20H, m), 2.05 (3H, s, 
OAc, CH3), 2.69 (1H, t, J 6.1, 24-CH for both  and ), 4.50 (1H, dd, J 11.2, 4.7, 3-CH). 
Peaks in the 
1
H NMR spectrum are indistinguishable for the R and S isomers. However, clear 
differences can be deciphered in the 
13
C NMR spectrum. Key distinctions between the R and 




δC (75 MHz, CDCl3) 15.7 (18-CH3), 16.5 (CH3), 18.1 (6-CH2), 18.73 (27-CH3), 19.2 (19-
CH3), 21.0 (11-CH2), 21.3 (OAc, CH3), 24.2 (30-CH3), 24.2 (2-CH2), 24.9 (26-CH3), 25.61 
(23-CH2), 26.4 (7-CH2), 27.9 (28-CH3), 28.22 (16-CH2), 30.8 (15-CH2), 30.90 (12-CH2), 
32.60 (22-CH2), 35.3 (1-CH2), 36.21 (20-CH), 36.9 (10-quaternary C), 37.8 (4-quaternary C), 
44.5 (13-quaternary C), 44.9 (14-quaternary C), 50.27 (17-CH), 50.5 (5-CH), 58.41 (25-
quaternary C), 64.79 (24-CH), 80.9 (3-CH), 134.3 (9-quaternary C), 134.4 (8-quaternary C), 
171.0 (OAc, quaternary C).  








δC (75 MHz, CDCl3) 15.7 (18-CH3), 16.5 (CH3), 18.1 (6-CH2), 18.66 (27-CH3), 19.2 (19-
CH3), 21.0 (11-CH2), 21.3 (OAc, CH3), 24.2 (30-CH3), 24.2 (2-CH2), 24.9 (26-CH3), 25.91 
(23-CH2), 26.4 (7-CH2), 27.9 (28-CH3), 28.17 (16-CH2), 30.8 (15-CH2), 30.95 (12-CH2), 
32.80 (22-CH2), 35.3 (1-CH2), 36.34 (20-CH), 36.9 (10-quaternary C), 37.8 (4-quaternary C), 
44.5 (13-quaternary C), 44.9 (14-quaternary C), 50.38 (17-CH), 50.5 (5-CH), 58.14 (25-
quaternary C), 64.94 (24-CH), 80.9 (3-CH), 134.3 (9-quaternary C), 134.4 (8-quaternary C), 






The first fraction from the column described above 
was 3-Acetoxy-5α-lanost-8-ene 11, isolated as a 
white solid with minor agnosterol impurity (<5%): mp 
104 – 106 °C (literature,
10
 119 – 121 °C); 
νmax(KBr)/cm
−1
 2927, 1737; H (300 MHz, CDCl3) 
0.69 (3H, s, 18-CH3), 0.85 – 0.90 (18H, m, containing 
21-CH3, 26-CH3, 27-CH3, 28-CH3, 29-CH3, 30-CH3), 
1.01 (3H, s, 19-CH3), 1.13 – 2.00 (25H, m, containing 5-CH, 17-CH, 20-CH, 25-CH), 2.05 
(3H, s, OAc, CH3), 4.50 (3H, dd, J 11.2, 4.6, 3-CH); δC (75 MHz, CDCl3) 15.8 (18-CH3), 
16.5 (29-CH3), 18.1 (6-CH2), 18.7 (21-CH3), 19.2 (19-CH3), 21.0 (11-CH2), 21.4 (OAc, CH3), 
22.6 (26-CH3), 22.9 (27-CH3), 24.12 (23-CH2 or 2-CH2), 24.18 (30-CH3), 24.27 (23-CH2 or 
2-CH2), 26.4 (7-CH2), 27.9 (28-CH3), 28.0 (25-CH), 28.2 (16-CH2), 29.7 (CH2), 30.8 (15-
CH2), 31.0 (12-CH2), 35.3 (1-CH2), 36.5 (22-CH2), 36.9 (20-CH), 37.8 (4-quaternary C), 39.5 
(24-CH2), 44.5 (13-quaternary C), 49.8 (14-quaternary C), 50.5 (5-CH), 81.0 (3-CH), 134.2 












10% potassium hydroxide in ethanol (6 mL) was added 
to 3-acetoxy-5α-lanost-8-ene 11 (0.200 g, 0.42 mM). 
The solution was stirred at reflux for 2 h and allowed to 
cool to room temperature. The resulting mixture was 
poured onto ice cold water (20 mL) and left to stand for 
1 h. The solution was filtered through a Büchner funnel 
to yield the crude product as an off white solid (0.141 g). 
Purification by column chromatography on silica gel (hexane:ethyl acetate 90:10) yielded the 
title compound 7 as a white solid (0.106 g, 59%): mp 125 – 128 °C (literature,
11
 125 – 125.5 
°C); Found C, 83.53; H, 12.13. C30H52O requires C, 84.04; H, 12.23%; νmax(KBr)/cm
−1
 3308, 
2953; H (300 MHz, CDCl3) 0.69 (3H, s, 18-CH3), 0.75 – 0.93 [15H, m, containing 21-CH3, 
26-CH3, 27-CH3, 30-CH3, and 0.81 (3H, s, 29-CH3)], 0.98 (3H, s, 19-CH3), 1.00 (3H, s, 28-
CH3), 1.06 – 1.07 (1H, m, H-5), 1.10 – 2.06 (25H, m, containing 17-CH, 20-CH, 25-CH), 
3.23 (1H, dd, J 11.3, 4.7, H-3); δC (75 MHz, CDCl3) 15.4 (29-CH3), 15.8 (18-CH3), 18.3 (6-
CH2), 18.7 (21-CH3), 19.2 (19-CH3), 21.0 (11-CH2), 22.6 (26-CH3), 22.9 (27-CH3), 24.1 (23-
CH2), 24.3 (30-CH3), 26.5 (7-CH2), 27.8 (2-CH2), 27.97 (28-CH3), 28.02 (25-CH), 28.2 (16-
CH2), 29.7 (CH2), 30.9 (15-CH2), 31.0 (12-CH2), 35.6 (1-CH2), 36.5 (20-CH2 and 22-CH2 
possibly overlapping signals), 37.0 (10-quaternary C), 38.9 (4-quaternary C), 39.5 (24-CH2), 
44.5 (13-quaternary C), 49.8 (14-quaternary C), 50.4 (5-CH), 50.5 (17-CH), 79.0 (3-CH), 

















A ~1:1 mixture of isomers 3-acetoxy-5α-24R,S,25-
epoxy-lanost-8-ene 22a and 22b (2.105 g, 4.3 mM) 
was added to a stirring solution of periodic acid (1.192 
g, 6.2 mM) in diethyl ether (400 mL) at 25 °C. The 
solution was stirred under a blanket of nitrogen for 10 
min. Water (200 mL) was added and the ether layer 
was separated and washed with water (2 × 100 mL). The organic layer was dried with 
magnesium sulfate and concentrated under reduced pressure to yield the crude product as an 
off white solid (1.73 g). Purification by column chromatography on silica gel (hexane:ethyl 
acetate 90:10) yielded the title compound 21 as a white solid (0.224 g, 12%. 88% of the 
material was of ≥ 95% purity and synthetically useful). mp 153 – 156 °C (literature,
9
 155 – 
156 °C), νmax(KBr)/cm
−1
 1717, 1735, 2952; H (300 MHz, CDCl3) 0.69 (3H, s, 18-CH3), 0.80 
– 0.95 (12H, m, containing 21-CH3, 28-CH3, 29-CH3, 30-CH3), 1.00 (3H, s, 19-CH3), 1.15 – 
2.00 (22H, m, containing 17-CH, 20-CH), 2.05 (3H, s, Ac-CH3), 2.31-2.52 (2H, m, H-23), 
4.50 (1H, dd, J 11.2, 4.7, 3-CH), 9.77 (1H, t, J 1.9, 24-CH); exact mass calculated for 
C29H46O3 [M + H]
+
 443.3525, found 443.3193. 
13
C NMR data obtained 3 months after 
1
H NMR data, in which time sample decomposition 
may have occurred. 
 δC (75 MHz, CDCl3) 15.8 (18-CH3), 16.5 (29-CH3), 18.1 (6-CH2), 18.4 (21-CH3), 19.2 (19-
CH3), 21.0 (11-CH2), 21.3 (OAc, CH3), 24.2 (2-CH2), 24.2 (30-CH3), 26.4 (7-CH2), 28.0 (28-
CH3), 28.1 (22-CH2 or 23-CH2), 28.2 (16-CH2), 30.8 (15-CH2), 31.0 (12-CH2), 35.3 (1-CH2), 
36.0 (20-CH), 41.1 (23-CH2 or 22-CH2), 50.3 (CH), 50.5 (5-CH), 80.3 (3-CH), 134.3 (9-
quaternary C), 134.4 (8-quaternary C), 171.1 (OAc, C=O), 178.9 (C=O), 203.3 (24-CH, 
C=O);  
This reaction to synthesise the key aldehyde intermediate was carried out numerous times. In 
another attempt of this reaction, carried out on a separate occasion, a minor by product was 
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A by-product of the reaction to synthesise 21 was also isolated. Quantities used in the 
reaction on this occasion are as follows: -Acetoxy-24R,S,25-epoxy-5α-lanost-8-ene 22a 
and 22b (1.63 g, 3.4 mM), periodic acid (1.1 g, 4.8 mM), diethyl ether (50 mL). Experimental 
procedure thereafter is as described above for the synthesis of 21. By-product 30 was isolated 





mp 88 – 90 °C (literature,
13
 136 – 137 °C); 
νmax(KBr)/cm
−1
 2954, 1735, 1717; H (300 MHz, 
CDCl3) 0.68 (3H, s, 18-CH3),0.70 – 2.13 [45H, m, 
containing 21-CH3, 28-CH3, 29-CH3, 30-CH3), 1.00 
(3H, s, 19-CH3), 1.09 (3H, d, J 6.9, 26-CH3 or 27-
CH3),  2.05 (3H, s, OAc, CH3)], 2.26 – 2.69 (2H, m, 
23-CH2), 4.50 (1H, dd, J 4.7, 11.2, 3-CH); δC (75 
MHz, CDCl3) 15.8 (30-CH3), 16.5 (18-CH3), 18.1 (6-CH2), 18.3, 18.4, and 18.5 (21-CH3, 26-
CH3 and 27-CH3), 19.2 (19-CH3), 21.0 (11-CH2), 21.3 (OAc, CH3), 24.16 (2-CH2), 24.23 (28-
CH3), 26.4 (7-CH2), 27.9 (29-CH3), 28.1 (16-CH2), 30.1 (23-CH2), 30.8, 31.0 (12-CH2 and 
15-CH2), 35.3 (1-CH2), 36.1 (20-CH), 36.9 (10-quaternary C), 37.5 (22-CH2), 37.8 (4-
quaternary C), 40.8 (25-CH), 44.5 (13-quaternary C), 49.8 (14-quaternary C), 50.4 (5-CH or 
17-CH), 50.5 (5-CH or 17-CH), 80.9 (3-CH), 134.3 (8-quaternary C or 9-quaternary C), 134.5 

















 23a and 23b 
3-Hydroxy-5α-lanost-8-ene 7 and 3-hydroxy-5α-lanost-
8,24-diene 6 (50:50) (0.500 g, 1.2 mM) was dissolved in 
dichloromethane (20 mL) and stirred at room 
temperature. m-CPBA (0.137 g, 0.80 mM) and sodium 
bicarbonate (0.104 g, 1.24 mM) powders were mixed 
together. Half of this mixture was added to the stirring 
solution at room temperature and half was added at 0 °C, 
over 30 minute periods respectively. The reaction mixture was stirred at 0 °C for 1 h. The 
reaction mixture was filtered and washed with sodium bicarbonate (4 × 25 mL) and brine (1 × 
25 mL). The organic layer was dried over magnesium sulfate and concentrated under reduced 
pressure to yield the crude product as an off white solid (0.354 g). 
1
H NMR analysis showed 
that the majority of the crude material consisted of a 50:50 mixture of unreacted 3-hydroxy-
5α-lanost-8-ene 7 and 3-hydroxy-24,25-epoxy-5α-lanost-8-ene 23a and 23b as well as trace 
steroid and aromatic impurities. Purification by column chromatography on silica gel 
(hexane:ethyl acetate 90:10) yielded the title compounds as a white solid in 16% yield: mp 
125 – 126 °C (literature,
14
 123 – 124 °C); νmax(KBr)/cm
−1





 (17%), 267 (100); exact mass calculated for C30H51O2 [M + H]
+
 443.3889, found 
443.3888.  
 H (300 MHz, CDCl3) 0.70 (3H, s, 18-CH3), 0.81 (3H, s, 29-CH3), 0.88 (3H, s, 30-CH3), 0.92 
(3H, d, J 6.0, 21-CH3), 0.98 (3H, s, 19-CH3), 1.00 (3H, s, 28-CH3),1.03 – 1.26 (4H, m), 1.27 
(3H, s, 27-CH3), 1.31 (3H, s, 26-CH3), 1.39 – 2.06 (20H, m), 2.69 (1H, t, J 6.1, 24-CH), 3.23 
(1H, dd, J 11.3, 4.6, 3-CH); 
Peaks in the 
1
H NMR spectrum are indistinguishable for the R and S isomers. However, clear 
differences can be deciphered in the 
13
C NMR spectrum. Key distinctions between the R and 





δC (75 MHz, CDCl3) 15.4 (29-CH3), 15.8 (18-CH3), 18.3 (6-CH2), 18.65 (21-CH3), 18.75 (27-
CH3), 19.1 (19-CH3), 21.0 (11-CH2), 24.2 (30-CH3), 24.9 (26-CH3), 25.6 (23-CH2), 26.5 (7-
CH2), 27.9 (2-CH2), 28.0 (28-CH3), 28.24 (16-CH2), 30.8 (15-CH2), 30.98 (12-CH2), 32.62 
(22-CH2), 35.6 (1-CH2), 36.22 (20-CH), 37.0 (10-quaternary C), 38.9 (4-quaternary C), 44.5 
(13-quaternary C), 49.8 (14-quaternary C), 50.29, 50.38, 50.42 (CH due to C-5 or C-17 for R 
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and S isomers), 58.40 (25-quaternary C), 64.79 (24-CH), 79.0 (3-CH), 134.4 (8-quaternary 






δC (75 MHz, CDCl3) 15.4 (29-CH3), 15.8 (18-CH3), 18.3 (6-CH2), 18.58 (21-CH3), 18.67 (27-
CH3), 19.1 (19-CH3), 21.0 (11-CH2), 24.2 (30-CH3), 24.9 (26-CH3), 25.9 (23-CH2), 26.5 (7-
CH2), 27.9 (2-CH2), 28.0 (28-CH3), 28.19 (16-CH2), 30.8 (15-CH2), 31.00 (12-CH2), 32.81 
(22-CH2), 35.6 (1-CH2), 36.33 (20-CH), 37.0 (10-quaternary C), 38.9 (4-quaternary C), 44.5 
(13-quaternary C), 49.8 (14-quaternary C), 50.29, 50.38, 50.42 (CH due to C-5 or C-17 for R 
and S isomers), 58.11 (25-quaternary C), 64.93 (24-CH), 79.0 (3-CH), 134.4 (8-quaternary 






Epoxide 3-hydroxy-5α-24R,S,25-epoxy-lanost-8-ene 23a 
and 23b  (1.835 g, 4.1 mM) was added to a stirring 
solution of periodic acid (1.351 g, 5.9 mM) in diethyl 
ether (350 mL) at 25 °C. The solution was stirred under a 
blanket of nitrogen for 10 min. Water (200 mL) was 
added and the ether layer was separated and washed with 
water (2 × 100 mL). The organic layer was dried with magnesium sulfate and concentrated 
under reduced pressure to yield the desired product 25 as an off white solid (1.21 g, 73%). 
νmax(KBr)/cm
−1
 3520, 2948, 1715; H (300 MHz, CDCl3) 0.69 (3H, s, 18-CH3), 0.81 (3H, s, 
29-CH3), 0.88 (3H, s, 30-CH3), 0.91 (3H, d, J 5.9, 21-CH3), 0.98 (3H, s, 19-CH3), 1.00 (3H, s, 
28-CH3), 1.02 – 2.24 (30H, m), 2.25 – 2.55 (2H, m, 23-CH2), 3.25 (1H, dd, J 4.7, 11.2, 3-
CH), 9.77 (1H, t, J 1.9, 24-CH); δC (75 MHz, CDCl3) 15.4 (29-CH3), 15.8 (18-CH3), 18.3 (6-
CH2), 18.4 (21-CH3), 19.2 (19-CH3), 21.0 (11-CH2), 24.2 (30-CH3), 26.5 (7-CH2), 27.9 (2-
CH2), 28.0 (28-CH3), 28.2 (16-CH2), 28.3 (22-CH2), 30.8 (15-CH2), 31.0 (12-CH2), 35.6 (1-
CH2), 36.1 (20-CH), 37.1 (10-quaternary C), 38.9 (4-quaternary C), 41.2 (23-CH2), 44.6 (13-
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quaternary C), 49.8 (14-quaternary C), 50.3 (5-CH), 50.4 (17-CH), 79.0 (3-CH), 134.3 (9-
quaternary C), 134.5 (8-quaternary C), 203.2 (24-CH, C=O);  
 
3-Hydroxy-5α-4,4,14-trimethyl-chol-8,9-epoxy-24-al 72 
m-CPBA (0.362 g, 2.09 mM) was added to a stirring 
solution of aldehyde 25 (0.600 g, 1.49 mM) in 
dichloromethane (50 mL). The solution was stirred at 
room temperature over 48 h. The solution was then 
filtered and washed with NaHCO3 (2 × 50 mL) which led 
to the formation of emulsions. Extensive washing of the 
emulsion with brine and drying of the organic layer with magnesium sulfate led to the 
formation of the desired product 72 (0.947 g) which contains residual m-CPBA. The product 
could not be purified after several recrystallisation attempts, and is ~ 30% pure. H (300 MHz, 
CDCl3) 0.60 – 2.16 [48H, m, containing 0.77 (3H, s, 18-CH3), 0.88 (3H, s, 30-CH3), 1.12 
(3H, s, 19-CH3) 21-CH3, 28-CH3, 29-CH3], 2.35 – 2.55 (2H, m, 23-CH2), 3.21 (1H, dd, J 
11.2, 4.0, 3-CH), 9.77 (1H, br s, 24-CH); δC (300 MHz, CDCl3) characteristic epoxide peaks 
68.1 (8-quaternary C) and 70.7 (9-quaternary C). 
 
3-Keto-24,25-dihydro-lanost-8-ene 27 and 3-keto-lanost-8-ene
15
 26 
An inseparable mixture of lanosterol 6 and 
dihydrolanosterol 7 in a 50:50 ratio (0.300 g, 0.70 
mM) was stirred in t-butanol (60 mL). Iodine 
(0.714 g, 2.81 mM, 4 eq.) and potassium 
carbonate (0.388 g, 2.81 mM, 4 eq.) was added 
and the solution was stirred at reflux for 36 h. 
After this time, the solution was removed from 
the oil bath, allowed to cool to room temperature, then further cooled to 0 °C in an ice bath. 
Saturated sodium thiosulfate (50 mL) was added at 0 °C and the solution was extracted with 
ethyl acetate (3 × 30 mL). The organic layer was washed with brine (50 mL) and dried over 
MgSO4 and concentrated under reduced pressure to yield the crude product mixture of 27 and 
26 as a brown solid (0.305 g). Purification by column chromatography (gradient 95:5 to 90:10 
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hexane:ethyl acetate) yielded the desired mixture of 3-keto-24,25-dihydro-lanost-8-ene 27 
and 3-keto-lanost-8-ene 26 in a 40:60 ratio (0.106 g).  
Note: Mass yields ranged from 35% to 57% upon increase of the reaction time to 48 h, to 50% upon increase of 
the I2 and K2CO3 to 4 equivalents and shortening of reaction time to 36 h, as per the reaction described above,. 
Spectra below described as a mixture of compounds. 
 
3-Keto-24,25-dihydro-lanost-8-ene 27
H (300 MHz, CDCl3) 0.72 (3H, s, 18-CH3), 0.78 – 2.34 [45H, m containing 0.80 – 0.94 (9H, 
m, containing 21-CH3, 30-CH3), 1.07 (3H, s, 29-CH3), 1.09 (3H, s, 28-CH3), 1.12 (3H, s 19-
CH3), 1.15 – 2.32 (27H, m)] 2.35 – 2.50 (1H, m, one of 2-CH2), 2.50 – 2.65 (1H, m, one of  
2-CH2). 
3-keto-lanost-8-ene 26 
H (300 MHz, CDCl3) 0.72 (3H, s, 18-CH3), 0.78 – 2.34 [42H, m containing 0.80 – 0.94 (9H, 
m, containing 21-CH3, 30-CH3), 1.07 (3H, s, 29-CH3), 1.09 (3H, s, 28-CH3), 1.12 (3H, s 19-
CH3), 1.15 – 2.32 (27H, m)] 2.35 – 2.50 (1H, m, one of 2-CH2), 2.50 – 2.65 (1H, m, one of  




3-Keto-5α-lanost-8-ene 26 and 3-keto-24,25-dihydro-
lanost-8-ene  27 (60:40) (0.106 g, 0.23 mM) was dissolved 
in dichloromethane (15 mL). m-CPBA (0.028 g, 0.16 mM) 
and sodium bicarbonate (0.021 g, 0.25 mM) powders were 
mixed together. Half of this mixture was added to the 
stirring solution at room temperature and half was added 
at 0 °C, over 30 minute periods respectively.
1,8
 The 
reaction mixture was stirred at 0 °C for 1 h. The reaction mixture was filtered and washed 
with 10% sodium bicarbonate (4 × 25 mL) and brine (1 × 25 mL). The organic layer was 
dried over magnesium sulfate and concentrated under reduced pressure to yield the crude 
product as a mixture of unreacted 27 (spectral details described separately below) and 
stereoisomers 24a and 24b as an off white solid mixture (0.102 g). Purification by 
chromatography on silica gel hexane:ethyl acetate (95:5) yielded the desired products 24a and 
24b as a yellow solid mixture (0.024 g, 44%): mp 104 – 106 °C; νmax(KBr)/cm
−1
 2951, 1708; 
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H (300 MHz, CDCl3) 0.73 (3H, s, 18-CH3), 0.89 (3H, s, 30-CH3),  0.92 (3H, d, J 6.1, 21-
CH3), 1.06 (3H, s, 29-CH3), 1.10 (3H, s, 28-CH3), 1.12 (3H, s, 19-CH3), 1.20 – 2.30 [25H, m, 
containing 1.27 (3H, s, 27-CH3), 1.31 (3H, s, 26-CH3)], 2.32 – 2.44 (1H, m, one of 2-CH2), 
2.46 – 2.63 (1H, m, one of 2-CH2), 2.69 (1H, t, J 6.2, 24-CH); m/z (ESI
+
) 441 [M + H]
+
 
(48%), 267 (100); exact mass calc for C30H48O2 [M + H]
+
 441.3688, found 441.3750. 
Peaks in the 
1
H NMR spectrum are indistinguishable for the R and S isomers. However, clear 
differences can be deciphered in the 
13
C NMR spectrum. Key distinctions between the R and 
S isomers are seen at C-16, C-17, C-20, C-22, C-23, C-24 and C-25 
 
R isomer 24a 
 δC (75 MHz, CDCl3) 15.9 (18-CH3), 18.5 (21-CH3), 18.7 (27-CH3), 18.8 (19-CH3), 19.4 (6-
CH2), 21.1 (11-CH2), 21.3 (29-CH3), 24.3 (30-CH3), 24.9 (26-CH3), 25.6 (15-CH2), 25.61 
(23-CH2), 26.2 (28-CH3), 26.3 (7-CH2), 28.20 (16-CH2), 30.9 (12-CH2), 32.59 (22-CH2), 34.6 
(2-CH2), 36.1 (1-CH2),  36.21 (20-CH), 36.9 (10-quaternary C), 44.5 (13-quaternary C), 47.4 
(4-quaternary C), 49.9 (14-quaternary C), 50.27 (17-CH), 51.2 (5-CH), 58.44 (25-quaternary 
C), 64.78 (24-CH), 133.1 (8-quaternary C), 135.3 (9-quaternary C), 217.9 (3-quaternary C, 
C=O). 
S isomer 24b 
δC (75 MHz, CDCl3) 15.9 (18-CH3), 18.5 (21-CH3), 18.7 (27-CH3), 18.8 (19-CH3), 19.4 (6-
CH2), 21.1 (11-CH2), 21.3 (29-CH3), 24.3 (30-CH3), 24.9 (26-CH3), 25.6 (15-CH2), 25.92 
(23-CH2), 26.2 (28-CH3), 26.3 (7-CH2), 28.16 (16-CH2), 30.9 (12-CH2), 32.76 (22-CH2), 34.6 
(2-CH2), 36.1 (1-CH2), 36.34 (20-CH), 36.9 (10-quaternary C), 44.5 (13-quaternary C), 47.4 
(4-quaternary C), 49.9 (14-quaternary C), 50.38 (17-CH), 51.2 (5-CH), 58.14 (25-quaternary 




3-Hydroxy-24(R,S)-25-epoxy-5α-lanost-8-ene 23a and 23b (1:1) (0.100 g, 0.26 mM) was 
dissolved in t-butanol (50 mL). Iodine (0.115 g, 0.45 mM, 2 eq.) and potassium carbonate 
(0.062 g, 0.45 mM, 2 eq.) was added and the solution was stirred at reflux for 36 h. 
Experimental procedure thereafter as per described for the synthesis of 26 and 27. Product 
was retrieved as a yellow oily solid (0.78 g) with 
1
H NMR analysis showing ~10% product 
formation. 






An inseparable 50:50 mixture of 3-keto-lanost-8-ene 26 
and 3-keto-24,25-dihydro-lanost-8-ene 27 (0.97 g, 2.28 
mM) was dissolved in 100 mL DCM. mCPBA (0.266 g, 
1.55 mM) and sodium bicarbonate (0.203 g, 2.42 mM) 
powders were mixed together. Half of this mixture was 
added at room temperature over a 30 minute period. The 
second half was added at 0 °C over a 30 minute period. 
The reaction solution was stirred at 0 °C for 1 h. The reaction mixture was filtered, washed 
with saturated sodium bicarbonate solution (2 × 50 mL) and brine (1 × 50 mL), dried over 
magnesium sulfate and concentrated under reduced pressure to yield the crude product as a 
mixture of 3-keto-24,25-dihydro-lanost-8-ene 27 and 3-keto-24(R,S)-25-epoxy-lanost-8-ene 
24a and 24b (0.827 g). Purification required repeated column chromatography using 90:10 
hexane: ethyl acetate, and yielded the desired product 27 as an off white solid (0.043 g, 9%) 
from the second column. 3-Keto-24(R,S)-25-epoxy-lanost-8-ene 24a and 24b (0.158 g) was 
isolated from the first column and contained impurities including aromatic contaminants. This 
material was not further purified. Spectral analysis of a pure sample of the mixture of isomers 
24a and 24b is described above. The following analysis pertains to compound 27: mp 117 – 
120 °C (literature,
16
 119 – 120 °C); νmax(KBr)/cm
−1
 2956, 1708; H (300 MHz, CDCl3) 0.72 
(3H, s, 18-CH3), 0.82 – 0.92 (12H, m, containing 21-CH3, 26-CH3, 27-CH3, 30-CH3), 1.07 
(3H, s, 29-CH3), 1.09 (3H, s, 28-CH3), 1.12 (3H, s 19-CH3), 1.23 – 2.35 (24H, m), 2.37 – 2.49 
(1H, m, one of 2-CH2), 2.51 – 2.63 (1H, m, one of 2-CH2); δC (75 MHz, CDCl3) 15.8 (18-
CH3), 18.7 (19-CH3), 18.7 (21-CH3), 19.4 (6-CH2), 21.1 (7-CH2), 21.3 (29-CH3), 22.6 (26-
CH3), 22.8 (27-CH3), 24.1 (23-CH2), 24.3 (30-CH3), 26.2 (28-CH3), 26.3 (11-CH2), 28.0 (25-
CH), 28.2 (16-CH2), 30.91 (15-CH2), 30.93 (12-CH2), 34.6 (2-CH2), 36.1 (1-CH2), 36.4 (22-
CH2), 36.5 (20-CH), 36.9 (4-quaternary C), 39.5 (24-CH2), 44.4 (13-quaternary C), 47.5 (10-
quaternary C), 49.9 (14-quaternary C), 50.5 (17-CH), 51.2 (5-CH), 133.1 (8-quaternary C), 
135.4 (9-quaternary C), 218.0 (3-quaternary C, C=O); exact mass calc for C30H51O [M + H]
+
 










Periodic acid (0.078 g, 0.34 mM) was ground using a pestle 
and mortar and dissolved in diethyl ether (50 mL). 3-Keto-
24(R,S)-25-epoxy-5α-lanost-8-ene 24a and 24b (0.106 g, 
0.24 mM) was added and the solution was stirred at 25 °C 
for 15 min. Water (20 mL) was added and the ether layer 
was separated. The ether layer was washed with water (2 × 
20 mL) and brine (1 × 20 mL), dried over MgSO4 and 
concentrated under reduced pressure to yield the crude product as an off white solid (0.076 g). 
Purification by column chromatography using 90:10 hexane: ethyl acetate yielded the desired 
product 29 as a white solid (0.015 g, 16% analytically pure sample, 84% of the material was 
of ≥ 95% purity and synthetically useful): mp 111 – 114 °C (literature,
17
 110 – 115 °C); 
νmax(KBr)/cm
−1
 2948, 1719, 1707; H (300 MHz, CDCl3) 0.72 (3H, s, 18-CH3), 0.87 – 0.94 
(6H, m, containing 21-CH3 and 30-CH3), 1.07 (3H, s, 29-CH3), 1.10 (3H, s, 28-CH3), 1.17 
(3H, s, 19-CH3), 1.20 – 2.30 (20H, m), 2.36 – 2.63 (4H, m, containing 2-CH2 and 23-CH2), 
9.78 (1H, t, J 1.8, 24-CH); δC (75 MHz, CDCl3) 15.9 (29-CH3), 18.4 (18-CH3), 18.7 (21-
CH3), 19.4 (6-CH2), 21.1 (11-CH2), 21.3 (19-CH3), 24.3 (30-CH3), 26.2 (28-CH3), 26.3 (7-
CH2), 28.1 (16-CH2), 28.2 (22-CH2), 30.86 (15-CH2), 30.90 (12-CH2), 34.6 (1-CH2), 36.0 
(20-CH), 36.1 (2-CH2), 36.9 (4-quaternary C), 41.2 (23-CH2), 44.5 (13-quaternary C), 47.4 
(10-quaternary C), 49.9 (14-quaternary C), 50.3 (5-CH), 51.2 (17-CH), 133.2 (8-quaternary 
C), 135.2 (9-quaternary C), 203.2 (24-quaternary C, C=O), 217.9 (3-quaternary C, C=O); 
exact mass calc for C27H43O2 [M + H]
+






Dihydrolanosterol acetate 11 (0.400 g, 0.85 mM) was 
dissolved in dicloromethane (100 mL) and m-CPBA 
(0.205 g, 1.19 mM) was added. The reaction mixture 
was stirred at room temperature while the reaction 
progress was monitored by TLC analysis. After 4 h 
the reaction had gone ~ 50% to completion. A further 
2.8 equivalents of m-CPBA was added, and the 
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solution was allowed to stir at room temperature for 72 h. After this time TLC analysis 
showed the main component of the reaction mixture to be the desired product 1. The reaction 
mixture was then filtered, washed with 10% sodium bicarbonate (2 × 50 mL) and brine (1 × 
50 mL), dried over MgSO4 and concentrated under reduced pressure to yield the crude 
product as an off white solid (0.342 g). Purification by column chromatography using 90:10 
hexane: ethyl acetate yielded the desired product 1 as a white solid (0.158 mg, 38%); mp 173 
– 175 °C (literature,
18
 175 – 177 °C); νmax(KBr)/cm
−1
 2957, 1724; H (300 MHz, CDCl3) 0.77 
(3H, s, 18-CH3), 0.80 – 0.90 [18H, m, containing 0.82 (3H, s, 28-CH3), 0.85 – 0.86 (6H, m, 
26-CH3 and 29-CH3), 0.87 – 0.89 (9H, m, containing 21-CH3, 27-CH3 and 30-CH3)], 1.05 – 
1.22 [6H, m, containing 1.14 (3H, s, 19-CH3)], 1.23 – 1.44 (12H, m), 1.45 – 1.66 (6H, m), 
1.67 – 1.79 (3H, m), 1.80 – 2.00 (4H, m), 2.03 (3H, s, OAc, CH3), 4.46 (1H, dd, J 11.0, 4.2, 
3-CH);  δC (75 MHz, CDCl3) 16.2 (29-CH3), 16.3 (18-CH3), 16.4 (6-CH2), 17.1 (19-CH3), 
19.0 (21-CH3), 19.9 (30-CH3), 21.3 (OAc, CH3), 21.5 (11-CH2), 22.6 (26-CH3), 22.8 (27-
CH3), 23.3 (7-CH2), 23.5 (2-CH2), 24.1 (23-CH2), 26.8 (12-CH2), 28.0 (25-CH), 28.3 (28-
CH3), 28.6 (16-CH2), 29.7 (CH2), 31.9 (15-CH2), 32.5 (1-CH2), 36.3 (20-CH), 36.4 (22-CH2), 
37.4 (4-qaternary C), 37.8 (10-quaternary C), 39.5 (24-CH2), 41.9 (5-CH), 43.6 (13-
quaternary C), 48.3 (17-CH), 48.8 (14-quaternary-C), 68.0 (8-quaternary C), 70.5 (9-
quaternary C), 80.5 (3-CH), 170.8 (quaternary C, OAc, C=O); m/z (ESI
+
) 487 [M + H]
+
 
(30%), 469 (100); exact mass calculated for C32H55O3 [M + H]
+







A mixture of epoxide 3-acetoxy-lanost-8,9-epoxide 1 
(0.100 g, 0.21 mM) and p-toluenesulfonic acid (0.004 
g, 0.02 mM) in toluene was stirred for 2.5 h at 60 °C. 
The reaction was quenched with triethylamine (3 L, 
0.02 mM) and filtered through celite. The celite was 
washed with toluene (15 mL) and the solvent was 
removed under reduced pressure to yield the crude 
product as a white solid (0.087 g). Inspection of the 
1
H NMR spectrum of the crude material 
showed an impurity with a characteristic splitting pattern, 4.46 ppm (0.5H, dd, J 11.0, 4.2), 
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which is characteristic of the 3-CH of the starting epoxide 1. Purification required repeated 
column chromatography using 90: 10 hexane: ethylacetate. The desired compound 2 was 
obtained as a white solid (0.021 g, 22%); mp 168 – 171 °C (literature,
19
 169 – 170°C); 
νmax(KBr)/cm
−1 
2945, 1735; H (300 MHz, CDCl3) 0.56 (3H, s, 18-CH3), 0.80 – 0.91 [15H, m, 
containing 0.86 (3H, s, 26-CH3), 0.87 (6H, s, 27-CH3 and 30-CH3), 0.88 (3H, s, 21-CH3), 
0.89 (3H, s, 28-CH3)], 0.95 (3H, s, 29-CH3), 1.01 (3H, s, 19-CH3), 1.06 – 1.21 (4H, m 
containing 5-CH), 1.22 – 1.44 (7H, m, containing 20-CH), 1.46 – 1.82 (8H, m, containing 17-
CH and 25-CH), 1.85 – 2.30 [5H, m, containing 2.06 (3H, s, OAc, CH3)], 4.52 (1H, dd, J 
11.1, 4.8, 3-CH), 5.34 (1H, br d, J 6.2, 11-CH), 5.46 (1H, br s, 7-CH); δC (75 MHz, CDCl3) 
15.7 (18-CH3), 16.9 (29-CH3), 18.5 (21-CH3), 21.3 (OAc, CH3), 22.6 (26-CH3), 22.79 (19-
CH3), 22.83 (6-CH2), 24.1 (23-CH2), 24.3 (2-CH2), 25.6 (30-CH3), 27.9 (16-CH2), 28.0 (25-
CH), 28.1 (28-CH3), 31.5 (15-CH2), 35.4 (1-CH2), 36.3 (20-CH), 36.4 (22-CH2), 37.2 (10-
quaternary C), 37.6 (4-quaternary C), 37.9 (12-CH2), 39.5 (24-CH2), 43.7 (13-quaternary C), 
49.3 (5-CH), 50.3 (14-quaternary C), 51.1 (17-CH), 80.9 (3-CH), 116.6 (11-CH), 119.8 (7-
CH), 142.9 (8-quaternary C), 145.6 (9-quaternary C), 170.9 (quaternary C, OAc, C=O); exact 
mass calculated for C32H52O2 [M + H]
+
 469.4046, found 469.4030.  
 
3-Keto-lanost-8,9-epoxide 28 
3-Keto-24,25-dihydro-lanost-8-ene 27 (0.250 g, 0.59 
mM) was dissolved in dichloromethane (100 mL) and 
the reaction mixture was stirred at room temperature for 
24 h. After this time the reaction mixture was filtered 
and washed with 10% sodium bicarbonate (2 × 50 mL) 
followed by brine (50 mL). The solvent was removed 
under reduced pressure to yield the crude product as an 
off white solid (0.209 g). The crude product was purified by repeated column 
chromatography using 90:10 hexane : ethylacetate as the eluant. Due to insufficient sample, 
further purification was not possible. The sample described contains minor amounts of 
residual m-CPBA. H (300 MHz, CDCl3) 0.78 (3H, s, 18-CH3), 0.85 – 0.90 (17H, m, 
containing 21-CH3, 30-CH3), 1.02 (3H, s, 29-CH3), 1.04 (3H, s, 28-CH3), 1.25 (3H, s 19-
CH3), 2.39 – 2.61 (2H, m, 2-CH2). 
 




3-Hydroxy-24(R,S)-25-epoxy-5α-lanost-8,9-epoxide 38a and 38b 
A 1:1 mixture of lanosterol 6 and dihydrolanosterol 7 (1 
g, 2.33 mM), were dissolved in dichloromethane (50 
mL). m-CPBA (1.200 g, 7 mM) was added and the 
mixture was stirred at room temperature for 72 h. The 
resulting solution was filtered and washed with 10% 
aqueous sodium bicarbonate (2 × 50 mL) and brine (1 × 
50 mL). The organic layer was dried over magnesium 
sulfate and concentrated under reduced pressure to yield the crude product as a yellow solid 
(1.245 g) which contained trace amounts of unreacted alkenes as indicated by analysis of the 
13
C NMR spectrum. Purification required repeated column chromatography using 90: 10 
hexane: ethylacetate. The desired mixture of compounds 38a and 38b was obtained as a white 
solid (0.234 g, 60%); mp 156 – 158 °C; νmax(KBr)/cm
−1
 3271, 2961; H (300 MHz, CDCl3) 
0.79 (6H, s, 18-CH3 and 29-CH3), 0.83 – 1.04 [10H, m, containing (3H, s, 30-CH3), (3H, s, 
21-CH3) and (3H, s, 28-CH3)], 1.12 (3H, s, 19-CH3), 1.21 – 2.20 [28H, m, containing 1.26 
(3H, s, 27-CH3), 1.31 (3H, s, 26-CH3)], 2.68 (1H, t, J 5.9, 24-CH), 3.21 (1H, br d, J 10.7, 3-
CH); exact mass calc for C30H51O3 [M + H]
+
 459.3838, found 459.3828. 
Peaks in the 
1
H NMR spectrum are indistinguishable for the R and S isomers. However, clear 
differences can be deciphered in the 
13
C NMR spectrum. Key distinctions between the 24-R 
and 24-S isomers are seen at C-16, C-20, C-21, C-22, C-23, C-24, C-25 and C-27. Signals 
pertaining to C-21 and C-27 of both R and S isomers could not be unambiguously assigned as 
these 4 peaks occur within 0.27 ppm of each other. All literature precedent indicates internal 




24-R isomer 38a 
δC (75 MHz, CDCl3) 15.1 (29-CH3), 16.2 (18-CH3), 16.5 (6-CH2), 17.0 (19-CH3), 18.65, 
18.76, 18.81, 18.92 (4 × CH3, 21-CH3 and 27-CH3 for both R and S isomers), 19.9 (30-CH3), 
21.4 (11-CH2), 23.4 (7-CH2), 24.9 (26-CH3), 25.5 (23-CH2), 26.8 (12-CH2), 27.1 (2-CH2), 
28.3 (28-CH3), 28.46 (16-CH2), 31.8 (15-CH2), 32.5 (22-CH2), 32.8 (1-CH2), 36.0 (20-CH), 
37.9 (10-quaternary C), 38.5 (4-quaternary C), 41.7 (5-CH), 43.6 (13-quaternary C), 48.2 (17-
CH), 48.8 (14-quaternary C), 58.5 (25-quaternary C), 64.7 (24-CH), 68.1 (8-quaternary C), 
70.7 (9-quaternary C), 78.4 (3-CH). 
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24-S isomer 38b 
δC (75 MHz, CDCl3) 15.1 (29-CH3), 16.2 (18-CH3), 16.5 (6-CH2), 17.0 (19-CH3), 18.65, 
18.76, 18.81, 18.92 (4 × CH3, 21-CH3 and 27-CH3 for both R and S isomers), 19.9 (30-CH3), 
21.4 (11-CH2), 23.4 (7-CH2), 24.9 (26-CH3), 25.9 (23-CH2), 26.8 (12-CH2), 27.1 (2-CH2), 
28.3 (28-CH3), 28.50 (16-CH2), 31.8 (15-CH2), 32.7 (22-CH2), 32.8 (1-CH2), 36.2 (20-CH), 
37.9 (10-quaternary C), 38.5 (4-quaternary C), 41.7 (5-CH), 43.6 (13-quaternary C), 48.1 (17-
CH), 48.8 (14-quaternary C), 58.2 (25-quaternary C), 64.9 (24-CH), 68.1 (8-quaternary C), 






  31a and 31b 
All glassware to be used for the Grignard reaction 
was dried overnight at 150 °C prior to use. The 
reaction was carried out in an anhydrous 
atmosphere, using a blanket of nitrogen at all stages 
of reagent addition. Glassware joints were greased 
to avoid air entering the reaction system.1-Bromo-
2-methyl propane (0.26 mL) was dissolved in 
diethyl ether (5mL) and added dropwise, via an addition funnel, to a mixture of freshly 
ground magnesium turnings (0.054 g) and one crystal of iodine in diethyl ether (5mL). Reflux 
was initiated spontaneously and the solution was maintained at reflux, by use of an oil bath, 
for 30 minutes to form the Grignard reagent. The resulting solution was allowed to cool to 
room temperature. 3-Acetoxy-5-4,4,14-trimethyl-chol -8-ene-24-al 21 (0.200 g, 0.45 mM) 
dissolved in diethyl ether (10 ml) was added dropwise to the Grignard reagent, via an addition 
funnel, at 0 °C. The reaction mixture was allowed to warm to room temperature. The mixture 
was then stirred at room temperature for 1 h and at reflux for 6 h. The reaction mixture was 
removed from reflux and allowed to cool to room temperature. Ice cold saturated ammonium 
chloride solution (20 mL) was added and the ether layer was washed with saturated sodium 
carbonate (3 × 20 mL) and water (1 × 20 mL). The organic layer was dried over magnesium 
sulfate and concentrated under reduced pressure to yield the desired product 31 as a dark 
orange oil (0.144 g, 66%). νmax(NaCl)/cm
−1
 3441, 2953, 1734; 
1
H NMR spectrum shows 
grease is present in the sample. TMS standard was offset by 0.069 ppm and chemical shifts 
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are therefore corrected by calculation; H (300 MHz, CDCl3) 0.69 (3H, s, 18-CH3), 0.78 – 
2.15 [50H, m, containing 0.88 (6H, s, 28-CH3 and 29-CH3), 0.90 (3H, s, 21-CH3), 1.00 (3H, s, 
19-CH3), 2.05 (3H, s, OAc, CH3)], 3.52 – 3.72 (1H, m, C-24 O-H), 4.50 (1H, dd, J 11.3, 4.7, 
3-CH). δC (75 MHz, CDCl3) 15.8 (29-CH3), 16.5 (18-CH3), 18.1 (6-CH2), 19.2 (19-CH3), 
21.0 (11-CH2), 21.3 (21-CH3), 22.0 (OAc, CH3), 22.1 (30-CH3), 23.5 (26-CH3), 23.6 (27-
CH3), 24.17 (2-CH2), 24.7 (25-CH), 26.4 (23-CH2), 27.9 (28-CH3), 28.2 (7-CH2), 29.7 (16-
CH2), 30.8 (15-CH2), 31.0 (12-CH2), 35.3 (1-CH2), 36.9 (4-quaternary C), 37.5 (20-CH), 37.8 
(10-quaternary C), 44.5 (13-quaternary C), 46.9 (22-CH2), 49.8 (14-quaternary C), 50.3 (5-
CH or 17-CH), 50.5 (5-CH or 17-CH), 71.4 (24-CH R or S), 71.7 (24-CH R or S), 82.0 (3-
CH), 134.3 (8-quaternary C or 9-quaternary C), 134.5 (8-quaternary C or 9-quaternary C), 
171.0 (quaternary C, OAc, C=O). 
 
 
3-Acetoxy-5-lanost-8-ene-24-ol- 26- methyl ester
20
 32 
All glassware to be used for the Grignard 
reaction was dried overnight at 150 °C prior to 
use. The reaction was carried out in an 
anhydrous atmosphere, using a blanket of 
nitrogen at all stages of reagent addition. 
Glassware joints were greased to avoid air 
entering the reaction system. Methyl 3-bromo-2-
methylpropanoate (0.22 mL) was dissolved in diethyl ether (5mL) and added dropwise, via an 
addition funnel, to a mixture of freshly ground magnesium turnings (0.040 g) and one crystal 
of iodine in diethyl ether (5mL). Bubbling of the reaction solution initiated spontaneously. 
The solution was brought to reflux, by use of an oil bath, and maintained at reflux for 30 
minutes to form the Grignard reagent. The resulting solution was allowed to cool to room 
temperature. 3-Acetoxy-5-4,4,14-trimethyl-chol-8-ene-24-al 21 (0.200 g, 0.45 mM) 
dissolved in diethyl ether (10 ml) was added dropwise to the Grignard reagent, via an addition 
funnel, at 0 °C. The reaction mixture was allowed to warm to room temperature. The mixture 
was then stirred at room temperature for 1 h and at reflux for 6 h. The reaction mixture was 
removed from reflux and allowed to cool to room temperature. Ice cold saturated ammonium 
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chloride solution (20 mL) was added and the ether layer was washed with saturated sodium 
carbonate (3 × 20 mL) and water (1 × 20 mL). The organic layer was dried over magnesium 
sulfate and concentrated under reduced pressure to yield the crude product as a yellow oil 
(0.178 g). Inspection of the 
1
H NMR spectrum of the crude material showed that a mixture of 
compounds is present*. The starting aldehyde is still present due to the characteristic signal at 
9.77 ppm. An unidentified alkene signal at 5.12 ppm is also observed in the spectrum. There 
is no evidence of the formation of the desired product 32. There is an excess of bromide 
starting material in relation to the steroid component. Characteristic signals for methyl 3-
bromo-2-methylpropanoate are: H (300 MHz, CDCl3) 1.23 (3H, d, J 7.0), 2.91 (1H, q, J 13.2, 
6.7), 3.53 (2H, ddd, J 48.7, 10.0, 6.3) 3.73 (3H, s). 
* As in the previous Grignard reaction description, TMS standard was offset by 0.070 ppm. Chemical shifts are 





Phosphorous pentachloride (0.435 g, 2.09 mM) was added 
to a stirring solution of dihydrolanosterol 7 (0.435 g, 1.02 
mM), which contained ~ 17% lanosterol 6 in hexane (44 
mL). The reaction mixture was stirred at room temperature 
for 2 h after which time it was heated at reflux for 1 h. The 
reaction mixture was diluted with ether (50 mL), washed 
with water (4 × 50 mL), 5% sodium hydrogen carbonate (2 
× 50 mL) and again with water (2 × 50 mL). The organic 
layer was dried over magnesium sulfate and concentrated under reduced pressure to yield the 
crude product as a brown oil (0.382 g). 
1
H NMR analysis of the crude material showed it 
contained the desired product, and a side product characterised by a free alkene hydrogen. 
Purification by column chromatography using hexane eluant led to isolation of the desired 
product 35 as white needles (0.162 g, 39%) and the side product 36 as yellow crystals (0.074 
g, 9%). mp 143 – 147 °C (literature,
22
 143 – 144 °C; H (300 MHz, CDCl3) 0.73 (3H, s, 18-
CH3), 0.80 (3H, s, 19-CH3,), 0.82 – 0.94 (12H, m, 30-CH3, 26-CH3, 27-CH3, 21-CH3) 0.95 – 
1.60 (22H, m), 1.61 – 1.82 (6H, m, 28-CH3, 29-CH3) 1.83 – 2.41 (10H, m); C (75 MHz, 
CDCl3) 15.6 (18-CH3), 18.8 (21-CH3), 19.5 (19-CH3), 19.7 (28-CH3 or 29-CH3), 22.57 (26-
CH3), 22.62 (CH2), 22.8 (27-CH3), 22.9 (28-CH3 or 29-CH3), 22.9 (11-CH2), 24.1 (23-CH2), 
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24.6 (CH3), 25.8 (7-CH2), 28.0 (25-CH), 28.3 (16-CH2), 29.8 (6-CH2), 30.6 (15-CH2), 30.7 
(12-CH2), 34.5 (1-CH2), 36.5 (20-CH), 36.6 (22-CH2), 39.6 (24-CH2), 44.4 (13-quaternary 
C), 44.9 (10-quaternary C), 49.3 (14-quaternary C), 50.3 (17-CH), 51.3 (5-CH), 121.6 (4-
quaternary C), 133.6 (8-quaternary C or 9-quaternary C), 134.2 (8-quaternary C or 9-





Spectral details of the side product arising from the minor 
impurity in the starting material of the previous reaction: mp 
135 – 138 °C (literature,
23
 136 – 140 °C); H (300 MHz, 
CDCl3) 0.65 – 2.45 [45H, m, containing 0.73 (3H, s, 18-
CH3), 0.80 (3H, s, 19-CH3), 0.88 (3H, s, 30-CH3), 0.93 (3H, 
d, J 6.3, 21-CH3), 1.59 (3H, d, J 11.6, 27-CH3), 1.71 (3H, d, 
J 15.1, 26-CH3)], 5.12 (1H, t, J 7.1, 24-CH); C (75 MHz, 
CDCl3) 15.6 (18-CH3), 17.7 (27-CH3), 18.7 (21-CH3), 19.5 (19-CH3), 19.7 (28-CH3 or 29-
CH3), 22.6 (11-CH2), 22.8 (27-CH3), 22.9 (2-CH2), 24.6 (30-CH3), 24.9 (23-CH2), 25.75 (26-
CH3), 25.82 (7-CH2), 28.3 (16-CH2), 29.8 (6-CH2), 30.6 (15-CH2), 30.7 (12-CH2), 34.4 (1-
CH2), 36.3 (20-CH), 36.4 (22-CH2), 44.4 (13-quaternary C), 44.9 (10-quaternary C), 49.3 
(14-quaternary C), 50.3 (5-CH or 17-CH), 51.4 (5-CH or 17-CH), 121.6 (4-quaternary C), 
125.3 (24-CH), 130.9 (25-quaternary C), 133.5 (8-quaternary C or 9-quaternary C), 134.2 (8-
quaternary C or 9-quaternary C), 135.2 (3-quaternary C),  
 




(0.160 g, 0.42 mmol) was dissolved in hexane (10 mL) in a 
100 ml Shlenck tube. The Shlenck tube inlet was connected 
via rubber tubing to an ozone generator. The outlet was 
connected to two dreschel bottles containing 350 mL and 150 
mL 10% KI solution respectively. Oxygen was passed 
through the reaction apparatus for 5 minutes to ensure 
connections were well sealed. The ozone generator was switched on and ozone was passed 
Chapter 3: Experimental 
263 
 
through this solution at −78 °C for 10 minutes. Excessive ozone was removed with a stream 
of oxygen for 5 minutes. Excess triphenylphosphine was added and the reaction mixture was 
stirred overnight to break down any residual ozonide. Celite was added directly to the 
reaction mixture in solvent. The solvent was removed in vacuo. Purification by column 
chromatography (hexane:ethyl acetate 90:10) led to the isolation of 14-methyl-8,9-




 37  
max (film)/cm
-1
: 2954, 1742; H (300 MHz, CDCl3) 0.70 – 
2.45 [43H, m, containing 0.80 (3H, s, 18-CH3), 0.85 – 0.92 
(12H, m, 26-CH3, 27-CH3, 21-CH3, 30-CH3), 1.02 (3H, s, 19-
CH3), 2.29 (1H, dt, J 9.5, 1.5), 2.36 (1H, dt, J 7.1, 5.5), 2.68 
(1H, dd, J 12.0, 3.8, 5-CH)]; C (75 MHz, CDCl3) 14.6 (6-
CH2), 16.2 (18-CH3), 17.4 (19-CH3), 19.0 (21-CH3), 20.0 (30-
CH3), 21.3 (7-CH2), 21.7 (11-CH2), 22.5 (26-CH3), 22.8 (27-
CH3), 24.0 (23-CH2), 26.4 (12-CH2), 28.0 (25-CH), 28.4 (16-CH2), 28.9 (1-CH2), 31.7 (15-
CH2), 34.58 (2-CH2), 36.2 (20-CH), 36.3 (22-CH2), 39.46 (24-CH2), 43.76 and 43.98 (13-
quaternary C and 10-quaternary C), 48.2 (5-CH), 48.6 (14-quaternary C), 51.9 (17-CH), 68.6 
(8-quaternary C), 69.3 (9-quaternary C), 217.4 (3-quaternary C); m/z (ESI
+
) 401 [M + H]
 +
, 
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3.3 Amine Derivatives of Lanosterol 
Note: The reductive aminations described in this section were carried out on ≥ 95%pure starting 
aldehydes. 
3-Acetoxy-5-4,4,14-trimethyl-24-piperadino-chol-8-ene 41  
Sodium triacetoxyborohydride (0.067 g, 0.32 mM) 
was added to a solution of 3-acetoxy-5-4,4,14-
trimethyl-chol-8-ene-24-al 21 (0.100 g, 0.23 mM) 
and piperidine (22 L, 0.23 mM) in 1,2-
dichloroethane (10 mL). The reaction mixture was 
stirred at room temperature for 1.5 h, after which 
time saturated aqueous sodium bicarbonate solution 
(10 mL) was added. The reaction mixture was 
extracted into ethyl acetate (10 mL) and washed with brine (2 × 10 mL). The organic extracts 
were then dried over magnesium sulfate and concentrated under reduced pressure to yield the 
desired product 41 as an off white solid (0.110 g, 91%): mp 150 – 151 °C; νmax(KBr)/cm
−1
 
2940, 1735; H (300 MHz, CDCl3) 0.68 (3H, s, 18-CH3), 0.80 – 0.95 (12H, m, containing 21-
CH3, 28-CH3, 29-CH3, 30-CH3), 1.00 (3H, s, 19-CH3), 1.03 – 1.80 (24H, m), 1.82 – 2.15 [8H, 
m, containing 2.05 (3H, s, OAc, CH3)], 2.25 – 2.30 (2H, m, 24-CH2), 2.41 (4H, br s, 
piperidine CH2 × 2), 4.50 (1H, dd, J 11.5, 4.5, 3-CH); δC (75 MHz, CDCl3)
24
 15.7 (18-CH3), 
16.5 (29-CH3), 18.1 (6-CH2), 18.7 (21-CH3), 19.2 (19-CH3), 21.0 (11-CH2), 21.3 (OAc, CH3), 
23.4 (23-CH2), 24.17 (2-CH2), 24.24 (30-CH3), 24.4 (piperidine CH2), 25.8 (piperidine CH2 × 
2), 26.4 (7-CH2), 27.9 (28-CH3), 28.2 (16-CH2), 30.8 (15-CH2), 31.0 (12-CH2), 34.1 (22-
CH2), 35.3 (1-CH2), 36.4 (20-CH), 36.9 (10-quaternary C), 37.8 (4-quaternary C), 44.5 (13-
quaternary C), 49.8 (14-quaternary C), 50.3 (5-CH or 17-CH), 50.5 (5-CH or 17-CH), 54.5 
(piperidine N-CH2 × 2), 59.9 (24-CH2), 80.9 (3-CH), 134.3 (9-quaternary C), 134.5 (8-
quaternary C), 171.0 (quaternary C, OAc, C=O); m/z (ESI
+
) 512 [M + H]
+
; exact mass 
calculated for C34H58NO2 [M + H]
+
 512.4468, found 512.4476. 
 
Reaction was also carried out using piperidine (4.2 eq), NaBH3CN (3.6 eq), ZnCl2 (1.8 eq) in MeOH at room 
temperature for 16 h, resulting in 84% yield. 









Sodium triacetoxyborohydride (0.074 g, 0.35 mM) was 
added to a solution of 3-hydroxy-5-4,4,14-trimethyl-
chol-8-ene-24-al 25 (0.100 g, 0.25 mM) and piperidine 
(25 L, 0.25 mM) in 1,2-dichloroethane (10 mL).  The 
reaction mixture was stirred at room temperature for 1.5 
h, after which time saturated aqueous sodium 
bicarbonate solution (10 mL) was added. The reaction 
mixture was extracted into ethyl acetate (10 mL) and 
washed with brine (2 × 10 mL). The organic extracts were then dried over magnesium sulfate 
and concentrated under reduced pressure to yield the desired product 42 as a white solid 
(0.100 g, 85%) mp 119 – 121 °C; νmax(KBr)/cm
−1
 3432, 2941; H (300 MHz, CDCl3) 0.69 
(3H, s, 18-CH3), 0.75 – 1.80 [40H, m, containing 0.81 (3H, s, 29-CH3), 0.87 (3H, s, 30-CH3), 
0.90 (3H, d, J 6.2, 21-CH3), 0.98 (3H, s, 19-CH3), 1.00 (3H, s, 28-CH3)], 1.81 – 2.13 (6H, m), 
2.20 – 2.30 (2H, m, 24-CH2), 2.31 – 2.52 (4H, m, piperidine CH2 × 2), 3.23 (1H, dd, J 4.5, 
11.5, 3-CH); δC (75 MHz, CDCl3) 15.4 (29-CH3), 15.7 (18-CH3), 18.3 (6-CH2), 18.8 (21-
CH3), 19.1 (19-CH3), 21.0 (11-CH2), 23.4 (23-CH2), 24.3 (30-CH3), 24.4 (piperidine CH2), 
25.7 (piperidine CH2 × 2), 26.5 (7-CH2), 27.9 (2-CH2), 28.0 (28-CH3), 28.2 (16-CH2), 30.8 
(15-CH2), 31.0 (12-CH2), 34.1 (22-CH2), 35.6 (1-CH2), 36.3 (20-CH), 37.0 (10-quaternary 
C), 38.9 (4-quaternary C), 44.5 (13-quaternary C), 49.8 (14-quaternary C), 50.3 (5-CH), 50.4 
(17-CH), 54.6 (piperidine N-CH2 × 2), 60.0 (24-CH2), 78.9 (3-CH), 134.37 (8-quaternary C 
or 9-quaternary C), 134.42 (8-quaternary C or 9-quaternary C). The following peaks were 
distinguishable for the minor dihydrolanosterol component 7 at a level <4%: 22.5 (26-CH3), 
22.8 (27-CH3); m/z (ESI
+
) 470 [M + H]
+
 (100%); exact mass calculated for C33H56NO [M + 
H]
+
 470.4362, found 470.4362.  
 












Sodium triacetoxyborohydride (0.067 g, 0.32 mM) 
was added to a solution of 3-acetoxy-5-4,4,14-
trimethyl-chol-8-ene-24-al 21 (0.100 g, 0.23 mM) 
and diethylamine  (23 L, 0.23 mM) in 1,2-
dichloroethane (10 mL). The reaction mixture was 
stirred at room temperature for 1.5 h, after which 
time saturated aqueous sodium bicarbonate solution 
(10 mL) was added. The reaction mixture was extracted into ethyl acetate (10 mL) and 
washed with brine (2 × 10 mL). The organic extracts were then dried over magnesium sulfate 
and concentrated under reduced pressure to yield the desired product 43 as a white solid 
(0.073 g, 65%) mp 87 – 89 °C; νmax(KBr)/cm
−1
 2953, 1735, 1714; H (300 MHz, CDCl3) 0.68 
(3H, s, 18-CH3), 0.78 – 0.95 (12H, m, containing 21-CH3, 28-CH3, 29-CH3, 30-CH3), 0.96 – 
1.10 [9H, m, containing 1.00 (3H, s, 19-CH3) and 1.06 (6H, t, J 7.2, diethylamine CH3 × 2)], 
1.12 – 1.80 (12H, m), 1.81 – 2.15 (8H, m, containing 2.05 (3H, s, OAc, CH3)], 2.32 – 2.51 
(2H, m, 24-CH2), 2.52 – 2.67 (4H, m, diethylamine CH2 × 2), 4.50 (1H, dd, J 11.5, 4.5, 3-
CH); δC (300 MHz, CDCl3) diethylamine CH3 × 2), 15.8 -CH3), 16.5 -CH3), 18.1 
-CH2), 18.7 -CH3), 19.2 -CH3), 21.0 -CH2), 21.3 OAc, CH3), 23.1 23-CH2), 
24.16 -CH2), 24.23 -CH3), 26.4 -CH2), 27.9 -CH3), 28.2 16-CH2), 30.8 -CH2), 
31.0 -CH2), 34.0 22-CH2), 35.3 -CH2), 36.4 20-CH), 36.9 -quaternary C), 37.8 -
quaternary C), 44.5 -quaternary C), 46.6 diethylamine N-CH2 × 2), 49.8 -quaternary 
C), 50.4 -CH or 17-CH), 50.5 -CH or 17-CH), 53.2 24-CH2), 80.9 -CH), 134.3 -
quaternary C or 9-quaternary C), 134.5 -quaternary C or 9-quaternary C), 171.0 quaternary 
C, OAc, C=O); m/z (ESI
+
) 498 [M - H]
+
 (18%) 316 (100); exact mass calculated for 
C33H58NO2 [M + H]
+
 500.4468, found 500.4465.  
 
The following peaks were distinguishable for the minor dihydrolanosterol acetate component 
at a level <4%: 22.5 (26-CH3), 22.8 (27-CH3), 27.9 (25-CH). Although no aldehyde signal 
can be seen at ~ 9 ppm in the 
1
H NMR spectrum, a trace amount of aldehyde is present in the 
product due to a very minor signal at 206.5 ppm in the 
13
C NMR spectrum. 
 
 




Sodium triacetoxyborohydride (0.074 g, 0.35 mM) was 
added to a solution of 3-hydroxy-5-4,4,14-trimethyl-
chol-8-ene-24-al 25 (0.100 g, 0.25 mM) and 
diethylamine  (26 L, 0.25 mM) in 1,2-dichloroethane 
(10 mL). The reaction mixture was stirred at room 
temperature for 1.5 h, after which time saturated 
aqueous sodium bicarbonate solution (10 mL) was 
added. The reaction mixture was extracted into ethyl 
acetate (10 mL) and washed with brine (2 × 10 mL). The organic extracts were then dried 
over magnesium sulfate and concentrated under reduced pressure to yield the desired product 
44 as a white solid (0.086 g, 75%): mp 135 – 137 °C; νmax(KBr)/cm
−1
 3432, 2944; H (300 
MHz, CDCl3) 0.69 (3H, s, 18-CH3), 0.74 – 1.80 [43H, m, containing 0.81 (3H, s, 29-CH3), 
0.87 (3H, s, 30-CH3), 0.91 (3H, d, J 6.3, 21-CH3), 0.98 (3H, s, 19-CH3), 1.00 (3H, s, 28-CH3), 
1.07 (6H, t, J 7.2, diethylamine CH3 × 2)], 1.81 – 2.30 (4H, m), 2.38 – 2.50 (2H, m, 24-CH2), 
2.54 – 2.64 (4H, m, diethylamine CH2 × 2), 3.23 (1H, dd, J 11.5, 4.5, 3-CH); δC (75 MHz, 
CDCl3) 11.2 (diethylamine CH3 × 2), (29-CH3), 15.8 (18-CH3), 18.3 (6-CH2), 18.7 (21-
CH3), (19-CH3), 21.0 (11-CH2), (23-CH2), (30-CH3), 26.5 (7-CH2), 27.9 (2-
CH2),  20 (28-CH3), 28.2 (16-CH2), (15-CH2), 31.0 (12-CH2), 34.1 (22-CH2), 6(1-
CH2), 36.4 (20-CH), 37.0 (10-quaternary C), 38.9 (4-quaternary C), 44.5 (13-quaternary C), 
46.8(diethylamine N-CH2 × 2), 49.8 (14-quaternary C), 50.38 (-CH or 17-CH), 50.41 (-CH 
or 17-CH), (24-CH2), 79.0 (3-CH), 134.4 (-quaternary C or 9-quaternary C), 134.4 (-
quaternary C or 9-quaternary C), The following peaks were distinguishable for the minor 
dihydrolanosterol component at a level <4%: 22.6 (26-CH3), 22.9 (27-CH3), 29.7 (25-CH); 
m/z (ESI
+
) 458 [M + H]
+
 (100%); exact mass calculated for C31H56NO [M + H]
+
 458.4362, 
found 458.4366.  
 
Assignments for diethylamine derivatives are based on Lavrado paper
26










Sodium triacetoxyborohydride (0.100 g, 0.47 mM) 
was added to a solution of 3-acetoxy-5-4,4,14-
trimethyl-chol-8-ene-24-al 21 (0.150 g, 0.34 mM) 
and morpholine (30 L, 0.34 mM) in 1,2-
dichloroethane (40 mL). The reaction mixture was 
stirred at room temperature for 1.5 h, after which 
time saturated aqueous sodium bicarbonate solution 
(20 mL) was added. The reaction mixture was 
extracted into ethyl acetate (10 mL) and washed with brine (2 × 40 mL). The organic extracts 
were then dried over magnesium sulfate and concentrated under reduced pressure to yield the 
desired product 45 as an off white solid (0.094 g, 54%): mp 135 – 137 °C; Found C, 77.53; H, 
10.60. C33H55NO3 requires C, 77.14; H, 10.79%; νmax(KBr)/cm
−1
 2949, 1737; H (300 MHz, 
CDCl3) 0.69 (3H, s, 18-CH3), 0.80 – 0.94 [12H, m, containing 21-CH3, 28-CH3, 29-CH3, 30-
CH3], 1.00 (3H, s, 19-CH3), 1.03 – 1.80 (18H, m), 1.82 – 2.10 [8H, m, containing 2.05 (3H, s, 
OAc, CH3)], 2.29 (2H, t, J 7.1, 24-CH2), 2.44 (4H, br s, morpholine N-CH2 × 2), 3.72 (4H, t, 
J 4.7, morpholine O-CH2 × 2), 4.50 (1H, dd, J 11.5, 4.5, 3-CH); δC (75 MHz, CDCl3) 15.8 
(18-CH3), 16.5 (29-CH3), 18.1 (6-CH2), 18.7 (21-CH3), 19.2 (19-CH3), 21.0 (11-CH2), 21.3 
(OAc, CH3), 23.2 (23-CH2), 24.17 (2-CH2), 24.24 (30-CH3), 26.4 (7-CH2), 27.9 (28-CH3), 
28.2 (16-CH2), 30.8 (15-CH2), 31.0 (12-CH2), 33.9 (22-CH2), 35.3 (1-CH2), 36.3 (20-CH), 
36.9 (10-quaternary C), 37.8 (4-quaternary C), 44.5 (13-quaternary C), 49.8 (14-quaternary 
C), 50.3 (5-CH or 17-CH), 50.5 (5-CH or 17-CH), 53.8 (morpholine N-CH2 × 2), 59.7 (24-
CH2), 67.0 (morpholine O-CH2 × 2), 80.9 (3-CH), 134.3 (9-quaternary C), 134.5 (8-
quaternary C), 171.0 (quaternary C, OAc, C=O); m/z (ESI
+
) 514 [M + H]
+
 (100%); exact 
mass calculated for C33H56NO3 [M + H]
+
 514.4260, found 514.4257. The following peaks 
were distinguishable for the minor dihydrolanosterol acetate component at a level <4%: 22.5 











Sodium triacetoxyborohydride (0.148 g, 0.70 mM) was 
added to a solution of 3-hydroxy-5-4,4,14-trimethyl-
chol-8-ene-24-al 25 (0.200 g, 0.50 mM) and morpholine 
(39 L, 0.50 mM) in 1,2-dichloroethane (40 mL). The 
reaction mixture was stirred at room temperature for 1.5 
h, after which time saturated aqueous sodium 
bicarbonate solution (20 mL) was added. The reaction 
mixture was extracted into ethyl acetate (10 mL) and 
washed with brine (2 × 40 mL). The organic extracts were then dried over magnesium sulfate 
and concentrated under reduced pressure
25
 to yield the desired product 46 as an off white 
solid (0.204 g, 87%): mp 132 – 134 °C; νmax(KBr)/cm
−1
 3422, 2955; H (300 MHz, CDCl3) 
0.69 (3H, s, 18-CH3), 0.75 – 1.81 [34H, m, containing 0.81 (3H, s, 29-CH3), 0.87 (3H, s, 30-
CH3), 0.91 (3H, d, J 6.2, 21-CH3), 0.98 (3H, s, 19-CH3), 1.00 (3H, s, 28-CH3)], 1.83 – 2.16 
(5H, m), 2.29 (2H, t, J 6.8, 24-CH2), 2.44 (4H, br s, morpholine N-CH2 × 2), 3.23 (1H, dd, J 
11.5, 4.5, 3-CH), 3.72 (4H, t, J 4.7, morpholine O-CH2 × 2); δC (75 MHz, CDCl3) 15.4 (29-
CH3), 15.7 (18-CH3), 18.3 (6-CH2), 18.7 (21-CH3), 19.1 (19-CH3), 21.0 (11-CH2), 23.2 (23-
CH2), 24.2 (30-CH3), 26.5 (7-CH2), 27.8 (2-CH2), 28.0 (28-CH3), 28.2 (16-CH2), 30.8 (15-
CH2), 31.0 (12-CH2), 33.9 (22-CH2), 35.6 (1-CH2), 36.3 (20-CH), 37.0 (10-quaternary C), 
38.9 (4-quaternary C), 44.5 (13-quaternary C), 49.8 (14-quaternary C), 50.3 (5-CH or 17-
CH), 50.4 (5-CH or 17-CH), 53.8 (morpholine N-CH2 × 2), 59.7 (N-CH2), 67.0 (morpholine 
O-CH2 × 2), 79.0 (3-CH), 134.3 (9-quaternary C), 134.5 (8-quaternary C); m/z (ESI
+
) 472 [M 
+ H]
+
 (100%); exact mass calculated for C31H54NO2 472.4155, found 472.4153.  
 














Sodium triacetoxyborohydride (0.067 g, 0.32 
mM) was added to a solution of 3-acetoxy-5-
4,4,14-trimethyl-chol-8-ene-24-al 21 (0.100 g, 
0.23 mM) and aniline (21 L, 0.23 mM) in 1,2-
dichloroethane (35 mL). The reaction mixture 
was stirred at room temperature for 1.5 h, after 
which time saturated aqueous sodium 
bicarbonate solution (20 mL) was added. The reaction mixture was extracted into ethyl 
acetate (10 mL) and washed with brine (2 × 40 mL). The organic extracts were then dried 
over magnesium sulfate and concentrated under reduced pressure to yield the desired product 
47 as an off white oily solid (0.160 g, 94%): Found C, 80.11; H, 10.42. C35H53NO2 requires 
C, 80.87; H, 10.28%; νmax(KBr)/cm
−1
 2949, 1733; H (300 MHz, CDCl3) 0.69 (3H, s, 18-
CH3), 0.76 – 1.03 [16H, m, containing 21-CH3, 28-CH3, 29-CH3, 30-CH3 and 1.00 (3H, s, 19-
CH3)], 1.04 – 1.83 (18H, m), 1.84 – 2.15 [8H, m, containing 2.05 (3H, s, OAc, CH3)], 3.01 – 
3.13 (2H, m, 24-CH2), 4.50 (1H, dd, J 11.6, 4.5, 3-CH), 6.59 (2H, d, J 7.7, Ar-CH × 2), 6.67 
(1H, t, J 7.3, p-Ar CH), 7.14 – 7.18 (2H, m, Ar-CH); δC (75 MHz, CDCl3) 15.8 (18-CH3), 
16.6 (29-CH3), 18.1 (6-CH2), 18.7 (21-CH3), 19.2 (19-CH3), 21.0 (11-CH2), 21.3 (OAc, CH3), 
24.2 (2-CH2), 24.3 (30-CH3), 26.4 (7-CH2), 27.9 (28-CH3), 28.2 (16-CH2), 30.8 (15-CH2), 
31.0 (12-CH2), 33.7 (22-CH2), 35.3 (1-CH2), 36.3 (20-CH), 36.9 (10-quaternary C), 37.8 (4-
quaternary C), 44.5 (13-quaternary C), 44.6 (24-CH2), 49.8 (14-quaternary C), 50.4 (5-CH or 
17-CH), 50.5 (5-CH or 17-CH), 80.9 (3-CH), 112.7 (Ar-CH × 2), 117.1 (Ar-CH), 129.2 (Ar-
CH × 2), 134.3 (8-quaternary C or 9-quaternary C), 134.5 (8-quaternary C or 9-quaternary C), 
148.6 (Ar-quaternary C), 171.0 (OAc, C=O, quaternary C), The following peaks were 
distinguishable for the minor dihydrolanosterol acetate component at a level <4%: 22.6 (26-
CH3), 22.9 (27-CH3), 29.7 (25-CH); m/z (ESI
+
) 520 [M + H]
+
 (12%) 102 (100); exact mass 
calculated for C35H54NO2 [M + H]
+
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 -Hydroxy-5-4,4,14-trimethyl-24-anilino-chol-8-ene 48 
Sodium triacetoxyborohydride (0.015 g, 0.07 mM) 
was added to a solution of 3-hydroxy-5-4,4,14-
trimethyl-chol-8-ene-24-al 25 (0.020 g, 0.05 mM) 
and aniline (4.5 L, 0.05 mM) in 1,2-
dichloroethane (15 mL). The reaction mixture was 
stirred at room temperature for 1.5 h, after which 
time saturated aqueous sodium bicarbonate 
solution (10 mL) was added. The reaction mixture was extracted into ethyl acetate (10 mL) 
and washed with brine (2 × 20 mL). The organic extracts were then dried over magnesium 
sulfate and concentrated under reduced pressure to yield the desired product 48 as an off 
white oily solid (0.024 g, 93%): νmax(KBr)/cm
−1
 3324, 2951; H (300 MHz, CDCl3) 0.60 – 
2.20 [43H, m, containing 0.69 (3H, s, 18-CH3), 0.81 (3H, s, 29-CH3), 0.88 (3H, s, 30-CH3), 
0.92 (3H, d, J 6.1, 21-CH3), 0.98 (3H, s, 19-CH3), 1.00 (3H, s, 28-CH3)], 2.98 – 3.15 (2H, m, 
24-CH2), 3.23 (1H, dd, J 11.5, 4.5, 3-CH), 6.60 (2H, d, J 7.7, Ar-CH × 2), 6.68 (1H, t, J 7.2, 
p-Ar CH), 7.14 – 7.18 (2H, m, Ar-CH × 2); δC (75 MHz, CDCl3) 15.4 (29-CH3), 15.8 (18-
CH3), 18.3 (6-CH2), 18.7 (21-CH3), 19.1 (19-CH3), 21.0 (11-CH2), 24.3 (30-CH3), 26.4 
(CH2), 26.5 (7-CH2), 27.9 (2-CH2), 28.0 (28-CH3), 28.2 (16-CH2), 29.7 (CH2), 30.8 (15-CH2), 
31.0 (12-CH2), 33.6 (22-CH2), 35.6 (1-CH2), 36.3 (20-CH), 37.0 (10-quaternary C), 44.5 (13-
quaternary C), 44.6 (24-CH2), 49.8 (14-quaternary C), 50.39 (5-CH or 17-CH), 50.42 (5-CH 
or 17-CH), 79.0 (3-CH), 112.7 (Ar-CH × 2), 117.1 (Ar-CH), 129.2 (Ar-CH × 2), 134.4 (-
quaternary C or 9-quaternary C), 134.5 (-quaternary C or 9-quaternary C); exact mass 
calculated for C33H52NO [M + H]
+
 478.4049, found 478.4041. 
 
3-Acetoxy-5-4,4,14-trimethyl-24-thiomorpholino-chol-8-ene 49 
Sodium triacetoxyborohydride (0.080 g, 0.38 mM) 
was added to a solution of 3-acetoxy-5-4,4,14-
trimethyl-chol-8-ene-24-al 21 (0.120 g, 0.27 mM) 
and thiomorpholine (27 L, 0.27 mM) in 1,2-
dichloroethane (40 mL). The reaction mixture was 
stirred at room temperature for 1.5 h, after which 
time saturated aqueous sodium bicarbonate solution 
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(20 mL) was added. The reaction mixture was extracted into ethyl acetate (10 mL) and 
washed with brine (2 × 40 mL). The organic extracts were then dried over magnesium sulfate 
and concentrated under reduced pressure to yield the desired product 49 as an orange solid 
(0.142 g, 71%): mp 137 – 139 °C; νmax(KBr)/cm
−1
 2949, 1735, 1715; H (300 MHz, CDCl3) 
0.68 (3H, s, 18-CH3), 0.80 – 0.92 [12H, m, containing 21-CH3, 28-CH3, 29-CH3, 30-CH3], 
1.00 (3H, s, 19-CH3), 1.05 – 1.80 (20H, m), 1.81 – 2.10 [8H, m, containing (2.05, 3H, s, OAc, 
CH3)], 2.20 – 2.40 (2H, m, 24-CH2),  2.60 – 2.80 (8H, m, thiomorpholine CH2 × 4), 4.45 (1H, 
dd, J 11.5, 4.5, 3-CH); δC (75 MHz, CDCl3) 15.8 (18-CH3), 16.5 (29-CH3), 18.1 (6-CH2), 
18.7 (21-CH3), 19.2 (19-CH3), 21.0 (11-CH2), 21.3 (OAc, CH3), 23.2 (23-CH2), 24.2 (2-CH2),  
24.3 (30-CH3), 26.4 (7-CH2), 27.9 (28-CH3), 28.0 (thiomorpholine S-CH2 × 2), 28.2 (16-
CH2), 30.8 (15-CH2), 31.0 (12-CH2), 33.9 (22-CH2), 35.3 (1-CH2), 36.3 (20-CH), 36.9 (10-
quaternary C), 37.8 (4-quaternary C), 44.5 (13-quaternary C), 49.8 (14-quaternary C), 50.3 
(5-CH or 17-CH), 50.5 (5-CH or 17-CH), 55.1 (thiomorpholine N-CH2 × 2), 59.9 (24-CH2), 
80.9 (3-CH), 134.1 (-quaternary C or 9-quaternary C), 134.3 (-quaternary C or 9-
quaternary C), 171.0 (quaternary C, OAc, C=O); m/z (ESI
+
) 530 [M + H]
+
 (12%), 326 (100); 
exact mass calculated for C33H55NO2S [M + H]
+




Sodium triacetoxyborohydride (0.059 g, 0.28 mM) was 
added to a solution of 3-hydroxy-5-4,4,14-trimethyl-
chol-8-ene-24-al 25 (0.080 g, 0.20 mM) and 
thiomorpholine (20 L, 0.20 mM) in 1,2-dichloroethane 
(40 mL). The reaction mixture was stirred at room 
temperature for 1.5 h, after which time saturated 
aqueous sodium bicarbonate solution (20 mL) was 
added. The reaction mixture was extracted into ethyl 
acetate (10 mL) and washed with brine (2 × 40 mL). The organic extracts were then dried 
over magnesium sulfate and concentrated under reduced pressure to yield the desired product 
50 as an orange solid (0.094 g, 96%), mp 131 – 134 °C; νmax(KBr)/cm
−1
 3316, 2939; H (300 
MHz, CDCl3) 0.68 (3H, s, 18-CH3), 0.75 – 1.10 [16H, m, containing 0.81 (3H, s, 29-CH3), 
0.87 (3H, s, 30-CH3), 0.90 (3H, d, J 6.3, 21-CH3), 0.98 (3H, s, 19-CH3), 1.00 (3H, s, 28-
CH3)], 1.11 – 1.79 (18H, m), 1.81 – 2.13 (5H, m), 2.21 – 2.40 (2H, m, 24-CH2), 2.57 – 2.80 
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(8H, m, thiomorpholine CH2 × 4), 3.23 (1H, dd, J 11.5, 4.6, 3-CH); δC (75 MHz, CDCl3) 15.4 
(29-CH3), 15.7 (18-CH3), 18.3 (6-CH2), 18.8 (21-CH3), 19.1 (19-CH3), 21.0 (11-CH2), 23.1 
(23-CH2), 24.3 (30-CH3), 26.5 (7-CH2), 27.9 (2-CH2), 28.0 (thiomorpholine S-CH2 × 2), 28.2 
(16-CH2), 30.8 (15-CH2), 31.0 (12-CH2), 33.9 (22-CH2), 35.6 (1-CH2), 36.3 (20-CH), 37.0 
(10-quaternary C), 38.9 (4-quaternary C), 44.5 (13-quaternary C), 49.8 (14-quaternary C), 
50.3 (5-CH or 17-CH), 50.4 (5-CH or 17-CH), 55.1 (thiomorpholine N-CH2 × 2), 60.0 (24-
CH2), 78.9 (3-CH), 134.35 (-quaternary C or 9-quaternary C), 134.44 (-quaternary C or 9-
quaternary C); m/z (ESI
+
) 488 [M + H]
+
 (100%); exact mass calculated for C31H54NOS [M + 
H]
+
 488.3926, found 488.3912. 
 
Attempted synthesis of 3-acetoxy-5-4,4,14-trimethyl-24-piperazino-chol-8-ene 55 
Sodium triacetoxyborohydride (0.134 g, 0.73 mM) 
was added to a solution of 3-acetoxy-5-4,4,14-
trimethyl-chol-8-ene-24-al 21 (0.200 g, 0.45 mM) 
and piperazine (0.038 g, 0.45 mM) in 1,2-
dichloroethane (40 mL). The reaction mixture was 
stirred at room temperature for 1.5 h, after which 
time saturated aqueous sodium bicarbonate solution 
(20 mL) was added. The reaction mixture was 
extracted into ethyl acetate (20 mL) and washed with brine (2 × 40 mL). The organic extracts 
were then dried over magnesium sulfate and concentrated under reduced pressure to yield 3-
acetoxy-5-4,4,14-trimethyl-24-piperazino-chol-8-ene dimer 56 as a white solid (0.120 g, 
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3-Acetoxy-5-4,4,14-trimethyl-24-piperazino-chol-8-ene dimer 56 
mp 200 – 202 °C; νmax(KBr)/cm
−1
 
2945, 1734, 1287;H (300 MHz, 
CDCl3)
29
 0.69 (6H, s, 18-CH3 × 
2), 0.79 – 0.93 (24H, m, 21-CH3 × 
2, 28-CH3 × 2, 29-CH3 × 2, 30-
CH3 × 2), 0.94 – 1.10 [8H, m, 
containing 1.00 (6H, s, 19-CH3 × 
2)], 1.11 – 1.80 (40H, m), 1.81 – 
2.15 [16H, m containing 2.05 (3H, 
s, OAc, CH3 × 2)], 2.19 – 2.32 
(4H, m, 24-CH2),  2.33 – 2.70 
(8H, m, piperazine CH2 × 4), 4.50 (2H, dd, J 11.2, 4.7, 3-CH × 2); δC (75 MHz, CDCl3) 15.7 
(18-CH3), 16.5 (29-CH3), 18.1 (6-CH2), 18.8 (21-CH3), 19.2 (19-CH3), 21.0 (11-CH2), 21.4 
(OAc, CH3), 23.6 (23-CH2), 24.2 (2-CH2), 24.3 (30-CH3), 26.4 (7-CH2), 27.9 (28-CH3), 28.2 
(16-CH2), 30.8 (15-CH2), 30.9 (12-CH2), 34.0 (22-CH2), 35.2 (1-CH2), 36.4 (20-CH), 36.9 
(10-quaternary C), 37.8 (4-quaternary C), 44.4 (13-quaternary C), 50.2 (5-CH or 17-CH), 
50.5 (5-CH or 17-CH), 53.3 (piperazine CH2 × 4), 59.4 (24-CH2), 80.9 (3-CH), 134.2 (8-
quaternary C or 9-quaternary C), 134.4 (8-quaternary C or 9-quaternary C), 170.0 (quaternary 
C, OAc, C=O); exact mass calculated for C62H103N2O4 [M + H]
+




Sodium triacetoxyborohydride (0.074 g, 0.35 mM) 
was added to a solution of 3-hydroxy-5-4,4,14-
trimethyl-chol-8-ene-24-al 25 (0.100 g, 0.25 mM) and 
piperazine (0.022 g, 0.25 mM) in 1,2-dichloroethane 
(30 mL). The reaction mixture was stirred at room 
temperature for 1.5 h, after which time saturated 
aqueous sodium bicarbonate solution (20 mL) was 
added. The reaction mixture was extracted into ethyl 
acetate (20 mL) and washed with brine (2 × 20 mL). 
The organic extracts were then dried over magnesium sulfate and concentrated under reduced 
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pressure to yield the desired product 57 as an orange solidifying oil (0.089 g, 76%): 
νmax(KBr)/cm
−1
 3431, 2944; H (300 MHz, CDCl3) 0.69 (3H, s, 18-CH3), 0.72 – 1.80 [35H, m, 
containing 0.81 (3H, s, 29-CH3), 0.87 (3H, s, 30-CH3), 0.90 (3H, d, J 6.1, 21-CH3), 0.98 (3H, 
s, 19-CH3), 1.00 (3H, s, 28-CH3)], 1.81 – 3.00 [13H, m, containing 24-CH2, piperazine CH2 × 
2, 2.94 (2H, br, s, CH2 adjacent to NH)], 3.23 (1H, dd, J 11.3, 4.7, 3-CH); δC (75 MHz, 
CDCl3) 15.4 (29-CH3), 15.8 (18-CH3), 18.3 (6-CH2), 18.7 (21-CH3), 19.1 (19-CH3), 21.0 (11-
CH2), 23.3 (23-CH2), 24.3 (30-CH3), 26.5 (7-CH2), 27.9 (2-CH2), 28.0 (28-CH3), 28.2 (16-
CH2), 30.8 (15-CH2), 31.0 (12-CH2), 34.0 (22-CH2), 35.6 (1-CH2), 36.3 (20-CH), 37.0 (10-
quaternary C), 38.9 (4-quaternary C), 44.5 (13-quaternary C), 45.8 (piperazine CH2 × 2, 
adjacent to free NH), 50.3 (5-CH or 17-CH), 50.4 (5-CH or 17-CH), 53.6 (piperazine CH2 × 
2, adjacent to tertiary N), 59.8 (24-CH2), 79.0 (3-CH), 134.38 (8-quaternary C or 9-
quaternary C), 134.44 (8-quaternary C or 9-quaternary C); m/z (ESI
+
) 471 [M + H]
+
 (4%), 42 
(100); exact mass calculated for C31H55N2O [M + H]
+
 471.4314, found 471.4309. Due to a 
slight discrepancy in integration values in the 
1
H NMR spectrum, it is inferred that a trace 
amount of dihydrolanosterol 7 from the starting material is present in the product.  




Sodium triacetoxyborohydride (0.161 g, 0.76 mM) 
was added to a solution of 3-acetoxy-5-4,4,14-
trimethyl-chol-8-ene-24-al 21 (0.241 g, 0.54 mM) 
and 1-(2-hydroxyethyl)piperazine (0.070 g, 66 L, 
0.54 mM) in 1,2-dichloroethane (40 mL). Owing to 
the fact that 1-(2-hydroxyethyl)piperazine is a very 
viscous oil and could not be measured by 
microsyringe, the reagent was weighed in the 
following manner: a drop of 1-(2-
hydroxyethyl)piperazine was placed in a vial and it’s 
mass was recorded as 0.100 g. 10 mL of the reaction solvent was added and the amine was 
allowed to go into solution. 7 mL of this resulting solution was measured by syringe and 
transferred into the reaction vessel. The reaction mixture was stirred at room temperature for 
1.5 h, after which time saturated aqueous sodium bicarbonate solution (20 mL) was added. 
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The reaction mixture was extracted into ethyl acetate (20 mL) and washed with brine (2 × 40 
mL). The organic extracts were then dried over magnesium sulfate and concentrated under 
reduced pressure to yield the desired product 58 as a light orange solid (0.286 g, 94%): mp 
131 – 132 °C; νmax(KBr)/cm
−1
 3412, 2948, 1724; H (300 MHz, CDCl3) 0.69 (3H, s, 18-CH3), 
0.77 – 1.80 [35H, m, containing 21-CH3, 28-CH3, 29-CH3, 30-CH3), 1.00 (3H, s, 19-CH3)], 
1.81 – 2.15 [8H, m, containing 2.05 (3H, s, OAc, CH3)], 2.24 – 2.37 (2H, m, 24-CH2), 2.38 – 
2.64 (10H, m, containing piperazine N-CH2 × 4 and N-CH2 of hydroxyethyl moiety), 3.28 
(1H, br s, CH2-OH), 3.62 (2H, t, J 5.4 CH2-OH), 4.50 (3H, dd, J 11.2, 4.7, 3-CH); δC (75 
MHz, CDCl3) 15.7 (18-CH3), 16.5 (29-CH3), 18.1 (6-CH2), 18.7 (21-CH3), 19.1 (19-CH3), 
21.0 (11-CH2), 21.3 (OAc, CH3), 23.5 (23-CH2), 24.16 (2-CH2), 24.23 (30-CH3), 26.4 (7-
CH2), 27.9 (28-CH3), 28.2 (16-CH2), 30.8 (15-CH2), 30.9 (12-CH2), 34.0 (22-CH2), 35.3 (1-
CH2), 35.3 (quaternary C), 36.3 (20-CH), 36.8 (10-quaternary C), 43.5 (13-quaternary C), 
49.5 (14-quaternary C), 50.3 (5-CH or 17-CH), 50.5 (5-CH or 17-CH), 52.8 (piperazine CH2 
× 2), 53.2 (piperazine CH2 × 2), 57.7, 59.2, 59.3 (24-CH2 or hydroxyethyl N-CH2 or 
hydroxyethyl O-CH2), 80.9 (3-CH), 133.3 (8-quaternary C or 9-quaternary C), 133.5 (8-
quaternary C or 9-quaternary C), 170.0 (OAc, C=O, quaternary C); m/z (ESI
+
) 557 [M + H]
+
 
(100%); exact mass calculated for C35H61N2O3 [M + H]
+




Sodium triacetoxyborohydride (0.248 g, 1.17 mM) was 
added to a solution of 3-hydroxy-5-4,4,14-trimethyl-
chol-8-ene-24-al 25 (0.335 g, 0.84 mM) and 1-(2-
hydroxyethyl)piperazine (0.10 mL, 0.84 mM) in 1,2-
dichloroethane (50 mL). In this case, 0.1 mL of 1-(2-
hydroxyethyl)piperazine was measured using a standard 
1 mL plastic syringe. The reaction mixture was stirred 
at room temperature for 1.5 h, after which time 
saturated aqueous sodium bicarbonate solution (40 mL) 
was added. The reaction mixture was extracted into 
ethyl acetate (20 mL) and washed with brine (2 × 50 mL). The organic extracts were then 
dried over magnesium sulfate and concentrated under reduced pressure to yield the desired 
product 59 as an off white solid (0.380 g, 88%): mp 175 – 178 °C; νmax(KBr)/cm
−1
 3430, 
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2945; H (300 MHz, CDCl3) 0.69 (3H, s, 18-CH3), 0.71 – 1.80 [44H, m, containing 0.81 (3H, 
s, 29-CH3), 0.87 (3H, s, 30-CH3), 0.90 (3H, d, J 6.1, 21-CH3), 0.98 (3H, s, 19-CH3), 1.00 (3H, 
s, 28-CH3)], 1.81 – 2.13 (5H, m), 2.20 – 2.35 (2H, m, 24-CH2), 2.36 – 2.62 (8H, m, 
containing piperazine N-CH2 × 2 and N-CH2 of hydroxyethyl moiety), 3.23 (1H, dd, J 11.1, 
4.6, 3-CH) 3.52 – 3.66 (2H, m, CH2-OH); δC (75 MHz, CDCl3) 15.4 (29-CH3), 15.7 (18-
CH3), (6-CH2), (21-CH3), 19.2 (19-CH3), 21.0 (11-CH2), (23-CH2), (30-
CH3), (7-CH2), (2-CH2), (28-CH3), (16-CH2), (15-CH2), (12-
CH2), (22-CH2), (1-CH2), (20-CH),  -quaternary C), 38.9 -
quaternary C), 44.5 -quaternary C), 49.8 -quaternary C), 50.3 (5-CH or 17-CH), 
(5-CH or 17-CH), (piperazine CH2 × 2), (piperazine CH2 × 2), , , 
(24-CH2 or hydroxyethyl N-CH2 or hydroxyethyl O-CH2), (3-CH),  134.3 8-





 (100%); exact mass calculated for C33H59N2O2 [M + H]
+




Sodium triacetoxyborohydride (0.074 g, 0.35 mM) was 
added to a solution of 3-keto-5-4,4,14-trimethyl-chol-
8-ene-24-al 29 (0.100 g, 0.25 mM) and 1-(2-
hydroxyethyl)piperazine (0.032 g, 0.31 L, 0.25 mM) in 
1,2-dichloroethane (30 mL). The reagent was weighed in 
the following manner: a drop of 1-(2-
hydroxyethyl)piperazine was placed in a vial and its mass 
was recorded as 0.100 g. 10 mL of the reaction solvent 
was added and the amine was allowed to go into solution. 
3.2 mL of this resulting solution was measured by 
syringe and transferred into the reaction vessel. The reaction mixture was stirred at room 
temperature for 1.5 h, after which time saturated aqueous sodium bicarbonate solution (15 
mL) was added. The reaction mixture was extracted into ethyl acetate (20 mL) and washed 
with brine (2 × 20 mL). The organic extracts were then dried over magnesium sulfate and 
concentrated under reduced pressure to yield the desired product 60 an orange solidifying oil 
(0.092 g, 72%): νmax(KBr)/cm
−1
 3394, 2946, 1707; H (300 MHz, CDCl3) 0.60 – 2.18 [44H, 
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m, containing 0.72 (3H, s, 18-CH3), 0.89 (3H, s, 30-CH3), 0.91 (3H, d, J 6.3, 21-CH3), 1.07 
(3H, s, 29-CH3), 1.09 (3H, s, 28-CH3), 1.12 (3H, s 19-CH3)], 2.25– 2.95 (12H, m, containing 
2.33 (2H, t, J 7.7, 24-CH2), piperazine N-CH2 × 4 and N-CH2 of hydroxyethyl moiety), 3.63 
(2H, t, J 5.4, CH2-OH); δC (75 MHz, CDCl3) 15.9 (29-CH3), 18.70 (18-CH3 or 21-CH3), 
18.74 (18-CH3 or 21-CH3), 19.4 (6-CH2), 21.1 (11-CH2), 21.3 (19-CH3), 23.4 (23-CH2), 24.3 
(30-CH3), 26.2 (28-CH3), 26.3 (7-CH2), 28.2 (22-CH2), 29.7 (15-CH2 or 12-CH2), 30.9 (15-
CH2 or 12-CH2), 33.9 (22-CH2), 34.6 (1-CH2), 36.1 (2-CH2), 36.3 (20-CH), 36.9 (4-
quaternary C), 44.5 (13-quaternary C), 47.4 (10-quaternary C), 49.9 (14-quaternary C), 50.3 
(5-CH or 17-CH), 51.2 (5-CH or 17-CH), 52.6 (piperazine CH2 × 2), 53.0 (piperazine CH2 × 
2), 57.6, 59.1, 59.2 (24-CH2 or hydroxyethyl N-CH2 or hydroxyethyl O-CH2),  133.2 (8-
quaternary C or 9-quaternary C), 135.3 (8-quaternary C or 9-quaternary C), 218.0 (3-
quaternary C, C=O); m/z (ESI
+
) 513 [M + H]
+
 (100%); exact mass calculated for C33H57N2O2 
[M + H]
+
 513.4420, found 513.4422.  
 
3-Acetoxy-5-4,4,14-trimethyl-24-(2-(piperazin-1-yl)ethyl)amino-chol-8-ene  61, 3-
Acetoxy-5-4,4,14-trimethyl-24-piperazino-N-2-aminoethyl-chol-8-ene 63 and dimer 62 
Sodium triacetoxyborohydride (0.131 g, 
0.62 mM) was added to a solution of 
3-acetoxy-5-4,4,14-trimethyl-chol-8-
ene-24-al  21 (0.196 g, 0.44 mM) and 1-
(2-aminoethyl)piperazine (58 L, 0.44 
mM) in 1,2-dichloroethane (40 mL). 
The reaction mixture was stirred at 
room temperature for 1.5 h, after which 
time saturated aqueous sodium 
bicarbonate solution (20 mL) was 
added. The reaction mixture was 
extracted into ethyl acetate (20 mL) and 
washed with brine (2 × 40 mL). The 
organic extracts were then dried over 
magnesium sulfate and concentrated 
under reduced pressure to yield a mixture of the desired product 61 regioisomer 63 and dimer 
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62 in an indecipherable ratio, as a light orange solid (0.232 g). All attempts to remove the 
minor regioisomer, by recrystallisation and chromatography, were unsuccessful: mp 125 – 
128 °C; νmax(KBr)/cm
−1
 2950, 1735, 1716; H (300 MHz, CDCl3) 0.68 (3H, s, 18-CH3), 0.72 – 
1.80 [42H, m, containing 21-CH3, 28-CH3, 29-CH3, 30-CH3 and 1.00 (3H, s, 19-CH3)], 1.81 – 
2.13 [8H, m containing 2.05 (3H, s, OAc, CH3)], 2.15 – 2.90 [12H, m, containing (2H, m, 24-
CH2), piperazine N-CH2 × 4 and N-CH2 of aminoethyl moiety adjacent to tertiary N, for both 
regioisomers], 4.50 (1H, dd, J 11.2, 4.7, 3-CH); δC (75 MHz, CDCl3) 15.7 (29-CH3), 16.5 
(29-CH3), 18.1 (6-CH2), 18.7 (21-CH3), 19.2 (19-CH3), 21.0 (11-CH2), 21.3 (OAc, CH3), 23.6 
(23-CH2), 24.16 (2-CH3), 24.23 (30-CH2), 26.3 (7-CH2), 27.9 (28-CH3), 28.2 (16-CH2), 29.7 
(CH2), 30.8 (15-CH2), 31.0 (12-CH2), 34.0 (22-CH2), 35.3 (1-CH2), 36.3 (quaternary C), 36.4 
(20-CH), 36.8 (10-quaternary C), 37.8 (quaternary C), 38.5 (H2N-CH2 of aminoethyl chian in 
regioisomer 63), 44.4 (13-quaternary C), 45.8 and 45.9 (2 × CH2 adjacent to free NH of 
piperazine ring in regioisomer 61), 49.7 (14-quaternary C), 50.3 (5-CH or 17-CH), 50.5 (5-
CH or 17-CH), 53.2 (piperazine N-CH2 × 2), 59.3 (N-CH2 of aminoethyl chain, and or 24-
CH2 in regioisomer 63, and or N-CH2 of aminoethyl chain in regioisomer 61), 80.9 (3-CH), 
133.3 (8-quaternary C or 9-quaternary C), 133.5 (8-quaternary C or 9-quaternary C), 170.0 
(OAc, C=O, quaternary C); m/z (ESI
+
) 556 [M + H]
+
 (52%), 249 (100); exact mass calculated 
for C35H62N3O2 [M + H]
+
 556.4842, found 556.4841, for compounds 61and 63; exact mass 
calculated for C64H108N3O4 [M + H]
+















Hydroxy-5-4,4,14-trimethyl-24-piperazino-N-2-aminoethyl-chol-8-ene 65 and dimer 66 
Sodium triacetoxyborohydride (0.236 g, 1.11 
mM) was added to a solution of 3-hydroxy-
5-4,4,14-trimethyl-chol-8-ene-24-al 25 
(0.319 g, 0.79 mM) and 1-(2-
aminoethyl)piperazine (0.1 mL, 0.79 mM) in 
1,2-dichloroethane (50 mL). The reaction 
mixture was stirred at room temperature for 
1.5 h, after which time saturated aqueous 
sodium bicarbonate solution (50 mL) was 
added. The reaction mixture was extracted 
into ethyl acetate (20 mL) and washed with 
brine (2 × 40 mL). The organic extracts were 
then dried over magnesium sulfate and 
concentrated under reduced pressure to yield 
a mixture of the desired product 64, 
regioisomer 65 and dimer 66, in an indecipherable ratio as an off white solid (0.347 g). All 
attempts to remove the minor regioisomer, by recrystallisation and chromatography, were 
unsuccessful: mp 123 – 126 °C; νmax(KBr)/cm
−1
 3413, 2945; H (300 MHz, CDCl3) 0.50 – 
2.20 [46 H, m, containing 0.69 (3H, s, 18-CH3), 0.81 (3H, s, 29-CH3), 0.87 (3H, s, 30-CH3), 
0.90 (3H, d, J 6.0, 21-CH3), 0.98 (3H, s, 19-CH3), 1.00 (3H, s, 28-CH3)], 2.21 – 2.90 [12 H, 
m, containing (2H, m, 24-CH2), piperazine N-CH2 × 4 and N-CH2 of aminoethyl moiety 
adjacent to tertiary N, for both regioisomers], 3.23 (1H, dd, J 11.3, 4.7, 3-CH); δC (75 MHz, 
CDCl3) 15.4 (29-CH3),  15.7 (18-CH3),  18.3 (6-CH2),  18.7 (21-CH3),  19.1 (19-CH3),  21.0 
(11-CH2),  24.3 (30-CH3),  26.5 (7-CH2),  27.9 (2-CH2),  28.0 (28-CH3),  28.2 (16-CH2),  30.8 
(15-CH2),  31.0 (12-CH2),  33.7 (22-CH2),  35.6 (1-CH2),  36.3 (20-CH),  36.4 (10-quaternary 
C), 38.9 (4-quaternary C),  43.4 (CH2),  44.5 (13-quaternary C), 45.5 and 46.2 (2 × CH2 
adjacent to free NH of piperazine ring in regioisomer), 49.8 (14-quaternary C),  50.3 (5-CH or 
17-CH),  50.4 (5-CH or 17-CH),  53.3 (piperazine N-CH2 × 2),  59.3 (N-CH2 of aminoethyl 
chain, and or 24-CH2 in regioisomer 65, and or N-CH2 of aminoethyl chain in regioisomer 
64),  78.9 (3-CH),  134.3 (8-quaternary C or 9-quaternary C),  134.4 (8-quaternary C or 9-
quaternary C); m/z (ESI
+
) 514 [M + H]
+
 (40%), 74 (100); exact mass calculated for 
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C33H60N3O [M + H]
+
 514.4736, found 514.4719, for compounds 64 and 65; exact mass 
calculated for C60H104N3O2 [M + H]
+
 898.8050, found 898.8117, for dimer 66. 
3-Keto-5-4,4,14-trimethyl-24-(2-(piperazin-1-yl)ethyl)amino-chol-8-ene 67 and 3-Keto-
5-4,4,14-trimethyl-24-piperazino-N-2-aminoethyl-chol-8-ene 68 
Sodium triacetoxyborohydride (0.089 g, 0.42 
mM) was added to a solution of 3-keto-5-
4,4,14-trimethyl-chol-8-ene-24-al 29 (0.120 g, 
0.30 mM) and 1-(2-aminoethyl)piperazine (40 
L, 0.30 mM) in 1,2-dichloroethane (50 mL). 
The reaction mixture was stirred at room 
temperature for 1.5 h, after which time 
saturated aqueous sodium bicarbonate solution 
(25 mL) was added. The reaction mixture was 
extracted into ethyl acetate (50 mL) and 
washed with brine (2 × 50 mL). The organic 
extracts were then dried over magnesium 
sulfate and concentrated under reduced 
pressure to yield a mixture of the desired product 67 and regioisomer 68 in an indecipherable 
ratio, as an orange solidifying oil (0.098 g,): H (300 MHz, CDCl3) 0.60 – 1.85 [34H, m, 
containing 0.72 (3H, s, 18-CH3), 0.89 – 0.92 (9H, m, containing 21-CH3, 30-CH3), 1.07 (3H, 
s, 29-CH3), 1.09 (3H, s, 28-CH3), 1.12 (3H, s 19-CH3)], 1.86 – 2.17 (7H, m), 2.18 – 3.00 
[16H, m, containing 24-CH2, piperazine N-CH2 × 2 and N-CH2 of aminoethyl moiety]; δC (75 
MHz, CDCl3); 14.1 (CH3), 15.9 (29-CH3), 18.7 (18-CH3 or 21-CH3), 19.4 (6-CH2), 21.1 
(CH3), 21.3 (19-CH3), 24.3 (30-CH3), 26.2 (28-CH3), 26.3 (7-CH2), 28.2 (22-CH2), 29.7 (15-
CH2 or 12-CH2), 30.9 (15-CH2 or 12-CH2), 34.6 (1-CH2), 39.5 (H2N-CH2 of aminoethyl chian 
in regioisomer 68), 36.1 (2-CH2), 36.9 (4-quaternary C), 44.5 (13-quaternary C), 47.4 (10-
quaternary C), 49.9 (14-quaternary C), 51.2 (5-CH or 17-CH), 59.2 (N-CH2 of aminoethyl 
chain, and or 24-CH2 in regioisomer 68, and or N-CH2 of aminoethyl chain in regioisomer 
67), 133.2 (8-quaternary C or 9-quaternary C), 135.3 (8-quaternary C or 9-quaternary C), 
217.9 (3-quaternary C, C=O); m/z (ESI
+
) 512 [M + H]
+
 (38%), 56 (100); exact mass 
calculated for C33H58N3O [M + H]
+
 512.4580, found 512.4576, for compounds 67 and 68. 
 





m-CPBA (0.062 g, 0.36 mM), was added to a stirring 
solution of 3-acetoxy-5-4,4,14-trimethyl-24-
diethylamino-chol-8-ene 43 (0.128 g, 0.26 mM) in 
dichloromethane (20 mL). The solution was stirred at 
room temperature for 24 h.
1
 The solution was twice 
filtered by gravity through a fluted filter paper to 
remove excess m-CPBA. The organic layer was then 
washed with saturated aqueous sodium bicarbonate solution (3 × 20 mL) and brine (1 × 20 
mL). The solution was dried over magnesium sulfate, and concentrated under reduced 
pressure to yield the crude product as an orange solidifying oil (0.166 g). The crude product 
was recrystallised from ethyl acetate to yield the desired compound 69 as a light orange solid 
(0.056 g, 34%): mp 185 – 188 °C; νmax(KBr)/cm
−1
 2952, 1735; H (300 MHz, CDCl3) 0.69 
(3H, s, 18-CH3), 0.78 – 1.03 [15H, m, containing 21-CH3, 28-CH3, 29-CH3, 30-CH3, 1.00 
(3H, s, 19-CH3)], 1.05 – 1.80 (24H, m), 1.81 – 2.15 [8H, m, containing 2.05 (3H, s, OAc, 
CH3)], 3.20 – 3.40 (2H, m, 24-CH2), 3.42 – 3.57 (4H, m, diethylamine CH2 × 2), 4.50 (1H, 
dd, J 11.6 , 4.5, 3-CH); δC (75 MHz, CDCl3) 8.4 (diethylamine CH3 × 2), 15.8 (18-CH3), 16.5 
(29-CH3), 18.1 (6-CH2), 18.6 (21-CH3), 19.2 (19-CH3), 19.6 (CH2), 21.0 (11-CH2), 21.3 (23-
CH3), 24.1 (2-CH2), 24.2 (30-CH3), 27.9 (28-CH3), 28.2 (16-CH2), 30.7 (15-CH2), 31.0 (12-
CH2), 35.3 (1-CH2), 36.2 (20-CH), 36.9 (10-quaternary C), 37.8 (4-quaternary C), 44.6 (13-
quaternary C), 49.8 (14-quaternary C), 50.4 (-CH or 17-CH), 50.5 (-CH or 17-CH), 59.2, 
63.8, 70.4 (24-CH2 or either of diethylamine CH2 × 2), 80.9 (3-CH), 134.3 -quaternary C or 
9-quaternary C), 134.4 -quaternary C or 9-quaternary C), 171.0 (quaternary C, OAc, C=O); 
m/z (ESI
+
) 516 [M + H]
+
 (100%); exact mass calculated for C33H58NO3 [M + H]
+
 516.4417, 
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3-Acetoxy-5-4,4,14-trimethyl-24-piperazino-chol-8,9-epoxide-N-oxide dimer 71 
m-CPBA (0.067 g, 0.39 mM) was 
added to a solution of 3-acetoxy-
5-4,4,14-trimethyl-24-piperazino-
chol-8-ene dimer 56 (0.100 g, 0.19 
mM) in dichloromethane (50 mL). 
The reaction mixture was stirred for 
at room temperature for 24 h.
1
 The 
solution was twice filtered by 
gravity through a fluted filter paper 
to remove excess m-CPBA. The 
organic layer was then washed with 
saturated aqueous sodium bicarbonate solution (4 × 20 mL) and brine (1 × 20 mL). The 
organic extract was dried over magnesium sulphate and concentrated under reduced pressure. 
The crude material was recrystallized from the minimum volume of hot ethyl acetate to yield 
product 71 as a yellow solid (0.060 g), among other minor products: mp 155 – 156 °C; 
νmax(KBr)/cm
−1
 3435, 2954, 1736; H (300 MHz, CDCl3) 0.60 – 2.20 [47H, m, containing 
0.69 (3H, s, 18-CH3), 21-CH3, 28-CH3, 29-CH3, 30-CH3, 1.00 (3H, s, 19-CH3), 2.05 (3H, s, 
OAc, CH3)], 2.82 – 3.55 (6H, m, 24-CH2 and piperazine CH2 × 2 adjacent to N-oxide), 4.22 
(2H, br s), 4.48 (1H, dd, J 24.2, 4.3, 3-CH); δC (75 MHz, CDCl3) 15.8 (18-CH3), 16.2 (29-
CH3), 18.1 (6-CH2), 18.6 (21-CH3), 19.2 (19-CH3), 21.0 (11-CH2), 21.3 (OAc, CH3), 23.3 
(23-CH2), 24.15 (2-CH2), 24.24 (30-CH3), 26.4 (7-CH2), 27.9 (28-CH3), 28.5 (16-CH2), 30.8 
(15-CH2), 30.9 (12-CH2), 35.2 (1-CH2), 36.8 (10-quaternary C),  37.8 (4-quaternary C),  44.5 
(13-quaternary C),  49.8 (14-quaternary C),  50.2 (5-CH or 17-CH), 50.5 (5-CH or 17-CH), 
59.1 (24-CH2), 67.8 (8-quaternary C or 9-quaternary C), 70.4 (8-quaternary C or 9-quaternary 
C), 80.9 (3-CH), 171.0 (quaternary C, OAc, C=O);  
Other peaks in the 
13
C NMR spectrum indicate a mixture of minor products is present. The 
following peaks could not be accounted for in the structure of the major product: 16.24 (CH3), 
16.3 (CH2), 16.5 (CH3), 17.1 (CH3), 18.8 (CH3), 19.1 (CH2), 19.9 (CH3), 21.4 (CH2), 23.5 
(CH2), 26.8 (CH2), 28.3 (CH3), 31.8 (CH2), 32.5 (CH2), 32.8 (CH2), 36.2 (CH3), 36.3 (CH3), 
41.8 (CH3), 48.1 (CH3), 71.6 (CH2), 80.4 (CH), 134.3 (quaternary C).  
Exact mass calculated for C62H103N2O8 [M + H]
+
 1003.7714, found 1003.7683. 




m-CPBA (0.244 g, 1.45 mM) was added to a solution 
of 3-acetoxy-5-4,4,14-trimethyl-24-piperidino-
chol-8-ene 41 (0.362 g, 0.71 mM) in 
dichloromethane (100 mL). The reaction mixture 
was stirred for at room temperature for 24 h.
1
 The 
solution was twice filtered by gravity through a 
fluted filter paper to remove excess m-CPBA. The 
organic layer was then washed with saturated 
aqueous sodium bicarbonate solution (4 × 50 mL) and brine (2 × 50 mL). Several emulsions 
formed in the washing process. The organic extract was dried over magnesium sulphate and 
concentrated under reduced pressure to yield the crude product 70 (0.170 g) as an orange oil. 
Multiple recrystallisations from hexane and ethyl acetate could not remove the excess m-
CPBA in this case. The analysis described below is taken on the sample with m-CPBA 
present, as indicated by distinctive aromatic signals in the 7.30 – 8.10 ppm region of the 
1
H 
NMR spectrum.  
H (300 MHz, CDCl3) 0.50 – 2.10 [52H, m, containing 18-CH3, 19-CH3, 21-CH3, 28-CH3, 29-
CH3, 30-CH3, 2.05 (3H, s, OAc, CH3)], 2.20 – 2.40 (1H, m), 3.15 (1H, br s), 3.38 – 3.62 (1H, 
m), 3.75 (1H, br s), 4.40 – 4.55 (1H, m, 3-CH); exact mass calculated for C32H58NO4 [M + 
H]
+
 544.4366, found 544.4367. 
 
Test Reductive Amination 
3-Hydroxy-5-4,4,14-trimethyl-24-morpholino-chol-8,9-epoxide 73 
Sodium triacetoxyborohydride (0.071 g, 0.33 mM) was 
added to a solution of morpholine (21 L, 0.24 mM) 
and a sample containing ~ 30% 3-hydroxy-5-4,4,14-
trimethyl-chol-8,9-epoxide-24-al 72 (0.100 g, 0.24 mM) 
in 1,2-dichloroethane (50 mL). The reaction mixture 
was stirred at room temperature for 1.5 h, after which 
time saturated aqueous sodium bicarbonate solution (30 
mL). The reaction mixture was extracted into ethyl 
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acetate and washed with brine (2 × 40 mL). The organic extracts were then dried over 
magnesium sulfate and concentrated under reduced pressure to yield a yellow oil (0.061 g), 
consisting of numerous unidentifiable products. The crude material was not further purified. 
Characteristic signals for the desired product 73 are described below: 
νmax(KBr)/cm
−1
 3400, 2929; H (300 MHz, CDCl3) 0.60 – 4.00 [53H, m, containing 0.78 (3H, 
s, 18-CH3), 19-CH3, 21-CH3, 26-CH3, 27-CH3, 28-CH3, 29-CH3, 30-CH3, 24-CH2, 3.21 (1H, 
dd, J 11.2, 4.2, 3-CH), 3.82 (4H, br s, morpholine CH2 × 2)]; δC (75 MHz, CDCl3) 15.1 (29-
CH3), 16.3 (18-CH3), 16.5 (6-CH2), 17.0 (19-CH3), 19.9 (30-CH3), 21.5 (11-CH2), 23.5 (2-
CH2), 26.9 (12-CH2), 27.1 (CH2), 28.25 (28-CH3), 28.32 (CH2), 28.4 (16-CH2), 29.7 (CH2), 
31.9 (15-CH2), 32.9 (1-CH2), 36.0 (20-CH), 37.8 (4-quaternary C), 38.5 (10-quaternary C), 
41.8 (5-CH), 43.6 (13-quaternary C), 48.1 (17-CH), 48.9 (14-quaternary C), 52.6 (morpholine 
N-CH2 × 2), 65.6 (morpholine O-CH2 × 2), 68.1 (8-quaternary C), 70.7 (9-quaternary C), 78.5 
(3-CH); m/z (ESI
+
) 488 [M + H]
+
 (100%); exact mass calculated for C31H54NO3 [M + H]
+
 
488.4104, found 488.4103.  
 
Attempted Reductive Aminations 
3-Hydroxy-5-4,4,14-trimethyl-24-oxazolodinone-chol-8-ene 53 
Sodium triacetoxyborohydride (0.126 g, 0.59 mM) 
was added to a solution of 3-hydroxy-5-4,4,14-
trimethyl-chol-8-ene-24-al 25 (0.170 g, 0.42 mM) and 
oxazolodinone (0.037 g, 0.42 mM) in 1,2-
dichloroethane (30 mL). The reaction mixture was 
stirred at room temperature for 1.5 h, after which time 
saturated aqueous sodium bicarbonate solution (15 
mL). The reaction mixture was extracted into ethyl acetate and washed with brine (2 × 20 
mL). The organic extracts were then dried over magnesium sulfate and concentrated under 
reduced pressure to yield the crude product as a white solid (0.168 g). By inspection of the 
1
H 
NMR spectrum, the crude product consisted of 75% starting aldehyde 25 with trace (3%) 
oxazolodinone signals at 3.64 and 4.45 ppm, and no unambiguous evidence of product 
formation.  
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The reaction was repeated, using the crude material from the first attempt, however, with the 
reaction time increased to 24 h. In this case, the product consisted of 55% starting aldehyde 
25, with no increase in oxazolodinone signals.  
 
3-Acetoxy-5-4,4,14-trimethyl-24-dicyclohexylamino-chol-8-ene 51 
Sodium triacetoxyborohydride (0.100 g, 0.47 
mM) was added to a solution of 3-acetoxy-5-
4,4,14-trimethyl-chol-8-ene-24-al 21 (0.150 g, 
0.34 mM) and dicyclohexylamine (68 L, 0.34 
mM) in 1,2-dichloroethane (20 mL). The 
reaction mixture was stirred at room 
temperature for 1.5 h, after which time saturated 
aqueous sodium bicarbonate solution (20 mL) 
was added. The reaction mixture was extracted into ethyl acetate (30 mL) and washed with 
brine (2 × 20 mL). The organic extracts were then dried over magnesium sulfate and 
concentrated under reduced pressure to yield a mixture of the desired product 51 and both 
aldehyde 21 (25%) and amine starting materials.  
The reaction was repeated using 1.5 equivalents of dicyclohexylamine and a reaction time of 
3 h in an attempt to consume all of the aldehyde starting material. In this case, an increase in 
aldehyde consumption was observed, with 14% aldehyde remaining, as indicated by the 
signal at 9.77 ppm in the 
1
H NMR spectrum of the product. However, the product contained 
significant amounts of dicyclohexylamine, as indicated in the 
13
C NMR spectrum.  
H (300 MHz, CDCl3) 0.69 (3H, s, 18-CH3), 0.80 – 2.15 [60H, m, containing 18-CH3, 19-
CH3, 21-CH3, 28-CH3, 29-CH3, 30-CH3, 2.04 (3H, s, OAc, CH3)], 2.30 – 2.61 (8H, m), 4.50 
(1H, dd, J 11.6, 4.5, 3-CH); δC (75 MHz, CDCl3) 15.7 (18-CH3), 16.5 (29-CH3), 18.1 (6-
CH2), 18.8 (21-CH3), 19.2 (19-CH3), 21.0 (11-CH2), 21.3 (OAc, CH3), 24.16 (2-CH2), 24.22 
(30-CH3), 26.4 (7-CH2), 26.5 (CH2), 27.9 (28-CH3), 28.1 (16-CH2), 28.4 (CH2), 30.8 (15-
CH2), 31.0 (12-CH2), 31.6 (CH2), 31.7 (CH2), 33.8 (22-CH2), 35.3 (1-CH2), 36.3 (20-CH), 
36.8 (10-quaternary C), 37.8 (4-quaternary C), 44.4 (13-quaternary C), 47.0 (CH2), 49.8 (14-
quaternary C), 50.5 (5-CH or 17-CH), 58.0 (CH), 80.9 (3-CH), 134.2 (8-quaternary C or 9-
quaternary C), 134.5 (8-quaternary C or 9-quaternary C), 170.9 (quaternary C, OAc, C=O); 





) 608 [M + H]
+
 (21 %), 182 (100); exact mass calculated for C41H70NO2 [M + H]
+
 
608.5407, found 608.5410. 
The following peaks in the 
13
C NMR spectrum are attributable to excess dicyclohexylamine: 
25.3, 26.2, 34.3, 53.0.  
3-Acetoxy-5-4,4,14-trimethyl-24-diisopropylamino-chol-8-ene 52 
Sodium triacetoxyborohydride (0.67 g, 0.32 mM) 
was added to a solution of 3-acetoxy-5-4,4,14-
trimethyl-chol-8-ene-24-al 21 (0.100 g, 0.23 mM) 
and diisopropylamine (32 L, 0.23 mM) in 1,2-
dichloroethane (20 mL). The reaction mixture was 
stirred at room temperature for 1.5 h, after which 
time saturated aqueous sodium bicarbonate solution 
(20 mL) was added. The reaction mixture was extracted into ethyl acetate (30 mL) and 
washed with brine (2 × 20 mL). The organic extracts were then dried over magnesium sulfate 
and concentrated under reduced pressure to yield the crude product as a black solidifying oil 




Attempted Synthesis of 3-tetra-O-acetyl--D-glucopyranose-5-4,4,14-trimethyl-24-
piperadino-chol-8-ene 74 
Triethylamine (0.004 g, 0.04 mM) in 
dichloromethane (20 mL) was added to a 
mixture of penta-O-acetyl--D-
glucopyranose (0.027 g, 0.07 mM) and 
3-hydroxy-5-4,4,14-trimethyl-24-
piperadino-chol-8-ene 42 (0.050 g, 0.11 
mM) under a nitrogen atmosphere. Boron 
trifluoride diethyl etherate (0.025 g, 22 
L, 0.18 mM) in dichloromethane (5 mL) was then added to the reaction solution. The 
additions took place over a 30 minute period.
30,31
 The reaction mixture was stirred at room 
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temperature for 24 h. Saturated aqueous sodium bicarbonate (20 mL) was added to the 
reaction mixture, and the reaction mixture was then extracted with ethyl acetate (2 × 30 mL). 
The organic layer was dried over magnesium sulfate and concentrated under reduced pressure 
to yield the crude product as a dark orange solid (0.080 g). Analysis of the 
1
H NMR spectrum 
of the crude material, in conjunction with the 
1
H NMR spectra of the starting alcohol and 
sugar, showed that a mixture of the two starting materials was present, with no evidence of 
the desired glycosylation product 74 having been formed. Characteristic signals for the 
mixture of starting materials are described below: 
νmax(KBr)/cm
−1
 3372 (OH of 42). 
H (300 MHz, CDCl3) 2.02, 2.038, 2.039, 2.09, 2.12 (5 × OAc, CH3 of penta-O-acetyl--D-
glucopyranose), 3.23 (1H, dd, J 11.5, 4.54, 3-CH of 42), 5.72 (1H, d, J 8.3, 1-CH of penta-O-
acetyl--D-glucopyranose). 
δC (75 MHz, CDCl3) 78.9 (3-CH of 42), 168.9, 169.2, 169.4, 170.1, 170.6 (5 × quaternary C, 
C=O, of penta-O-acetyl--D-glucopyranose) 
 
Method B: 
1-Bromo-1-deoxy-2,3,4,6-tetra-O-acetyl--D-glucose (0.066 g, 0.16 mM) was dissolved in 
acetonitrile (15 mL) with 3-hydroxy-5-4,4,14-trimethyl-24-piperadino-chol-8-ene 42 
(0.050, 0.11 mM) and 4 Å molecular sieves. The solution was cooled to 0 °C using an ice 
bath. Silver oxide (0.037 g, 0.16 mM) was added to the stirring solution in the dark. The 




 The bed of 
Celite 
®
 was washed with acetonitrile (3 × 30 mL), and the solvent was removed under 
reduced pressure. Analysis of the 
1
H NMR spectrum of the crude material, in conjunction 
with the 
1
H NMR spectra of the starting alcohol and sugar, showed that a mixture of the two 
starting materials was present, with no evidence of the desired glycosylation product 74 
having been formed. Characteristic signals for the mixture of starting materials are described 
below: 
H (300 MHz, CDCl3) 2.04, 2.06, 2.10, 2.11 (4 × OAc, CH3 of 1-bromo-1-deoxy-2,3,4,6-
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3.4 Stigmasterol Chemistry 
 
Attempted Selective Epoxidation 
Stigmasterol 22-23 epoxide
32
 76a and 76b 
Stigmasterol 9 (0.050 g, 0.12 mM) was dissolved in 
dichloromethane (50 mL). m-CPBA (0.028 g, 0.16 
mM) and sodium bicarbonate (0.021 g, 0.25 mM) 
powders were mixed together. Half of this mixture 
was added to the stirring stigmasterol solution at 
room temperature, and the second half was added at 0 
°C over two 10 min periods respectively. The reaction 
mixture was then stirred for 3 h. The reaction mixture was filtered, washed with 10% sodium 
bicarbonate (4 × 20 mL) followed by brine (1 × 20 mL) and dried over magnesium sulfate to 
yield the crude product as a white solid (0.041 g). The crude material consisted of 30% 
starting material 9, 60% product 77a and 10% product 77b, with no evidence of the formation 
of desired product 76a and 76b. Purification by column chromatography using hexane : ethyl 
acetate (90:10) led to the isolation of starting material stigmasterol 9 (0.010 g,) as the first 
fraction from the column. The second fraction from the column was a mixture of epoxides 





H (300 MHz, CDCl3) 0.63 (3H, s, 18-CH3), 0.71 – 0.89 
[9H, m, containing 26-CH3, 27-CH3 and 29-CH3], 0.90 
– 1.75 [37H, m, containing 1.00 (3H, d, J 6.6, 21-CH3), 
1.06 (19-CH3)], 1.77 – 2.18 (5H, m), 2.90 (1H, d, J 4.4, 
6-CH), 3.83 – 3.99 (1H, m, 3-CH), 5.00 (1H, dd, J 15.2, 
8.6, one of 22-CH or 23-CH), 5.14 (1H, dd, J 15.2, 8.6, 
one of 22-CH or 23-CH). 
 






H (300 MHz, CDCl3) 0.71 – 0.89 [9H, m, containing 
0.78 (3H, s, 18-CH3), 26-CH3, 27-CH3 and 29-CH3], 
0.90 – 1.75 [37H, m, containing 1.00 (3H, d, J 6.6, 21-
CH3)], 1.77 – 2.18 (5H, m), 3.05 (1H, d, J 2.2, 6-CH), 
3.67 – 3.78 (1H, m, 3-CH), 5.00 (1H, dd, J 15.2, 8.6, 
one of 22-CH or 23-CH), 5.14 (1H, dd, J 15.2, 8.6, one 






Stigmasterol 9 (0.100 g, 0.24 mM) was dissolved in dichloromethane (100 mL) and m-CPBA 
(0.155 g, 0.90 mM) was added at 0 °C. The reaction solution was allowed to warm to room 
temperature and stirred for 48 h. The reaction mixture was filtered and washed with 10% 
sodium bicarbonate (4 × 50 mL) and brine (1 × 50 mL). The organic solution was dried over 
magnesium sulfate and concentrated under reduced pressure to yield the crude product as a 
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white solid (0.136 g) which contained residual m-CPBA but was not further purified. 
Analysis of the 
1
H NMR spectrum of the product shows the following ratio of the four 
diastereomers: 39a: 39b: 39c: 39d 3.7: 3.7: 1: 1. 
Isomers 39a and 39b: H (300 MHz, CDCl3) 0.55 – 2.18 [42H, m, containing 0.61 (3H, m, 18-
CH3), 26-CH3, 27-CH3, 29-CH3, 21-CH3, 1.05 (3H, s, 19-CH3)], 2.45 – 2.55 (3H, m, 22(R)-
CH, 22(S)-CH, one of 23-CH), 2.72 – 2.77 (1H, m, one of 23-CH), 2.92 (1H, d, J 4.3, 6-CH), 
3.87 – 3.98 (1H, m, 3-CH). 
 
Isomers 39c and 39d, distinguishable signals: H (300 MHz, CDCl3) 2.45 – 2.55 (3H, m, 
22(R)-CH, 22(S)-CH, one of 23-CH), 2.72 – 2.77 (1H, m, one of 23-CH), 3.08 (1H, d, J 1.9, 
6-CH), 3.66 – 3.77 (1H, m, 3-CH). 
 
Attempted synthesis of 3-hydroxy-5,6-epoxy-20(S)-methyl-pregnane-21-al 78 
Diepoxide 39, containing residual m-CPBA from the previous 
reaction, (0.136 g, 0.31 mM) was added to ground periodic 
acid (0.100 g, 0.44 mM) in dry ether (40 mL). The solution 
was stirred at 25 °C for 10 min, after which time water (20 
mL) was added and the ether layer was separated. The ether 
layer was washed with water (2 × 20 mL) and brine (1 × 20 mL), dried over magnesium 
sulfate and concentrated under reduced pressure
12
 to yield the crude product (0.132 g). 
Analysis of the 
1
H NMR spectrum of the crude material showed no formation of the desired 
product 78, given that the C-22,23 epoxide signals at 2.45 – 2.55 and 2.72 – 2.77 ppm were 
still present. The C-5,6 epoxide signals at 2.92 and 3.08 ppm diminished by ~ 80%, while 
there was evidence of an aldehyde formation due to a new broad singlet at 9.62 ppm, 
accounting for ~ 5%. There is also evidence of unidentified products in 
1
H NMR spectrum, 
due to new signals at 3.55 and 4.13 ppm.  
The reaction was repeated using the crude material from the previous attempt. In this 
instance, 2.86 equivalents of periodic acid were used and the reaction time was increased to 2 
h. All other procedures remained identical and 0.127 g crude product was retrieved. Analysis 
of the 
1
H NMR spectrum of the crude material showed no formation of the desired product 
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78, given that the C-22,23 epoxide signals at 2.45 – 2.55 and 2.72 – 2.77 ppm were still 
present. The C-5,6 epoxide had been consumed in the reaction and two new aldehyde signals 
at 9.62 and 9.71 ppm were observed. The crude mixture was purified by column 
chromatography using hexane : ethyl acetate 90:10 eluent, which led to the isolation of two 
products. 
 
Stigmasterol 22,23-epoxy-5-ol-6-al 79a and 79b 
The first product isolated from the column is being 
tentatively assigned as 79. Characteristic signals for the 




C NMR spectra are 
listed below: 
H (300 MHz, CDCl3) 2.45 – 2.55 (3H, m, 22-CHR, 22-
CHS, one of 23-CH), 2.72 – 2.77 (1H, m, one of 23-
CH), 3.49 (1H, d, J 9.5, 5-OH), 4.08 – 4.20 (1H, m, 3-CH), 9.71 (1H, t, J 2.8, 6-CH). δC (300 
MHz, CDCl3) 204.5 (aldehyde CH) 
 
Stigmasterol 22,23-epoxy-5-one-6-al 80a and 80b 
The second product isolated from the column is being 
tentatively assigned as 80. Characteristic signals for the 




C NMR spectra are 
listed below: 
H (300 MHz, CDCl3) 2.45 – 2.55 (3H, m, 22-CHR, 22-
CHS, one of 23-CH), 2.72 – 2.77 (1H, m, one of 23-
CH), 3.11 (1H, apparent dt, J 13.7, 3.8, 2-CH2), 9.62 (1H, br s, 6-CH); δC (300 MHz, CDCl3) 










A solution of stigmasterol 9 (1.850 g, 4.48 
mM), 4-DMAP (0.054 g, 0.45 mM), and p-
toluenesulfonyl chloride (1.614 g, 8.46 mM) 
in pyridine (18.5 mL) was stirred at room 
temperature for 22 h. The reaction mixture 
was poured into 10% aqueous sodium 
bicarbonate (74 mL), and the precipitate was 
filtered by suction. The resulting solid was washed with water (40 mL) and recrystallised 
from acetone to give the desired tosylate 81 as a white solid (1.930 g, 76%), mp 144 – 145 °C 
(literature,
33
 142 – 144 °C); νmax(KBr)/cm
−1
 2957, 1664, 1191, 943; H (300 MHz, CDCl3) 
0.68 (3H, s, 18-CH3), 0.77 – 1.35 [24H, m,  containing 26-CH3, 27-CH3 and 29-CH3, 1.00 
(3H, s, 19-CH3), 1.02 (3H, d, J 6.6, 21-CH3)], 1.36 – 1.60 (9H, m), 1.62 – 1.87 (4H, m), 1.88 
– 2.10 (3H, m), 2.21 – 2.32 (1H, m), 2.35 – 2.50 [4H, m, containing 2.45 (3H, s, Ar, CH3)], 
4.24 – 4.38 (1H, m, 3-CH), 5.01 (1H, dd, J 15.2, 8.6, one of 22-CH or 23-CH), 5.15 (1H, 
dd, J 15.2, 8.5, one of 22-CH or 23-CH), 5.30 (1H, d, J 4.8, 6-CH), 7.33 (2H, d, J 8.0, ArH), 
7.80 (2H, d, J 8.3, ArH); δC (75 MHz, CDCl3) 12.0 (29-CH3), 12.2 (18-CH3), 19.0 (19-CH3), 
19.1 (27-CH3), 21.0 (11-CH2), 21.1 (26-CH3 or Ts, CH3), 21.2 (26-CH3 or Ts, CH3), 21.6 (21-
CH3), 24.3 (15-CH2), 25.4 (28-CH2), 28.7 (CH2), 28.9 (CH2), 31.76 (8-CH), 31.84 (7-CH2), 
31.9 (CH), 36.4 (10-quaternary C), 36.9 (CH2), 38.9 (CH2), 39.6 (12-CH2), 40.5 (20-CH), 
42.2 (4-quaternary C), 50.0 (9-CH), 51.2 (CH), 55.9 (17-CH), 56.8 (14-CH), 82.4 (3-CH), 
123.5 (6-CH), 127.6 (Ar-CH × 2), 129.3 (23-CH), 129.7 (Ar-CH × 2), 134.8 (Ar-quaternary 





Tosylate 81 (1.542 g, 2.27 mM), and pyridine (0.70 mL, 8.22 
mM) were dissolved in anhydrous methanol (37.5 mL) and 
heated under reflux for 6 h. The solution was evaporated, 
extracted into ethyl acetate (35 mL) and washed with water 
(2 × 50 mL). The organic layer was washed with brine (1 × 
50 mL), dried over magnesium sulfate and concentrated 
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under reduced pressure to give the crude product as a yellow oily solid, as a mixture (4.15:1) 
of i-stigmasterol methyl ether 82 and stigmasterol methyl ether 83 (0.902 g). Purification by 
column chromatography using 98:2 hexane : ethyl acetate yielded the desired compound 82 





 2955, 1456; H (300 MHz, CDCl3) 0.43 (1H, dd, J 8.0, 5.1, 3-CH), 0.61 – 
0.67 (1H, m), 0.74 (3H, s, 18-CH3), 0.75 – 0.94 (12H, m, containing 26-CH3, 27-CH3 and 29-
CH3), 0.96 – 1.33 (13H, m, containing 19-CH3 and 21-CH3), 1.34 – 1.63 (8H, m), 1.64 – 1.83 
(3H, m), 1.84 – 2.12 (3H, m), 2.76 (1H, t, J 2.6, 6-CH), 3.32 (3H, s, OMe, CH3), 5.01 (1H, 
dd, J 15.1, 8.7, one of 22-CH or 23-CH), 5.15 (1H, dd, J 15.1, 8.6, one of 22-CH or 23-CH); 
δC (75 MHz, CDCl3) 12.3 (CH3), 12.4 (CH3), 13.1 (CH2), 19.0 (CH3), 19.3 (CH3), 21.1 (CH3), 
21.2 (CH3), 21.5 (CH), 22.8 (CH2), 24.3 (15-CH2), 25.0 (CH2), 25.4 (28-CH2), 29.0 (CH2), 
30.5 (CH), 31.9 (CH), 33.4 (CH2), 35.2 (CH2), 35.3 (10-quaternary C), 40.3 (CH2), 40.6 (20-
CH), 42.7 (quaternary C), 43.4 (quaternary C), 48.1 (CH), 51.3 (CH), 56.2 (17-CH), 56.55 
(OMe, CH3), 56.61 (14-CH), 82.4 (CH), 129.2 (23-CH), 138.4 (22-CH). 
 
The second fraction from the column was side product stigmasterol methyl ether 83, retrieved 







 2938, 1460, 1105; H (300 MHz, CDCl3) 
0.70 (3H, s, 18-CH3), 0.74 – 1.34 [24H, m, containing 
1.00 (3H, s, 19-CH3), 1.02 (3H, d, J 6.6, 21-CH3), 26-
CH3, 27-CH3, and 29-CH3], 1.35 – 1.62 (10H, m), 1.63 
– 1.80 (1H, m), 1.81 – 2.24 (6H, m), 2.39 (1H, ddd, J 
13.2, 4.7, 2.2), 2.98 – 3.13(1H, m, 3-CH ), 3.35 (3H, s, 
OMe, CH3), 5.02 (1H, dd J 15.2, 8.5, one of 22-CH or 23-CH), 5.16 (1H, dd, J 15.2, 8.4, one 
of 22-CH or 23-CH), 5.35 (1H, d, J 5.3 6-CH). δC (75 MHz, CDCl3) 12.1 (29-CH3), 12.3 (18-
CH3), 19.0 (19-CH3), 19.4 (27-CH3), 21.06 (11-CH2), 21.10 (26-CH3 or 21-CH3), 21.2 (26-
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CH3 or 21-CH3), 24.4 (15-CH2), 25.4 (28-CH2), 28.0 (CH2), 28.9 (CH2), 31.88 (8-CH), 31.94 
(7-CH2), 36.9 (10-quaternary C), 37.2 (CH2), 38.7 (CH2), 39.7 (12-CH2), 40.5 (20-CH), 42.2 
(4-quaternary C), 50.2 (9-CH), 51.2 (CH), 55.6 (OMe, CH3), 55.9 (17-CH), 56.9 (14-CH), 





i-Stigmasterol methyl ether 82 (0.500 g, 1.17 mM) was dissolved 
in dichloromethane (37 mL) in a 100 mL Shlenck tube. The inlet 
of the Shlenck tube was connected, via rubber tubing, to an ozone 
generator. The outlet was connected in series to two dreschel 
bottles containing 10% potassium iodide in water solution (100 
mL and 50 mL respectively). The solution was cooled to −78 °C 
using acetone and liquid nitrogen. A stream of oxygen was allowed to pass through the 
apparatus for 5 min to ensure there were no leakages. The ozone generator was switched on 
and ozone was allowed to pass through the substrate for 40 min. Upon reaction completion, 
excess ozone was removed by passing a stream of oxygen through the apparatus for 5 min. 
Excess triphenylphosphine was added to the Shlenck tube and was allowed to stir with the 
reaction solution overnight. An aliquot of the reaction solution was concentrated under 
reduced pressure and 
1
H NMR analysis was obtained on this material. The 
1
H NMR spectrum 
of the crude product showed only peaks in the aromatic region, owing to the vast excess of 
triphenyl phosphine oxide present. The remainder of the reaction solution was transferred 
onto celite, and concentrated under reduced pressure. Purification required repeated column 
chromatography using gradient hexane to 98:2 hexane : ethyl acetate, in order to remove 
excess triphenylphosphine oxide, and yielded the desired product 85 as a white solid (0.314 g, 
54%): νmax(KBr)/cm
−1
 2930, 1726; H (300 MHz, CDCl3) 0.43 (1H, dd, J 8.0, 5.1), 0.63 – 
0.68 (1H, m), 0.77 (3H, s, 18-CH3), 0.82 – 0.98 (7H, m), 1.02 – 2.05 [19H, m, containing 
1.03 (3H, s, 19-CH3) and 1.13 (3H, d, J 6.8, 21-CH3)], 2.32 – 2.45 (1H, m, 20-CH), 2.78 (1H, 
t, J 2.8, 6-CH), 3.33 (3H, s, OMe, CH3), 9.58 (1H, d, J 3.2, 22-CH); δC (75 MHz, CDCl3) 
12.6 (CH3), 13.1 (CH2), 13.4 (CH3), 19.3 (CH3), 21.5 (CH), 22.7 (CH2), 24.6 (CH2), 24.9 
(CH2), 27.1 (CH2), 30.5 (CH), 33.4 (CH2), 35.1 (CH2), 40.0 (CH2), 43.39 (quaternary C), 
43.41 (quaternary C), 48.0 (CH), 49.5 (CH), 51.2 (CH), 55.8 (CH), 56.6 (OMe, CH3), 82.3 
(CH), 205.3 (22-CH). 
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i-Stigmasterol methyl ether 22,23 epoxide
32
 84a and 84b 
i-Stigmasterol methyl ether 82 (0.255 g, 0.60 mM) was 
dissolved in dichloromethane (150 mL) and m-CPBA (0.103 
g, 0.60 mM) was added at 0 °C. The reaction solution was 
allowed to warm to room temperature and stirred for 6 h. 
The reaction mixture was filtered and washed with 10% 
sodium bicarbonate (4 × 50 mL) and brine (1 × 50 mL). The 
organic solution was dried over magnesium sulfate and 
concentrated under reduced pressure to yield the crude product (0.270 g) as a pale yellow 
solid. Purification by column chromatography using hexane : ethyl acetate (95:5) yielded the 
desired compounds 84a and 84b as a white solid (0.175 g, 66%). The analysis described 
below pertains to the mixture of  and  epoxides in a 1:1 ratio, which were inseparable: mp 
184 – 185 °C (literature,
32
 186 – 188); H (300 MHz, CDCl3) 0.40 – 0.47 (2H, m, 3-CH for 
both diastereomers), 0.61 – 0.68 (2H, m), 0.715 and 0.722 (3H, s, 18-CH3 of  and 
diastereomers), 0.75 – 2.03 [78H, m, containing 0.93 (6H, d, J 6.9, 26-CH3 and 27-CH3), 
1.02 (3H, s, 19-CH3), 21-CH3 and 29-CH3 for both diastereoisomers], 2.43 – 2.54 (3H, m, 22-
CHR, 22-CHS, 23-CH of one diastereomer), 2.70 – 2.80 (3H, m, 23-CH of one diastereomer, 
6-CH for both diastereomers), 3.32 (3H, s, OMe, CH3 of one diastereomer), 3.33 (3H, s, 
OMe, CH3 of one diastereomer); δC (75 MHz, CDCl3) 12.24 (CH3), 12.38 (CH3), 12.46 
(CH3), 16.13 (CH3), 16.27 (CH3), 19.27 (CH3), 19.31 (CH3), 19.36 (CH3), 19.44 (CH3), 19.60 
(CH3), 20.18 (CH3), 20.89 (CH2), 20.94 (CH2), 21.44 (CH), 21.56 (CH), 22.72 (CH2), 22.77 
(CH2), 24.43 (CH2), 24.44 (CH2), 24.95 (CH2), 24.98 (CH2), 27.20 (CH2), 28.02 (CH2), 29.14 
(CH), 29.32 (CH), 30.47 (CH), 30.52 (CH), 33.35 (CH2), 33.36 (CH2), 34.94 (CH2), 35.12 
(CH2), 35.20 (quaternary C), 35.36 (quaternary C), 38.64 (CH), 38.92 (CH), 40.06 (CH2), 
40.18 (CH2), 43.08 (quaternary C), 43.13 (quaternary C), 43.38 (quaternary C), 43.39 
(quaternary C), 48.01 (CH), 48.07 (CH), 48.30 (CH), 48.79 (CH), 53.60 (CH), 56.09 (CH), 
56.14 (CH), 56.20 (CH), 56.57 (OMe, CH3 of one diastereomer), 56.59 (OMe, CH3 of one 
diastereomer), 58.55 (23-CH of one diastereomer), 62.07 (CH), 62.17 (23-CH of one 
diastereomer), 63.18 (22-CH for both diastereomers), 82.36 (6-CH of one diastereomer), 
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Attempted synthesis of 20(S)-methyl-6(R)-methoxy-3,5-cyclo-pregnane-21-al 85  
Periodic acid (0.044 g, 0.19 mM) was added to a stirring solution 
of epoxides 84a and 84b (0.030 g, 0.07 mM) in diethyl ether (20 
mL). The resulting solution was stirred for 3 h at 25 °C and 
monitored by TLC analysis. Upon reaction completion, the 
solution was cooled to room temperature and water (20 mL) was 
added. The organic layer was separated and washed with water (2 
× 50 mL) and brine (1 × 50 mL). The organic component was dried over magnesium sulfate 
and concentrated under reduced pressure
12
 to yield the crude product as an off white solid 
(0.035 g). Analysis of the 
1
H NMR spectrum of the crude product showed no evidence of the 
formation of the desired aldehyde. Purification by column chromatography using gradient 
elution 90:10 to 80:20 hexane : ethyl acetate led to the isolation of 76a and 76b as a white 
solid in a 1:1 ratio (0.020 g, 67%). 
1
H NMR analysis described below: 
22,23-Epoxy-stigmasterol 
32
 76a and 76b 
H (300 MHz, CDCl3) 0.69 (3H, s, 18-CH3), 0.80 – 1.73 
[38H, m, containing 21-CH3, 19-CH3, 26-CH3, 27-CH3, 
and 29-CH3], 1.76 – 2.11 (6H, m), 2.19 – 2.37 (2H, m), 
2.46 – 2.54 (1H, m, one of 22-CH R or S, or 23-CH R or 
S), 2.74 (1H, dd, J 7.1, 2.3, one of 22-CH R or S, or 23-






Periodic acid (0.190 g, 0.83 mM) was added to a stirring 
solution of aldehyde 85 (0.100 g, 0.29 mM) in diethyl ether 
(50 mL). The resulting solution was stirred for 3 h at 25 °C 
and monitored by TLC analysis. Upon reaction completion, 
the solution was cooled to room temperature and water (20 
mL) was added. The organic layer was separated and washed with water (2 × 50 mL) and 
brine (1 × 50 mL). The organic component was dried over magnesium sulfate and 
concentrated under reduced pressure to yield the crude product 75 as an off white solid (0.076 
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g, 79%); mp 140 – 145 °C (literature,
34
 142 – 143 °C); νmax(KBr)/cm
−1
 3435, 2925, 1720; H 
(300 MHz, CDCl3) 0.60 – 2.45 [31H, m, containing (0.73, 3H, s, 18-CH3), 1.02 (3H, s, 19-
CH3), 1.13 (3H, d, J 6.9, 21-CH3) and 20-CH], 3.46 – 3.59 (1H, m, 3-CH), 5.35 (1H, d, J 5.3, 
6-CH), 9.57 (1H, d, J 3.3, 22-CH); δC (75 MHz, CDCl3) 11.2 (CH3), 12.4 (CH3), 18.4 (CH3), 
20.0 (CH2), 23.6 (CH2), 26.0 (CH2), 28.7 (CH2), 30.6 (CH2), 30.8 (CH2), 30.9 (CH), 30.9 
(quaternary C), 35.5 (quaternary C), 36.2 (CH2), 38.5 (CH2), 41.3 (CH2), 48.5 (CH), 49.1 
(CH), 50.0 (CH), 55.0 (CH), 70.7 (3-CH), 120.5 (6-CH), 139.8 (5-quaternary C), 204.1 (24-
CH); exact mass calculated for C22H35O2 [M + H]
+
 331.2637, found 331.2626.  
 
Method B:  
Epoxide 76 (0.018 g, 0.02 mM) was stirred in diethyl ether (10 mL). Periodic acid (0.027 g, 
0.12 mM) was added and the reaction mixture was stirred at a gentle reflux for 6 h and room 
temperature for a further 16 h. Water (20 mL) was added. The organic layer was separated 
and washed with water (2 × 50 mL) and brine (1 × 50 mL). The organic component was dried 
over magnesium sulfate and concentrated under reduced pressure
12
 to yield the crude product 
as an off white oily solid (0.016 g). Analysis of the 
1
H NMR spectrum of the crude material 
showed no indication of formation of the desired aldehyde 75, and only starting material 76 




Sodium periodate (0.016 g, 0.07 mM) was stirred for 5 min in a 2:1 mixture of 
tetrahydrofuran and water. Epoxide 76 (0.016 g, 0.04 mM) was added and the reaction was 
stirred at room temperature until the starting material appeared to have been consumed, as 
indicated by TLC analysis. The reaction mixture was filtered and washed with diethyl ether 
(20 mL). The water layer was separated and washed with diethyl ether (2 × 10 mL). The 
combined ether extracts were washed with water (2 × 20 mL), followed by brine (20 mL). 
The organic layer was dried over magnesium sulfate and concentrated under reduced pressure 
to yield an off white oily solid (0.010 g). Inspection of the 
1
H NMR spectrum of the crude 
material showed peaks characteristic of the starting material 76. The aqueous layer was 
concentrated under reduced pressure, however, no evidence of product formation was present. 
The aqueous layer was then extracted with dichloromethane and chloroform respectively, 
with no evidence of product formation.  






Sodium periodate (0.017 g, 0.08 mM) was stirred for 5 min in a 4:1 mixture of acetonitrile 
and water. Epoxide 76 (0.009 g, 0.02 mM) was added and the reaction was stirred at room 
temperature for 6 h. The reaction mixture was filtered and washed with diethyl ether (10 mL). 
The water layer was separated and washed with diethyl ether (2 × 5 mL). The combined ether 
extracts were washed with water (2 × 10 mL), followed by brine (10 mL). The organic layer 
was dried over magnesium sulfate and concentrated under reduced pressure to yield an off 
white oily solid (0.006 g). Inspection of the 
1
H NMR spectrum of the crude material showed 
peaks characteristic of the starting material 76, with no evidence of product formation. 
 
20(S)-Methyl-6(R)-methoxy-3,5-cyclo-21-morpholio-pregnane 86 
Sodium triacetoxyborohydride (0.022 g, 0.07 mM) was added to 
a solution of 20(S)-methyl-6(R)-methoxy-3,5-cyclo-pregnane-21-
al 85 (0.025 g, 0.10 mM) and morpholine (6 L, 0.07 mM) in 
1,2-dichloroethane (10 mL).  The reaction mixture was stirred at 
room temperature for 1.5 h, after which time saturated aqueous 
sodium bicarbonate solution (10 mL) was added. The reaction 
mixture was extracted into ethyl acetate (10 mL) and washed 
with brine (2 × 10 mL). The organic extracts were then dried 
over magnesium sulfate and concentrated under reduced pressure to yield the crude product 
as an off white solid with 60% conversion. The product was purified by column 
chromatography using 85:15 ethyl acetate : ether to yield the desired product 86 as a white 
solid (0.013 g, 43%): mp 162 – 164 °C; νmax(KBr)/cm
−1
 2930, 1119, 1099; H (300 MHz, 
CDCl3) 0.43 (1H dd, J 8.0, 5.1, 3-CH), 0.61 – 0.67 (1H, m), 0.74 (3H, s, 18-CH3), 0.78 – 2.10 
[40H, m, containing 1.00 (3H, d, J 6.5, 21-CH3), 1.02 (3H, s, 19-CH3), 2.02 (1H, dt, J 12.5, 
3.0, 1 hydrogen of 22-CH2)], 2.14 – 2.32 (3H, m, containing 2 hydrogens of N-CH2 and 1 
hydrogen of 22-CH2), 2.42 – 2.55 (2H, m, 2 hydrogens of N-CH2), 2.77 (1H, t J 2.7, 6-CH), 
3.33 (3H, s, OMe, CH3), 3.60 – 3.77 (4H, m, morpholine O-CH2 × 2); δC (75 MHz, CDCl3) 
12.4 (CH3), 13.1 (CH2), 17.9 (CH3), 19.3 (CH3), 21.5 (CH), 22.8 (CH2), 24.3 (CH2), 25.0 
(CH2), 28.3 (CH2), 29.7 (CH2), 30.5 (CH), 33.4 (CH2), 33.8 (CH), 35.1 (CH2), 40.2 (CH2), 
43.2 (quaternary C), 43.4 (quaternary C), 48.1 (CH), 54.3 (CH2), 55.4 (CH), 56.3 (CH), 56.6 
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(OMe, CH3), 65.2 (CH2), 67.2 (CH2), 82.4 (CH); exact mass calculated for C27H46NO2 [M + 
H]
+
 416.3529, found 416.3535. 
 
For reductive aminations in this section: Procedure as per Abdel-Magid reference.
25




Attempted synthesis of 3-hydroxy-20(S)-methyl-21-morpholino-pregnan-5-ene 94 by 
deprotection of 20(S)-methyl-6(R)-methoxy-3,5-cyclo-21-morpholio-pregnane 86  
Periodic acid (0.008 g, 0.03 mM) was added to a stirring 
solution of 20(S)-methyl-6(R)-methoxy-3,5-cyclo-21-
morpholio-pregnane 86  (0.010 g, 0.02 mM) in diethyl ether 
(10 mL). The resulting solution was stirred for 3 h at 25 °C 
and monitored by TLC analysis. Upon consumption of the 
starting material, the solution was cooled to room 
temperature and water (10 mL) was added. The organic 
layer was separated and washed with water (2 × 20 mL) and brine (1 × 20 mL). The organic 
component was dried over magnesium sulfate and concentrated under reduced pressure to 
yield the crude product (0.007 g). The 
1
H NMR spectrum of the crude material showed no 
evidence of formation of the desired product 94. The aqueous layer from the work up was 
extracted into ethyl acetate and concentrated under reduced pressure. Again the 
1
H NMR 
spectrum of the crude material showed no evidence of formation of the desired product.  
 
20(S)-Methyl-6(R)-methoxy-3,5-cyclo-21-piperidino-pregnane 87 
Sodium triacetoxyborohydride (0.074 g, 0.35 mM) was added to 
a solution of 20(S)-methyl-6(R)-methoxy-3,5-cyclo-pregnane-21-
al 85 (0.086 g, 0.25 mM) and piperidine (25 L, 0.25 mM) in 
1,2-dichloroethane (20 mL).  The reaction mixture was stirred at 
room temperature for 1.5 h, after which time saturated aqueous 
sodium bicarbonate solution (20 mL) was added. The reaction 
mixture was extracted into ethyl acetate (20 mL) and washed 
with brine (2 × 20 mL). The organic extracts were then dried over magnesium sulfate and 
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concentrated under reduced pressure to yield the crude product as a dark orange solid with 
50% conversion. The product was purified by column chromatography using 85:15 ethyl 
acetate : ether to yield the desired product 87 as an orange solid (0.019 g, 13%): mp 167 – 
168 °C; νmax(KBr)/cm
−1
 2932; H (300 MHz, CDCl3) 0.43 (1H, dd, J 8.0, 5.1, 3-CH), 0.61 – 
0.67 (1H, m), 0.70 – 2.06 [39H, m, containing 0.73 (3H, s, 18-CH3), 1.00 (3H, d, J 6.3, 21-
CH3), 1.02 (19-CH3), 2.01 (2H, dt, J 7.1, 3.0, 22-CH2 1 hydrogen of 22-CH2); piperidine 
(CH2 × 3)], 2.09 – 2.28 (3H, m, containing 2 hydrogens of N-CH2 and 1 hydrogen of 22-
CH2), 2.30 – 2.53 (2H, m, 2 hydrogens of N-CH2), 2.77 (1H, t, J 2.70, 6-CH), 3.33 (3H, s, 
OMe, CH3); δC (75 MHz, CDCl3) 12.4 (CH3), 13.1 (CH2), 18.1 (CH3), 19.3 (CH3), 21.5 (CH), 
22.8 (CH2), 24.4 (CH2), 25.0 (CH2), 28.3 (CH2), 30.5 (CH), 33.4 (CH2), 35.1 (CH2), 40.2 
(CH2), 48.0 (CH), 56.3 (CH), 56.6 (OMe, CH3), 82.4 (CH); exact mass calculated for 
C28H48NO [M + H]
+
 414.3736, found 414.3729. 
 
20(S)-Methyl-6(R)-methoxy-3,5-cyclo-21-thiomorpholino-pregnane 88 
Sodium triacetoxyborohydride (0.086 g, 0.41 mM) was added to 
a solution of 20(S)-methyl-6(R)-methoxy-3,5-cyclo-pregnane-21-
al 85 (0.100 g, 0.29 mM) and thiomorpholine (30 L, 0.29 mM) 
in 1,2-dichloroethane (50 mL).  The reaction mixture was stirred 
at room temperature for 1.5 h, after which time saturated aqueous 
sodium bicarbonate solution (50 mL) was added. The reaction 
mixture was extracted into ethyl acetate (50 mL) and washed 
with brine (2 × 50 mL). The organic extracts were then dried over magnesium sulfate and 
concentrated under reduced pressure to yield the crude product as an off white solid with 80% 
conversion. Purification required repeated column chromatography using 85:15 ethyl acetate : 
ether, yielding the desired product 88 as a yellow solid (0.051 g, 29%) mp 158 – 160 °C; 
νmax(KBr)/cm
−1
 2926; H (300 MHz, CDCl3) 0.43 (1H, dd, J 8.0, 5.0, 3-CH), 0.64 – 0.70 (1H, 
m), 0.71 – 1.95 [29H, m, containing 0.73 (3H, s, 18-CH3), 0.97 (3H, d, J 6.4, 21-CH3), 1.02 
(3H, s, 19-CH3)], 2.01 (1H, dt, J 11.8, 2.8, 1 hydrogen of 22-CH2), 2.31 (1H, dd, J 12.4, 3.2, 1 
hydrogen of 22-CH2), 2.40 – 2.72 (9H, m, containing 6-CH and thiomorpholine CH2 × 4), 
3.33 (3H, s, OMe, CH3); δC (75 MHz, CDCl3) 12.4 (CH3), 18.0 (CH3), 19.3 (CH3), 21.5 (CH), 
22.7 (CH2), 24.4 (CH2), 25.0 (CH2), 28.1 (CH2), 28.3 (CH2), 29.7 (CH2), 30.5 (CH), 34.2 
(CH), 35.1 (CH2), 40.2 (CH2), 43.1 (quaternary C), 43.4 (quaternary C), 48.0 (CH), 55.4 
Chapter 3: Experimental 
302 
 
(CH), 55.7 (CH2), 56.3 (CH), 56.6 (OMe, CH3), 65.4 (CH2), 82.3 (CH); m/z (ESI
+
) 432 [M + 
H]
+
 (87%) 400 (100); exact mass calculated for C27H46NOS [M + H]
+




Sodium triacetoxyborohydride (0.047 g, 0.22 mM) was 
added to a solution of 20(S)-methyl-6(R)-methoxy-3,5-
cyclo-pregnane-21-al 85 (0.055 g, 0.16 mM) and 1-(2-
hydroxyethyl piperazine) (0.020 g, 18 L, 0.16 mM) in 1,2-
dichloroethane (30 mL). The reagent was weighed in the 
following manner: a drop of 1-(2-hydroxyethyl)piperazine 
was placed in a vial and its mass was recorded as 0.100 g. 
10 mL of the reaction solvent was added and the amine was 
allowed to go into solution. 2 mL of this resulting solution 
was measured by syringe and transferred into the reaction vessel. The reaction mixture was 
stirred at room temperature for 24 h, and monitored by TLC analysis. After this time, 
saturated aqueous sodium bicarbonate solution (30 mL) was added. The reaction mixture was 
extracted into ethyl acetate (30 mL) and washed with brine (2 × 30 mL). The organic extracts 
were then dried over magnesium sulfate and concentrated under reduced pressure to yield the 
desired product 89 as an off white solid with ≥ 95% conversion (0.023 g, 31% isolated yield) 
mp 166 – 169 °C; νmax(KBr)/cm
−1
 2930, 1099; H (300 MHz, CDCl3) 0.43 (1H, dd, J 8.0, 5.1, 
3-CH), 0.64 – 0.70 (1H, m), 0.73 (3H, s, 18-CH3), 0.77 – 2.08 [27H, m, containing 0.99 (3H, 
d, J 6.4, 21-CH3), 1.02 (3H, s, 19-CH3) and one hydrogen of 22-CH2], 2.10 – 2.40 (5H, m, 
containing N-CH2 × 2 and one hydrogen of 22-CH2), 2.45 – 2.70 (6H, m containing N-CH2 × 
3), 2.77 (1H, t, J 2.7, 6-CH), 3.33 (3H, s, OMe, CH3), 3.61 (2H, t, J 5.3, CH2-OH); δC (75 
MHz, CDCl3) 12.4 (CH3), 13.1 (CH2), 18.0 (CH3), 19.3 (CH3), 21.5 (CH), 22.8 (CH2), 24.4 
(CH2), 25.0 (CH2), 28.3 (CH2), 29.7 (CH2), 30.5 (CH), 33.4 (CH2), 34.1 (CH), 35.1 (CH2), 
40.2 (CH2), 43.1 (quaternary C), 43.4 (quaternary C), 48.1 (CH), 53.0 (CH2), 55.5 (CH), 56.3 
(CH), 56.6 (CH3), 57.6 (CH2), 59.2 (CH2), 64.7 (CH2), 82.4 (CH); m/z (ESI
+
) 459 [M + H]
+
 
(100%); exact mass calculated for C29H51N2O2 [M + H]
+
 459.3951, found 459.3938.  
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Attempted Synthesis of 20(S)-Methyl-6(R)-methoxy-3,5-cyclo-21-diethylamino-pregnane 
90 
Sodium triacetoxyborohydride (0.051 g, 0.24 mM) was added to 
a solution of 20(S)-methyl-6(R)-methoxy-3,5-cyclo-pregnane-
21-al 85 (0.060 g, 0.17 mM) and diethylamine (18 L, 0.17 mM) 
in 1,2-dichloroethane (30 mL). The reaction mixture was stirred 
at room temperature for 1.5 h. After this time, saturated aqueous 
sodium bicarbonate solution (30 mL) was added. The reaction 
mixture was extracted into ethyl acetate (30 mL) and washed 
with brine (2 × 30 mL). The organic extracts were then dried over magnesium sulfate and 
concentrated under reduced pressure to yield the crude product. Analysis of the 
1
H NMR 
spectrum of the crude material showed only starting aldehyde 85 was present, with no 
evidence of formation of the desired product 90. 
The reaction was repeated using the crude material from the first attempt. Identical reaction 
conditions were employed, with the reaction time being increased to 24 h. Again, there was 
no evidence of formation of the desired product by analysis of the 
1
H NMR spectrum of the 




Sodium triacetoxyborohydride (0.047 g, 0.22 mM) was 
added to a solution of 3-hydroxy-20(S)-methyl-
pregnan-5-ene-21-al 75  (0.052 g, 0.16 mM) and 1-(2-
hydroxyethyl piperazine) (0.020 g, 19 L, 0.16 mM) in 
1,2-dichloroethane (30 mL). The reagent was weighed 
in the following manner: a drop of 1-(2-
hydroxyethyl)piperazine was placed in a vial and its 
mass was recorded as 0.100 g. 10 mL of the reaction 
solvent was added and the amine was allowed to go into solution. 2 mL of this resulting 
solution was measured by syringe and transferred into the reaction vessel. The reaction 
mixture was stirred at room temperature for 24 h, and monitored by TLC analysis. After this 
time, saturated aqueous sodium bicarbonate solution (30 mL) was added. The reaction 
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mixture was extracted into ethyl acetate (30 mL) and washed with brine (2 × 30 mL). The 
organic extracts were then dried over magnesium sulfate and concentrated under reduced 
pressure to yield the desired product 91 as a light yellow solid with ≥ 95% conversion (0.019 
g, 24% isolated yield): mp 162 – 166 °C; νmax(KBr)/cm
−1
 3432, 2962, 1261; H (300 MHz, 
CDCl3) 0.60 – 2.40 [38H, m, containing (0.70, 3H, s, 18-CH3), 1.01 (3H, s, 19-CH3), 21-
CH3], 2.45 – 2.73 (6H, m, containing piperazine N-CH2 × 3), 3.46 – 3.59 (1H, m, 3-CH), 3.63 
(1H, t, J 5.2, CH2-OH), 5.35 (1H, apparent d, J 5.2, 6-CH); δC (75 MHz, CDCl3) 11.9 (CH3), 
18.0 (CH3), 19.4 (CH3), 21.0 (CH2), 24.4 (CH2), 28.2 (CH2), 29.7 (CH2), 31.6 (CH2), 31.9 
(CH), 32.0 (CH2), 34.1 (CH), 37.2 (CH2), 39.7 (CH2), 42.3 (CH2), 42.3 (quaternary C), 42.7 
(quaternary C), 50.1 (CH), 52.9 (CH2), 55.2 (CH), 56.5 (CH), 57.5 (CH2), 59.3 (CH2), 64.6 
(CH2), 71.8 (CH), 121.6 (CH), 140.8 (quaternary C); m/z (ESI
+
) 445 [M + H]
+
 (98%), 490 
(100); exact mass calculated for C28H49N2O2 [M + H]
+
 445.3794, found 445.3801.  
 
Attempted synthesis of 3-Hydroxy-20(S)-methyl-21-(4-hydroxymethylpiperidino)-
pregnan-5-ene 92  
Sodium triacetoxyborohydride (0.039 g, 0.18 mM) was 
added to a solution of 3-hydroxy-20(S)-methyl-
pregnan-5-ene-21-al 75  (0.045 g, 0.13 mM) and 4-
piperidine methanol (0.015 g, 0.13 mM) in 1,2-
dichloroethane (20 mL). The reaction mixture was 
stirred at room temperature for 1.5 h. After this time, 
saturated aqueous sodium bicarbonate solution (20 mL) 
was added. The reaction mixture was extracted into ethyl acetate (20 mL) and washed with 
brine (2 × 20 mL). The organic extracts were then dried over magnesium sulfate and 
concentrated under reduced pressure to yield the crude product. Analysis of the 
1
H NMR 
spectrum of the crude material showed ~40% starting aldehyde remained, with new multiplets 
at 2.75 – 2.85 and 2.86 – 3.00 ppm integrating for ~30% each.  
The reaction was repeated using the crude product from the previous attempt. Reaction 
conditions were identical. In this case, 20% aldehyde remained, with the new multiplets 
increasing to ~60% each.  
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The reaction was repeated using the crude product from the previous attempt. Reaction 
conditions were identical. In this case, 5% aldehyde remained, with the new multiplets 
increasing by 5% to ~65% each.  
The reaction was not pursued further. 
 
Attempted synthesis of 3-hydroxy-20(S)-methyl-21-(4-hydroxyethylpiperidino)-
pregnan-5-ene  93 
Sodium triacetoxyborohydride (0.017 g, 0.08 mM) was 
added to a solution of 3-hydroxy-20(S)-methyl-
pregnan-5-ene-21-al 75 (0.020 g, 0.06 mM) and 4-
piperidine ethanol (0.008 g, 0.06 mM) in 1,2-
dichloroethane (10 mL). The reaction mixture was 
stirred at room temperature for 1.5 h. After this time, 
saturated aqueous sodium bicarbonate solution (10 mL) 
was added. The reaction mixture was extracted into ethyl 
acetate (10 mL) and washed with brine (2 × 10 mL). The organic extracts were then dried 
over magnesium sulfate and concentrated under reduced pressure to yield the crude product 
(0.011 g). Analysis of the 
1
H NMR spectrum of the crude material showed ~70% starting 
aldehyde remained, with no evidence of formation of the desired product 93. The reaction 
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°C: degrees Celsius  




br, s: broad singlet 
CaCo-2: human colon cancer cell line 
CDCl3: deuterated chloroform 
Cr
III
: Chromium in the +3 oxidation state 
Cr
VI




dd: doublet of doublets 
DDQ: 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone 
DEPT: Distortionless Enhancement by Polarisation Transfer 
DMAP: 4-dimethylaminopyridine 
DMF: N,N-Dimethylformamide 
DNA: deoxyribonucleic acid 
E. coli: Escherichia coli 
ECIS50: half inhibitory concentration measured using Electric Cell Impedance Sensing 
ED50: effective dose for 50% of a population base 
eq: equivalent 
ESI: electrospray ionisation 
FDA/EtBr: Fluorescein Diacetate/Ethidium Bromide (A biological assay) 
g: gram 
h: hour 
HRMS: High Resolution Mass Spectrometry 
Hz: Hertz 
IC50: half maximal inhibitory concentration 
IR: infrared 
LDL: low density lipoprotien 











mp: melting point 
MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (A biological assay) 
NAD
+
: nicotinamide adenine dinucleotide 
NADH: the reduced form of nicotinamide adenine dinucleotide 
NADP
+
: nicotinamide adenine dinucleotide phosphate 
NADPH: the reduced form of nicotinamide adenine dinucleotide phosphate 
nM: nanomolar 
NMO: N-methylmorpholine N-oxide 
NMR: Nuclear Magnetic Resonance 
p: para 
Pd/C: palladium on carbon 
ppm: parts per million 
psi: pound per square inch  
r.t: room temperature 
Rf: retardation factor 
s: singlet 
Sf9: Spodoptera frugiperda insect cells 
SM: Starting Material 
t: triplet 
THF: tetrahydrofuran 
TLC: Thin Layer Chromatography 
TMS: tetramethylsilane 
Ts: tosyl 
U937: human lymphoma cell line 







: Position of the alkene bond at integer n 
g: microgram 
L: microlitre 
M: micromolar 
 
 
 
 
 
 
